




Quantitative Analysis of Proteome Dynamics 
in Chinese Hamster Ovary Cells 
 
Beata D Florczak 
 
 
In partnership with: 






A thesis submitted in partial fulfilment of the requirements for the 
degree of 




The Department of Chemical & Biological Engineering 










I, Beata Dorota Florczak, declare that the work presented in this thesis is to the best of my 
knowledge and belief original, except as acknowledged in the text. I confirm that this work 























Table of Contents 
 
Acknowledgements ........................................................................................................................... x 
List of Figures ....................................................................................................................................xi 
List of Tables ................................................................................................................................... xvi 
Abbreviations ................................................................................................................................ xviii 
Thesis Abstract ................................................................................................................................. xx 
Chapter 1: Introduction ................................................................................................................... 21 
1.1 Chinese hamster ovary (CHO) cells and recombinant protein production ............................... 21 
1.1.1 Biopharmaceuticals and biosimilars ................................................................................ 21 
1.1.2 Mammalian cell factories ................................................................................................ 21 
1.1.3 Strategies for cell line development ................................................................................ 22 
1.1.4 Strategies for clonal selection.......................................................................................... 22 
1.1.5 Origins of Chinese hamster ovary (CHO) cell lines ............................................................ 23 
1.1.6 Structure and function of monoclonal antibodies ............................................................ 24 
1.2 Basics of Animal Cell Culture and Metabolism ........................................................................ 25 
1.2.1 Cell growth...................................................................................................................... 25 
1.2.2 Phases of cell growth ...................................................................................................... 25 
1.2.3 Types of cell culture processes ........................................................................................ 27 
1.2.4 Subculture of mammalian cells........................................................................................ 28 
1.2.5 Outline of cell culture metabolism................................................................................... 28 
1.2.6 Metabolism and transport of amino acids ....................................................................... 29 
1.2.7 Development of culture media ........................................................................................ 30 
1.3 Review of engineering strategies for CHO cells ....................................................................... 32 
1.3.1 Traditional engineering approaches ................................................................................ 32 
1.3.2 RNA-based engineering approaches ................................................................................ 33 
1.3.3 Heading towards ‘omic’ based engineering approaches .................................................. 34 
iv 
 
1.3.3.1 Genomic analysis of CHO cells ...................................................................................... 34 
1.3.3.2 Transcriptomic analysis of CHO cells ............................................................................. 35 
1.3.3.3 Outline of proteomic research for CHO cells ................................................................. 35 
1.3.3.4 Integration of ‘multi-omic’ approaches to engineer better host cells ............................ 36 
1.4 Mass spectrometry-based proteomics ................................................................................... 37 
1.4.1 Definition of proteomics ................................................................................................. 37 
1.4.2 Gel-based proteomics ..................................................................................................... 38 
1.4.2 Sample preparation for mass spectrometry analysis ........................................................ 38 
1.4.3 Peptide fractionation by liquid chromatography.............................................................. 39 
1.4.4 Principles of mass spectrometry ...................................................................................... 40 
1.4.4 Types of mass analysers .................................................................................................. 41 
1.4.5 Tandem MS and peptide identification ............................................................................ 43 
1.5 Quantitative proteomics approaches ..................................................................................... 44 
1.5.1 Classification of quantitative proteomics approaches ...................................................... 44 
1.5.2 Label-free quantification ................................................................................................. 45 
1.5.3. Absolute and label-free quantification approaches based on spectral counting .............. 45 
1.5.4. Absolute and label-free quantification approaches based on spectral intensity .............. 46 
1.5.5 Absolute quantification using stable isotopically labelled standards ................................ 48 
1.5.6 In vitro chemical labelling with stable isotopes ................................................................ 49 
1.5.7 In vivo metabolic labelling with stable isotopes ............................................................... 50 
1.5.8 Challenges in analysis of quantitative proteomics data .................................................... 51 
1.5.9 Difference between protein “abundance” and protein “regulation” ................................ 52 
1.6 Principles of SILAC, Stable Isotope labelling of amino acids in cell culture ............................... 53 
1.6.1 Definition of SILAC .......................................................................................................... 53 
1.6.2 Stable isotope incorporation and issues with arginine to proline conversion ................... 54 
1.6.3 Normalisation and transformation of SILAC data ............................................................. 56 
1.6.4 Analysis of SILAC data using biological significance .......................................................... 56 
1.6.4 Analysis of SILAC data using statistical significance .......................................................... 57 
v 
 
1.7 Temporal quantitative proteomics – studying protein turnover ............................................. 60 
1.7.1 Definition of protein turnover ......................................................................................... 60 
1.7.2 Protein synthesis ............................................................................................................. 61 
1.7.3 Protein degradation ........................................................................................................ 61 
1.6.4 Defining steady state systems ......................................................................................... 62 
1.6.5 Methods to study protein turnover ................................................................................. 63 
1.6.6 Pulse SILAC strategies to study protein turnover ............................................................. 64 
1.6.7 Analysis of protein turnover data .................................................................................... 65 
1.7 Aims and objectives ............................................................................................................... 66 
1.8 Outline................................................................................................................................... 67 
Chapter 2: Materials & Methods ..................................................................................................... 69 
2.1 Abstract ................................................................................................................................. 69 
2.2 Mammalian cell culture ......................................................................................................... 70 
2.2.1 Characteristics of CHO cell lines ...................................................................................... 70 
2.2.2 Routine subculture .......................................................................................................... 70 
2.2.3 Cell cryopreservation protocol ........................................................................................ 71 
2.2.4 Cell revival protocol ........................................................................................................ 72 
2.2.5 Calculation of cell culture parameters ............................................................................. 72 
2.2.6 Measurement of specific monoclonal antibody productivity ........................................... 73 
2.3 Optimization of sample preparation for mass spectrometry ................................................... 74 
2.3.1 Lysis buffer for in-gel trypsin digestion ............................................................................ 74 
2.3.2 Estimation of protein concentration ................................................................................ 76 
2.3.3 SDS-PAGE analysis ........................................................................................................... 76 
2.3.4 Selection of conditions for in-gel trypsin digest ............................................................... 77 
2.3.5 Optimisation of in-solution trypsin digest conditions ....................................................... 77 
2.3.6 Optimisation of FASP buffer conditions ........................................................................... 78 
2.3.7 Improvement of the original FASP protocol ..................................................................... 78 
2.3.8 Verification of trypsin digestion ....................................................................................... 79 
vi 
 
2.3.9 Peptide fractionation by liquid chromatography using Hypercarb.................................... 79 
2.3.10 Protein extraction from spent media ............................................................................. 80 
2.3.11 Data acquisition using Amazon ETD, ion trap mass spectrometer .................................. 81 
2.3.11 Raw data analysis using Data Analysis and Mascot Daemon .......................................... 81 
2.4 Standard SILAC experimental design and data analysis ........................................................... 82 
2.4.1 SILAC adaptation phase ................................................................................................... 82 
2.4.2 Calculation of % incorporation of lysine and arginine ...................................................... 83 
2.4.3 Calculation of arginine-to-proline conversion .................................................................. 83 
2.4.4 SILAC experiment phase .................................................................................................. 84 
2.4.5 Cell lysis and in-gel trypsin digestion ............................................................................... 84 
2.4.6 Data acquisition using MaXis 4G UHR-TOF mass spectrometer ........................................ 84 
2.4.7 Data analysis using Mascot Distiller search engine .......................................................... 85 
2.4.8 Data acquisition using Q-Exactive HF orbitrap mass spectrometer ................................... 85 
2.4.9 Raw data analysis using MaxQuant ................................................................................. 86 
2.4.10 Downstream processing using Perseus & public databases ............................................ 87 
2.4.11 Bioinformatics analysis of differentially expressed proteins ........................................... 88 
2.5 Enhanced pulse SILAC and TPA - experimental design and data analysis ................................. 88 
2.5.1 Pilot study with the media exchange ............................................................................... 89 
2.5.2 Enhanced pulse SILAC adaptation phase.......................................................................... 89 
2.5.3 Enhanced pulse SILAC experiment phase ......................................................................... 90 
2.5.4 Filter-aided sample preparation (FASP), data acquisition and analysis ............................. 90 
2.5.5 Estimation of protein copy number using total protein amount (TPA) method ................ 91 
2.5.6 Data extraction for the calculation of the protein turnover and half-lives ........................ 91 
2.5.7 Determination of protein half-life and turnover .............................................................. 92 
2.5.8 Curation of enhanced pulse SILAC data ........................................................................... 93 
2.5.9 Implementation of Levenberg-Marquardt algorithm ....................................................... 93 
2.5.10 Total biomass and rate of protein turnover calculation ................................................. 94 
2.5.11 Bioinformatic analysis of protein turnover data ............................................................. 94 
vii 
 
2.5.12 Calculation of amino acid usage in CHO cells ................................................................. 95 
2.5.13 Calculation of codon usage in CHO cells ........................................................................ 95 
Chapter 3: Optimisation of sample preparation for mass spectrometry to achieve high-coverage CHO 
proteome ........................................................................................................................................ 96 
3.1 Abstract ................................................................................................................................. 96 
3.2 Introduction ........................................................................................................................... 96 
3.2 Aims and objectives ............................................................................................................. 100 
3.3 Results and discussion ......................................................................................................... 100 
3.3.1. Cell line characterisation .............................................................................................. 100 
3.3.1.1 Growth profile of GS-KO parental and E22 producing cell lines in chemically defined 
medium (CD-CHO) ................................................................................................................. 100 
3.3.1.2 Calculation of secretion rate of monoclonal antibody in E22 producing cell line ......... 101 
3.3.2 Comparison of lysis buffers for in-gel trypsin digest ....................................................... 102 
3.3.3 Comparison of lysis buffers for in-solution trypsin digest ............................................... 105 
3.3.4 Compatibility of protein concentration assay ................................................................ 108 
3.3.5 Comparison of the number of protein identifications between in-gel trypsin digest 
protocols ............................................................................................................................... 109 
3.3.6 Protein extraction from spent media ............................................................................. 111 
3.3.7 Comparison of the number of protein identification between in-solution trypsin digest and 
filter-aided sample preparation (FASP) .................................................................................. 114 
3.3.8 Development of peptide fractionation method using Hypercarb column ....................... 115 
3.4 Conclusions.......................................................................................................................... 119 
Chapter 4: Relative quantitation of proteome changes between exponential and stationary phase in 
CHO cells using SILAC .................................................................................................................... 122 
4.1 Abstract ............................................................................................................................... 122 
4.2 Introduction ......................................................................................................................... 123 
4.2 Aims and objectives ............................................................................................................. 125 
4.3 Results and discussion ......................................................................................................... 125 
4.3.1 Forward and reverse SILAC experiment in GS-KO cell lines ............................................ 126 
viii 
 
4.3.1.1 Growth profile of GS-KO and E22 producing cell lines in custom SILAC medium .......... 126 
4.3.1.2 % incorporation of arginine and lysine into proteins ................................................... 128 
4.3.1.3 Arginine to proline conversion ................................................................................... 129 
4.3.1.4 SILAC experiment phase and sample preparation for mass spectrometry ................... 132 
4.3.1.5 Data distribution and quality between replicates ....................................................... 132 
4.3.1.6 Reproducibility of forward and reverse SILAC experiments ......................................... 136 
4.3.1.7 Determination of differential protein expression ........................................................ 138 
4.3.1.8 Significance B and fold-change methods of choice for SILAC data analysis .................. 142 
4.3.2 Comparison of SILAC experiments in GS-KO parental and E22 producing cell lines ........ 143 
4.3.2.1 Overlap between the two separate SILAC labelling experiments ................................. 143 
4.3.3 Bioinformatic analysis of differentially expressed proteins ............................................ 147 
4.3.3.1 Gene Ontology functional classification ...................................................................... 147 
4.3.3.2 Pathway analysis of differentially expressed proteins using KEGG .............................. 149 
4.3.3.4 Analysis of differentially expressed enzymes using ExplorEnz database ...................... 152 
4.4 Conclusions.......................................................................................................................... 153 
Chapter 5: Defining the protein biomass objective in CHO cells using enhanced pulse SILAC and total 
protein approach (TPA) ................................................................................................................. 157 
5.1 Abstract ............................................................................................................................... 157 
5.2 Introduction ......................................................................................................................... 158 
5.2 Aims and objectives ............................................................................................................. 161 
5.3 Results and discussion ......................................................................................................... 161 
5.3.1 Enhanced pulse SILAC and TPA method development ................................................... 163 
5.3.1.1 Spent media experiment – pilot study ........................................................................ 163 
5.3.1.2 Growth of GS-KO parental and E22 producing cell line in SILAC medium supplemented 
with light, medium or heavy isotopes .................................................................................... 164 
5.3.1.3 Data distribution after raw data analysis .................................................................... 165 
5.3.1.4 Recycling of medium isotope of lysine and arginine .................................................... 166 
5.3.1.5 Estimation of total cellular protein concertation......................................................... 170 
ix 
 
5.3.1.6 Estimation of global protein abundance by TPA method............................................. 172 
5.3.1.7 Calculation of protein turnover using flexible model coefficients ................................ 174 
5.3.1.8 Estimation of protein turnover using fixed model coefficients .................................... 176 
5.3.1.9 Estimation of rate of protein turnover ........................................................................ 180 
5.3.1.10 Calculation of total protein mass .............................................................................. 181 
5.3.1.11 Protein turnover and abundance of recombinant antibody ...................................... 182 
5.3.2 Bioinformatic analysis of protein turnover and abundance data .................................... 183 
5.3.2.1 Visual representation of abundance of CHO cell proteins with Proteomaps ................ 183 
5.3.2.2 Defining protein biomass objective ............................................................................ 185 
5.3.2.3 Combining data sets of GS-KO parental and E22 producing cell lines .......................... 186 
5.3.2.4 Functional analysis of up-regulated proteins using Gene Ontology classification ........ 187 
5.3.2.5 Pathway analysis of up-regulated proteins using KEGG database ................................ 189 
5.3.2.6 Dynamic usage of amino acids .................................................................................... 193 
5.3.2.7 Dynamic usage of codons and estimation of codon usage bias ................................... 194 
5.4 Conclusions.......................................................................................................................... 197 
Chapter 6: Conclusions and future work ........................................................................................ 201 
6.1 Conclusions.......................................................................................................................... 201 
6.2 Future work ......................................................................................................................... 204 
References .................................................................................................................................... 207 
Appendix A: Suppliers of reagents and equipment ......................................................................... 228 
Appendix B: Differentially expressed proteins for E22 producing cell line classified in the main GO 
classes. .......................................................................................................................................... 231 
Appendix C: Differentially expressed proteins for GS parental cell line classified in the main GO 
classes. .......................................................................................................................................... 236 
Appendix D: Matlab scripts for analysis of enhanced pulse SILAC data ........................................... 248 
Appendix E: Matlab scripts for calculating amino acid and codon usage ........................................ 269 
Appendix F: attached CD with presented proteomic data .............................................................. 280 




First, I would like to thank Prof David James and Prof Mark Dickman for the opportunity to 
work on this project and learn about challenges in studying quantitative proteomics and 
production of biopharmaceuticals in CHO cells.  
I would also like to thank Lonza Biologics Ltd for providing me with financial support and 
expertise. Special thanks to Dr Robert Young for guidance and supervision from the beginning 
of this project. Lastly, I would like to thank Dr Olga Obrezanova on help with struggles of a 
typical biologist, namely statistics and programming. I am also grateful for EPSRC for funding 
of this project. 
Special thanks for Dr Joseph Longworth for helping me to set up my very first SILAC 
experiments and for helping with data analysis and programming. I would also like to thank 
Dr Phil Jackson, Dr Narciso Couto and Dr Trong Khoa Pham for providing me advice and 
support in sample processing and helping to solve other mass spectrometry issues. I would 
also like to thank Ilyana Kaneva for providing me topics for the discussion of SILAC data 
analysis. I would also like to thank technical staff for making our laboratories functional. 
Special thanks to James Grinham, Dave Wengraf and Katarzyna Okurowska.  
I would also like to thank all other post-docs and PhD students in both David’s and Mark’s 
group through the years. I really appreciate the help, insights, tips and criticism, however 
small they were Special thanks to Claire Bryant, Devika Kalsi, Tom Minshull, Joby Cole and An-
Wen Kung for sharing and overcoming many struggles together.  
I would also like to thank fellow students that I havemet during my journey, especially Ben, 
David, Vi, Andrew, Alison, Karen, Ana, Tom, Silvia, Gloria and Stephen for all the support, 
encouragement and patience with me.  
Lastly, I would like to thank my family: my mum, for always encouraging me to go higher, my 
dad and brothers Damian, Tomasz and Zbigniew for helping me to ‘take it easy’ and to my 
sister Iwona for always believing in me. Without your encouragement and support I would 




List of Figures 
Figure 1.1 Overview of clonal selection strategies. ........................................................................... 23 
Figure 1.2 The family tree of most commonly used Chinese Hamster ovary (CHO) cell lines. ............ 24 
Figure 1.3 Schematic structure of immunoglobulin (IgG) monoclonal antibody. ............................... 25 
Figure 1.4 Typical Growth Curve for a Mammalian Cell.. .................................................................. 26 
Figure 1.5 The schematic representation of typical metabolism of mammalian cells.. ...................... 29 
Figure 1.6  Overview of genetic engineering strategies in CHO cells. ................................................ 33 
Figure 1.7 The “central dogma of biology” is displayed together with the associated ‘omic’ studies 
and various research strategies. ...................................................................................................... 34 
Figure 1.8 The possible roles of ‘omic’ tools in bioprocess development.. ........................................ 37 
Figure 1.9 The overview of sample preparation methods for mass spectrometry. ............................ 39 
Figure 1.10 The workflow of a typical mass spectrometry-based proteomic experiment. ................. 40 
Figure 1.11 The components of mass spectrometer. ........................................................................ 41 
Figure 1.12 The diagram of quadrupole mass analyser. .................................................................... 42 
Figure 1.13 The schematic of hybrid Q-Exactive HF mass spectrometer ........................................... 43 
Figure 1.14 The schematic representation of peptide fragmentation during MS/MS ........................ 44 
Figure 1.15 Outline of quantitative proteomics approaches.. ........................................................... 45 
Figure 1.16 Explanation of total protein amount (TPA) and ‘proteomic ruler’ methodology. ............ 47 
Figure 1.17 Comparison of in vivo and in vitro stable isotope labelling approaches.. ........................ 50 
Figure 1.18 Common sources of errors in quantitative proteomics workflows... .............................. 51 
Figure 1.19 Examples of light, medium and heavy amino acids for SILAC.. ....................................... 54 
Figure 1.20 Metabolic conversion of arginine to proline in SILAC experiments.. ............................... 55 
Figure 1.21  Visualization of SILAC data. ........................................................................................... 59 
Figure 1.22 Theoretical model of protein turnover.. ........................................................................ 60 
Figure 1.23 Schematic of experimental designs using pulse SILAC to measure protein turnover. ...... 65 
Figure 1.24 Mathematical methods used to fit pulse SILAC data to the line.. ................................... 66 
Figure 3.25 The growth profiles of CHOKSV GS K-O parental  and E22 stably producing cell lines in 
chemically-defined medium (CD-CHO), .......................................................................................... 101 
Figure 3.26 The HPLC gradient used to elute IgG1 kappa standard and CB72.3 mAb. ..................... 102 
Figure 3.27 Testing of RIPA buffer lysis efficiency.. ......................................................................... 103 
Figure 3.28 Optimisation of lysis buffers for in-gel trypsin digestion.. ............................................ 104 
Figure 3.29 Testing the performance of 4xLB lysis buffer and comparison with protein extraction 
using the standard RIPA buffer. ..................................................................................................... 105 
xii 
 
Figure 3.30 In-solution trypsin digest in 0.5M TEAB buffer.. ........................................................... 106 
Figure 3.31 Lysis buffer for filter-aided sample preparation (FASP) method. .................................. 106 
Figure 3.32 Steps of filter aided sample preparation (FASP) method visualised on SDS-PAGE gel. .. 108 
Figure 3.33 Standard curves of the protein standard, bovine serum albumin (BSA), dissolved in RIPA 
buffer 4xLB buffer or DIGE buffer .................................................................................................. 109 
Figure 3.34 Standard curves of protein standard, bovine serum albumin, in TEAB buffer. .............. 109 
Figure 3.35 Venn diagram showing the overlap of validated protein identifications between the three 
buffer conditions: mild denaturing (RIPA) and strong denaturing (4xLB or urea) ............................ 110 
Figure 3.36 SDS-PAGE gel shows the results of protein analysis in unconcentrated spent media 
before and after precipitation ....................................................................................................... 112 
Figure 3.37 Venn diagram showing the overlap between the number of identified intracellular and 
extracellular proteins..................................................................................................................... 113 
Figure 3.38 Total ion chromatograms (TIC) for in-solution derived TEAB samples and FASP method 
derived peptides ........................................................................................................................... 114 
Figure 3.39 The number of protein matches against CHO database from in-solution trypsin digest 
using TEAB buffer or FASP method. ............................................................................................... 115 
Figure 3.40 Distribution of the number of protein matches against CHO database (Mascot Daemon) 
per peptide fraction eluted from the Hypercarb ............................................................................ 116 
Figure 3.41 Total ion chromatograms (TIC) for selected peptide fractions eluted from Hypercarb 
column.. ........................................................................................................................................ 117 
Figure 3.42 Comparison of number of protein hits and unique proteins obtained by the complete 
analysis of FASP/Hypercarb method using trypsin and trypsin/Lys-C digest conditions .................. 118 
Figure 3.43 Comparison of the number of unique protein identifications after optimised in-gel 
trypsin digest and FASP protocols. ................................................................................................. 119 
Figure 4.44 The workflow of forward SILAC experiment. ................................................................ 126 
Figure 4.45 Growth profile of cells cultured in light SILAC medium, heavy SILAC medium and CD-CHO 
(control).. ...................................................................................................................................... 127 
Figure 4.46 Graph showing the % incorporation rate of heavy isotopes of lysine (Lys8) and arginine 
(Arg10) against the passage number for E22 and GS K-O cell lines. ................................................ 128 
Figure 4.47 The survey spectra of a representative heavy lysine labelled peptide .......................... 130 
Figure 4.48 The survey spectra of a representative heavy arginine labelled peptide,. .................... 131 
Figure 4.49 (A) Representative SDS-PAGE gel from SILAC experiment in E22 producing cell line.. ... 132 
Figure 4.50 Representative histograms of H/L ratios before and after median normalisation. ........ 133 
xiii 
 
Figure 4.51 Histograms of log2 transformed H/L (A) and L/H (B) median normalized ratios derived 
from forward SILAC experiment in E22 producing cell line.. ........................................................... 134 
Figure 4.52 Representative scatterplots of log2 H/L (A) and log2 L/H (B) ratios against log2 intensities 
in forward and reverse SILAC experiments..................................................................................... 135 
Figure 4.53 The scatterplots of log2 intensities and log2 ratios show high Pearson correlation (R) 
between forward and reverse SILAC labelling experiments in E22 producing cell line. ................... 136 
Figure 4.54 Scatterplots of log2 H/L ratios normalised and log2 L/H ratios normalised from forward 
SILAC (FS) and reverse SILAC (RS) experiments .............................................................................. 138 
Figure 4.55 Volcano plots are a function of t-test difference (equivalent to SILAC ratios) plotted 
against –log (negative log) t-test p-value. ...................................................................................... 139 
Figure 4.56 (A)The scatterplot of t-test significant proteins at p-value of 0.05 shows perfect linear 
relationship  .................................................................................................................................. 140 
Figure 4.57 The scatterplots of log2 H/L ratios normalised (forward SILAC) and log2 L/H ratios 
normalised (reverse SILAC). . ......................................................................................................... 140 
Figure 4.58 Volcano plots describe the function of fold-change (FC) cut-off plotted against –log 10 
(negative log) significance B for forward SILAC (FS) and for reverse SILAC (RS). .............................. 141 
Figure 4.59 Venn diagram depicting the overlap between differentially expressed proteins found 
using fold change (FC) cut-off of 2, significance A and B and t-test. ................................................ 141 
Figure 4.60 The scatterplots of log2 H/L ratios normalised (forward SILAC) and log2 L/H ratios 
normalised (reverse SILAC for E22 cell line..................................................................................... 142 
Figure 4.61 The scatterplots of log2 H/L ratios normalised (forward SILAC) and log2 L/H ratios 
normalised (reverse SILAC) for GS K-O cell line. ............................................................................. 143 
Figure 4.62 Venn diagram of the overlap of differentially expressed proteins for E22 producing and 
GS K-O parental cell line.. .............................................................................................................. 144 
Figure 4.63 The scatterplots of log2 ratio H/L (FS) and log2 L/H ratio (RS) for E22 and GS cell line 
plotted against each other. ............................................................................................................ 146 
Figure 4.64 The scatterplots of log2 intensities (summed peptide intensities) obtained in label-swap 
SILAC experiments for E22 and GS cell line plotted against each other.. ......................................... 146 
Figure 4.65 The combined bar chart shows differentially expressed proteins for E22 producing and 
GS K-O parental cell lines. .............................................................................................................. 148 
Figure 4.66 Enlarged fragments of the KEGG pathway map of the lysosome pathway highlighting the 
proteins that were up-regulated in the stationary phase. .............................................................. 150 
Figure 4.67 Enlarged fragments of KEGG pathway map of Aminoacyl-tRNA biosynthesis pathway  
highlighting the proteins up-regulated in the stationary phase ...................................................... 151 
xiv 
 
Figure 4.68 Enlarged fragments of KEGG pathway map of cell cycle  highlighting the proteins up-
regulated in the exponential phase................................................................................................ 151 
Figure 4.69 Enlarged fragments of KEGG pathway map of HIF-1 signalling pathway  highlighting 
protein up-regulated in stationary phase ....................................................................................... 152 
Figure 4.70 Comparison of the number of enzyme classes identified in E22 producing and GS K-O cell 
lines using The Enzyme Database, ExplorEnz.................................................................................. 153 
Figure 5.71 The workflow of enhanced pulse SILAC experiment to study protein turnover ............ 162 
Figure 5.72 Growth and % viability of stably producing E22 producing cell line growing in CD-CHO 
medium in 125 ml working volume. ............................................................................................... 163 
Figure 5.73 Growth profile of E22 producing and GS K-O parental cell lines during enhanced pulse 
SILAC experiment.. ........................................................................................................................ 165 
Figure 5.74 Overview of data sets obtained for GS K-O and E22 cell lines. ...................................... 166 
Figure 5.75 Correlation between the ratio H/L / ratio M/L values and derived H/M ratios for all 
peptide-to-spectrum matches (PSMs)  obtained for GS K-O and E22 producing cell line ................ 166 
Figure 5.76 Representative mass spectra of three doubly charged lysine labelled peptides ........... 168 
Figure 5.77 Representative mass spectra of three doubly charged arginine labelled peptides ........ 169 
Figure 5.78 Correlation of the estimated protein copy number per cell between two replicates for GS 
K-O and E22 producing cell line using Person correlation ............................................................... 172 
Figure 5.79 Global assessment of the number of protein copies per cell in ranking order .............. 173 
Figure 5.80 The overview of non-linear square fitting. ................................................................... 175 
Figure 5.81 Ranked protein turnover (h) for GS K-O parental and E22 producing cell line ............... 176 
Figure 5.82 The normalised M/L ratios fitted to the exponential decay model according to the 
original method. ............................................................................................................................ 177 
Figure 5.83 Examples of 4 different proteins proteins  fitted with the original method and three fixed 
parameter conditions .................................................................................................................... 178 
Figure 5.84 Examples of 4 different protein fitted with the original method and two fixed B 
parameter conditions .................................................................................................................... 179 
Figure 5.85 Ranked protein turnover (h) for GS K-O and E22 producing cell lines. .......................... 180 
Figure 5.86 Calculation of recombinant protein turnover.. ............................................................. 183 
Figure 5.87 Quantitative representation of the global proteome composition between GS K-O 
parental and E22 producing cell lines............................................................................................. 184 
Figure 5.88 Pie charts highlighting the proportion of the total protein mass and the rate of protein 
turnover encompassed by the top 10, top 100 and top 1000 proteins in E22 producing cell line. ... 186 
xv 
 
Figure 5.89 Venn diagram of common proteins between two data sets for E22 producing and GS K-O 
parental cell lines. ......................................................................................................................... 187 
Figure 5.90 A) Pie chart shows 2-fold up-regulated PANTHER protein classes.. .............................. 188 
Figure 5.91 Fragment of KEGG map of RNA transport (mmu03013) showing translation initiation 
factors (eIFs) and exon-junction complex (EJC) (A), Nuclear pore complex (NPC) ........................... 190 
Figure 5.92 KEGG map of ribosome biogenesis in eukaryotes, highlighting multiple proteins up-
regulated  in E22 producing cell line. ............................................................................................. 191 
Figure 5.93 Fragment of KEGG map showing protein processing in endoplasmic reticulum ............ 192 
Figure 5.94 Combined bar charts showing rates of usage of individual amino acids in descending 
order for E22 producing and GS K-O parental cell lines. ................................................................. 193 
Figure 5.95 Combined bar chart of rates of codon usage in descending order for E22 producing and 



















List of Tables 
Table 1.1 Proteinogenic amino acids with abbreviations and codons................................................ 31 
Table 1.2 Guidance to analyse combined forward and reverse SILAC data. ...................................... 57 
Table 2.3 Cryopreservation medium components. ............................................................................ 71 
Table 2.4 Lysis buffer composition for in-gel trypsin digest .............................................................. 75 
Table 2.5 SDS-PAGE composition used for the protein separation .................................................... 76 
Table 2.6 Lysis buffer composition for filter-aided sample preparation (FASP) .................................. 78 
Table 2.7 Protein groups upload in Perseus for standard SILAC data analysis ................................... 87 
Table 2.8 Theoretical estimation of properties of LC, HC and full mAb using PostParam tool ......... 102 
Table 2.9 Comparison between buffer and digest conditions based on the number of proteins 
significantly identified and total number of proteins identified. ...................................................... 111 
Table 3.10 Fraction number and their corresponding %B buffer ..................................................... 116 
Table 4.11 The comparison of dynamic ranges between forward and reverse SILAC experiments in 
E22 producing cell line. .................................................................................................................. 135 
Table 4.12 The comparison of dynamic ranges between forward and reverse SILAC experiments in GS 
K-O parental cell line. .................................................................................................................... 135 
Table 4.13 Statistics for forward and reverse SILAC experiments in E22 producing cell line. ............ 137 
Table 4.14 Statistics of forward and reverse SILAC experiments for GS parental cell line................. 137 
Table 4.15 The list of common differentially expressed proteins between E22 producing and GS 
parental datasets. ......................................................................................................................... 145 
Table 4.16 Top 10 KEGG pathways found for differentially expressed proteins for E22 producing GS K-
O parental cell lines. ...................................................................................................................... 149 
Table 5.17 Typical quantitative values for E.coli, yeast and Hela cell lines. ..................................... 159 
Table 5.18 Table showing possible doubly charged peptides containing two stable isotope labels. . 167 
Table 5.19 Estimated protein content per cell for several CHO cell lines. ........................................ 170 
Table 5.20 Relationship between protein content per cell, total cellular concentration and cell 
volume. ......................................................................................................................................... 171 
Table 5.21 Top 10 most abundant (in protein copy numbers) proteins for GS-KO and E22 cell lines. 173 
Table 5.22 Overview of the number of proteins identified and fitted with original method ............. 176 
Table 5.25 The overview of the numbers of protein fitted and rejected using fixed B coefficient model
...................................................................................................................................................... 179 
Table 5.24 Top 10 proteins in terms of turnover rate (h-1) for GS K-O and E22 cell lines. ................ 180 
Table 5.25 Top 10 protein with highest total cellular mass (kDa) for GS-KO and E22 cell lines. ....... 181 
xvii 
 
Table 5.26 Top 15 KEGG pathways matched to up-regulated proteins.. .......................................... 189 
Table 5.27 Comparison of the genomic codon bias (control) and the corrected dynamic codon use 


























ABC – ammonium bicarbonate 
ACN- acetonitrile 
BP – biological process 
BSA – bovine serum albumin 
cB72.3 - chimeric B72.3 mouse/human antibody 
CC – cellular compartment 
CD – chemically defined 
CHO – Chinese Hamster ovary 
CHOK1SV – Chinese Hamster ovary cell line suspension variant 
CID – collision induced dissociation 
DHFR – dihydrofolate reductase 
DMSO – dimethyl sulphoxide 
DNA – deoxyribonucleic acid 
DTE – difficult to express 
DTT – dithiothreitol 
E22 – CHOK1SV GS knock out cell line stably producing anti-insulin Mab 
ELISA – enzyme linked immune absorbent assay 
ER - endoplasmic reticulum 
ESI - electrospray ionisation 
FASP – filter-aided sample preparation 
FDA – U.S. Food and Drug Administration 
G - g Force or Relative Centrifugal Force (RCF) 
GO – gene ontology 
MF – molecular function 
GS – glutamine synthetase 
HC – heavy chain 
HCD – Higher-energy collisional dissociation 
HPLC – high performance liquid chromatography 
iTRAQ – isobaric tags for relative and absolute quantification 
IVCC – integral of viable cell count 
IAA – iodoacetamide 
K - lysine 
xix 
 
kDa – kilodalton 
KEGG – Kyoto Encyclopedia of Genes and Genomes 
K-O – knock-out 
LC – light chain 
LC-MS - liquid chromatography mass spectrometry 
Lys – L-lysine 
mAb – monoclonal antibody 
MALDI – matrix addicted laser desorption ionization 
mRNA – messenger ribonucleic acid 
MS – mass spectrometry 
MS/MS – tandem mass spectrometry 
mW – molecular weight 
PBS – phosphate buffered saline 
qP – cell specific productivity 
Q-TOF – quadrupole time-of-flight 
R – arginine 
RP – reverse phase 
rpm – rotation per minute 
SDC – sodium deoxycholate 
SILAC – stable isotope labelling of amino acids in the cell culture 
SDS – sodium dodecyl sulphate 
SDS-PAGE – sodium dodecyl sulphate polyacrylamide gel electrophoresis 
SILAC – stable isotope labelling of amino acids in the cell culture 
T1/2 – protein half-life 
TCA – trichloroacetic acid 
TCC – the cell cycle (length) 
TFA – trifluroacetic acid 
TIC – total ion chromatogram 
TPA – total protein amount 
Tris-HCL - Tris(hydroxymethyl) aminomethane hydrochloride 
R&D – research and development 
TF – transcription factor 
tPA – tissue plasminogen activator 
VCC – viable cell count 
xx 
 
Thesis Abstract  
The overall goal of this research was to better understand the mechanisms underlying the 
physiology of CHO cells, the most important mammalian host for recombinant protein 
production. The publication of complete genome of CHO cells allowed the use of mass-
spectrometry based proteomic tools to study protein expression. Among several different 
sample preparation methods for mass spectrometry, in-gel trypsin digest and FASP were 
found to be the most robust and optimal for high-coverage CHO proteome analysis. Global 
changes in protein expression between exponential and stationary phases were determined 
using SILAC for parental GS K-O and producing E cell lines. > proteins have been 
quantified and more than  proteins have been statistically differentiated.  Proteins up-
regulated in exponential phase control cell cycle and DNA replication, while proteins up-
regulated in the stationary phase are involved in stress response and signalling, making them 
interesting targets for cellular engineering. In addition to quantifying relative changes in 
protein expression between two phases of cell culture, more than 4000 protein copy numbers 
were calculated for parental and producing cell lines using TPA method. Protein turnover, 
described as the balance between protein synthesis and degradation, was calculated for 
>3000 cellular proteins. Combining these two parameters together allowed determination of 
top 10 proteins corresponding to 20% of global turnover rate. Production of monoclonal 
antibody was top priority, causing metabolic burden on cells. KEGG and GO annotation 
suggests that 600 up-regulated proteins in E22 producing cell line explained their clonal 
selection based on highest growth and productivity. Interestingly, there was no major 
differences found between amino acid and codon usage between parental and producing cell 
lines. In summary, a large-scale proteomic data set containing qualitative, quantitative and 
dynamic information on protein expression for industrially relevant CHO cell lines. 
 
 
Chapter 1: Introduction 
1.1 Chinese hamster ovary (CHO) cells and recombinant protein production 
1.1.1 Biopharmaceuticals and biosimilars 
Biopharmaceuticals can be defined as a group of recombinant therapeutic proteins produced 
using both prokaryotic and eukaryotic biological systems. Examples of such proteins include 
monoclonal antibodies, enzymes or hormones that can be used to treat medical conditions 
including cancer, autoimmune diseases and endocrine disorders. Since approval of tissue 
factor plasminogen (tPa) in 1986, more than 90 recombinant proteins have been produced 
using mammalian cells, bringing US $110 billion in annual income. These numbers are 
expected to grow as an average of 15 new approvals have been reported annually by the Food 
and Drug Administration (FDA) in 2006-2011(Lai, Yang, and Ng 2013). Biosimilars, which are 
essentially copies of biological drugs after the expiration of the patent, offer lower production 
costs and greater affordability, which improves access to treatment for millions of patients 
(McCamish and Woollett 2012). 
1.1.2 Mammalian cell factories 
Recombinant therapeutic proteins can be manufactured in bacterial, plant, yeast or animal 
cells. The choice of the expression system depends on both quality and functionality of 
recombinant protein. E. coli (Escherichia coli) is the most commonly used prokaryotic host 
due to its rapid growth, high product expression and ease of culture. It is ideal for industrial 
production of non-glycosylated proteins. However, E.coli cells are not capable of producing 
proteins containing multiple disulphide bonds and other post-translational modifications, 
mainly glycosylation (Demain and Vaishnav 2009). Glycosylation, involving attachment of 
glycan composed of various sugar residues, is important for about 70% of therapeutic 
proteins, mainly monoclonal antibodies. Despite recent improvements in the production of 
glycoproteins in E.coli (Jaffé et al. 2014), mammalian cells are the main hosts for industrial 
production of therapeutic proteins. There are several established mammalian cell lines such 
as baby hamster kidney, mouse myeloma-derived NSO, human embryonic kidney. 
Nevertheless, Chinese hamster ovary (CHO) cells are the most commonly used (Kim, Kim, and 
Lee 2012).  There are several reasons why using CHO cells is so popular. First, CHO cells have 
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been demonstrated to be safe hosts for the last 20 years, making it is easier to obtain approval 
to market therapeutic proteins from regulatory agencies such as previously mentioned FDA. 
Secondly, CHO cells can produce recombinant proteins with post-translational modifications 
that are similar to human. It is also easy to adapt CHO cells to grow in serum-free media which 
not only reduces cost but also allows better reproducibility (Kim, Kim, and Lee 2012).  
Furthermore, cloning techniques, design of expression vectors and clonal selection methods 
were significantly improved (Datta, Linhardt, and Sharfstein 2013),which has led to increase 
in the specific productivity from 0.05g/L to even 10g/L of recombinant product  (Wurm 2004; 
Huang et al. 2010).  
1.1.3 Strategies for cell line development  
The development of production cell lines is the first and probably the most important stage 
in the production of biopharmaceuticals using mammalian cell systems. The procedure starts 
with the selection of stable, high-productivity cell clones for large-scale production, followed 
by bioprocess optimization. Such stable clones are able to achieve high volumetric yields 
which can be defined by two parameters: cell specific production rate (Qp; pg/cell/day) and 
the integral viable cell concentration (IVCC; cell time per unit volume; (Dinnis and James 
2005).  
The cell line development technologies used by most biopharmaceutical companies around 
the world are based on two expression systems: MTX/DHFR amplification technology, 
developed in early 1980’s  (Kaufman and Sharp 1982) and Lonza’s glutamine synthetase (GS) 
system (Bebbington et al. 1992). 
1.1.4 Strategies for clonal selection  
DHFR system is based on the use of folate analogue methotrexate (MTX) to inhibit the 
function of dihydrofolate reductase (DHFR). DHFR converts dihydrofolate into 
tetrahydrofolate, which is a methyl group shuffle required for de novo synthesis of purines, 
thymidylic acid and certain amino acids. Transfection with an expression vector containing 
the DHFR gene does not allow MTX to poison transfected cells, while the antibiotic resistance 
gene can act as a selection marker. As a result, the only function of the DHFR gene is to amplify 




Figure 1.1 Overview of clonal selection strategies. A) The chemical reaction catalysed by dihydrofolate reductase (DHFR); B) 
Two-step process of glutamine synthesis from glutamate which is catalysed by glutamine synthetase (GS).  
The GS system is based on glutamine synthetase (GS), which is an enzyme whose function is 
to synthesize glutamine from glutamate and ammonia. Because glutamine is an essential 
amino acid, transfection of cells lacking endogenous GS with the GS vector allows the growth 
of cells in the glutamine-free medium.  
The use of any of the two systems will lead to strong gene amplification, which can be defined 
as an increase in the number of copies of the recombinant gene after transfection (Schimke 
1984).  To ensure the selection of cells that produce recombinant proteins, either single cell 
dilution or limiting dilution techniques are used. Typically, protein titre analysis is performed 
to select clones for progressive expansion. Finally, the growth profile of selected clones is 
evaluated in bioreactors and used to create Master Working Cell (MWC) banks. 
1.1.5 Origins of Chinese hamster ovary (CHO) cell lines 
The Chinese hamster ovary cell line was first derived from a population of immortalized 
fibroblasts from Chinese hamster ovary (Cricetulus griseus) by means of single cell cloning in 
1957. The Chinese hamster was found to be interesting in genetic research because of its low 
chromosome number (2n = 22) (Tjio 1958). Numerous cell lines containing various mutations 
have diverged since (Fig 1.2) due to various factors including mutations, selection pressures 
and clonal isolation methods (Lewis et al. 2013). 
The most commonly used CHO strain based on the DHFR system is the DG44 cell line. On the 
other hand, strains based on the GS system include the strain CHO-K1 and its suspension-
adapted derivative CHOK1SV.  Because both CHO-K1 and CHOK1SV still express the functional 
GS enzyme, addition of GS inhibitor, methionine sulphoximine (MSX) in the medium allows 
efficient use of GS expression vectors (Birch and Racher 2006).  The recent development of 
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CHOK1SV  GS knock-out (GS-KO) cell line using zinc finger nuclease (ZFN) technology has 
further improved selection of high-performance cell lines for a given recombinant product 
(Fan et al. 2012).  
 
Figure 1.2 The family tree of most commonly used Chinese Hamster ovary (CHO) cell lines. Adapted from Lewis 
et al. 2013.  
1.1.6 Structure and function of monoclonal antibodies 
Monoclonal antibodies (mAbs) are monospecific antibodies that are clones derived from a 
unique parental cell. In other words, monoclonal antibodies have monovalent affinity and can 
only bind to one single epitope. Their ability to bind to the target makes them an important 
tool in biochemistry and molecular biology to detect different substances (Chandel and 
Harikumar 2013). However, the greatest potential for the use of monoclonal antibodies 
occurs in many therapeutic applications. In fact, cancer treatment based on monoclonal 
antibodies was considered one of the most successful strategies in both haematological and 
solid tumours. The choice of the molecular target (antigen) for the development of the 
antibody depends on the understanding of the pathology of the disease, e.g. a different 
pattern of expression of specific genes in normal versus cancerous cells (Scott et al. 2012; 
Nelson, Dhimolea, and Reichert 2010). Most monoclonal antibodies currently used in 




Figure 1.3 Schematic structure of immunoglobulin (IgG) monoclonal antibody (A) The CDRs within Fab region of 
mAb bind to specific targets and cause antagonism, signalling or even ADCC (antibody-dependent cell-mediated 
toxicity). On the other hand, the Fc region, consisting of a hinge region and heavy chain constant domains, has 
other functions, including complement recruitment or binding to Fc receptors. B) Advances in genetic engineering 
have contributed to great progress in the development of monoclonal antibodies from murine mAbs through 
chimeric mAbs and humanized mAbs to fully human mAbs. Adapted from Hansel et al., 2010.        
As an example, trastuzumab (known under the trade name Herceptin(R)) was developed to 
target the HER2 receptor which is a member of transmembrane tyrosine kinase receptors 
responsible for intracellular signalling pathways controlling cells proliferation. HER2 receptor 
is often upregulated in breast cancers. Using this antibody revolutionised the treatment of 
HER2-positive cancers (Baselga and Swain 2009).            
1.2 Basics of Animal Cell Culture and Metabolism 
1.2.1 Cell growth  
Cell growth is defined as the increase in all its components as a direct result of the substrate 
uptake. It is known that changes in the behaviour of cells and biochemical components occur 
at every stage of cell growth. Mammalian cells grown in cell culture increase in number when 
a single cell divides mitotically after a period of adaptation and stops when the system 
becomes saturated. The growth of mammalian cells display similar growth pattern as simple 
bacteria and it can also be divided into separate phases (Sinha and Kumar 2008). 
1.2.2 Phases of cell growth 
Lag phase is the first stage of the growth curve (Figure 1.4) and it is the time it takes for cells 
to adapt to growth in fresh culture medium until the logarithmic phase begins. Cells may 
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require adaptation to new conditions, including medium components, supplementation or 
even different osmolality. The duration of this phase can vary and depends mainly on several 
conditions, including size of the inoculum, medium constituents and temperature (Sinha and 
Kumar 2008).  
In the exponential phase (logarithmic phase) the number of cells grows rapidly 
(exponentially), which can last from 2 to 8 days. At this stage, the cells have adapted to the 
new conditions, the media is rich in nutrients and there is enough room for growth, so there 
is no competition for space or nutrients. The rate of exponential growth is called generation 
(or doubling) time and it might range from 12 to 36 hours. The cells cease to divide when the 
primary nutrient is depleted or inhibiting substances are formed (Sinha and Kumar 2008).  The 
stationary phase occurs when the cell division stops, meaning that the growth rate is equal to 
the death rate. Some researchers describe the transition between the exponential phase and 
the stationary phase as the deceleration phase. The cells in response to the rapidly changing 
culture environment cause unsustainable growth. 
 
Figure 1.4 Typical Growth Curve for a Mammalian Cell. It is a function of viable cell concentration (VCC, solid line) 
and time (days). The viability (%, dashed line), defined as the ratio of viable cell concentration to total cell 
concentration, is also displayed. A) Lag phase, B) Exponential phase C) Stationary phase and (D) Death phase. 
In contrast to the exponential phase in which the cellular metabolic system is directed to 
achieve maximum reproduction rates, the onset of the stationary phase indicates 
reorientation of cell metabolism to increase chances of cell survival in response to rapidly 
changing conditions. Although the net growth is close to zero, cells are still metabolically 
active and produce secondary metabolites (non-growth-related products). It has been studies 
that the production of certain metabolites (such as hormones or antibodies) increases in the 
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stationary phase due to the deregulation of metabolism. Total cell concentration (TCC) 
remains constant but viable cell concentration (VCC) is constantly decreasing. The second 
phase of growth (cryptic growth) can occur when the cells use the lysed cell products (Shuler 
and Kargi 2002). The death phase follows the stationary phase and is the last phase of cell 
growth in culture. 
1.2.3 Types of cell culture processes 
The industrial production of recombinant proteins requires a large-scale fermentation 
strategy. There are three of the most popular cell culture strategies: batch culture, fed-batch 
culture and continuous culture. 
In batch culture, the cells are inoculated into a fixed volume of  proprietary medium and 
follow a sigmoid growth pattern. As the cells grow, nutrients are consumed, and metabolites 
accumulate. The environment in which the cells reside is constantly changing, and this in turn 
forces changes in the metabolism of cells, referred to as physiological differentiation. 
Multiplication of cells ceases when nutrients are depleted and accumulation of toxic 
metabolites or density-dependent growth restriction in monolayer culture, known as contact 
inhibition occurs (Masters 2000).  There are several strategies to prolong the life of a batch 
culture and to increase productivity by means of various scale-up methods, including 
intermittent replacement of a solid culture fraction with a volume of fresh medium (fed-
batch). The systems retain accumulated waste products to a certain extent and have a 
changing environment as opposed to a standard batch culture. 
When fresh medium is added continuously in connection with the continuous removal of the 
medium, this type of process is called a continuous batch. Working with continuous culture 
allows to achieve high cell density and high productivity without any compromise due to the 
reduction of nutrients or the accumulation of toxins (Masters 2000). Fed-batch provides a 
compromise between the standard series and continuous batch culture. In addition, it also 
helps to minimize the disadvantages of both. Fed-batch process consists of the gradual 
addition of fresh medium without removing the spent medium. As a result, the volume of the 
cell culture is gradually increasing. The main advantage of this process is that nutrients are 
continuously added to the culture to ensure prolonged cell growth and maintenance to 
achieve high cell densities. Furthermore, toxic metabolites do not accumulate to inhibitory 
levels. Fed-batch is relatively easy to carry out and do not require high technical skills or 
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instrumentation to operate as opposed to continuous culture (Agrawal, Koshy, and Ramseier 
1989). 
1.2.4 Subculture of mammalian cells 
Subculture (also referred as passage) is important for mammalian cells for several reasons. 
First, mammalian cells tend to be quite heterogeneous at the beginning of the culture and 
have a low growth fraction. What is more, CHO cell populations have been shown to be 
functionally heterogeneous even in transformed cell lines (Davies et al. 2013) and is due to 
their inherent genetic instability that can modify chromosome arrangement, gene copy 
number and transcriptional activity (Xu et al. 2011). The subculture allows expansion of cell 
culture and generation of cell lines, ensures greater uniformity and enables cloning and 
conservation. The biggest advantage of the subculture is the supply of large amounts of 
consistent material suitable for long-term use. 
1.2.5 Outline of cell culture metabolism  
Despite advances in research on CHO cells and other mammalian cells, intracellular 
metabolism in cell culture is still not fully understood. This limited knowledge of intracellular 
fluxes and in vivo metabolism during industrially relevant culture conditions limits the use of 
metabolic engineering techniques to further improve product yield and quality as well as 
overall bioprocess performance (Ahn and Antoniewicz 2011; Ahn, W. S., & Antoniewicz 2012).  
Studies have shown that the metabolism of CHO cells in culture is characterized by a high 
level of glucose uptake (the main carbon source) and glutamine uptake. This results in high  
rates of ammonium and lactate secretion (metabolic by-products) which are well known 
inhibitors of cell growth and protein production and may also have a negative effect on the 
glycosylation pattern of recombinant proteins. (Neermann and Wagner 1996; Yang and Butler 
2000). Proliferation requires that mammalian cells switch their metabolism from optimal 
energy production to maximum synthesis (Heiden et al. 2009). The cells  are required to 
increase the rate of glucose and amino acids uptake from the medium (DeBerardinis et al. 
2007). Most mammalian cells, including CHO cells, can metabolize glucose to lactate 
regardless of the oxygen levels. This is called aerobic glycolysis or “the Warburg effect”, which 




There is still much to discover how CHO cells regulate their metabolic pathways to achieve a 
balance between energy and biomass production (Fig 1.5).  Since the main component of 
cellular biomass is a protein, proliferating cells have to maintain stable protein synthesis, 
which is also important in the production of recombinant protein.  
 
Figure 1.5 The schematic representation of typical metabolism of mammalian cells. The cells need energy to 
maintain homeostasis and carry out cellular maintenance, which may involve generating a concentration 
gradient, basal transcription and translation, protein turnover or DNA repair. While maintaining homeostasis, 
cells also need additional energy for growth and division. Mammalian cells require various nutrients because 
their synthetic capacity is much more limited compared to microorganisms. Nutrients are provided in the 
environment (chemically-defined medium) and are necessary for conversion into biosynthetic building blocks. 
1.2.6 Metabolism and transport of amino acids 
Mammalian cells depend on the uptake of essential amino acids for both protein synthesis 
and cell growth. Amino acids are molecules that have both a carboxylic (-COOH) and an amino 
group (-NH2) together with a specific side chain (R-group). Amino acids that are key 
components for the synthesis of cellular proteins are known as proteinogenic amino acids. 
There 22 proteinogenic amino acids: 20 are encoded in the genetic code, while the other two 
non-standard amino acids are selenocysteine and pyrrolysine (Table 1.1).  
Amino acid metabolism in mammalian cells can be studied using stable carbon isotopes (13C) 
that can directly measure amino acid uptake and production rates. If the biomass composition 
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for mammalian cells is known, it is possible to calculate fractions of amino acids utilized for 
catabolism (energy production) and anabolism (biomass synthesis). Further research into the 
differential contribution of amino acids to anabolism and catabolism could direct medium 
optimization in CHO cells (Ahn & Antoniewicz 2012).  
Furthermore, recombinant cell lines, such as CHO cells, have an increased demand for amino 
acids to support high titre of recombinant protein. The availability of amino acids in cells 
grown in chemically-defined medium depends not only on cellular metabolism requirements. 
It is also influenced by individual physical and chemical properties of amino acids, including 
solubility and stability (Salazar, Keusgen, and Von Hagen 2016). The movement of amino acids 
across mammalian cell is facilitated by transporter membrane proteins. This group of large 
proteins contains multiple transmembrane domains that span the phospholipid bilayer and 
can transport substances in the same (symport) or opposite (antiporter) direction. Amino acid 
transporters have been traditionally grouped into systems characterized by substrate 
specificity, transport mechanism and ion dependency (Christensen 1990).  Balanced delivery 
of amino acids into cells is essential for optimal cell growth and metabolism. 
1.2.7 Development of culture media 
Defining the cell culture environment was recognized early to be important in maintaining 
continuous (immortalized) mammalian cell lines. The role of essential amino acids, vitamins, 
minerals, salts, trace metals and other nutrients was demonstrated in 1950’s (Eagle 1955). To 
mimic the composition of body fluids, the media development was further amplified by the 
addition of serum (most commonly foetal bovine serum, FBS). The serum provides a huge 
variety of substances necessary for growth, such as hormones (e.g. insulin), growth factors 
(e.g. PDGF), and trace elements (Fe2+) as well as attachment factors (e.g. fibronectin). The 
serum also helps to maintain the desired pH and osmolality in cell culture. There are several 
drawbacks to the use of serum, which include high costs, batch-to-batch variation and the 
risk of contamination (Sinha and Kumar 2008). On the other hand, the advantages of using 
serum-free media are cheaper production costs, facilitating purification of recombinant 
proteins and nutrient composition tailored to specific needs of different cell lines. Basic 
components of any serum-free media include inorganic salts such as sodium chloride, 
vitamins and glucose.  Serum-free media also needs to provide essential amino acids to 
auxotrophic mammalian cells. There are 12 essential amino acids essential for proliferating 
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cells: arginine, cysteine, isoleucine, leucine, lysine, methionine, histidine, phenylalanine, 
tryptophan, threonine, tyrosine and valine. Additionally, some cells may have a higher 
requirement for cysteine, tyrosine  and glutamine (Sinha and Kumar 2008). Amino acids are 
not only precursors for protein and peptide biosynthesis but can also become metabolic 
intermediates for synthesising other biomolecules or used directly to generate energy. 
Table 1.1 Proteinogenic amino acids with abbreviations and codons.  
Name  Abbreviations Codons 
Essential amino acids 
L-Arginine Arg or A CGU, CGC, CGA, CGG, AGA & AGG 
L-Cysteine Cys or C UGU & UGC 
L-Glutamine Gln or Q CAA & CAG 
L-Histidine His or H CAU & CAC 
L-Leucine Leu or L UUA, UUG, CUU, CUC, CUA & CUG 
L-Methionine Met or M AUG 
L-Phenylalanine Phe or F UUU & UUC 
L-Threonine Thr or T ACU, ACC, ACA & ACG 
L-Tryptophan Trp or W UGG 
L-Tyrosine Tyr or Y UAC & UAU 
L-Valine Val or V GUU, GUC, GUA & GUG  
Nonessential amino acids 
Glycine Gly or G GGU, GGC, GGA &GGG 
L-Alanine Ala or A GCU, GCC, GCA & GCG 
L-Asparagine Asn or N  AAU & AAC 
L-Aspartic Acid Asp or D GAU & GAC 
L-Glutamic Acid Glu or E GAA & GAG 
L-Proline Pro or P CCU, CCC, CCA & CCG 
L-Serine Ser or S UCU, UCC, UCA, UCG, AGU & AGC 
Non-standard amino acids 
Selenocysteine Sec or U - 







1.3 Review of engineering strategies for CHO cells 
1.3.1 Traditional engineering approaches  
Since CHO cells have been used for in the production of recombinant proteins for decades, 
numerous engineering strategies have already been developed to increase both growth and 
productivity. They can be broadly divided into genetic and cellular engineering approaches 
Genetic engineering is based on the introduction of genes to produce heterologous proteins. 
This has been the most popular approach in the last 20 years, in which CHO cells were 
genetically modified for the production of recombinant protein (Jayapal et al. 2007; Walsh 
2010). The basic methods of increasing the production of recombinant proteins were 
improvements in gene-of-interest design, optimization of expression vectors and clone 
selection strategies (Fig 1.6).  
Cellular engineering aims to alter cell phenotypes and it mainly involves optimization of 
metabolic processes. These approaches engineer cells to reduce lactate production (Zhou et 
al. 2011), enhance cell growth profiles e.g. by resisting apoptosis (Dorai et al. 2009) or 
oxidative stress (Malhotra et al. 2008) or increase productivity through the improvement of 
glycosylation patterns (Jefferis 2009). Out of all these strategies, the reduction in lactate 
production proved to be the most effective: it was shown that by knocking out lactate 
dehydrogenase, the production of lactate was decreased by 80% and the product titre was 
increased up to 3-fold  (Richelle and Lewis 2017). Recent studies have also shown that over-
expression of pyruvate carboxylase, which catalyses carboxylation of pyruvate to 
oxaloacetate, has multiple positive effects, including prolonged lifespan of the cell culture, 
increased product titre and enhanced glycosylation profile (Gupta et al. 2017).   
Recently, engineering strategies have also been developed to increase the secretory capacity 
of CHO cells. Many studies have shown that post-transcriptional bottlenecks in the protein 
biosynthetic pathway lead to suboptimal levels of recombinant protein. The efficiency of CHO 
cells can be significantly increased by both expressing genes involved in protein translocation 
and ER folding and addition of small molecule chemical chaperones into medium (Hansen et 





Figure 1.6  Overview of genetic engineering strategies in CHO cells. Adapted from Datta et al. 2013. 
1.3.2 RNA-based engineering approaches 
Over the past decade, RNA interference (RNAi) technology has become an important tool in 
biotechnology to silence gene expression in cells. There are many approaches by which RNAi 
can be used to increase CHO cell productivity, e.g. by silencing genes associated with 
apoptosis. Future use of this technology can also be extended to silence multiple targets in 
cellular pathways involved in metabolism or protein secretion (S.-C. Wu 2009).  
In addition to RNA interference technology, the use of small non-coding RNAs to engineer 
CHO cells also gained popularity. miRNAs are 18-25 nucleotides long, which can post-
transcriptionally affect gene expression via mechanisms well conserved in eukaryotic cells 
(Berezikov 2011). What makes using miRNA so attractive is the fact that they can alter key 
cellular phenotypes without having additional burden on translation. Due to imperfect 
binding to mRNAs targets, they can reduce the expression of many genes at the same time, 
instead of affecting a single target as in traditional engineering approaches. The change in the 
expression of specific miRNAs has already been used to successfully engineer CHO cells with 
a delayed onset of apoptosis or with higher specific productivity. By investigating low and 
non-producing CHO cells, the most interesting engineering targets were identified to use 
during industrial fed-batch monoclonal antibody production (Stiefel et al. 2016) or even 
optimise difficult-to-express (DTE) protein production (S. Fischer et al. 2017).  
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1.3.3 Heading towards ‘omic’ based engineering approaches  
Currently CHO cells engineering is moving into the direction of ‘omic’ based approaches 
(Figure 1.7). Generation of large-scale datasets will improve the basic knowledge of CHO cell 
physiology and lead to the development of tools for targeted engineering of new cell lines. 
The following sections highlight the most-important "omics" research in CHO cells over the 
last 10 years. 
 
Figure 1.7 The “central dogma of biology” is displayed together with the associated ‘omic’ studies and various 
research strategies. The individual gene activity can be regulated at the DNA level by means of epigenetic 
modifications. Genetic information encoded by DNA is directly transcribed into messenger RNA and translated 
into individual proteins. Following translation, proteins can be further modified to fully functional biomolecule 
that can take part in multiple cellular and metabolic processes. 
1.3.3.1 Genomic analysis of CHO cells 
Genomics can be defined as a comprehensive analysis of the genetic content of an organism 
(Gupta and Lee 2007). Publication of the CHO-K1 cell line genome sequence was a milestone 
in CHO cell research. The CHO-K1 genome sequence was established using de novo 
sequencing technique and assembled by short oligonucleotide analysis package (SOAP). It was 
found that the cell line has the 2.45 Gb genome and over 24,000 genes have been predicted 
based on transcriptomic analysis (Xu et al. 2011). This data can be now used as a tool for 
genetic and cellular engineering of CHO cells. 
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It is worth noting that genomes of cell lines derived from CHO-K1 may contain large-scale 
rearrangements and that even clonal populations have a high degree of heterogeneity 
(Pilbrough, Munro, and Gray 2009; Davies et al. 2013). Following the publication of first 
complete CHO genome, another study involved resequencing and analysis of the genomes of 
six CHO cell lines from 3 main lineages: CHO-K1 (anchorage-dependent), DG44 and CHO-S 
(both suspension-adapted). The results have been compared to the genomic sequence of a 
female Chinese hamster (see Fig 1.2). More than 3.7 million single nucleotide polymorphisms 
(SNPs), numerous indels (deletion or insertion of bases) and copy variants have been found. 
What is more, certain genes have been missing or mutated. Interestingly, many of these 
mutations are located in genes with functions related to bioprocessing such as apoptosis 
(Lewis et al. 2013). Based on these studies, new bioinformatics resource for CHO cells, 
CHOgenome.org, was made available (Hammond et al. 2012; Kremkow et al. 2015).  
1.3.3.2 Transcriptomic analysis of CHO cells 
Sequencing the CHO cell genome was the first step to a better understanding of cell 
physiology. Further research into global gene expression (transcriptomics) may reveal new 
engineering goals. Recent studies using next generation sequencing (NGS) technology have 
revealed that there are over 29,000 genes expressed by CHO cells under different growth 
conditions. Interestingly, more than 50% of genes were similar to mice (Mus musculus) and 
closely related to rats (Rattus norvegicus) (Baycin-Hizal et al. 2012) Using transcriptomic data, 
it is possible to reconstruct cellular pathways involved in central sugar metabolism and 
protein glycosylation (Becker et al. 2011). Moreover, transcriptomics can give a better insight 
into clonal variability and find specific features associated with  higher cellular growth (Doolan 
et al. 2013; Vishwanathan et al. 2015).   
1.3.3.3 Outline of proteomic research for CHO cells 
In addition to genomics and transcriptomics, measuring protein expression at a specific time, 
known as proteomics, can also aid in optimization of bioprocesses. It is believed that studying 
proteomics provide more valuable information about physiological state of the cell rather 
than global gene or transcript analyses. There were several studies concerned with CHO 
proteomic analysis before the publication of complete CHO-K1 genome. This included the 
investigation of the effects of low temperature shift and sodium butyrate, the two common 
ways of increasing productivity of CHO cells, on changes in protein expression (Joon et al. 
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2008; Kantardjieff et al. 2010). The studies have shown a correlation between higher 
productivity and the increased expression of proteins involved in protein processing and 
secretion, including Golgi apparatus, and cytoskeleton binding proteins. A later study 
monitored intracellular responses of CHO cells grown in serum-free media supplemented 
with hydrolysates to optimize growth or specific productivity (Baik et al. 2011).  Up-regulation 
of proteins involved in metabolism and protein folding was associated with higher growth 
while the expression of apoptotic proteins was down-regulated. On the other hand, higher 
specific productivity phenotype was correlated with increase of proteins involved in folding 
(chaperones) and those responsible for cell proliferation.  
One of the first studies following publication of CHO genome in 2011 analysed both 
intracellular proteins and extracellular proteins secreted into media, including glycoproteins. 
By comparing proteomic data to transcriptomic information, a good correlation was found 
between transcript levels and protein expression. However, the number of genes were 
significantly underrepresented in the dataset. For instance, both mRNA and protein were 
present at detectable levels while in some only mRNA was observed. The study emphasized 
the importance of integrating genomic, transcriptomic and proteomic data together to study 
biological pathways (Baycin-Hizal et al. 2012).   
In addition to measuring of protein expression, codon usage bias of CHO cells was 
determined. Codon bias, which can be described as unequal use of synonymous codons for a 
particular amino acid, is a common phenomenon, considered to be crucial in shaping gene 
expression and cellular function (Plotkin and Kudla 2011). The study showed that there was a 
significant difference between CHO and human codon biases for five amino acids: proline, 
alanine, aspartate, cysteine and threonine. The study suggests strategies for codon 
optimization for production of human proteins in CHO cells (Baycin-Hizal et al. 2012).  
1.3.3.4 Integration of ‘multi-omic’ approaches to engineer better host cells  
Many studies suggest that only by integrating various ‘omic’ data sets could we truly 
understand the physiology of CHO cells. By analysing such multidimensional data, it is possible 
to gain a deeper understanding of basic mechanistic changes taking place inside the cell which 
may guide optimization of the bioprocesses (Chen et al, 2015). Previously, only the most the 
most relevant studies were highlighted, namely publication of the CHO genome and initial 
transcriptomic and proteomic analyses. Other possible directions of ‘omic’ studies include the 
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analysis of glycosylation profile (glycomics), hereditary DNA modifications that can alter gene 
expression (epigenomics), measurement of mRNA translation within a cell and unit time 
(translatomics)  or analysis of metabolic activity (metabolomics).  
 
Figure 1.8 The possible roles of ‘omic’ tools in bioprocess development. The continued use of various “omic” tools 
in monitoring industrial bioprocesses could facilitate the selection of top producing cell lines. What is more, 
improving both product yield and quality as well as impurity characterization between different cell lines can 
result in better strategies for both upstream and downstream processing. Multiple “omic” approaches (“multi-
omics”) have the potential to be combined into quality monitoring systems and used at all stages of bioprocess 
development. Adapted from Gupta & Lee 2007.  
The availability of reliable databases and analytical tools are vital for successful integration of 
large ‘omic’ datasets. It has been predicted that there are many ways in which ‘omic’ tools 
could benefit large scale industrial bioprocesses (Figure 1.8). Design and development of 
novel bioinformatic resources is of great importance for both academic and industrial 
Research & Development (R&D). 
1.4 Mass spectrometry-based proteomics 
1.4.1 Definition of proteomics 
Proteomics is a study of the total complement of protein expressed by a genome of an 
organism (Wilkins et al. 1996), which makes it a powerful tool in molecular biology. It allows 
the analysis of the components of small protein complexes and large organelles, 
determination of post-translational modifications and monitoring of global changes in protein 
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profiles (Steen and Mann 2004). Isolation, separation and analysis of proteins pose much 
more technical challenges than DNA or RNA testing due to heterogeneous protein chemistry. 
Two primary technologies are most often used to study proteomics: two-dimensional gel 
electrophoresis (2D-GE) and mass spectrometry (MS). 
1.4.2 Gel-based proteomics 
Gel-based approaches include using two-dimensional separation of proteins by SDS 
electrophoresis based on their molecular weight, followed by isoelectric focusing (IEF) to 
separate proteins according to their isoelectric point (iP), at which the total net charge is equal 
to 0. This technique is called 2D-GE and can be used directly to assess the amount of protein 
present in a sample using densitometry, or it can be used as protein fractionation technique 
prior to MS-based analysis. The extension of this technique is known as 2D difference gel 
electrophoresis (2D-DiGE) in which proteins derived from different experimental conditions 
are fluorescently labelled with Cy2, Cy3 or Cy5 (Lilley and Friedman 2004). 2D-GE can 
theoretically resolve up to 10 000 proteins, but there are some limitations to this technique. 
First, a single protein spot may contain more than one protein, making data analysis difficult. 
Furthermore, 2D-GE cannot resolve certain groups of proteins, including highly hydrophobic 
and membrane proteins that are poorly soluble in aqueous solutions (McDonald and Yates III 
2000). For these reasons, gel-based approaches to proteomics testing have been largely 
replaced by mass spectrometry (Shao-En Ong and Mann 2005).  
1.4.2 Sample preparation for mass spectrometry analysis 
One of the main challenges in mass spectrometry analysis is sample complexity. Regardless 
of the organism being studies, each cell contains thousands of different proteins at varying 
abundance. Due to limitations in analytical resolution, reduction of sample complexity is 
essential (Stasyk and Huber 2004). There are two main strategies to prepare samples for mass 
spectrometry: in-gel and in-solution digest. The first method is based on the fractionation of 
complex protein sample by SDS-PAGE (sodium dodecyl sulphate-polyacrylamide based 
electrophoresis), hence it is called GeLC-MS/MS. Following band staining, individual bands (or 
even an entire lane) can be excised and divided into several fractions. The proteins in the gel 
slices are then digested with a protease, peptides are extracted and can be analysed by mass 
spectrometry (Fig 1.9).  
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Protein mixtures can be also digested directly in solution, as opposed to gel fractionation, and 
is known as shotgun proteomics. The protein mixture is often denatured in the presence of 
chaotropes or detergents, and then digested to produce peptides suitable for mass-
spectrometry analysis. In general, trypsin digestion is a preferred way of generating peptides 
(“tryptic peptides”) because it cleaves specifically at the C-terminus of arginine and lysine, 
generating positively charged peptides (Cravatt, Simon, and Yates 2007). Extension of in-
solution method is known filter-aided sample preparation (FASP), where protein extraction is 
facilitated by high concentration of detergents while protease digestion occurs on 
nitrocellulose filters (Jacek R Wiśniewski and Mann 2012). The advantage of using FASP is the 
possibility of solubilising highly hydrophobic or membrane proteins. 
 
Figure 1.9 The overview of sample preparation methods for mass spectrometry. HPLC, high-pressure liquid 
chromatography; MS; mass spectrometry; IMAC, immobilised matrix affinity chromatography; HILIC, hydrophilic 
interaction chromatography; carbon 18; Q-TOF, quadrupole-time-of-flight; SDS-PAGE, sodium dodecyl sulphate.   
1.4.3 Peptide fractionation by liquid chromatography 
Since peptide mixture, following either in-gel or in-solution digest, is still very complex, it 
requires further fractionation. The optimal fractionation method offers good compromise 
between reducing sample complexity and the speed of analysis to achieve best quality data. 
Currently used fractionation methods use liquid chromatography (LC) that can separate 
peptides according to their physicochemical properties (Stasyk and Huber 2004). 
The most commonly used LC method is known as reversed-phase liquid chromatography 
(RPLC), which separates peptides according to their hydrophobicity. If peptide mixture is very 
complex, especially following in-solution digest, the introduction of second dimension 
separation is recommended. When using GeLC-MS/MS method, the sample is first 
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fractionated at protein level according to their molecular weight (mW) so the sample is much 
less complex in comparison to in-solution digest.  
To further reduce sample complexity or if the proteins of interest are of relatively low 
abundance, it is possible to use enrichment steps. For example, it is possible to specifically 
enrich phosphoproteins by the use of phosphorylation-specific antibodies or affinity-based 
techniques, such as immobilized metal ion affinity chromatography (IMAC) (reviewed by Fílla 
& Honys 2012). Another common approach to peptide fractionation is the use of strong 
cation-exchange chromatography (SCX) which separates peptides based on their positive 
charges. SCX can be used offline  (unconnected to any mass spectrometer), followed by online 
RPLC fractionation and MS analysis (Cravatt et al.,  2007). The complete proteomic workflow 
is presented in Figure 1.10. 
 
 
Figure 1.10 The workflow of a typical mass spectrometry-based proteomic experiment. The protein population is 
prepared from a biological source e.g. a cell culture. The gel lane is cut into several slices and subjected to in-gel 
digestion. A variety of enzymes and/or chemicals can be used to modify proteins if necessary. The resulting 
peptide mixture is separated using single or multiple liquid chromatography (LC) dimensions. Peptides are ionized 
by ESI (depicted) or MALDI and can be analysed by various mass spectrometers. Finally, the peptide-sequencing 
data that is obtained from the mass spectra is searched against protein databases using a database-searching 
programme. Adapted from Steen & Mann, 2004.  
1.4.4 Principles of mass spectrometry  
The basic principle of mass spectrometry (MS) is the generation of ions from either organic or 
inorganic compounds in the gas phase and the separation of these ions by their mass-to-
charge ratio (m/z) to detect them qualitatively of quantitatively by their respective m/z 
abundance. The separation of ions is influenced by static or dynamic fields that can be either 
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or magnetic (Gross 2011). A typical mass spectrometry instrument consists of an ion source, 
a mass analyser, which measures the mass-to-charge ratio (m/z) of analytes and a detector 
that allows identification of the number of ions at a given m/z value (Fig 1.11). 
 
Figure 1.11 The components of mass spectrometer. After introducing the sample through the sample inlet, the 
sample is ionised (typically by ESI or MALDI). Mass analysers separate ions in space or by time according to m/z 
ratio, while ion detectors generate a current signal from the incident ions. Vacuum pump allows ions to reach 
the detector without collision with other molecules or atoms. Mass spectra are generated using a computer 
software. 
Matrix-assisted laser desorption/ionization (MALDI) and electrospray ionization (ESI) are the 
two techniques used to volatize and ionize large biomolecules such as proteins for MS 
analysis. MALDI sublimates and ionizes samples from a dry crystalline matrix by laser pulses. 
In contrast, ESI can easily ionise analytes from a solution and therefore can easily be combined 
with liquid-based separation tools (chromatographic or electrophoretic). Integrated ESI-MS 
systems (or LC-MS to be more specific) are preferred for the analysis of complex samples.  
1.4.4 Types of mass analysers 
The type of mass analyser is important in proteomics and its main parameters are resolution, 
mass accuracy and the ability to generate complex ion mass spectra from peptide fragments, 
which are called tandem mass (MS/MS) spectra (Aebersold and Mann 2003). There are 
several types of mass analysers and each of them differs in terms of performance, design and 
resolution. It is also possible to combine them in tandem to create hybrid mass spectrometer 
that will combine features of both mass analysers. 
Quadrupole (Q) mass spectrometers have a mass-selective “quadrupole section” that allows 
only the passage of ions with a certain m/z value. The transition through the m/z range by 
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using different sinusoidal potentials allows to detect ions that pass through each m/z ratio 
value to generate the mass spectra. (Figure 1.12).  
 
Figure 1.12 The diagram of quadrupole mass analyser. The quadrupole consists of two pairs of parallel electrodes. 
By regulating the current passing through electrodes, the ions with the desired m/z value stably travel along the 
axis (known as resonant ions, marked in blue). The ions that are not selected do not have such a stable trajectory 
(marked as red) and do not reach the ion detector 
On the other hand, time-of-flight (TOF) analysers measure the time it takes for the ion to 
travel through the flight tube without the use of electric fields since all ions are accelerated 
to the same kinetic energy. As a result, lighter ions fly faster than heavier ones and reach the 
detector sooner (Steen and Mann 2004). There are two types of TOF instruments that are 
commonly used due to their high sensitivity, resolution and mass accuracy: TOF-TOF type, in 
which two TOF sections are separated by a collision cell, and the hybrid quadrupole-TOF (Q-
TOF) instrument, where collision cell is placed between the quadrupole mass filter and the 
TOF mass analyser. The ions of the specified m/z are selected in the first mass analyser, 
fragmented in the collision cell and finally the TOF analyser detects the fragment ion masses. 
These instruments can be operated with either MALDI or ESI as an ionization source 
(Aebersold and Mann 2003). 
Another group of mass analysers is designed to trap ions in a high electric field. In the basic 
ion trap analyser, the ions are first captured for a certain period and then subjected to MS or 
MS/MS analyses. Ion traps are robust and relatively inexpensive, but have relatively low mass 
accuracy. In contrast, Fourier-transform ion cyclotron resonance (FT-ICR) analysers capture 
the ions under high pressure vacuum within a fixed magnetic field and determine mass-to-
charge based on the cyclotron frequency. FT-ICR have high sensitivity, mass accuracy and 
dynamic range, but they are difficult to operate and have low efficiency of peptide 
fragmentation (Aebersold and Mann 2003). Finally, the newest addition to the trap type of 
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mass analysers are Orbitraps (Scigelova and Makarov 2006), which revolutionised the 
proteomics research in the last decade.  
Orbitrap shares some features with older types of mass analysers, namely with the use of ion 
traps in a precisely defined electrode line in FT-ICR and the use of electrostatic fields similar 
to TOF. The Orbitrap mass analyser consists of an external barrel-shaped electrode and a 
central spindle-shaped electrode along the axis, connected to independent voltage sources. 
The space between the internal and external electrodes forms a measuring chamber 
connected to the vacuum system to provide high vacuum conditions. The injected ions cycle 
around the central electrode and simultaneously oscillate along the horizontal axis (Fig 1.13). 
Using Orbitrap mass analysers is beneficial in comparison to other mass analysers due to 
resolution, mass accuracy and linear dynamic range at relatively low cost and bench-top size 
(Zubarev and Makarov 2013). Furthermore, hybrid instruments were further developed by 
combining the power of a quadrupole and an Orbitrap analyser (to form what is called Q-
Exactive) to increase the number of peptides that could be analysed. In addition, other 
improvements have been made over the past few years, including compacting the Orbitrap 
analyser to increase field strength (Q-Exactive HF) or adding a low resolution pre-filter to 
exclude unwanted ions from entering the analyser (Q-Exactive Plus) (Scheltema et al. 2014).  
 
 
Figure 1.13 The schematic of hybrid Q-Exactive HF mass spectrometer, featuring Ultra High Field Orbitrap mass 
analyser, C-trap and HyperQuad Mass Filter. From Thermo Fisher Scientific. 
1.4.5 Tandem MS and peptide identification 
After determining the m/z values and the peak intensities in the spectrum, the mass 
spectrometer can obtain information about the primary structure (sequence) of peptides. 
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This is called tandem MS (MS/MS) because it combines two steps of MS. In the former, a 
specific peptide ion is isolated, the energy is imparted by a collision with an inert gas (such as 
nitrogen or argon) and this energy causes the peptides to break apart (known as collision-
induced dissociation, CID). The spectrum of the resulting fragments is then generated. The 
species that is fragmented are called “the precursor ion” while the ions in the tandem MS are 
known as “product ions”.  
The product ions are indicated by a, b and c if the charge is retained on the N-terminus and x, 
y and z - if charge is maintained on the C-terminus. The peptides are mainly fragmented by 
cleavage of amide bonds (because it has the lowest energy), which leads to the so-called  b-
ions, when the charge is retained by the N-terminus fragment and y-ions - if by the C-terminus 
fragment (Fig 1.14). Protein identification is carried out using one of the available search 
engines, e.g. Mascot uses an algorithm that calculates theoretically predicted fragments for 
all peptides in the database and matches them to the experimental fragments in a top-down 
fashion (probability-based matching, Steen & Mann 2004).  
 
Figure 1.14 The schematic representation of peptide fragmentation during MS/MS (A) Peptide identification 
based on probability-based matching (B)  
1.5 Quantitative proteomics approaches 
1.5.1 Classification of quantitative proteomics approaches 
Mass spectrometry has been used to characterize and identify proteins in complex mixtures, 
but the results are mainly qualitative. Quantitative proteomics can give insight into how much 
protein is present in the sample (absolute quantitation) and compare differences in protein 
expression between different conditions (relative quantitation). Quantitative proteomic 




1.5.2 Label-free quantification  
At present, absolute label-free quantification methods have been based on either spectral 
counting or spectral intensity. In spectral counting, the number of fragment spectra (MS2 or 
MS/MS) of peptides corresponding to a given protein is counted and compared with other 
proteins in the sample to assess the abundance of the protein (Neilson et al. 2011). 
 
Figure 1.15 Outline of quantitative proteomics approaches. IEF, isoelectric focusing; pI, isoelectric point; mW, 
molecular weight; XIC, extracted ion chromatogram; 2D-GE, two-dimensional gel electrophoresis; 2D-DiGE, two-
dimensional differential gel electrophoresis; SDS, sodium-dodecyl sulphate; m/z, mass-to-charge ratio.   
In contrast, spectral intensity approach relies on alignment of chromatographic peaks of 
peptides from MS1 scans. Each peptide with a mass-to-charge ratio generates a monoisotopic 
mass peak.  The intensity of this peak is a function of the retention time, which can be 
visualised in the extracted ion chromatogram (XIC) and the area under the curve (AUC) can 
be calculated (Megger et al. 2013). Both methods have high reproducibility in peptide and 
protein level quantification and are cost-effective.  
1.5.3. Absolute and label-free quantification approaches based on spectral counting  
One of the first developed methods was the protein abundance index (PAI), which is defined 
as the ratio between sequenced protein peptides and the total number of theoretical tryptic 
peptides. This method is not accurate but serve as a guide to distinguish between high and 
low abundant proteins (Rappsilber et al.,  2002).  Improvement of this method, exponentially 
modified protein abundance index (emPAI), which converts PAI to 10PAI minus one, is 
proportional to the protein content in the mixture (Ishihama 2005). Reporting emPAI values 
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was recommended in any large-scale proteomic experiments because it was readily available 
as part of many software packages for the analysis of mass spectrometry data. 
Since spectral counting can be often biased by physicochemical properties of peptides that 
affect MS detection, this method can underestimate the protein abundance. Another spectral 
counting technique, termed absolute protein expression (APEX), includes a correction factor 
to each protein (called Oi value) to negate variable peptide detection in MS/MS. Machine 
learning is necessary to estimate the probability of detecting peptides that can be compared 
to the observed spectral counts of MS (Braisted et al. 2008). A similar approach, called 
normalised spectral abundance factor (NSAF), takes into account the length of the protein for 
data normalisation (Zybailov et al. 2006; Florens et al. 2006). Both APEX and NSAF methods 
are believed to be more accurate in estimating protein abundance than previously mentioned 
PAI and emPAI but are more difficult to implement. 
1.5.4. Absolute and label-free quantification approaches based on spectral intensity  
The discovery of the relationship between MS signal response and protein concentration led 
to the development of ways of quantifying protein abundance. It has been shown that that 
the three most intense tryptic peptides for a given protein are enough to allow an accurate 
estimation of a given amount of protein. This method, termed “Top3”, requires an internal 
standard to calculate a universal signal response factor, defined as counts/mol (Silva et al., 
2006).  
Similarly, intensity-based absolute quantification (iBAQ) of proteins uses the MS signal an 
approximation to protein abundance. First, the spectral intensities for individual proteins are 
divided by the number of theoretical tryptic peptides to derive iBAQ values, which are then 
logged and plotted against known concentrations of spiked-in standard proteins. The slope 
and the intercept from the obtained linear regression are used to calculate molar amounts 
for all identified proteins (Schwanhäusser et al. 2011).  
In contrast to the Top3 and iBAQ methods, total protein approach (TPA) calculates the 
absolute amount of protein based on the proportion of their MS signal to total MS signal 
(Figure 1.16). In addition, the TPA method does not require any additional protein standards 
(Jacek R Wiśniewski and Mann 2012; Jacek R Wiśniewski and Rakus 2014). It is assumed that 
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total MS signal from sample of interest reflects the total protein content within the cell while 
the total signal for a given protein is proportional to its abundance within a cell: 
		 	
  	
	   
Protein concentration can be calculated by multiplying total protein by molecular weight 
(mW) of a given protein: 
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In addition to ease of use and no requirement for expensive reagents or standards, the TPA 
method can be also applied to the meta-analysis of already published data sets. The feasibility 
of using TPA method for protein quantification was verified using a mixture of proteins with 
defined concentrations (Jacek R Wiśniewski et al. 2012).  The method was demonstrated to 
have high accuracy for quantifying E.coli proteome (Jacek R. Wiśniewski and Rakus 2014).  
Individual protein copy numbers can be calculated by using total protein concentration that 
is specific to cells and should be determined separately. This value for most cell types is  
around 200-300 g/l. The TPA method was further developed into ‘proteomic ruler’ approach 
that uses intensity of histones to calculate protein copy number (Figure 1.16). 
 
Figure 1.16 Explanation of total protein amount (TPA) and ‘proteomic ruler’ methodology. Adapted from 
Wisniewski et al., 2014. 
Histones are tightly wrapped around DNA with a defined mass ratio of 1:1. The amount of 
DNA per cell depends both on ploidy and on the size of the genome, which are usually well-
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known for a given organism (Jacek R Wiśniewski et al. 2014). Protein copy number is 
calculated from Avogadro’s number (NA; 6.022140857 × 1023) according to the following 
equation:  
		 	
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1.5.5 Absolute quantification using stable isotopically labelled standards 
Absolute quantitation can achieve the high level of accuracy when using spiked-in labelled 
standards.  In principle, the labelled standard is added in known concentrations to the test 
sample prior to MS analysis. The MS signal of spiked-in standard allows the direct comparison 
and quantification of all proteins present in the sample (Shao-En Ong and Mann 2005).  There 
are several methods that use spiked-in labelled standards in MS analysis. Both AQUA and 
QconCAT use peptides with incorporated stable isotopes and have become well established 
in the last decade. 
Absolute quantification (AQUA) method is based on the use of synthetic peptides that have 
been labelled with stable isotopes to compare against native peptides in the test sample. 
AQUA synthetic peptides are added in known concentrations into the, which allows 
quantitative determination of absolute protein concentrations (Gerber et al. 2003). The main 
disadvantage of using AQUA method is high cost of producing many synthetic peptides to 
quantify several proteins at the same time. 
In contrast to AQUA peptides, QConCAT is an artificially designed protein that is made of  
concatemers of tryptic Q peptides for several target proteins. Each QConCAT consists of at 
least two proteotypic (specific to a given target protein) peptides for each of the proteins of 
interest. Peptides are combined together into a single gene, which is expressed in E.coli grown 
with stable isotopes and subsequently purified (Beynon et al. 2005). Digesting a known 
amount of QconCAT by trypsin generates a set of labelled peptides that can be used to 
quantify unlabelled peptides derived from proteins of interests. By using QConCAT, it is 
possible to accurately quantitate up to 30 target proteins at the same time (Simpson and 
Beynon 2012).  
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1.5.6 In vitro chemical labelling with stable isotopes 
Stable isotope labelling techniques can be divided into two groups: in vitro chemical labelling 
or in vivo metabolic labelling (Fig 1.17). The former depends on post-harvest labelling of the 
protein samples before or after proteolysis. The labelling can be made by targeting thiol 
groups of cysteine residues using isotope coded affinity tags (ICAT) (Gygi et al. 1999) or by 
directly targeting amino acid termini of peptides using isobaric tags for relative and absolute 
quantification (iTRAQ) (Ross et al., 2004) or tandem mass tags (TMT) (Thompson et al. 2003).  
ICAT reagent consists of three functional elements: a specific thiol-reactive group, an 
isotopically-coded linker and biotin tag (Gygi et al. 1999). Two different isotope linkers are 
utilised to compare peptides from two different experimental conditions, while the biotin 
group allows selective capture and analysis of peptides containing (relatively uncommon) 
modified cysteine residues.  This leads, on the one hand, to reduced sample complexity, which 
simplifies data analysis, but also significantly decreases proteome coverage since proteins 
lacking cysteine cannot be quantified (Steen and Mann 2004).  
Unlike ICAT, iTRAQ can be used to investigate multiple (usually four, 4-plex, or eight, 8-plex) 
experimental conditions within a single experiment. The principle behind iTRAQ involves the 
use of isobaric mass labels at amino termini and lysine side chains of tryptic peptides in a 
digest mixture. The iTRAQ reagents are designed in such a way that all labelled peptides are 
isobaric (hence name) and have the same chemical properties, making them indistinguishable 
during liquid chromatography separations (Ross et al., 2004). Labelled peptides produce so-
called “reporter ions” in MS/MS following collision-induced dissociation (CID) that are used 




Figure 1.17 Comparison of in vivo and in vitro stable isotope labelling approaches. SILAC, stable isotope labelling 
with amino acids in cell culture; ICAT, Isotope-coded affinity tags; iTRAQ, isobaric tags for relative and absolute 
quantitation; TMT, tandem mass tags. Each method can be applied to study limited number of experimental 
conditions. 
The principle behind tandem mass tags (TMT) method is similar to iTRAQ. TMT reagent is 
comprised of an amino acid tag linked to a sensitization group, which has a guanidine 
functionality, an amino acid that normalizes the mass, and cleavage enhancement group 
(proline). The tags are designed in such a way that following CID, TMT fragment is released to 
generate an ion with specific mass-to-charge ratio (Thompson et al. 2003). The advantage of 
using iTRAQ or TMT method over ICAT is that every observable peptide can be labelled and 
not only cysteine-containing peptides. 
1.5.7 In vivo metabolic labelling with stable isotopes 
Metabolic labelling is based on the incorporation of stable isotope labels into proteins during 
cell growth. Proteins are quantitated by measuring the relative isotope ratios of light and 
heavy peptide pairs.  The prototrophic cells such as bacteria can be easily labelled by addition 
of stable nitrogen isotopes (14N/ 15N pair). Incorporation of 15N into a peptide will lead to 1Da 
mass shift per each nitrogen atom.  However, data analysis is challenging since the mass shift 
depends on the length of the peptide and its amino acid composition (Gruhler et al, 2005). 
The need for a better experimental design led to the development of stable isotope labelling 




1.5.8 Challenges in analysis of quantitative proteomics data 
The challenges of many proteomic studies result from both the complexity of the proteome 
and the wide dynamic range of concentrations for individual proteins. For example, human 
genome consists of 20,000 genes that, due to splicing or proteolysis, can translate to even 
100,000 of different proteins. The abundance of protein species can span more than 10 orders 
of magnitude. Many quantitative proteomics studies focus on the investigation of biological 
variation rather than technical variation arising from sample preparation and MS data 
acquisition. Proper experimental design and selection of statistical tests can significantly 
reduce errors (Käll and Vitek 2011). What is more, the comparison of quantitative proteomics 
data with published studies can be problematic due to variability in data acquisition, analysis 
and even instrument performance (Nesvizhskii et al., 2007).  
 
Figure 1.18 Common sources of errors in quantitative proteomics workflows.. Boxes in blue and orange represent 
different experimental conditions. Horizontal lines mark when two samples are combined, while dashed lines 
indicate points at which experimental variation is most likely to occur.. Adapted from Bantscheff et al. 2012. 
Regardless of what method is used to study changes in protein expression in several 
experimental conditions or over time, all methods have inherent errors and limitations (Figure 
1.18). For instance, metabolic labelling using stable isotopes have been shown to be the most 
accurate method, but the labels can be expensive and the technique cannot be applied to 
study clinical samples and primary cell lines. Another disadvantage of metabolic labelling is 
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that up to 2-3 conditions can be tested at the same time. This problem can be avoided by 
using chemical labelling methods such as iTRAQ or TMT (Bantscheff et al. 2012). On the other 
hand, chemical labelling might be inaccurate since sample mixing occurs at peptide level, so 
the sample loss might be unequal. In addition, co-elution of reporter ions can lead to 
substantial loss of quantitative data (Altelaar et al. 2013). 
Absolute quantification requires very good calibration of spike-in standard to achieve high 
quality quantitative dataset. In addition, the standards might be expensive. Recently, label-
free quantification (LFQ) has gained more popularity as no labels are required so, in theory, it 
can be applied to any type of organism to explore unlimited number of conditions at the same 
time. However, data analysis is more complicated and the sufficient number of biological 
replicates is required to obtain enough statistical power to find significant differences 
between experimental conditions (Neilson et al. 2011).. 
1.5.9 Difference between protein “abundance” and protein “regulation”  
Protein abundance describes a dynamic balance between all the cellular processes affecting 
the amount of protein within a cell. This includes protein transcription, mRNA processing and 
degradation, as well as translation, protein localization using signal peptides and 
modifications.  Protein abundance is often described in units of absolute concentrations, for 
example defined as number of molecules per cell or molar concentrations.  
Majority of proteomic studies have been designed to compare differences in protein 
abundance between two to ten different conditions. Such increase or decrease in protein 
abundance can be described as “up-regulation” or “down-regulation”, respectively. Such 
changes in protein abundance can only be described in relative terms (hence it is relative 








1.6 Principles of SILAC, Stable Isotope labelling of amino acids in cell culture 
1.6.1 Definition of SILAC  
In SILAC (stable isotope labelling of amino acids in cell culture), proteins can be labelled in cell 
culture with heavy isotopes of essential amino acids. The SILAC method was first introduced 
in  for in vivo incorporation of certain amino acids into mammalian proteins. Mammalian 
cell lines are cultured in media lacking an essential amino acid but are supplemented with 
isotopic (but non-radioactive) form of this amino acid. It is estimated that - cell doublings 
are needed for ≥% incorporation (Ong ; Ong and Mann ). This part of SILAC study 
is called adaptation phase.  
Typically, cells are labelled with lysine and arginine because trypsin, a commonly used 
protease, cleaves at C-termini of these amino acids, forming a complex peptide mixture in 
which all peptides are labelled and can be used for quantification. Each peptide has either 
“heavy” or “light” form that can be resolved in a mass spectrometer due to their mass 
difference. The differential treatment between light and heavy cell populations can be easily 
interchanged by the researcher. Such label swap experiments can both validate biological 
findings and exclude the possibility of any experimental error arising from SILAC labelling (Ong 
and Mann 2006).  
In the following sections  label swap experiments are referred as “forward SILAC” (FS) and 
“reverse SILAC” (RS) experiments. Reverse SILAC experimental ratios must be transformed 






Figure 1.19 Examples of light, medium and heavy amino acids for SILAC. Red asterisk indicates the position of 
stable isotopes (containing 13C and 15N). Incorporation of respective light and heavy amino acids into proteins by 
cells in various experimental conditions can be measured by mass spectrometry. 
As discussed already, one of the limitations of metabolic labelling experiments is the number 
of conditions that can be tested within a single experiment. Using the combination of lysine 
and arginine (“light”, “medium” and “heavy”, Fig 1.19), maximum of three experimental 
conditions (SILAC 2-plex or 3-plex) can be studied. It is also possible to run a SILAC 5-plex 
experiment with arginine alone, but the peptide quantitation becomes limited. Another 
option to study five experimental conditions is to perform two SILAC 3-plex experiments with 
staggered experimental design (Olsen et al. 2006; Dengjel et al. 2007). 
1.6.2 Stable isotope incorporation and issues with arginine to proline conversion  
One of the problems associated with the use of arginine in SILAC is the possibility of metabolic 




Figure 1.20 Metabolic conversion of arginine to proline in SILAC experiments. The conversion of isotopic arginine 
to proline causes inaccuracy in quantitative proteomic experiments based on A) Mass spectra of peptide 
containing arginine solely from 1:1 mixture of light and heavy labelled samples. Expected light and heavy 
counterparts of peptide ions have the same signals when the incorporation of the heavy isotopes is ≥97% B) Mass 
spectra from peptides containing proline(s) in which arginine to proline conversion occurred in the same 1:1 
mixture. Obtained heavy proline signal was subtracted from the expected heavy peptide signal C) Structures of 
heavy arginine (Arg10 & Arg6) and heavy proline (Pro6 & Pro5) D) The fragment of the metabolic pathway 
converting arginine and proline. Adapted from Bendall et al., 2008.  
The conversion of arginine to proline is an important factor that can affect the accuracy of 
SILAC quantitation. In the absence or minimal conversion of arginine to proline, a 1:1 mixture 
of light and heavy labelled samples is achieved (following the confirmation of full 
incorporation). On the other hand, in the case of conversion of arginine to proline, the 
expected heavy arginine signal is reduced and transferred to heavy proline containing 
peptide. If a peptide contains more than one proline, the signal can be further reduced. 
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As shown in the figure above, the peptide containing heavy proline reduced the signal of 
heavy arginine containing peptide by 20%, while the peptide containing two heavy prolines -  
by another 10%. This can lead to the light: heavy arginine ratio of 1: 0.7 instead of expected 
1:1. Quantification accuracy can be severely affected when conversion of arginine to proline 
exceeds more than 5% of all peptide-to-spectrum matches (PSMs). Additional 
supplementation with free proline (Bendall et al. 2008), deletion of genes involved in 
metabolic pathway (Bicho et al. 2010) or simply titration of arginine supplementation are one 
of the few methods of limiting proline conversion. 
1.6.3 Normalisation and transformation of SILAC data 
Any SILAC investigation should start from experimental design to include number of  biological 
and technical replication, selection of optimal sample preparation for mass spectrometry, 
choice of processing software and statistical tests. Visualization of SILAC ratios in the 
histogram can help to if the mixing ratio of the 1: 1 protein is correct. Ideally, the data should 
follow the normal distribution with median and median close to 1, because most of the 
protein expression does not change significantly between experimental conditions. Many 
researchers have found that due to inherent errors, the ratio can be shifted to the right 
(‘heavy-tailed’) and may not be exactly located at 1. To correct for such errors, median 
normalisation is performed which shifts the experimentally obtained median for the dataset 
towards 1. Median normalisation is done automatically in MaxQuant (Cox and Mann 2008) or 
can be performed using other available software such as R  (Gatto and Christoforou 2014) or 
Perseus (Tyanova et al. 2016).  
Logarithmic transformation of SILAC ratios has several functions, including data linearization 
and making the SILAC ratios more ‘normal-like’ distributed (Keene 1995). In addition, there is 
a better relationship between the results from fold-change and statistical tests, which is 
important if the two methods are to be combined. 
1.6.4 Analysis of SILAC data using biological significance 
Many methods for the analysis of  proteomic data sets, including SILAC, were derived from 
genomic and transcriptomic approaches (Allison et al. 2006). There are several reasons, above 
all a large number of variables with a small sample size and data distribution not always 
Gaussian (Li 2011). Identification of differentially expressed proteins between experimental 
conditions can provide valuable insights into the biological processes of an organism.  
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The use of fold-change (FC) cut-off for the differential determination of protein expression is 
the obvious choice for the analysis of SILAC data sets. It is believed that proteins that are not 
differentially expressed have H/L ratio close to 1 or (0 if the ratio is log-transformed). It was 
observed that SILAC quantitative results (H/L ratios) can be within 20% of standard deviation, 
hence at least 1.5 fold-change cut-off is appropriate (S. E. Ong, Foster, and Mann 2003). The 
validity of using cut-off is higher when label-swap (reverse SILAC) experiment is performed. 
Label-swap experiments not only validate quantitative results but also eliminate false 
positives and experimental artefacts.  
Differentially expressed proteins can be examined further by plotting forward SILAC and 
reverse SILAC ratios against each other (Fig 1.21 A). Vertical and horizontal zero lines not only 
help to compare the spread of data but also divide the plot into four squares (see Table 1.2 
for details). SILAC-based quantitation accuracy is high (Ong et al., 2003), meaning that  fewer 
biological and technical replicates are required which can substantially reduce both the time 
and cost of the experiment.  
Table 1.2 Guidance to analyse combined forward and reverse SILAC data using fold-change cut-off.   
Square Meaning Explanation 
Upper left & 
lower right 
False positives and 
experimental artefacts 
Disagreement between labelling experiments 
 
Upper right Up-regulation of light-labelled 
proteins 
Agreement between labelling experiments 
 
Lower left Up-regulation of heavy-labelled 
proteins 
Agreement between labelling experiments 
 
1.6.4 Analysis of SILAC data using statistical significance 
There are two statistical tests that can be used for SILAC data analysis available: one sample 
t-test and significance A or significance B test (Cox and Mann 2008).  
Significance A is a measure of the significance score for logarithmic protein ratios, which can 
be defined as the probability of obtaining a logarithmic ratio at least one order of magnitude 
under the null hypothesis that the distribution has normal upper and lower tails. But the 
problem is that in case for very abundant proteins, the statistical spread of up-regulated 
proteins is much more concentrated in the case of those with low abundance. To overcome 
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this problem, significance B was developed, which is calculated only on the protein subsets 
obtained by binning of their intensities (Cox and Mann 2008).   
One sample t-test can be used to check which SILAC ratios are significantly different from 0. 
When comparing multiple SILAC data sets, two-sample t-test or ANOVA might be appropriate 
to check for significantly differentially expressed proteins (Tyanova et al. 2016). When 
applying the t-test for SILAC data analysis, several requirements should be met, including data 
of continuous and independent type, with a distribution close to normal and without 
significant outliers. If the above criteria are not met, it is possible to use non-parametric 
version of the t-test called Wilcoxon rank test.  
Regardless of whether t-test or significance A or B is used for determine differential proteins 
expression, multiple tests are done on individual proteins. There are several methods that 
can be used for adjusting p-values to correct multiple-comparison errors. One of the oldest is 
Bonferroni correction, which determines the alpha value (probability of type I error) for each 
test performed and strongly controls the family-wise error rate (FWER), which incorrectly 
rejects the null hypothesis (‘false positives’) (Armstrong 2014). The related ‘single-step’ 
procedure, known as Holm-Bonferroni, adjusts p-values in sequential manner and is almost 
as strict as Bonferroni (Abdi 2010).  
One of the reasons that none of these methods is suitable for analysing "omic" data is because 
the actual levels of protein (or gene) expression are strongly correlated because proteins are 
co-regulated. Benjamini-Hochberg method (Benjamini and Hochberg 1995) offers a good 





Figure 1.21  A) Visualization of SILAC data. Scatter-plot of log2 H/L ratio normalized (forward SILAC) against log2 
L/H ratio normalized (reverse SILAC) shows up-regulated proteins (red dots), down-regulated proteins (blue dots) 
and false positives (black dots). B) The volcano plot of fold change (FC)  against –log10 of p-values derived from 
a statistical test shows non-significant proteins (grey dots), biologically significant (FC-only, orange dots), 
statistically significant (p-value, green dots) and both biologically and statistically significant (‘double-filtering’, 
red dots).  
Significance values can be visualized and compared to the size of the fold change (FC) for a 
given list of proteins. A ‘volcano plot’ is a type of scatter-plot that arranges genes or proteins 
along the dimensions of biological (FC) and statistical significance (Fig 1.21 B). The horizontal 
dimension is logarithmic fold change between the two groups, while the vertical axis 
represents the negative log (usually base 10) of the statistical values (e.g., p-values or q-
values, if the data is FDR-adjusted ). Negative logarithm of the p-values is a convenient way 
to visualize the data as the smallest (and most significant) p-values (or q-values) are plotted 
at the top, while the non-significant proteins are at the bottom of the plot. The first axis 
indicates the biological impact of the change, while the second indicates the statistical 
evidence or, in other words, the reliability of the observed fold change. The combination of 
both approached is called ‘double-filtering’ (Zhang and Cao 2009) and allows the selection of 






1.7 Temporal quantitative proteomics – studying protein turnover  
1.7.1 Definition of protein turnover 
Cellular proteins are in the process of continuous renewal in both prokaryotic and eukaryotic 
organisms. Interestingly, only 50% of protein abundance can be explained by changes in 
mRNA concentration (de Sousa Abreu et al. 2009). The protein abundance is controlled by the 
combined transcription and translation processes followed by post-translational 
modifications and localization (Vogel et al. 2010).  
“Protein turnover” is defined as the continuous degradation of intracellular proteins to their 
amino acids and replacing them with the same amount of newly synthesised proteins (Fig 
1.22). Protein turnover consists of two separate processes of protein degradation and protein 
synthesis. Ideally, each of them should be quantitated separately to allow for correct 
estimation of protein turnover (Hawkins 1991).  
 
Figure 1.22 Theoretical model of protein turnover. The abundance (concentration) of proteins in the cell is 
controlled by the opposing processes of synthesis and degradation. The rate of degradation is more related to 
the metabolome and depends mainly on the activity of degradation pathways and the state of the protein pool. 
On the other hand, the rate of synthesis is more dependent on the transcriptome, in particular mRNA 
concentration and the rate of initiation. Adapted from Beynon 2005.  
An increase in protein expression may be due to increased rates of synthesis or reduced rates 
of degradation. In contrast, there are several pathways involved protein degradation that 
differ by their dependence on the lysosome. 
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1.7.2 Protein synthesis 
Proteins are synthesised by ribosomes from mRNA in the process of translation, one of the 
core parts of central dogma of biology. Protein translation can be divided into four main 
stages: initiation, elongation, termination and recycling. 
The protein translation is mainly controlled at the initiation stage, where the initiation codon 
is base-paired with the corresponding tRNA in the ribosomal peptidyl (P) site (Jackson et al.,  
2010). During elongation, the aminoacyl tRNA (charged with a cognate amino acid) enters the 
acceptor (A) site. If the match between codon and tRNA is correct, the peptide bond is formed 
between the two amino acids. This process is repeated until a stop codon is encountered, 
which marks the termination stage. In the recycling phase, the ribosomes are released from 
mRNA and the deacetylated tRNAs are ready for the next initiation (Kapp and Lorsch 2004). 
Following translation, the synthesized protein can be translocated via signal peptide to the 
site in the cell (e.g. nucleus, mitochondrial membrane, etc.) and further modified to obtain a 
fully functional protein. 
The translation is usually cap-dependent and the translation codon is placed within highly 
conserved Kozak sequence (Kozak 1987). Translation initiation can be also controlled by 
specific sequences present in the 5’ untranslated regions upstream of genes (Calvo et al., 
2009).  
The elongation efficiency is also an important factor controlling steady-state protein 
abundance. Frequent codons are thought to have more tRNAs available than infrequent 
codons, which results in the specific codon usage and tRNA adaptation that can impact the 
rates of elongation. This correlation have been used to predict translation efficiency in 
bacteria and simple eukaryotes such as yeast (Ermolaeva 2001). 
1.7.3 Protein degradation  
Lysosome-dependent degradation is thought to be relatively non-selective and is usually 
induced by stress in response to changes in environmental conditions such as depletion of 
nutrients  or accumulation of protein aggregates in the cell. Lysosomes, containing various 
digestive enzymes, take up cellular proteins by fusion with autophagosomes, which are 
formed by the enclosure of the cytoplasmic or organelle areas (e.g., mitochondrium) in 
fragments of endoplasmic reticulum (ER). This fusion creates phagolysosomes that digest the 
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content of autophagosome (Cooper and Hausman 2009) in a process known as autophagy (or 
autophagocytosis). The resulting breakdown products are recycled to produce new cellular 
components or to generate energy (Settembre et al. 2013). 
In contrast to the lysosome-dependent proteolysis, the ubiquitin-dependent pathway is much 
more targeted. It involves labelling proteins for degradation by covalently linking ubiquitin 
molecules to lysine residues.  Polyubiquitinated  proteins are then recognized by a protease 
complex called a proteasome and degraded to peptides and component amino acids. The 
addition of ubiquitin molecules is regulated by three different enzymes: E1 (ubiquitin-
activating enzyme, E2 (ubiquitin-carrier enzyme) and E3 (ubiquitin ligase).  Polyubiquitinated 
chains are then released by de-ubiquitinating  enzymes (DUBs) and free ubiquitin molecules 
are recycled (Hegde 2004). 
Calcium-dependent pathway has a smaller role  in the degradation of cellular proteins 
(Hawkins 1991). Calcium-dependent proteases, known as calpains, are cysteine proteinases 
that are active at neutral pH and are dependent on Ca2+ for catalytic activity. There two known 
isomers (calpain-1 and calpain-2), which differ in their sensitivity to the amount of calcium in 
the cell. On the other hand, the function of calpastatin polypeptide is to inhibit the function 
of two calpains (Mellgren 1987). It has been suggested that the calpain system also  has other 
functions, including cell motility, signal transduction, apoptosis and even cell cycle regulation 
(Goll et al., 2003). 
1.6.4 Defining steady state systems 
It is important to consider certain factors when studying protein turnover. It is thought that 
rates of protein turnover are equivalent to the associated rates of protein degradation under 
conditions of growth. In contrast, during the periods of wasting, the rates of protein turnover 
are closer to the rates of protein synthesis (Pratt 2002). Assuming steady-state conditions, 
where there is zero net change of parameters in a given system, facilitate the study of protein 
turnover. In terms of protein abundance, the amount of protein may not change during the 
experiment because the rate of translation and degradation is completely balanced. In other 
words, the cell is in steady-state in terms of the concentration of this protein.  Cells may also 
encounter perturbed or non-steady state systems at high levels of stress, in response to 
change in environmental conditions or gene mutations (Vogel and Marcotte 2012).  
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It is believed that the population of cells growing in exponential (log) phase goes into steady-
state. Therefore, most research on protein turnover focuses solely on this part of cell growth. 
Despite of cells undergoing cell division, the average concentration of a given protein in the 
entire cell population remains approximately constant and thus agrees with the assumptions 
of steady-state (Vogel and Marcotte 2012).  
1.6.5 Methods to study protein turnover 
Measurement of protein turnover on a global scale is a challenge in many ways. Ideally, both 
protein synthesis and degradation should be measured simultaneously to obtain a true 
estimate of protein turnover. The first developed methods focused purely on the study of  
protein degradation and concerned only a few proteins at that time. With the discovery of 
new strategies, it is now possible to study hundreds of proteins in a single experiment 
(Yewdell et al. 2011). 
Approaches to the study of protein turnover can generally be divided into two groups: 
reporter-dependent and reporter-independent. In the first case, genes are expressed as 
fusion proteins with either a fluorescent protein or an epitope tag. Their stabilities, evaluated 
based on the presence of the marker, indicate the protein degradation. An extension of this 
method, called global protein stability profiling (GPSP) has been developed, and it is uses two 
different fluorescent proteins: red fluorescent protein (RFP) and green fluorescent protein 
(GFP). The ratio of the RFP/GFP is then converted  to a protein half-life value (Yen et al. 2008). 
However, this method is imperfect because the use of fluorescent proteins may impair 
protein biogenesis (e.g., binding of chaperones necessary for correct folding), disrupt 
ubiquitylation and even block the targeting of signal peptides (Snapp 2009). 
Another method to study protein turnover uses cycloheximide. Cycloheximide is an antibiotic 
produced by Streptomyces griseus and inhibits protein synthesis with little negative effect on 
growth (Ennis, H. L., & Lubin 1964). In this experimental setup, one cell culture is treated with 
cycloheximide for a specified time, while other is not treated (control). The comparison of 
protein abundance between untreated and treated cells allows to estimate the depletion rate 
of protein amount in the cell that can be attributed to the protein degradation (Larance and 
Lamond 2015). The advantage of this method is the high recovery of the proteins from cells, 
but at the expense of interference with some cellular functions, if the protein synthesis is 
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blocked for a long time. For this reason, ‘cycloheximide-chase’ method is not suitable for 
studying proteins with long half-lives (Yewdell et al. 2011). 
1.6.6 Pulse SILAC strategies to study protein turnover 
The SILAC method has been used to quantitate the proteome in two (duplex) or three (triplex) 
different conditions, but it can also be adapted to the study of protein turnover (Milner 2006). 
The cells are pulse-labelled with heavy isotopes of amino acids supplemented in the culture 
medium for a given period (hence this method is called “pulse SILAC”). The ratio of heavy (H) 
to light (L) peptides indicates the turnover rate of a protein. Protein turnover is affected by 
both synthesis and degradation, therefore H/L ratio cannot be used to directly provide 
information about the translation rate. For example, a high H/l ratio may suggest a high 
translation rate of a relatively stable protein or a low translation rate of a protein that is 
quickly degraded.  
There are several possible experimental designs of pulse SILAC study (Fig 1.23). In the first 
approach, the cells are grown in medium containing heavy isotopes of amino acids (lysine and 
arginine) till full incorporation. Upon the start of the experiment, the medium is switched into 
a medium containing light isotopes of amino acids. In this way, the H/L ratio describes the 
decay of heavy label over time and can be used to calculate protein degradation (Yee et al. 
2010). The situation is completely opposite in the second experimental design, in which the 
cells are grown in light isotope containing medium until full incorporation and switched into 
medium containing heavy isotope versions of amino acids. The measured H/L ratio refers to 
the label incorporation into de novo synthesized proteins (Schwanhäusser et al. 2011). It can 
be argued that starting with light isotope is more recommended since incorporation of 
naturally occurring light isotopes is 100%. When using incorporation with heavy labels, the 
incorporation will be upmost 99% due to label impurities, leading to errors in quantitation 
(Beynon 2005). 
A more accurate way of comparing the rate of protein translation  between two samples is to 
pulse-label with two different stable isotopes. In this method, the cells are cultured in media 
containing either light or medium isotopes of arginine and lysine until full incorporation. The 
medium of the cells growing with the medium isotopes is then changed for heavy isotopes. 
The cells are harvested at different time points, along with the equivalent number of cells 
growing in the light medium. As a result, M/L ratio measures the protein degradation, while 
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H/L ratio quantify the protein synthesis. In addition, H/M ratio estimates the overall protein 
turnover  (Boisvert et al. 2012). 
 
Figure 1.23 Schematic of experimental designs using pulse SILAC to measure protein turnover. A) The decay of 
the heavy label; B) The incorporation of the heavy label; C) Enhanced pulse SILAC design uses light, medium and 
heavy labels; light labelled sample serves as the control; the heavy label incorporation marks new protein 
synthesis, while the decay of medium label – protein degradation. 
1.6.7 Analysis of protein turnover data 
Regardless of the experimental design used, the type of data generated is similar: series of 
ratios collected at a specific time.  To recover a degradation rate (or time) from a change in 
the labelling of the protein, data must be fitted to the line using a linear model or exponential 
decay model (facilitated by non-linear square fitting), according to the experimental design 
(Figure 5.4). When the linear model is used to fit the data, SILAC ratios must be transformed 
logarithmically despite the fact this process can introduce distortions (Claydon and Beynon 
2012). On the other hand, experimental ratios can be used directly when using the 
exponential decay model.  
Exponential decay models are suitable for modelling many chemical and biological processes 
in which the speed of a process is proportional to the remaining amount. In the case of pulse 
SILAC experiment, this method is used to model degradation rate as M/L ratio decreases over 




Figure 1.24 Mathematical methods used to fit pulse SILAC data to the line. A) The linear model is used to fit the 
decay of the heavy isotope over time; B) Linear model is used to fit the incorporation of the heavy isotope over 
time C); Simple exponential model is used with non-linear square curve fitting to calculate both decay (due protein 
degradation) and incorporation (due to protein synthesis) of the isotope over time. 
1.7 Aims and objectives 
The aim of the project is to characterize the dynamic changes in protein biomass 
accumulation in industrially relevant CHOK1SV GS knock-out (GS-KO) cell lines using mass 
spectrometry-based quantitative proteomics tools.  
The first step of the project would be the development of robust sample preparation 
workflow for mass spectrometry analysis. This would include the optimization of protein 
extraction and quantification, followed by testing optimal protease conditions and finding 
suitable peptide fractionation strategies to achieve high-coverage proteomic analysis of CHO 
cells. Such optimised protocols would be used to obtain more quantitative information about 
protein expression in the cell culture. 
After the selection of the best sample preparation methods, differences in protein expression 
between exponential and stationary phases will be studies using SILAC. The importance of 
how these factors were considered to establish quantitative proteomics workflow for CHO 
cells. Determination of the number of differentially expressed proteins is the most important 
outcome of any SILAC experiment since they have the potential to become new targets for 
cellular and metabolic engineering. 
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After establishment of SILAC method in CHO cells, a novel way to quantifying dynamic 
changes in CHO cell proteome in absolute terms will be presented. The method has been 
designed on two separate mass spectrometry-based proteomic approaches: pulse SILAC and 
total protein amount (TPA) method. The measurement of discrete protein turnover and 
associated protein copy number values takes place during exponential phase. By combining 
two parameters together, it is possible to derive another value known as rate of protein 
turnover. This parameter measures the amount of cellular synthesis and degradation 
machinery that is invested in maintaining the abundance of individual proteins at steady 
state.  The values of rates of protein turnover will be calculated and compared for both stably 
producing and parental CHO cell lines.  
By referring obtained rates of protein turnover to the amino acid sequence, it may be possible 
to calculate dynamic amino acid usage that has the potential to form basis of novel fed-batch 
strategies for CHO cells. In addition, the protein sequence data can be linked to the 
corresponding transcript sequences to calculate the dynamic codon usage bias for CHO cells. 
This information may be used to develop novel in silico gene design methods for improved 
heterologous protein expression in CHO cells.   
1.8 Outline 
Below is a summary of each thesis chapter presented. 
Chapter 2: Materials and methods 
This chapter contains a full description of materials and methods used in experimental 
chapters 3, 4 and 5. Details will be given on types of cell lines used in the research project and 
calculation of cell culture parameters. For mass spectrometry experiments, information on 
sample preparation methods, MS data processing and bioinformatics analysis will be 
provided.  
Chapter 3: Optimization of sample preparation for mass spectrometry to achieve high-
coverage CHO proteome 
This chapter deals with the development of robust protocols for sample preparation for the 
shotgun analysis of CHO cell proteome. Several methods for protein extraction and two main 
sample preparation techniques, in-gel trypsin digest and filter-aided sample preparation 
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(FASP), will be explored. In addition, the feasibility of using porous graphitic carbon for 
peptide separation will be tested. Finally, the effectiveness of sample extraction protocols will 
be confirmed on several types of mass spectrometers. 
Chapter 4: Relative quantitation of proteome changes between exponential and stationary 
phases in cell culture of CHO cells using SILAC  
This chapter concerns with the application of standard SILAC (stable isotope labelling of amino 
acids in the cell culture) method to evaluate the fundamental changes in the cellular protein 
during the growth of CHO cells. Full incorporation of stable isotopes into newly synthesised 
proteins and no conversion of arginine to proline will be confirmed. The protocol for analysing 
raw MS data and further bioinformatic processing using publicly available software is also 
outlined and can be adapted to several other experimental projects. Several groups of 
differentially expressed proteins have been found that are involved in key cellular and 
metabolic processes. It is suggested that they will be suitable targets for cellular engineering. 
Chapter 5: Defining the protein biomass objective in CHO cells using enhanced pulse SILAC 
and total protein approach (TPA) 
The focus of this chapter will be the establishment of a novel protocol to quantify protein 
biomass accumulation in CHO cells. Two separate mass spectrometry methods will be used: 
total protein amount (TPA) approach, to estimate protein abundance, and enhanced pulse 
SILAC, to study protein turnover by de novo incorporation of stable isotopes of amino acids 
over time. By combining these two parameters, it will be possible to obtain a new parameter, 
termed “protein turnover rate”, which is a reflection of how much cellular synthesis and 
degradation is invested in maintaining steady-state abundance of individual proteins. Specific 
groups of proteins seem to be significantly up-regulated between producing and parental cell 
lines. Furthermore, dynamic rates of amino acid and codon usage will be determined using 
protein and mRNA sequence information, respectively. 
Chapter 6: Conclusions and future work 
The final chapter summarizes the major results of this project, describes limitation of the 




Chapter 2: Materials & Methods 
Presented research project contains a variety of methods for mammalian cell culture, sample 
preparation for mass spectrometry, experimental design of standard SILAC and pulse SILAC 
experiments and data analysis using publicly available software and bioinformatic databases. 
Results chapters will provide only a concise version of the methods detailed in this chapter 
with appropriate cross-referencing to this chapter.  
 2.1 Abstract  
The E22 stably producing cell line, expressing cB72.3 model antibody, was derived from Lonza 
Biologics’ proprietary CHOKSV GS-KO cell line. Its specific features are adaptation to growth 
in serum-free chemically defined media and the lack of functional glutamine synthetase 
enzyme. Routine culture of cells was performed using CD-CHO medium with (for GS-KO) or 
without (for E) glutamine supplementation and Viable Cell Count (VCC) was measured using 
Vi-CellTM, based on trypan exclusion assay. Routine subculture, cryopreservation and cell 
revival was performed according to biopharmaceutical industry standards. Specific mAb 
productivity was measured using Protein A chromatography. 
Following cell harvest with PBS, several protein extraction protocols were tested, including 
4xLB buffer, compatible with in-gel trypsin digest, TEAB buffer, suitable for in-solution trypsin 
digest or SDS-based buffer for filter-aided sample preparation (FASP). Details were also 
provided on protein quantification using RC DC protein assay and peptide fractionation using 
Hypercarb and reverse phase (RP) chromatography. Liquid chromatography (LC) and mass 
spectrometry (MS) parameters and associated conditions were described in detail for three 
different types of mass spectrometers (Amazon ETD, MaXis 4G UHR-TOF and Q Exactive HF). 
Additionally, steps of raw data processing and protein identification were specified for two 
database search engines: Mascot Daemon and MaxQuant. Details of experimental design 
were specified for both Standard Isotope Labelling in the Cell culture (SILAC) quantitative 
proteomics approaches: standard SILAC and enhanced pulse SILAC. Downstream processing 
of data with Perseus, including statistical analysis with significance A and B and calculation of 
settings for Total Protein Amount (TPA) method were provided. In-house developed script in 
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Matlab, facilitated by Levenberg-Marquardt algorithm, allowed fitting of pulse SILAC data to 
the exponential decay model and calculation of protein turnover. KEGG pathway, Gene 
Ontology and PANTHER database were used for functional annotation of proteins of interest. 
Finally, novel parameters of rates of protein turnover, amino acid usage and codon bias usage 
were derived.  
2.2 Mammalian cell culture 
This section describes the routine methods used in this project to monitor the growth of 
mammalian cells. 
2.2.1 Characteristics of CHO cell lines 
The cell lines producing monoclonal antibody (mAb) used in this project were derived from 
Lonza Biologics’ (Cambridge, UK) main proprietary Chinese hamster ovary (CHO) host called 
CHOKSV GS-KO (Xceed™).  This host cell line was derived from CHOKSV host, which was 
adapted to both growth in suspension and chemically-defined animal component-free 
medium. A specific feature of CHOKSV GS-KO  cell line is that both alleles of endogenous 
glutamine synthetase gene have been knocked out (hence the designation CHOKSV GS-KO), 
leading to the requirement of exogenous glutamine (http://www.lonza.com/custom-
manufacturing/development-technologies/gs-xceed-gene-expression-system.aspx).  
Stable producing cell line (referred to E22) was created by transfection of host cells with a GS 
Gene Expression vector encoding both glutamine synthetase (GS) and easy-to-express (ETE) 
chimeric B72.3 mouse/human (cB72.3) model antibody. Master working cell banks (MBCs) 
were provided by Lonza Biologics, from which working cell banks (WBCs) were generated in 
the laboratory in the University of Sheffield.  
2.2.2 Routine subculture 
A routine subculture of E22 cells was performed using 125 ml Erlenmeyer shake flasks with 
vented caps (Corning, Surrey, UK) in a volume of 30 ml of CD-CHO media (Life Technologies, 
Paisley, UK). Supplementation with 6mM glutamine was required only for subculture of 
parental (host) cell line (referred to GS-KO).  Shake flasks were incubated in at 37ᵒC with 5% 
CO2 (v/v) in air in shaking, non-humidified incubators (Infors UK, Reigate, UK) set at 140 rpm. 
The cells were subcultured every 3-4 days, while in mid-exponential phase of the growth, and 
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new cultures were seeded at an initial cell concentration of 2x105 cells/ml. Routine estimation 
of total cell concentration (TCC), viable cell concentration (VCC), viability (which is calculated 
by dividing viable cell concentration by total cell concentration and expressed as %) and cell 
diameter was performed by Trypan blue exclusion assay using a Vi-CellTM Cell Viability 
Analyzer (Beckman Coulter, High Wycombe, UK). 
2.2.3 Cell cryopreservation protocol 
CHOK1SV GS-KO cells were passaged 4 times before cryopreservation, which was performed 
on the 3rd day of subculture (i.e., mid-exponential phase), when the viability was >95 %. The 
volume of prepared cryopreservation medium (Vc) depended on the number of vials 
generated (Table 2.3). The volume of cell culture required to produce the appropriate number 




     (1) 
Where: Vsps: the required volume of cell culture  
               Vc = volume of cryopreservation medium 
               Xi=Viable cell concentration [106 cells/ml] 
 107 cell/ml = cell density to be added to each cryovial 
Freshly prepared cryopreservation medium was stored at 4ᵒC until use. The cell pellet was 
resuspended in cryopreservation medium containing DMSO as a cryoprotectant. The viable 
cell concentration and % viability was determined using Vi-CellTM before aliquots were 
dispensed into cryovials.  Vials were appropriately labelled and frozen at -70ᵒC freezer 
overnight in a Mr. Frosty™ Freezing Container (Sigma-Aldrich). The next day, the vials were 
transferred to the liquid nitrogen storage (at >130ᵒC).   
Table 2.3 Cryopreservation medium components. 
Component For 6 vials For 11 vials For 21 vials Final concentration 
CD-CHO 8.6 ml 14.6 ml 27.5 ml 1x 
Glutamine(200mM) 0.3 ml 0.51 ml 0.96 ml 6 mM 
DMSO 0.75 ml 1.275 ml 2.4 ml 7.5% (v/v) 




2.2.4 Cell revival protocol 
Vials containing 1.5x107 cells were thawed quickly (>1 minute) in a 37°C water bath set before 
being resuspended in 6 ml of CD-CHO medium (previously stored at 4°C to reduce 
temperature shock). Resuspended cells were centrifuged at 200 g for 5 min and the 
supernatant was removed. The cell pellet was then resuspended in 30 ml of CD-CHO medium 
(20% of working volume), pre-warmed to 37°C and the contents transferred to 125 ml 
Erlenmeyer flask with vented caps. The viable cell concentration and % viability was 
determined with ViCellTM. The cells were incubated at 37°C, 140 rpm 5% CO2 in shaking, non-
humidified incubator and were subcultured every 3 days (as described in section 2.2.2).  
2.2.5 Calculation of cell culture parameters  
Depending on the experiment, samples were taken every 24-72h and % viability was assessed 
with Vi-CellTM using the following equation 2: 
%= 

           (2) 
Where: 
TCC – total cellular concentration (x106 cells) 
VCC – viable cell concentration (x106 cells) 
The specific cell growth rate (µ; h-1), which is also related to the specific rate of biomass 
accumulation, is calculated using equation 3: 
 = 	()

   (3) 
Where: 
VCC – viable cell concentration (x106 cells) 
1 = end of exponential phase (h) 
0 = start of exponential phase (h) 
The time integral of viable cell concentration (IVCC; 106 cell day ml-1) is the area under the 
growth curve. If each cell has the same capacity to produce product in a given amount of time, 
IVCC quantifies the number of working cells in days (or hours) per unit of culture volume.  





	 × ∆+ IVCCt-1    (4) 
Where: 
VCC0 – viable cell concentration (x106 cells) 
0 = first point of analysis (day) 
1 = second point of analysis (day) 
The cumulative IVCC (IVCCtotal) can be calculated using equation 5: 
IVCCtotal = IVCCt + IVCCt-1   (5) 
Doubling time (Td) is defined as the interval between doubling the cells when the growth 




       (6) 
The daily specific production rate of culture (qMAb; pg cell-1day-1) was calculated using the 
equation 7: 
  =  
(		/
÷ ∆    (7) 
Where: 
T = titre (mg L-1) at first time point; 
0 = first point of sampling (day) 
1 = second point of sampling (day) 
The average specific production rate in culture (Qp; pg (cell day-1) is equal to the slope of 
linear regression analysis of antibody concentration (mg L-1) against IVCC (106 day ml-1). 
2.2.6 Measurement of specific monoclonal antibody productivity 
The amount of CB72.3 mAb produced by E22 cell line was assessed using Protein A 
chromatography. E22 cell line was grown in CD-CHO over 8 days. Cell culture samples were 
taken every day from time 0h to 192h. The supernatant was purified using Corning 0.2 µm  
filter tube (Corning, UK) to remove any remaining cells and debris. The samples have been 
analysed as two biological replicates. 25 µl of the purified  sample was transferred to the 
autosampler vials and 10 µl injected into 50 µl pick-up LC system.  
74 
 
The standard curve was prepared using the generic IgG1 kappa standard derived from human 
myeloma plasma (Sigma-Aldrich, UK). The standard comes as 1.25 mg/ml solution (in 20mM 
Tris buffered saline solution, pH 8.0), with an extinction coefficient of 1.4 at 280nm.The 
principle behind IgG antibody quantitation is based on selective binding to Protein A 
immunodetection column. Non-bound material is washed from the column and the remaining 
antibody released by decreasing the pH of the solvent. 
The standard curve using IgG1 kappa standard was produced based on 2 technical replicates. 
The sample was eluted over 5 min gradient and method was set up in Chromeleon (v 6.8) on 
u3000 LC system (Dionex, UK) using buffer A (50mM sodium phosphate, 5% acetonitrile, 150 
mM sodium chloride; pH 7.5) and buffer B (50mM sodium phosphate, 5% CAN, 150 mM 
sodium chloride; pH 2.5). The extinction coefficient for cB72.3 was calculated using Expasy 
ProtParam online tool (http://web.expasy.org/protparam/), which uses amino acid sequence 
of a protein to predict key physical and chemical parameters. The specific extinction 
coefficient was then applied to correct measured absorbance at 280 nm. 
2.3 Optimization of sample preparation for mass spectrometry  
This section describes the optimization and comparison of different methods used for sample 
preparation in mass spectrometry analysis. The data is presented in Chapter 3. 
2.3.1 Lysis buffer for in-gel trypsin digestion 
As protein extraction is one of the most crucial steps in sample preparation for mass 
spectrometry, several lysis buffers were tested for efficiency and robustness (Table 2.4). 107 
cells were harvested and washed twice with PBS pH 7.4, treated with 1 ml of RIPA buffer 
(typically used for radio immunoprecipitation assay, RIPA), incubated at 4ᵒC for 10 min and 
then centrifuged at 18,000g for 10 min (Sun et al. 1994). The supernatant was removed, and 
the remaining pellets were resuspended in 100 µl 4xLB (Laemmli buffer; commonly used to 
prepare samples for SDS-PAGE gels (Karlsson et al., 1994). After resuspension in 4xLB, the 
sample was incubated at 95ᵒC for 10 min. Similarly, 4xLB buffer was used on its own to directly 
lyse 107 cells. Each sample was further diluted (3:1, 1:2, 1:4, 1:5 and 1:10) with 4xLB buffer 
and loaded on the SDS-PAGE gel. 
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In addition to commonly used RIPA and 4xLB buffers, following buffers were also tested: GLB 
(general lysis buffer, mildly denaturing), urea DIGE buffer (Magdeldin et al. 2014), modified 
PTY buffer (Chen et al., 2010)  and 107 cells were lysed with 1 ml of urea DIGE buffer, incubated 
at room temperature for 10 min and centrifuged at 18,000 g for 20 min. Similarly, 107 cells 
were lysed with 1ml of PTY buffer or 1 ml of GLB buffer and incubated at 4ᵒC for 10 min and 
centrifuged for 10 min at 18,000g. Lysis efficiency was tested by treating any remaining pellet 
with 100 µl of 4xLB buffer (using method described above). Each sample was thoroughly 
vortexed and sonicated for 10 s with an interval of 20 s (repeated three times) to ensure DNA 
shearing. 
Table 2.4 Lysis buffer composition for in-gel trypsin digest 
 
Name Composition (Sigma-Aldrich or Fisher Scientific) 
RIPA 50 mM Tris-HCl pH 7.6 
150 mM NaCl 
0.1% SDS 
0.5% SDC 
1% Triton X-100 
10 µl of Halt Protease Inhibitor Cocktail  
4xLB 62.5 mM Tris-HCl pH 7.6 
2% SDS 
25% glycerol 
0.01% Bromophenol Blue 
5% 2-mercaptoethanol 
Urea DIGE 50 mM Tris-HCl pH 7.6 
7 M urea 
2 M thiourea 
0.5% Tween-20 
PTY 50 mM HEPES  
50 mM NaCl 
5 mM EDTA 
1% Triton X-100 
GLB 50 mM Tris-HCL pH 7.6 
150 mM NaCl 
1 mM DTT 
5% glycerol (v/v) 
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2.3.2 Estimation of protein concentration  
The total extracted protein was quantitated with RCDC protein assay (Bio-Rad, UK), which is  
based on the Lowry assay (Lowry et al., 1951) but modified to be compatible with reducing 
agents and detergent according to the manufacturer’s instructions. The assay sensitivity 
ranged from 0.1mg to 1.5mg/ml so sample dilution was also necessary. Bovine serum albumin 
(BSA; Sigma-Aldrich) was used as a protein standard from which a standard curve was 
produced. Due to the reagent interference with the assay, the samples lysed with 4xLB or 
urea DIGE buffer were diluted 10 times.  
2.3.3 SDS-PAGE analysis 
After estimating the protein concentration, each protein sample was resuspended in a ratio 
of 1:4 with the 4xLB and incubated at 95ᵒC for 10 min. Following incubation, the samples were 
centrifuged for 10 s at 13,000 g before loading onto the 10-well gel consisting of 10% resolving 
and 4% stacking gel (see Table 2.5 for details). 5 µl of the protein standard (pre-stained Protein 
Ladder, Broad Range (10-230 kDa), NEB) was also loaded to allow estimation of molecular 
weight (mW).  The proteins were separated according to their mW using 80V for the first 10 
min followed by 200V (Laemmli 1970). 
Table 2.5 SDS-PAGE composition used for the protein separation 
Size (7 cm x 7cm x 0.75ml) 4% stacking gel 10% resolving gel 
Deionized H2O (ml) 
40% Acrylamide/Bis (v/v) (ml) 
1.5 ml Tris HCl pH 8.8 (ml) 
1.5 ml Tris HCl pH 6.8 (ml) 
10% w/v SDS (ml) 

















After SDS-PAGE separation, the gels were stained with Colloidal Coomassie Blue stain 
prepared according to Neuhoff (Neuhoff et al., 1985). Briefly, the staining stock solution was 
prepared by mixing 20g of orthophosphoric acid, 100g of ammonium sulphate in 800 ml of 
deionized water, followed by addition of 1g of Coomassie Brilliant Blue and topped up to 1000 
ml with deionised H2O . A working solution was prepared by mixing 80% (v/v) the staining 
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stock with 20% (v/v) ethanol.  The gels were stained overnight, and destained the next day in 
10 % (v/v) methanol in deionized H2O prior to in-gel trypsin digest.  
2.3.4 Selection of conditions for in-gel trypsin digest 
In-gel trypsin digest was performed as described before  (Shevchenko et al., 2007). Each gel 
lane was cut into 10 pieces and placed into LoBind microcentrifuge tubes (Eppendorf®, UK) to 
minimize protein loss. All gel pieces were destained with 50% (v/v) acetonitrile (ACN, Fisher 
Scientific) in 50 mM ammonium bicarbonate (ABC, Sigma-Aldrich) in deionised H2O and then 
dehydrated in the vacuum concentrator (SpeedVac, Eppendorf®, UK). The gel pieces were 
reduced with 200 mM dithiothreitol (DTT) prepared in 50 mM ABC for 1 h at 56ᵒC, followed 
by alkylation with 55 mM IAA (iodoacetamide, also prepared in 50 mM ABC) for 20 min at 
room temperature in the dark. The gel pieces were washed three times with 50 mM ABC 
solution to ensure removal of IAA (to prevent trypsin alkylation). The gel pieces were dried in 
the vacuum concentrator and rehydrated in either trypsin (Sigma-Aldrich, UK) solution or Lys-
C/trypsin solution (both prepared according to the manufacturer’s instructions). The 
protease: sample ratio was about 1:50. The tubes were incubated at 37ᵒC overnight 
(approximately 18 h) in the humid chamber. The next day, the peptides were recovered from 
the gel pieces by incubation in acetonitrile and 5% formic acid (Fisher Scientific) at 37ᵒC for 
15 min. Recovered peptides were placed in into fresh LoBind tubes and the contents were 
dried in a vacuum centrifuge. 
2.3.5 Optimisation of in-solution trypsin digest conditions 
For the optimization of in-solution trypsin digest, 0.5 M Triethylammonium bicarbonate 
(TEAB) buffer (with 0.1% Triton X-100, 0.01% sodium dodecyl sulphate and 10 µl of Halt 
Protease Inhibitor Cocktail, EDTA-free, Thermo Fisher) commonly used for iTRAQ (León et al. 
2013) was chosen. 107 E22 cells were harvested by washing twice in PBS pH 7.4, then 
resuspended with 1 ml of 0.5 M TEAB buffer, incubated for 10 min on ice, vortexed and 
sonicated three times for 20 s at 30 s intervals and centrifuged at 21,000g for 20 min. The 
supernatant was transferred into the fresh tube and kept on ice. 
The total protein concentration was measured using the RCDC assay, as described above (see 
Section 2.3.4) and 50 µg was used for in-solution trypsin digest. Each sample was further 
diluted to 100 µl with 0.5 M TEAB before being reduced with 200 mM DTT solution for 1 h at 
56ᵒC. Next, the sample was alkylated with 55mM IAA solution for 30 min at room temperature 
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in the dark and then incubated for 20 min with 20 µl of DTT solution to quench excess IAA. 
The trypsin (Sigma-Aldrich, UK) solution was resuspended according to the manufacturer’s 
instructions and added to the tube in 1:50 protease: protein ratio and incubated overnight 
(about 18 h) at 37ᵒC in the humid chamber. The complete digestion was verified by loading 
the peptide sample on SDS-PAGE gel (using method described in section 2.3.3).  
2.3.6 Optimisation of FASP buffer conditions 
In addition to the standard in-solution trypsin digest, an extension of the method called filter-
aided sample preparation (FASP, Wisniewski et al., 2009) was also tested. Three different cell 
lysis buffers were tested that differ in their main detergent (chaotrope) component (see Table 
2.6 for details): sodium dodecyl sulphate (SDS-based), urea-based or sodium deoxycholate 
(SDC-based), as suggested by previous research (León et al. 2013). 
107 cells were lysed with tested buffers and incubated at 95ᵒC for 10 min. When using urea-
based buffer, the incubation conditions changed to 20 min at room temperature due to the 
tendency of the urea to carbamylate proteins in the temperatures above 30ᵒC (Geiger et al. 
2011). The lysates were clarified by centrifugation at 14,000 g for 5 min and were analysed 
on SDS-PAGE gel to compare lysis efficiency. 
Table 2.6 Lysis buffer composition for filter-aided sample preparation (FASP) 
Buffer name Composition 
SDS-based 4% SDS (w/v) 
100 mM DTT 
50 mM Tris-HCL buffer pH 8.5 
SDC-based 5% SDC 
100 mM DTT, 
50 mM Tris-HCL buffer pH 8.5 
Urea-based 8 M urea 
100 mM DTT 
50 mM Tris-HCL buffer pH 8.5 
  
2.3.7 Improvement of the original FASP protocol 
After visual inspection of SDS-PAGE gel, SDS-based buffer was chosen for further 
optimisation. The FASP protocol (Wiśniewski et al. 2009) has been slightly modified from the 
original. Briefly, 100 µg of protein was placed into a Microcon®-10 filter unit (Merck Millipore 
79 
 
Ltd.) and was washed with  200 µl of 8M urea in 100 mM ABC solution at 14,000g twice to 
displace SDS bound to the proteins. 100 µl of IAA was the added, the filter units were vortexed 
for 1 min and incubated at the room temperature in the dark for 20 min. Following alkylation, 
the samples were washed three times with 8 M urea in 100 mM ABC solution. To remove the 
urea, three washes with 100 mM ABC were performed to reduce the urea concentration to 
<2 M. Next, trypsin (Sigma-Aldrich, UK) solution was prepared according to the 
manufacturer’s instructions and added in 1:50 (protease: protein) ratio to each filter unit and 
vortexed for 1 min. The filter units were sealed with Parafilm to minimise evaporation and 
incubated at 37ᵒC overnight. The next day, the solution containing the digested peptides was 
exchanged into 100 mM ABC solution with three washes. Lastly, a 0.5 M NaCl solution was 
added to the filter units to release any peptides bound to the cellulose membrane. The 
resulting solution was dried in the vacuum centrifuge and stored at -20ᵒC till the next step. 
2.3.8 Verification of trypsin digestion 
To verify the digestion efficiency of both in-solution trypsin and FASP digestion samples, the 
respective samples (both the lysate and post-tryptic digestion samples) were analysed on 
SDS-PAGE gel. In addition, a small amount of digested peptides (<1 µg) were tip-cleaned using 
a HyperSepTM  extraction tip (Thermo Fisher Scientific, UK) to remove residual detergents 
(SDS) or salts (ABC or NaCl) and to allow rapid analysis on an Amazon ETD (ion trap mass 
spectrometer) to further confirm efficiency of trypsin digestion.   
As the FASP-digested peptides represent a very complex mixture, two-dimensional liquid 
chromatography (2D-LC) separation is required prior to in-depth mass spectrometry analysis.  
2.3.9 Peptide fractionation by liquid chromatography using Hypercarb 
A Hypercarb column has been previously shown to be effective as a first dimension in peptide 
separation following shotgun approaches as they show mixed mode of separation (Griffiths 
et al. 2012). Thermo Scientific™ Hypercarb™ HPLC Column (Catalogue No.: 35003-102130) 
was used for the peptide separation using mobile phases: Solvent A (0.1% (v/v) TFA in 3% 
(v/v) can) and solvent B (0.1% (v/v) TFA in 97% (v/v) ACN). The column temperature was set 
to 30ᵒC and the flow-rate on the loading pump was equal to 0.2ml/min. 50 µg of digested 
peptides were fractionated using a 2-70% gradient of solvent B over 60 min, collecting 
fractions every 1 min from 5 to 59 min run time (total number of fractions collected was 54). 
Following separation, the samples were pooled into 18 fractions to be analysed on Amazon 
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ETD using method described 2.3.11. It was assumed that the same concentration of peptides 
was present in a single FASP fraction to allow for direct comparison with in-gel trypsin digest 
method. 
2.3.10 Protein extraction from spent media 
To investigate the extracellular proteins (known as host cell proteins, HCPs) present in cell 
culture medium conditioned by either stably producing E22 or GS-KO cell line, three different 
methods of protein precipitation were tested: acetone-, trichloroacetic acid (TCA)- and 
ethanol-based precipitation.  
The conditioned (spent) medium was collected from cell cultures in the exponential phase 
(day 4) by pelleting the cells by centrifugation at 200 g for 5 min. The resulting supernatant 
was filtered through by 20 µm filter to remove any remaining cells or debris. Acetone (Fisher 
Scientific) precipitation was performed by mixing 1 volume of protein solution to 4 volumes 
of ice-cold acetone. The mixture was kept at -20ᵒC for 60 min and centrifuged at 15,000 g for 
15 min at 4ᵒC. The supernatant was discharged by inversion on tissue paper and the samples 
dried at room temperature to remove remaining acetone.  
TCA (Fisher Scientific) precipitation was performed by mixing one-ninth of the total volume 
of the sample with 100 % (v/v) TCA (for a final TCA concentration of 10 %). The sample was 
incubated on ice for 30 min and then centrifuged at 16,000 g for 15 min. The supernatant was 
then discharged and the pellet was washed twice with 100 µl of ice-cold acetone to remove 
the remaining acid (by centrifugation at 15,000g for 15 min at 4ᵒC). The samples were dried 
at room temperature to remove remaining acetone.  
Ethanol (Fisher Scientific) precipitation was performed by mixing 1 volume of protein solution 
to 9 volumes of cold ethanol 100%. The mixture was incubated at -20ᵒC for 60 min and 
centrifuged at 15,000 g for 15 min at 4ᵒC. The supernatant was discharged by inversion on 
tissue paper and the pellet washed with 90% cold ethanol, vortexed and centrifuged at 
15,000g for 5 min at 4ᵒC. The supernatant was discharged by inversion on tissue paper and 
the samples dried at room temperature to remove remaining ethanol. Bradford Reagent 
(Sigma-Aldrich, UK) was used to estimate the protein concentration, as it is commonly used 
in proteomic studies (Hunt et al. 2005) of the extracted proteins according to the 
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manufacturer’s instructions. 20 µg of the proteins were analysed by SDS-PAGE, which was 
followed by in-gel trypsin digest, as described in section 2.3.4.  
2.3.11 Data acquisition using Amazon ETD, ion trap mass spectrometer  
Dried peptides obtained by either in-gel trypsin digest, in-solution trypsin digest or FASP 
methods were resuspended in loading buffer (0.1% TFA, 3% ACN), briefly vortexed and 
sonicated for 3 min. The peptide samples were centrifuged at 13,000 g for 5 min to remove 
insoluble particles and transferred to the autosampler vials. Peptides were separated using 
an Ultimate U3000 (Dionex Corporation, UK) nanoflow LC-system consisting of a solvent 
degasser, micro and nanoflow pumps, flow control module and a thermostat-controlled 
autosampler. An estimated amount of 500 ng of digested peptides was loaded with a constant 
flow of 20 µl /min onto a PepMap C18 AcclaimTM trap column (0.3 mm I.D. x 5 mm, Dionex 
Corporation). After trap enrichment, peptides were eluted into a PepMap C18 nano column 
(75 µm x 15 cm, Dionex Corporation) with a linear gradient using mobile phase A (0.1% formic 
acid, 3% acetonitrile) and mobile phase B (0.1% formic acid, 97% acetonitrile), starting from 
buffer B 3% to 36% over 60 min at a flow rate of 300nl/min. MS/MS analysis was performed 
using Amazon ETD instrument (Bruker Daltonic, Germany). MS1 profile scans (m/z = 300-
1500) were acquired in enhanced resolution positive mode at the speed of 8,100 m/z s-1. 8 
precursor ions were chosen for collision-induced fragmentation (CID) with active exclusion 
after 2 spectra and release after 2 min. MS2 scan range was between 50 and 3000 m/z. For 
MS/MS fragmentation, the trap was loaded to the target value of 250,000 with a maximum 
accumulation time of 50 ms. 
2.3.11 Raw data analysis using Data Analysis and Mascot Daemon 
The raw mass spectra from Amazon ETD were processed by the complimentary software Data 
Analysis (v 4.1, Bruker Daltonics, Germany) using the following settings. The apex peak search 
algorithm was used for peak detection using a peak width at half maximum (PWHM) of m/z 
0.1, a S/N (signal-to-noise) ratio of 1, relative to base peak intensity of 0.1% and an absolute 
intensity threshold of 100. Spectra were deconvoluted with charge state deconvolution from 
fragment spectra. Data Analysis program generated an mgf (mascot generic file) that is 
compatible with automated database searching using Mascot Daemon (v 2.5.1, Matrix 
Science) search engine (http://www.matrixscience.com/daemon.html).  Mass accuracies were 
set to 1.2 Da for the peptide tolerance and 0.6 Da for MS/MS fragment tolerance. Methionine 
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oxidation, carbamidomethylation and N-terminal protein acetylation were used as variable 
modifications in searches against the Cricetulus griseus reference proteome database 
downloaded from the UniProt (UniProt ID 10029; 23,884 sequences) and against common 
contaminants. Maximum 1 missed cleavage for trypsin and or Lys-C was allowed. Positive 
protein identification using a significance threshold of 0.05 was used. Proteins with at least 
two unique peptides identified were considered as being true hits. The search was repeated 
against a decoy database to estimate the false discovery rate (FDR). The number of 
overlapping protein identifications between different methods was shown in Venn diagram. 
 
2.4 Standard SILAC experimental design and data analysis 
The following sections describe the methods used for the relative quantitation of the 
proteome changes between the exponential and stationary changes in CHO cells grown in the 
cell culture using SILAC. The details on cell culture, standard SILAC experimental design and 
the necessary quality controls are provided. The details of the data acquisition using LC-
MS/MS and downstream processing using MaxQuant and Perseus are also described. Finally, 
functional annotation of differentially expressed proteins using publicly available databases 
is also presented. The data is presented in Chapter 4. 
2.4.1 SILAC adaptation phase  
The E22 cell line was cultured in custom CD-CHO medium depleted of arginine and lysine (Life 
Technologies, Paisley, UK) that was supplemented with arginine and lysine where either were 
the “light” form (Arg0 and Lys0, both from Sigma-Aldrich) or the “heavy” form (Arg10 and 
Lys8, both from Cambridge Isotope Laboratories Ltd., UK). The isotopic forms were added to 
the medium to a final concentration of 2 nM for arginine and 3 nM for lysine in a working 
volume of 30 ml. For the GS-KO cell line, an additional supplementation of 6mM L-glutamine 
was necessary. Amino acid solutions were prepared as 10x stock solutions in PBS pH 7.4, 
filtered through 0.2 µm syringe-filter membrane (Corning® 28 mm diameter syringe filter, 
Sigma-Aldrich, UK) and stored at -20ᵒC (thawed in the water bath just before use). The cells 
were cultured in the appropriate medium for 3 passages (subcultures) to allow for ≥97% 
incorporation of amino acids into newly synthesised proteins (adaptation phase) before the 
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experiment began. To examine whether the external supplementation of arginine and lysine 
is not detrimental to the cell growth, a control flask of the cells growing in the original CD-
CHO medium was also included in the experiment.  
2.4.2 Calculation of % incorporation of lysine and arginine 
107 cells were harvested during passages 1-4 at 72h to estimate % of incorporation of amino 
acids. The cells were washed twice in PBS and lysed in 4xLB medium. 2 µl of sample, 
equivalent to 20 µg of protein was diluted with 4xLB and run on SDS-PAGE gel.  The most 
prominent band was cut from each lane (containing proteins containing heavy isotopes at 
each passage) and subjected to in-gel digest. The raw data has been analysed using MaxQuant 
with the same settings as for global proteomic analysis (see section 2.4.9), except for not using 
“Re-quantify” option. Using evidence.txt result file (containing all peptide-to-spectrum 
matches, PSMs), the % incorporation rate of heavy arginine and lysine was determined using 
equation 8: 
%		 = [1 −  
	
] X 100% (8) 
 
According to the guidelines outlined in commonly cited SILAC Methods and Protocols 
handbook (Warscheid 2014), the complete labelling is considered when the incorporation 
rate is >95 % (97-98% is ideal) because it is limited by the purity of the heavy amino acids used 
(typically 96-98%). In addition, heavy proline should not exceed 1% (how to calculate is 
described below). Prior to calculation of average ratio for each of the passage data, reverse 
and contaminant hits were removed. 
%		 = [ −  
	
 
2.4.3 Calculation of arginine-to-proline conversion 
Several researchers have reported an issue with using arginine to label proteins in SILAC 
(Bendall et al. 2008). To calculate the arginine-to-proline conversion, the search was repeated 
for heavy labelled sample using Pro6 (6 Da heavier than light proline) as a variable 
modification and “Re-quantify” option was turned off. The degree of arginine to proline 
conversion is calculated as the percentage ratio of peptides containing heavy proline to all 







2.4.4 SILAC experiment phase 
SILAC experiment commended at passage  5 following adaptation phase: cell cultures from 
each medium condition were split into the three separate flasks (light SILAC medium, heavy 
SILAC medium and CD-CHO – growth control). Cell culture samples were taken each day to 
monitor VCC and % viability using the Vi-CellTM. The cell samples were harvested at day 4 (to 
represent exponential phase) from light isotope-labelled flasks and at day 7 (to represent 
stationary phase) from heavy isotope-labelled flasks in forward SILAC (FS) experiment. For 
reverse SILAC (RS) experiments, a new adaptation phase was performed, while the sampling 
plan was reversed (day 4 sample was taken from heavy isotope-labelled flasks and day 7 
sampling - from light isotope-labelled flasks).  
2.4.5 Cell lysis and in-gel trypsin digestion 
107 cells were harvested from the appropriate culture at mid-exponential phase and 
stationary phase by centrifugation at 200 g, followed by washing twice in PBS pH 7.4.  The 
washed cells were lysed with 100 µl 4xLB buffer (as described in section 2.3.1). The protein 
concentration was determined using RCDC assay (Bio-Rad, UK), using BSA as a standard (as 
described in section 2.3.2).  Due to a high concentration of detergents in the lysis buffer, each 
lysate was diluted 10 times to limit the interference. 20 µg of each protein sample was 
analysed by SDS-PAGE, stained overnight with Colloidal Coomassie Blue stain and destained 
for 3 hr with 10% (v/v) ethanol. Each gel lane was cut into 8 fractions and subjected to in-gel 
trypsin digest (see section 2.3.4) 
2.4.6 Data acquisition using MaXis 4G UHR-TOF mass spectrometer 
Nano-scale liquid chromatography tandem mass spectrometry (nLC-MS/MS) was performed 
using maXis 4G UHR-TOF mass spectrometer (Bruker Daltonics, Germany). Briefly, dried 
peptide samples were resuspended in loading buffer (0.1%TFA, 3% ACN) and separated using 
an Ultimate 3000 capillary LC system (Dionex). 500 ng of peptides was loaded with a constant 
flow of 20 µl /min onto a PepMap C18 trap column (0.3 mm I.D. x 5 mm, Dionex Corporation). 
Linear gradient elution was performed using mobile phase A (0.1% FA) and mobile phase B 
(0.1% FA, 80% ACN), starting from 4% buffer B to 40% buffer B over 90 min at a flow rate of 
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300 nL/min. MS/MS analysis was performed using maXis 4G UHR-TOF mass spectrometer 
(Bruker Daltonics, Germany).  MS1 profile scans (m/z = 100-1800) were acquired in positive 
ionization mode using ESI Nano sprayer source (Bruker Daltonics, Germany). Precursor ions 
were selected for auto MS/MS (CID fragmentation experiments at m/z 100-1800) at an 
absolute threshold of 3000, with a maximum of three precursors per cycle and active 
exclusion set at two spectra released after 0.25 min. The capillary was set to 4500 V, end plate 
offset 500V, the nebuliser gas at 1 bar and the dry gas at 4L/min.  
2.4.7 Data analysis using Mascot Distiller search engine 
Raw MS/MS data acquired with MaXis 4G UHR-TOF were submitted into Mascot Distiller (v 
2.5.1.0) search engine for peak picking and quantification. Peak picking was performed using 
the default parameters for the MaXis 4G UHR-TOF (defined in maXis.opt file). For database 
searching and quantification, mass accuracies were set up to 0.2 Da for peptide tolerance and 
0.2 Da for MS/MS fragment tolerance. Methionine oxidation, carbamidomethylation and N-
terminal acetylation were set up as variable modifications. Quantitation based on SILAC 
method [K+8, R+10] was used to search against CHO UniProt 10029 database (23,884 
sequences, downloaded on 27/07/2015), with the sequence of mAb (CB72.3) manually 
added, and against common contaminants (262 sequences). If a threshold 0.05 was passed, 
positive protein identification was assigned. Proteins with at least two identified peptides  
identified were considered true matches, while proteins were quantitated based on at least 
two H/L ratios. The search was repeated against a decoy database to give estimate of false 
discovery rate (FDR).  
2.4.8 Data acquisition using Q-Exactive HF orbitrap mass spectrometer 
Trypsin digested peptides were separated using an Ultimate U3000 (Dionex Corporation) 
nanoflow LC-system consisting of a solvent degasser, micro and nanoflow pumps, flow control 
module and a thermostat-controlled autosampler. 5 µl of the sample (equivalent to 500 ng of 
peptides) was loaded with a constant flow of 20 µl/min onto a PepMap C18 trap column (0.3 
mm I.D. x 5 mm, Dionex Corporation). After trap enrichment, peptides were eluted onto an 
EASY-Spray PepMap C18 capillary (0.075 x 500 mm, 2µm, 100 Å, Thermo Scientific) with a 
linear gradient of 5-35% solvent B (80% ACN with 0.1% formic acid) over 75 min with a 
constant flow of 300 nl/min. The liquid chromatography system was coupled to Q-Exactive HF 
NSI ion source (Thermo Scientific, UK). Full scan MS survey spectra (m/z 375-1500) in positive 
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profile mode were acquired in an Orbitrap (Thermo Scientific, UK) with a resolution of 
120,000 with AGC (Automatic Gain Control) target set to 3x106. The ten most intense peptide 
ions from the preview scan were fragmented by CID after accumulation of 5x104 ions and with 
a resolution of 15,000 in m/z range of 200-2000. Maximum filling times were 100 ms for both 
MS and MS/MS scans. Isolation of precursors was performed with a window of 1.2 Th 
(thomsons).  The normalized collision energy was equal to 28. The “underfill ratio” (specifying 
the minimum percentage of the target ion value likely to be reached at the maximum fill time) 
was defined as 10%. Furthermore, the S-lens RF level was set at 60 to give optimal 
transmission of the m/z region occupied by the peptides. Data acquisition was performed 
with XCalibur software (v. 3.0.63, Thermo Scientific). If required, peak list in mascot generic 
format (.mgf) were generated using MSConvertGUI software 
(http://proteowizard.sourceforge.net/tools.shtml).  
2.4.9 Raw data analysis using MaxQuant  
Raw MS data generated by Q Exactive HF was analysed with MaxQuant software (v. 1.5.2.8; 
see Cox and Mann, 2008) with the Andromeda search engine (Cox et al, 2011).  The false 
discovery rate (FDR) was set to 1% for protein, peptide-to-spectrum match (PSM) and site 
decoy fraction levels. Peptides were required to have a minimum length of seven amino acids 
and a maximum mass of 4600 Da. MaxQuant was used to score fragmentation scans for 
identification based on a search with an allowed mass deviation of the precursor ion of up to 
4.5 ppm. Spectra were searched by Andromeda against CHO UniProt 10029 database (23,884 
sequences, downloaded on 27/07/15), with the sequence of mAb (CB72.3) manually added, 
and against common contaminants (262 sequences). Multiplicity (“labeling states”) was set 
to two and the label pairs were set as Arg0 and Arg10 & Lys0 and Lys8. Enzyme specificity was 
set to “trypsin/p”, allowing cleavage at lysine and arginine also when followed by proline 
bonds, and a maximum of two missed cleavages (meaning that a peptide could theoretically 
have maximum three labels). Carbamidomethylation of cysteines was a fixed modification 
while N-terminal protein acetylation and methionine oxidation set as variable modifications. 




2.4.10 Downstream processing using Perseus & public databases 
Following raw MS data processing in MaxQuant, data was exported to multiple tab-separated 
(.txt) files. The Protein Groups file contains the information on the identified proteins in the 
processed raw files. Each single row is presented as the groups of proteins that could be 
reconstructed from a set of identified peptides. After uploading the Protein Groups file using 
“generic matrix upload” function in Perseus, the following columns were uploaded in their 
respective subgroups: Expression, Numerical, Categorical and Text (Table 2.7). 
Table 2.7 Protein groups upload in Perseus for standard SILAC data analysis 
Subgroup name Data columns 
Expression Ratio H/L normalised 





Razor + unique peptides 
Unique + razor sequence coverage 
Mol. weight (kDa) 
Categorical Only identified by site 
Reverse 
Potential contaminant 
Text Protein IDs 
Majority protein IDs 
 
The first step in SILAC data analysis was the removal of irrelevant protein matches. Those 
groups were present in the categorical subgroup as “Reverse”: the proteins that have been 
matched to the reverse sequences and are therefore false identifications. The “Potential 
contaminants”, which were identified in the contaminants database, were also removed,  as 
these proteins are artefacts of sample preparation. In addition, “Only identified by site” 
matches were also eliminated from further analysis because they did not pass the required 
1% FDR value for the protein identification. In addition, the proteins that had only 1 razor + 
unique peptides (known as ‘one –hit wonders’’ in proteomics experiments) were removed as 
having insufficient coverage. 
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After filtering the data, SILAC ratios and intensities to log2 values were logarithmically 
transformed. This way up- and down-regulation of proteins with the same magnitude have 
equal distances in the visual representation. Only median normalised ratio H/L were used for 
is further analysis. The forward and reverse SILAC data sets for each cell line (E22 or GS-KO) 
were merged together and only proteins common to both experiments considered for further 
data analysis.  
To determine which protein groups were significantly changed between exponential and 
stationary phases, three different methods: a one-sample t-test, outlier testing (using 
significance A and B) and fold-change cut-off.  Benjamini-Hochberg FDR (false discovery rate) 
at 5% was chosen to correct p-values obtained from t-test and significance A and B multiple 
testing.  Within these significantly changed proteins, only the proteins that have at least 1.5 
ratio fold change (FC) were selected.  
2.4.11 Bioinformatics analysis of differentially expressed proteins 
To further examine if they are any trends in the differential expression, proteins of interest 
were functionally annotated using Gene Ontology (GO; http://www.geneontology.org/) 
molecular function (MF), biological process (BP) and cellular compartment (CC) definitions. 
The relevant terms have been downloaded from the UniProt (http://www.uniprot.org/) and 
further analysed in Excel. In addition, KEGG (Kyoto Encyclopaedia of Genes and Genomes; 
http://www.kegg.jp/kegg/tool/map_pathway2.html) database was used to examine if there 
any specific pathways involved. Since many of the differentially expressed proteins were 
enzymes, we have also analysed them separately using the information found in ExplorEnz 
database (http://www.enzyme-database.org/).  
2.5 Enhanced pulse SILAC and TPA - experimental design and data analysis 
The following sections describe the methods used for deriving absolute values of protein copy 
number and protein turnover by TPA method and enhanced pulse SILAC, respectively. The 
details on cell culture and enhanced SILAC experimental design are provided. The details of 
the data acquisition using LC-MS/MS and downstream processing using MaxQuant and 
Perseus are also described. The development of in-house program in Matlab to calculate 
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parameters of rate of protein turnover, amino acid usage and codon usage is outlined. The 
data is presented in Chapter 5. 
2.5.1 Pilot study with the media exchange 
Any pulse SILAC experiment requires a cell culture medium exchange step in which medium 
containing ‘light’ isotopes of arginine and lysine is replaced with medium containing ‘heavy’ 
isotopes of these amino acids. As with the standard SILAC experiment (see section 2.4.2), 
>97% of the light isotope must be incorporated into the proteins before the experiment 
starts. The pulse SILAC experimental design requires that the medium exchange occurs on 
day 4 of passage 5 when cells are in the mid-exponential phase. A pilot study was conducted 
to assess whether media exchange should be performed using conditioned (spent) or fresh 
media. Its purpose is to compare it with the control media to examine any adverse effects on 
the VCC and % viability. 
For the E22 cell line, the medium exchange was performed in 30 ml working volume in a 125 
ml Erlenmeyer flask grown in CD-CHO medium. The procedure was performed on day 5 (mid-
exponential) with either fresh or conditioned CD-CHO media without glutamine 
supplementation. Growth was monitored daily before and after media exchange using Vi-
CellTM. Concurrent growth control (no media exchange) was also measured. In each group, 
they were three biological replicates. 
2.5.2 Enhanced pulse SILAC adaptation phase 
Based on the data from the pilot study on the media exchange, it was found that the use of  
conditioned media was essential to replicate healthy cell growth. The experiment started with 
the SILAC adaptation phase, similarly to the standard SILAC experimental design (see section 
2.4.1). Briefly, (stably producing) E22 cell line was cultured in suspension using custom CD-
CHO medium (Life Technologies, Paisley, UK) that was deprived of arginine and lysine. Custom 
CD-CHO was supplemented with arginine and lysine, which were in either ‘light’ (Arg0 
andLys0, both from Sigma-Aldrich), ‘medium’ (Arg6 and Lys4, all from Cambridge Isotope 
Laboratories Ltd., UK) or ‘heavy’ (Arg10 and Lys8, all from Cambridge Isotope Laboratories 
Ltd., UK) isotopic form to a final concentration of 2 nM for arginine and 3 nM of lysine in 
working volume of 30 ml.  For (parental) GS-KO cell line, additional supplementation of 6mM 
L-glutamine was necessary.  
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Stock solutions of lysine and arginine were prepared as 10x stock solutions in PBS pH 7.4, 
filtered through 0.22µm syringe-filter membrane (Corning, UK) and stored at -20ᵒC (thawed 
in a water bath set to 37ᵒC just before use).  
2.5.3 Enhanced pulse SILAC experiment phase 
The pulse SILAC experiment phase started on day 4 (96h).  After measuring VCC and % viability 
with Vi-CellTM, media from heavy and medium isotope-labelled cultures (n=6) were 
transferred separately to Falcon tubes (Fisher Scientific, UK) and pelleted at 125g for 5 min ( 
low speed centrifugation was necessary to avoid cell damage). The supernatant was then 
transferred into fresh tubes and centrifuged at 200 g for 5 min to remove residual cell debris. 
All conditioned media was prepared this way and kept in the water bath at 37ᵒC until the 
resuspension with the respective cell pellet (heavy- medium with medium-labelled cells and 
vice versa). Following media switch, another measurement of VCC and % viability was taken. 
This procedure has marked the time 0h of pulse SILAC. The light-labelled medium was not 
exchanged but kept as internal control. Sampling of the cell cultures was performed at 6 time 
points post medium exchange: 0.5h, 4h, 7h, 11h, 27h and 48h. At each time point, 5x106 cells 
were harvested for further mass spectrometry analysis.  
2.5.4 Filter-aided sample preparation (FASP), data acquisition and analysis 
For mass spectrometry analysis of samples from enhanced pulse SILAC experiment, each cell 
pellet containing light isotope-labelled proteins was mixed in 1:1 ratio with equivalent cell 
pellet containing heavy isotope-labelled proteins (referred as “MTOH” sample). Cell pellets 
were lysed in 100 µl of SDS-based lysis buffer (see section 2.3.6) and processed using FASP 
protocol (2.3.7). Trypsin digested peptides were separated into 54 fractions on HypercarbTM 
column, which were then combined into 6 fractions for mass spectrometry analysis.  Data 
acquisition was performed using Q-Exactive HF mass spectrometer using the same 
parameters as for standard SILAC  (see section 2.4.8) except for the fragmentation of the 15 
most intense ions instead of 10 (due to sample complexity). The raw mass spectra were 
analysed in MaxQuant using same search settings as before (see section 2.4.9). The 
multiplicity was set to three and the label set as Arg0, Arg6 and Arg10, and Lys0, Lys4 and 
Lys8 were used. Two replicates (two injections of the same sample) were analysed for each 
of the cell lines.  
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2.5.5 Estimation of protein copy number using total protein amount (TPA) method 
The protein groups exported from MaxQuant (in tab-delimited files) were used to derive 
absolute protein concentration (nM) and protein copy number per cell using “proteomic 
ruler” function in Perseus (v 1.5.1.6). The method has been extensively described in 
Wisniewski et al., 2014 (see section 1.5.4) and is based on the assumption that the individual 
abundance of a protein in a cell is reflected by the ratio of its MS signal to the total MS signal 
(equation 10): 
  
   
≈    
   
    (10) 
Sum of peptide intensities for individual proteins are used to estimate both protein copy 
number and protein concentration. Two parameters are necessary for the scaling: protein 
amount per cell (in pg) and total cellular protein concentration (g/l).  
Since the amount of protein per cell could vary substantially between the mammalian cell 
lines and even between phases of cell culture (Milo et al., 2013), the average protein biomass 




= 	 			()   (11) 
Total cellular protein concentration was the calculated by taking into the account the cell 
volume. The average cell volume can be derived by assuming that the cells have a spherical 







  (12) 
Where: 
d = average cell diameter (µm), derived directly Vi-CellTM reading 
The estimated values were exported from Perseus in a tab-delimited file for further analysis. 
2.5.6 Data extraction for the calculation of the protein turnover and half-lives 
After analysing raw data with MaxQuant, the first step in the analysis was correlating peptide-
to-spectrum matches (PSMs) and the corresponding time points. This allowed to find any 
peptides present at the time point associated with a given protein so that the data can be fit 
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with non-linear square model. The “Leading Razor Protein” column was selected for protein 
identifications because it contains a single UniProt ID of the best scoring protein (according 
to a MaxQuant/Andromeda search) along with the raw file name (to match the time points) 
and associated ratios: H/L, M/L and H/M. All five columns were exported for further analysis. 
The estimation of cell cycle duration was important for the calculation of the half-lives. The 
VCC values were derived from the Vi-CellTM reading at each of the 6 time points. VCC were 
logged and plotted against the time points (0-48h) and linear model was used to obtain the 
coefficients. The inversion of the linear model coefficient provided the estimation of the cell 
cycle duration.  
2.5.7 Determination of protein half-life and turnover 
Determination of the protein half-life and turnover has been performed as described in 
Boisvert et al., 2012 with slight modifications. After the media exchange, the heavy isotopes 
of lysine and arginine were gradually incorporated into newly synthesised proteins, while the 
pre‐existing medium isotope-labelled proteins were degraded. Meanwhile, all the proteins in 
the control sample contain only light isotopes of amino acids. Thus, the M/L and H/L ratios 
for each protein represent the respective degradation and synthesis over time. The protein 
turnover (H/M ratio) is defined as the balance between those two processes. The first step in 
the analysis was the normalisation of H/L and M/L profiles for individual proteins according 




 = 1	(13) 
Next, the exponential function (equation 10) was used to fit the normalised M/L profiles: 
= 	

 + 	(14)   
 Where: A - normalised amplitude 
               B - offset in the data, related to the medium isotope amino acid recycling       
             		′ - time constant related to intrinsic e-folding factor 







The protein turnover can be defined as the crossing point between normalised M/L and H/L 
protein profiles: 
T= − × .

	(16) 
2.5.8 Curation of enhanced pulse SILAC data  
Since the enhanced pulse SILAC produces three different ratios: H/M, H/L and M/L, it is 
possible to calculate any ratio from the other two ratios. The quality of the data was examined 
using the Spearman correlation by multiplying H/L ratio and M/L ratio and dividing its product 
by H/M ratio.  
Prior to fitting the data to non-linear square model, the data was curated using several 
criteria. The minimum number of three time points was set up as a required threshold for 
fitting the data into the line. This was because the exponential function used to fit the data 
represented an underdetermined problem: this means that using a single equation, 3 
different parameters were calculated: A – amplitude of the curve, B – offset of the data and 
′ - the time constant (related to intrinsic e-folding factor). The protein turnover and the half-
lives were calculated from these parameters. 
2.5.9 Implementation of Levenberg-Marquardt algorithm  
To optimize fitting of the data, the Levenberg-Marquardt algorithm was implemented (as in 
Boisvert et al., 2012) using in-house program written in Matlab (R2016a, Mathworks) with the 
Optimisation toolbox. The non-linear square fitting required the setting of the initial 
conditions for the estimation of A, B and τ' coefficients. Two different sets of initial conditions 
were tested, defined by lower and upper boundaries: V1 (0.05<A<1, 0<B<1 and 0<	′ <50) and 
V2 (0.01<A<1, 0<B<1 and 0<	′ <100). In addition, a third set of starting parameters, where A 
and B values were fixed, was also tested and defined as V3 (A=1, B=0, 0<	′ <50). Using V1, V2 
or V3 parameters, 100 initial random conditions were generated using the random number 
generation function from uniform continuous distribution. In addition to the estimation of 
model coefficients, residual norm was also recorded to evaluate the goodness of the fit.  
After fitting data to the model, another curation was necessary to remove values that were 
outside logical boundaries using similar criteria as described in Boisvert et al. 2012:  0<	′ <70, 
0<A<2, 0<B<1. Any negative values for coefficients were removed as they cannot be used for 
the calculation of the protein turnover and half-lives. The data from the technical replicates 
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were fitted separately and the protein turnover and half-lives were calculated as average of 
the two. Any negative values for protein turnover were also removed.  
2.5.10 Total biomass and rate of protein turnover calculation 
After combining the protein turnover data and the protein copy data, the rate of turnover for 
a given protein was calculated using the following equation (17): 
				(

) = 	 		 
		()
 (17) 
By considering the molecular weight (mW) of the protein, estimation of the total protein mass 
could be also calculated (equation 18): 
		 		() = 			 		 	ℎ	()	 (18) 
The problem was identified while deriving such calculations: extremely low turnover values 
(<10 min) gave rise to unnaturally high turnover rates. The proposed solution was to set the 
threshold - any turnover value below 0.5 h was assigned to 0.5 h, as it was not possible to 
accurately estimate protein turnover for those proteins using the enhanced pulse SILAC.  
2.5.11 Bioinformatic analysis of protein turnover data 
The calculated protein composition for each of the cell lines was first visualised using publicly 
available Proteomap tool (https://www.proteomaps.net/). CHO identifiers were mapped to 
mouse homologs according to NCBI gene ID and matched with corresponding protein copy 
number data derived from TPA approach.  
To analyse any trends in clonal selection of CHO cells, 2-fold up-regulated proteins (according 
to the protein abundance) in E22 producing cell line were examined closer. PANTHER 
classification system (http://pantherdb.org/) was used to download available annotation 
from Gene Ontology (GO; http://www.geneontology.org/) website based on molecular 
function (MF), biological process (BP) and cellular compartment (CC). If available, the GO-slim 
annotation was used in the preference. In addition, KEGG (Kyoto Encyclopaedia of Genes and 
Genomes) database Search & Color function 
(http://www.kegg.jp/kegg/tool/map_pathway2.html) was used to further examine the 
protein function in cellular pathways. 
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2.5.12 Calculation of amino acid usage in CHO cells 
In addition to the calculation of the rate of the protein turnover in CHO cells, it was also 
important to examine CHO cell specific amino acid utilisation rate. Matlab (R2016a) 
Bioinformatics toolbox was used to calculate amino acid usage based on the amino acid 
sequences of the individual proteins. The amino acid sequences were extracted from Uniprot 
ID database and the number of individual amino acids calculated for each protein in the list. 
Derived values were multiplied by the associated protein turnover rates to estimate individual 
rates of amino acid usage (h-1).  
2.5.13 Calculation of codon usage in CHO cells 
It has been also hypothesized that the dynamic rates of the utilisation of individual codons 
might be significantly different from CHO genomic codon usage bias. In order to examine it 
closer, the protein sequences were matched to the corresponding transcripts using the EMBL-
EBI database (https://www.ebi.ac.uk/) and CHOgenome resources 
(http://www.chogenome.org/). The quality of the association was verified manually using the 
online resources available in UniProt and EMBL-EBI. ExpPASy Translate tool 
(http://web.expasy.org/translate/)  was used to check if the transcript sequences were 
complete. Clustal Omega tool (https://www.ebi.ac.uk/Tools/msa/clustalo/) for multiple 
sequence alignment was used to verify if the seemingly redundant transcript sequences were 
the same. Truncated or missing sequences were manually added to the list of transcripts. 
The codon calculation was performed in the similar manner to the amino acid calculation. 
After mapping the transcript sequences, the individual codons were calculated for each 
transcript in the list. The nonsense codons (UAA, UAG, and UGA) were also included in the 
calculations. If the sequence of the transcript was incomplete or ambiguous, the codon 
calculation was skipped. Derived values were multiplied by the calculated rate of turnover to 
estimate how many codons were utilised by unit time (h-1). Such estimated dynamic codon 







Chapter 3: Optimisation of sample preparation for mass 
spectrometry to achieve high-coverage CHO proteome 
3.1 Abstract  
The publication of complete genome of CHO cells has opened a possibility of utilisation of 
variety of ‘omic’ tools to increase fundamental understanding of this important mammalian 
host. Studying full proteome of complex organisms is challenging due to significant 
differences between number of proteins extracted from the sample and those truly identified 
and quantified. The development of sample extraction and preparation protocols is of crucial 
importance for any proteomic experiment. 
Among several cell lysis buffers tested, 4xLB buffer, compatible with in-gel trypsin digest and 
SDS-based buffer for filter-aided sample preparation (FASP) were the most robust. This was 
probably due to high concentration of detergents and reducing agents. There was an increase 
in the number of protein identifications when using FASP method and Amazon ETD mass 
spectrometer in comparison to in-gel trypsin digest. The difference was less pronounced 
when using high performance and resolution Q Exactive HF mass spectrometer. Interestingly, 
there was no significant improvement on the number of protein identifications when using 
combined trypsin and Lys-C digest. The feasibility of using Hypercarb (Porous Graphic Carbon, 
PGC) column as first dimension for peptide separation that is orthogonal with reverse phase 
separation was also confirmed. 
In conclusion, there was an increase in number of validated protein identification while using 
FASP extraction protocol over optimised in-gel trypsin digest. However, the difference was 
lost while using high-throughput mass spectrometer. Both methods of sample preparation 
were found to be optimal for high-coverage CHO proteome analysis, which will turn 
quantitative in the next two chapters. 
3.2 Introduction 
The recent studies into complete genome for Chinese Hamster ovary (CHO) cells (Xu et al. 
2011; Lewis et al. 2013) have created an important shift from traditional engineering to global 
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‘omic’ strategies (Datta, Linhardt, and Sharfstein 2013).  Generating large-scale ‘omic’ data 
sets have increased the fundamental understanding of CHO cells physiology and enabled 
development of novel engineering tools to increase both growth and productivity. 
Genomic studies have revealed that there are more than 24,000 predicted genes in CHO cells 
that can be transcribed into up to 29,000 transcripts (Becker et al. 2011) and similar number 
of individual proteins.  Such complexity of the proteome is typical for mammalian cell lines, 
therefore the optimisation of sample preparation for mass spectrometry (MS) analysis  is 
essential for any proteomic study, especially the quantitative approaches. Despite recent 
developments in the field of instrumentation in both liquid chromatography and mass 
spectrometry, it is still challenging to study full proteome for a complex organism. In addition, 
there is a significant difference in the number of proteins that can be extracted from sample 
and number of proteins truly identified and quantitated. Typically, the proteome coverage, 
described as the proportion of proteins identified in a proteomic study to complete number 
of proteins, is about 10% for mammalian cells (Bantscheff et al. 2007).  
There are several reasons for such poor proteome coverage for higher organisms. First, 
proteins are difficult to handle, meaning that are prone to degradation and may not be soluble 
under certain conditions (Steen and Mann 2004). For example, protein solubility differs 
substantially in aqueous solutions, e.g. membrane proteins are clearly insoluble, while many 
structural proteins, such as collagen, are also insoluble in physiological conditions. The choice 
of the lysis buffer for protein extraction should be tailored in accordance to the chosen 
method of sample preparation method for mass spectrometry analysis (Wu and Maccoss 
2002). 
All sample preparation workflows begin with cell (or tissue of interest) lysis and protein 
extraction in an optimized lysis buffer. Extracted proteins can be separated according to their 
molecular weight (mW) using SDS-PAGE (or 2-DE) and visualised using Coomassie- or silver-
based stains that are sensitive enough to detect even small amount of protein (Candiano et 
al. 2004). After staining, bands of interest (or even the entire sample lane for global proteomic 
analysis) are excised for further analysis (Shevchenko et al. 2007). Alternatively, the prepared 
lysate might be directly processed in solution without gel separation. This method is called in-
solution trypsin digest (León et al. 2013). The extension of in-solution method is called filter-
aided sample preparation (FASP) that is performed using spin-filter devices. Using spin-filter 
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devices is advantageous since it is possible to use high concentrations of sodium dodecyl 
sulphate that is very effective at protein solubilisation (Wiśniewski et al. 2009; Wiśniewski 
and Rakus 2014). 
Reduction and alkylation steps help in the linearization of proteins to expose amino acids 
targeted by a given protease. The most frequently used trypsin cuts at C-terminus of every 
lysine (K) and arginine (R). The estimation of the protein concentration within cell lysate is 
important to use the correct ratio of protein: protease for optimal digestion conditions and 
enough loading of the peptide sample into LC-MS/MS instruments (Steen and Mann 2004). 
Protein concentration can be measured using either absorbance-based or reagent-based 
commercially available assays using protein standards, such as bovine serum albumin (BSA). 
Fractionation of peptides prior to MS analysis ensures that correct amount of peptides is 
analysed at a given time. The most popular methods for peptide fractionation are separation 
based on reverse-phase liquid chromatography (RPLC) or hydrophilic interaction 
chromatography (HILIC) that separates proteins according to their hydrophobicity or 
hydrophilicity, respectively (Fílla and Honys 2012). Alternatively strong cation exchange (SCX) 
liquid chromatography can be used to separate peptides according to their positive charge 
(Cravatt, Simon, and Yates 2007).  Porous graphitic carbon (PGC) surface has mixed separation 
mode, combining properties of reverse phase columns separating on the basis on 
hydrophobicity and ion-exchange-like behaviour. Another advantage of using PGC for peptide 
separation is its mechanical and chemical stability, especially regarding pH. The performance 
of PGC as first dimension separation for proteomics and glycoproteomics research has been 
already proven (Griffiths et al. 2012; Zhao et al. 2014b).  
In addition to choosing the most optimal method for sample preparation and 
instrumentation, the next important factor for successful proteomic analysis are the software 
capabilities. In fact, all three components must be properly integrated into robust workflows 
to ensure reproducible and high-quality proteomic results. There is a large number of both 
open-source and commercial search engines that match experimental mass spectra to 
theoretically predicted and combine identified peptides into proteins.  The choice of software 
depends mainly on the method of quantitative proteomics and the type of data file produced 
by the instrument vendor. A full list of both open source and commercial software has been 
provided and extensively reviewed elsewhere (Gonzalez-Galarza et al. 2012). In this research 
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project, three programs were used: Mascot Daemon and Mascot Distiller from Matrix Science 
(http://www.matrixscience.com/) and MaxQuant (Cox and Mann 2008). The latter is open-
source software that has been well-established for the analysis of quantitative data using 
SILAC as well as iTRAQ and label-free quantification (LFQ).   
First, the identification of the peptide is obtained by searching experimental spectra against 
the protein sequence database using algorithms (reviewed by Steen & Mann 2004). The most 
popular approach is based on probability-based matching and it involves the calculating the 
probability that match between theoretical and experimental spectra (known as ‘peptide-to-
spectrum match’, PSM) is random. This algorithm was first implemented into Mascot search 
engine and its modified version is also used in MaxQuant and is called Andromeda score (Cox 
et al. 2011). The peptides are the distibuted to the corresponding proteins using the minimum 
number of proteins. In global proteomic experiments, it is important to report only proteins 
containing at least 2 unique (proteotypic) peptides. Other proteins, known as ’one-hit 
wonders’, must be excluded from further analysis. Some search engines, such as MaxQuant, 
refine the criteria by using at least 2 razor peptides and unique peptides. In this context, razor 
peptides are defined as peptides shared between several proteins but assigned to the protein 
with more associated peptides (Cox and Mann 2008).  
Since peptide assembly is performed using probability-based matching, there is a potential of 
getting a singificant number of false positives. One way to solve this problem is to use a decoy 
database search in which experimental spectra are searched against a database composed of 
reversed or random amino acid sequences (Wang et al. 2009).  The number of positive 
matches to the decoy database is used to estimate false discovery rate (FDR) that is defined 
as the expected number of false positives in the list of proteins selected using any statistical 
test (Campos 2010).  
In conclusion, a well-defined mass spectrometry workflow is needed to generate high-quality 
proteomic data. For any further quantitative analysis, only validated protein identifications 





3.2 Aims and objectives  
The aim of this chapter was to develop sample preparation workflow for acquisition of mass 
spectrometry data. First, different cell lysis methods were tested and compared on low-end 
mass spectrometer. Commercially available assay for measuring protein concentration was 
also verified to be compatible with cell extraction procedures. Next, popular methods of 
peptide extraction were optimized, namely in-gel trypsin digest and in-solution trypsin digest, 
and its further refinement, filter-aided sample preparation (FASP). Improvement of peptide 
extraction was attempted by using two proteases of varying specificity. PGC and RP columns 
were examined for their efficiency in peptide separation. Different types of mass 
spectrometers were used for data acquisition and the obtained numbers of protein 
identifications were compared. Pros and cons of using different software packages for 
downstream data analysis was also discussed.   
3.3 Results and discussion 
3.3.1. Cell line characterisation 
3.3.1.1 Growth profile of GS-KO parental and E22 producing cell lines in chemically defined 
medium (CD-CHO)  
The monoclonal antibody mAb-producing cell lines used within this study were derived from 
Lonza Biologics’ main proprietary Chinese hamster ovary (CHO) host, namely CHOKSV GS-KO 
(Xceed™).  The cells were revived from a cryovial containing 1x107 cells and passaged 4 times 
before studying their growth profiles (at passage 5, p5). Both parental GS K-O and producing 
E22 cell lines displayed growth profile that is typical of a batch culture, starting from lag phase 
that lasts about 2 days (48h), followed by exponential (log) phase till day 7 (GS K-O) or 8 (E22). 
Finally, stationary phase was very short-lived (1-2 days) before cells enter the death phase. 
The viability was high (98% on average) during throughout lag, exponential and stationary 
phase. IVCC was increasing steadily and reached 45 (106 cells days ml-1) on day 8 for both cell 
lines (Fig 3.25). However, the specific growth rate was similar for both cell lines (0.025 h-1 for 
E22 cell line and 0.024 h-1 for GS K-O cell line), which translated into a doubling time of 27h 
and 28h, respectively. The values for both specific growth and doubling time are within 




Figure 3.25 The growth profiles of CHOKSV GS K-O parental (marked in red) and E22 stably producing (marked 
in blue) cell lines in chemically-defined medium (CD-CHO), with or without L-glutamine (6mM) supplementation, 
respectively. Viable cell count (VCC; A), % viability (B) and average cell diameter (D) were measured every day 
with Vi-CellTM Beckman Coulter, based on Trypan blue exclusion essay. Integral viable cell concentration (IVCC) 
was also calculated (C). The values are displayed as mean±SEM values; n=3. 
For all consecutive studies of different sample preparation methods, cell samples were taken 
at mid-exponential phase of cell growth (day 3 or 4). The cells are believed to be the most 
viable at this point: they actively grow and divide and the accumulation of toxic metabolites 
is low. 
3.3.1.2 Calculation of secretion rate of monoclonal antibody in E22 producing cell line 
In addition to studying the growth profiles of E22 cell line, it was also important to measure 
the amount of monoclonal antibody produced. Cell culture samples were collected at p5 
every from day 0 to day 8 from two different batch cultures (two biological replicates). The 
reference standard curve was generated using IgG1 kappa standard with extinction 
coefficient of 1.4 (E=0.1%) measured at 280 nm. Five dilutions were prepared in duplicates 
(ranging from 0.078125 mg/ml to 1.25 mg/ml) and analysed on HPLC using decreasing pH 
gradient (Figure 3.26). Using the available sequences for the light chain and the heavy chain 
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of CB72.3 antibody, we have estimated molecular weights (mW) and extinction coefficients 
(assuming cystines) using ExPASy  ProtParam tool (Table 2.8). 
Table 2.8 Theoretical estimation of properties of LC, HC and full mAb using PostParam tool. 
 Length  Molecular weight (Da) Extinction coefficient 
Full Mab (2LC + 2HC) 1310 143845.01 1.477 
LC 214 23420.96 1.415 
HC 441 48528.57 1.503 
 
Based on results from ProtParam tool, the extinction coefficient for the complete antibody 
was estimated at 1.477, which is only slightly different from the extinction coefficient for the 
protein standard (1.40).  
 
Figure 3.26 The HPLC gradient used to elute IgG1 kappa standard and CB72.3 mAb (A), standard curve produced 
using IgG1 kappa standard (B) and the titre of mAb accumulated over time, calculated from the standard curve. 
Data is  presented as average of two replicates. 
Since E22 is a stably producing cell line, Mab titre is relatively high (1.184 mg/ml on day 8) 
even under batch culture conditions and no additional supplementation. Using the 
mathematical equation, the specific antibody productivity (qMab) was equal to 0.77 pg/cell/h 
(18.48 pg/cell/day). To estimate how many moles of mAb were secreted per hour, qMab value 
was divided by the estimated molecular weight to obtain 5.35x10^-18 moles/cell/h. Using the 
Avogadro number (6.022x1023), it was estimated that the number of complete monoclonal 
antibody produced by E22 producing cell line was 3.22e6 molecules/cell/h.  
3.3.2 Comparison of lysis buffers for in-gel trypsin digest  
Cell culture, equivalent to 107 cells, was collected at mid-exponential phase, centrifuged and 
washed twice in PBS to remove residual medium components. Cell pellets were treated with  
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various lysis buffers to determine the best method of protein extraction. Cell lysates were 
visually compared on SDS-PAGE (see section 2.3.3 for details). 
The first experiment was designed to check the effectiveness of radioimmunoprecipitation 
assay (RIPA) buffer, which was routinely used in our laboratories for protein extraction from 
many different cells (including bacterial and human). Cells were lysed with 1 ml of RIPA buffer. 
The supernatant was clarified by centrifugation and the remaining insoluble pellet was further 
treated with strongly denaturing 4xLB buffer. RIPA buffer was not found to be as effective in  
protein extraction. In contrast, pellet lysis with 4xLB buffer yielded prominent histone 
proteins (bands 15-20 kDa, Fig 3.27), as confirmed later by MS analysis. Histone proteins are 
one of the most abundant species in mammalian cells so their efficient extraction is very 
important.  
 
Figure 3.27 Testing of RIPA buffer lysis efficiency. The pellet remaining after supernatant removal was further 
lysed with 4xLB and resulting lysate was diluted and loaded on SDS-PAGE gel (5% stacking and 12 % resolving).  
Based on the literature, additional lysis buffers were selected for their compatibility with in-
gel trypsin digest: DIGE (urea) buffer, general buffer and PLY buffer. 
By visual examination of SDS-PAGE gels (Fig. 3.28), it can be concluded that neither PTY (lane 
6; used normally in phospho-enrichment studies) nor GLB (lane 8;) performed better than any 
of two tested RIPA buffers (lanes 2 and 3) or urea buffer (lane 4). The cell pellets following 
urea, PTY and GLB lysis were further treated with 4xLB to extract proteins from insoluble 
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fraction that was expected to include membrane proteins. It can be noticed that histone 
proteins were especially prominent (lanes 5, 7 and 9).  
 
Figure 3.28 Optimisation of lysis buffers for in-gel trypsin digestion. 107 cells were lysed in 1 ml of each of the 
buffers tested, and an equal volume of the resulting lysate was analysed on SDS-PAGE gel (5% stacking and 12 
% resolving). 
Based on the above results, it was decided to check whether 4xLB buffer can be used as the 
only lysis buffer for the extraction of all cellular proteins. It was found that 4xLB buffer was 
the most robust lysis buffer (Fig 3.29). There were several reasons of why the 4xLB buffer was 
so effective, including lysis at high temperature, high concentration of detergent (SDS) and 
reducing agents. The cell lysate following 4xLB treatment was very concentrated, therefore 





Figure 3.29 Testing the performance of 4xLB lysis buffer and comparison with protein extraction using the 
standard RIPA buffer. 107 cells were lysed in each case and the resulting lysates diluted and analysed on SDS-
PAGE gel (5% stacking and 12% resolving).  
3.3.3 Comparison of lysis buffers for in-solution trypsin digest  
Another popular method of sample preparation for mass spectrometry is in-solution trypsin 
digest. Based on the literature, tetraethylammonium bromide (TEAB) buffer (containing 
0.01% SDS and 0.1% Triton X-100) was selected as a mild denaturing buffer as it is commonly 
used in TMT and iTRAQ labelling experiments (Ernoult et al. 2010; Rauniyar and Yates 2014). 
50 µg of protein was reduced with DTT, alkylated with IAA and then digested with trypsin 
solution (prepared according to the manufacturer’s protocol) in 1:50 ratio (enzyme: protein 
ratio). The effectiveness of digestion was confirmed on SDS-PAGE gel (Fig 3.30).  
The procedure was repeated twice to ensure reproducibility. It can be assumed that the 
trypsin digestion worked well as only smears are seen in lane 3 (left gel) and lanes 4 and 5 
(right gel). They were some single bands still present in lane 4 (right gel) and this suggested 
issue with either buffer conditions or suboptimal trypsin: protein ratio. In general, TEAB buffer 






Figure 3.30 In-solution trypsin digest in 0.5M TEAB buffer. (A) First attempt of protein extraction in TEAB buffer, 
followed by in-solution trypsin digest. (B) The results were confirmed with the second attempt. Both analysed 
on SDS-PAGE gel (5% stacking and 12 % resolving).  
In addition to the original in-solution trypsin digest technique, filter-aided sample preparation 
(FASP) method was also tested, which uses spin filter tubes to improve both protein 
extraction and peptide yield. Based on the literature, 3 lysis buffers were tested for future 
FASP testing: SDS-based buffer, SDC-based buffer and urea-based buffer (see section 2.3.6). 
It can be concluded that all buffers had similar lysis efficiency (Fig. 3.31).  
 
Figure 3.31 Lysis buffer for filter-aided sample preparation (FASP) method. 107 cells were lysed with either urea-
based, SDS-based or SDC-based buffer and extracted proteins were separated on SDS-PAGE gel (5% stacking and 
12 % resolving). 
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The SDC-based buffer was particularly interesting since SDC is one of the few detergents 
compatible with mass spectrometry instruments and can be even more effective in 
solubilizing the protein. What is more, a low concentration of SDC (about 0.1%) may even 
increase the efficiency of trypsin digestion, which may lead to better proteome coverage 
(León et al. 2013). In contrast, the SDS-based buffer contains a high concentration of SDS, 
which not only reduces the trypsin activity, but can also interfere with MS ionization (Steen 
and Mann 2004). Using this buffer requires multiple wash steps with 8M urea buffer to lower 
critical micelle concentration (CMC) to ensure that the SDS concentration is below 0.01% 
(which is acceptable for MS).  
Based on the above results, it was difficult to determine which of the buffers is the most 
suitable for FASP method. A potential problem with using urea-based buffer can be  
carbamylation of samples, which can cause issue with peptide (and protein) identifications. 
On the other hand, a potential disadvantage of using the SDC-based buffer is that it can be 
biased toward more hydrophobic proteins (e.g. membrane proteins), leading to 
underrepresentation of the hydrophilic proteins. In contrast, SDS binds all proteins in similar 
fashion so it can be the most versatile detergent for solubilizing all types of cellular proteins.  
The SDS has a hydrophobic tail that interacts strongly with protein (polypeptide) chains. The 
number of SDS molecules that bind to a protein is proportional to the number of amino acids 
that make up the protein. Each SDS molecule contributes two negative charges, 
overwhelming any charge the protein may have (Lin et al. 2013). 
For the above reasons, it was decided to choose SDS-based buffer for further analysis and 
perform FASP method according to the original protocol (Jacek R Wiśniewski et al. 2009). 
Results of protein extraction and trypsin digestion were analysed on SDS-PAGE gel (Figure 
3.32). The original paper presented clearly that there was no sample loss following SDS 
displacement from proteins by urea and proteins bands disappeared following trypsin digest 
(3.11 B). By visual examination of the experimental gel, it was difficult to confirm that there 
was no loss of the sample due to uneven loading of the lysate before and after depletion of 
SDS. What is more, the lanes for peptides eluted from the spin filter tube still showed some 
protein bands, suggesting that the trypsin digestion was incomplete. Further MS analyses can 




Figure 3.32 The steps of filter aided sample preparation (FASP) method were visualised on SDS-PAGE gel (5% 
stacking and 12% resolving). The results from the first attempt of FASP method show the lysate, SDS-depleted 
and samples following trypsin digestion. In addition, two samples of eluted peptides (marked as 1 and 2; A) are 
presented. (B) The results are compared with the representative SDS-PAGE gel from original publication from 
Wiśniewski et al. 2009. 
3.3.4 Compatibility of protein concentration assay  
Determining the protein concentration after cell lysis in a buffer is critical to the success of 
any sample preparation method. Since the tested buffers differed in the concentration of 
chaotropes, detergents and reducing agents, it was important to find suitable protein 
concentration assay. The commercially available RC DCTM protein kit (Bio-Rad) was chosen as 
it was specifically designed to be compatible with a wide range of reagents.   
The RIPA buffer was found to be fully compatible with RC DCTM assay, therefore no dilution 
was required (Figure 3.33 A). 4xLB buffer was also compatible according to the 
manufacturer’s instructions, but it was found that 1:10 dilution produced a better standard 
curve (Figure 3.33 B).  The protein lysates containing high concentrations of SDS were highly 
concentrated so it was not possible to accurately determine the protein concentration 




Figure 3.33 Standard curves of the protein standard, bovine serum albumin (BSA), dissolved in RIPA buffer 
(undiluted; A), 4xLB buffer (1:10 dilution; B) or DIGE buffer (1:10 dilution; C) following RC DCTM protein assay. The 
equation of the fitted linear regression model is displayed together with goodness-of-the-fit value, R2.  
Similarly, DIGE buffer contained high concentration of urea and thiourea (8M and 2M, 
respectively), therefore standard curve was produced as 1:10 dilution. In general, BSA 
standard curves were found to be reproducible since R2 values are above 0.98, meaning that 
each data point fit linear regression almost ideally. 
Next, TEAB buffer and SDS-based buffer, used for in-solution trypsin digest and FAST method, 
respectively, were also tested for compatibility with RC DCTM assay. Both buffer components 
were found to cause interference with assay reagents, therefore 1:10 dilution was necessary. 
It was found that both standard curves were satisfactory when predicting the protein 
concentration in the lysates(R2 values above 0.99; Figure 3.34 A&B).  
 
Figure 3.34 Standard curves of protein standard, bovine serum albumin, dissolved in TEAB buffer (1:10 dilution; 
A) or SDS-based buffer (1:10 dilution; B) following RC DC protein assay. The equation of fitted linear regression 
model is displayed together with goodness-of-the-fit value, R2. 
3.3.5 Comparison of the number of protein identifications between in-gel trypsin digest 
protocols 
The first part of method optimisation was finding a buffer that provides a greater proteome 
coverage than the RIPA buffer. The comparison of the tested buffers was based on the 
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number of confirmed protein identifications that meet both 1% FDR (at peptide level) and ≥2 
unique peptides criteria. It was found that 4xLB buffer performed best (467), than urea (330) 
or RIPA (199). The overlap of validated protein identifications, also between two different 
digestion conditions (trypsin only versus trypsin and Lys-C), are shown below (Figure 3.35). 
Interestingly,  larger number of proteins was extracted using more denaturing lysis conditions, 
which lead to an overall increase in the number of identified proteins. As mentioned before, 
histone proteins were underrepresented in RIPA lysate (only histone H2A found). On the 
other hand. 4xLB lysate contained all major histone classes: histone H4, H3, H2A and H2B 
(please refer to Appendix F for full list).  In addition, protein extraction with 4xLB buffer was 
the quickest procedure as the lysis was performed at close to boiling (95ᵒC) temperature. The 
only issue with the obtained lysate was the high protein concentration and viscosity due to 
the high DNA content in the remaining insoluble fraction (that was impossible to separate by 
centrifugation). 
 
Figure 3.35 Venn diagram showing the overlap of validated protein identifications between the three buffer conditions: mild 
denaturing (RIPA) and strong denaturing (4xLB or urea), tested for compatibility with in-gel trypsin digest. The on-gel trypsin 
digest was then performed with either trypsin only (A) or combined Lys-C/trypsin (B). The search was carried out using 
Mascot Daemon (v 2.5.1) against CHO and contaminants databases (section 2.3.11) and only proteins that have ≥2 unique 
sequences were used for comparison. The figure was prepared using Venny 2.1 online tool (Oliveros 2007). 
 
The second part of in-gel trypsin digest optimization was to use two proteases of different 
specificity: Lys-C and trypsin , in contrast to using trypsin alone. All buffer conditions (RIPA, 
4XLB and urea) were taken into consideration. It was found that the use of Lys-C/trypsin 
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combination gave more protein identifications only when using RIPA buffer. It can be argued 
that RIPA buffer, having mild denaturing conditions, may not solubilise proteins as effectively 
as other denaturing buffers. It was possibly due to not all lysine residues were exposed for 
trypsin to cut. Lys-C/trypsin combination did not perform better when using  4xLB or  urea 
buffer. It is possible, however, that our results have been biased for several reasons, including 
the suboptimal Lys-C digestion conditions, underloading the sample due to errors in the 
amount of protein or lower LC-MS/MS performance. Additional replicates would be necessary 
to prove why the results of the combined Lys-C / trypsin did not increase the number of 
identifications. 
Table 2.9 Comparison of buffer and digest conditions based on the number of validated proteins identifications 
(excluding duplicates).  
Protein identifications 
Buffer Trypsin only Lys-C/Trypsin mix 
RIPA 199 241 
4xLB 467 315 
Urea 330 208 
 
In summary, the 4xLB buffer worked best to increase the number of identified protein, 
therefore it would be selected for further validation on higher sensitivity mass spectrometers 
(MaXis 4G UHR-TOF and Q-Exactive HF, see Appendix A). Since there was not enough evidence 
that the use of two proteases of different specificity had any positive effect on number of 
identifications, trypsin alone will be used. 
3.3.6 Protein extraction from spent media 
The second aim of this chapter was to find and compare methods of extracting proteins from 
spent media (supernatant). The interest in the analysis of host cell proteins (HCPs) has been 
growing in the last few years (Valente et al. 2014). Based on the results of this study, three 
methods were selected: acetone precipitation, ethanol precipitation and trichloroacetic acid 
(TCA) precipitation. The molecular basis of the precipitation is similar between the chemicals 
tested, but the protocols and incubation conditions are slightly different. There was no 
significant difference found between the three extraction methods, which was visually 
examined by SDS-PAGE gel (Figure 3.36). The results also agree with those already published 
(Valente et al. 2014), in which 10 different extraction protocols were tested. Of the three 
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methods, acetone precipitation was found to be the quickest as it used a single centrifugation 
step, meaning that sample loss can be minimal. This method was selected for further analysis.  
 
Figure 3.36 SDS-PAGE gel shows the results of protein analysis in unconcentrated spent media before and after 
precipitation with one of the three chemicals: ethanol, acetone and trichloroacetic acid (TCA) (A). Standard curve 
was prepared by serial dilutions of bovine serum albumin (BSA) in CD-CHO medium. Protein concentration was 
estimated using the Bradford assay at 595 nm absorbance.. 
Acetone precipitation method was used to extract proteins from (stably producing) E22 cell 
line. Distinct bands, corresponding to HC (mW = 48.5 kDa) and LC (mW = 23.4 kDa) for the 
mAb, were visible (see section 3.3.1.2). Following in-gel trypsin digest and MS analysis using 
Amazon ETD, 343 proteins with at least 2 unique peptides were identified. 
In addition, it was interesting to examine the overlap between extracellular and intracellular 
proteins. There were a lot of similarities between the two protein pools, with some proteins 
being exclusively present in spent media and some present only inside the cells (Figure 3.37). 
However, some of the proteins common to both pools could be products of degradation of 
native proteins, since only peptides were used to identify proteins (“bottom-up proteomics“).  
In addition, any differences in the identifications of proteins might also be due to technical 
errors  during sample preparation or the difference in instrument’s performance. What is 
more, qualitative proteomic data provide only limited information about the real state of the 
cellular protein pool. The method presented above can be easily adapted to quantitative 
proteomics approaches, including label-free and stable isotope labelling approaches.  
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Interestingly, among the proteins identified solely in the spent media (“extracellular”) there 
are many that are associated with intracellular processes, such as ribosomal proteins 
(different isoforms of 60S ribosomal proteins), involved in cytoskeleton regulation (for 
example F-actin-capping protein subunit beta-like protein or Cytoskeleton-associated protein 
4) or even translation elongation (Elongation factor 1-alpha and delta). These proteins may 
be present as degradation products from dead cells.  
What is more, there are also proteins having dual functions: they are not only related to 
intracellular processes, but also form a part of the extracellular exosome (cell-derived vesicle), 
such as proteasome-related proteins (Proteasome subunit alpha and beta). Another 
interesting protein, 15kDa selenoprotein, is usually present in the endoplasmic reticulum and 
is associated with the posttranslational protein folding but can also be found in extracellular 
exosome. 
 
Figure 3.37 Venn diagram showing the overlap between the number of identified intracellular proteins after 
extraction from the cell pellet with 4xLB buffer (n=476) and extracellular proteins following acetone extraction 
from spent media (n=343). Both data sets were obtained by in-gel trypsin digest and LC-MS/MS data acquisition 
on Amazon ETD. Numbers are presented as validated protein identifications, having FDR 1% at peptide level and 
at least 2 unique peptides.  
There also several proteins that can be found in the extracellular space, including those 
involved in cell-matrix adhesion (mammalian ependymin-related protein 1, nidogen-1) or that 
form the basal membrane (laminin subunit gamma and beta). Surprisingly, two proteins 
involved in complement system (Complement C1r-A subcomponent and Complement C3) 
were also identified.  
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3.3.7 Comparison of the number of protein identification between in-solution trypsin 
digest and filter-aided sample preparation (FASP) 
Following visual examination of digests from in-solution trypsin digest and filter-aided sample 
preparation (FASP), the next step was method validation using LC-MS/MS. Equal amounts of 
extracted peptides from each method were cleaned-up using Hypersep (see Chapter 2 for 
details) and MS/MS data were acquired using ion trap mass spectrometer, Amazon ETD. In 
contrast to the results of the SDS-PAGE gel, it was found that in-solution trypsin digest with 
TEAB buffer did not produce satisfactory results (Fig 3.38A). On the other hand, a good 
number of validated protein identifications was achieved using FASP method (Fig 3.38B). Total 
ion chromatograms (TIC) for both methods (Fig 3.38) and Mascot Daemon search results (Fig 
3.39) confirmed that FASP method was more efficient at extracting and digesting proteins 
that in-solution digest. 
 
Figure 3.38 Total ion chromatograms (TIC) for in-solution derived TEAB samples (A) and FASP method derived 
peptides (B).  
By further analysing these fractions using Mascot Daemon database search, FASP method 
successfully identified 215 proteins, from which 95 were validated with at least 2 unique 
peptides. In contrast, in-solution trypsin digest performed poorly: only 96 proteins were 
identified and only 17 of them were validated. (Figure 3.39). It is quite possible that the digest 
conditions were suboptimal despite satisfactory protein extraction from cell pellets. On the 
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other hand, the FASP method performed as expected, so it was selected for further 
fractionation and full proteome analysis. 
 
Figure 3.39 The number of protein matches against CHO database of a single injection of peptides coming from 
in-solution trypsin digest using TEAB buffer or FASP method. The number of unique proteins (identified with ≥2 
unique peptides) is also presented. The FDR 1% threshold was not applied here due to low number of decoy 
matches. 
 
3.3.8 Development of peptide fractionation method using Hypercarb column 
After validation of the FASP protocol using LC MS/MS analysis of a small unfractionated 
sample, it was important to develop a method for separating the peptides prior to full 
proteome analysis. After FASP digestion, peptides eluted from nitrocellulose filter contained 
salts and residual buffers that might interfere with MS analysis. Following promising results 
from Hypersep clean-up, the decision was made to use Hypercarb column which is also made 
from porous graphitic carbon (PGC). Peptide fractionated protocol previously developed in 
our lab used 2-70% peptide separation over 120 min gradient, collecting fractions from 5 min 
onwards, leading to total of 108 fractions. To reduce time and the number of fractions, the 
protocol was adjusted to 60 min.  
To determine how well Hypercarb performs as a first dimension of peptide fractionation, 11 
fractions (out of 54) were analysed by LC-MS/MS. Each peptide fraction was estimated to 
have between 200-450ng of peptides present (based on 50 µg of starting protein amount). 
The table below presents the analysed fractions together with corresponding %B (0.1% FA in 






Table 3.10 Fraction number and their corresponding %B buffer 













As expected, normal distribution for peptide elution profile was observed, with majority of 
peptides eluting in the middle of the gradient (30-60% of B) as shown below (Figure 3.40).  
 
Figure 3.40 Distribution of the number of protein matches against CHO database (Mascot Daemon) per peptide 
fraction eluted from the Hypercarb column. No FDR cut-off was applied because of low peptide abundance in 




Figure 3.41 Total ion chromatograms (TIC) for selected peptide fractions eluted from Hypercarb column. The 
least abundant fractions 2, 7 & 12 (A), were followed by the most abundant fractions 17, 22, 27, 32) and 
fractions eluted at the end of the gradient were 37,42, 47 & 52 (C).   
Based on the elution profile of separated peptides, the fractions eluting at the beginning and 
end of the gradient were combined together (Figure 3.41). In total 3 fractions were combined 
into a single tube, dried in the vacuum concentrator and analysed fully on Amazon ETD using 
trypsin only and trypsin/Lys-C digest conditions. In both digest conditions, more than 1000 
protein hits against CHO database were found after the removal of the contaminants. By 
applying FDR criteria, 652 validated protein identifications were obtained using trypsin only 





Figure 3.42 Comparison of number of protein hits and unique proteins obtained by the complete analysis of 
FASP/Hypercarb method using trypsin and trypsin/Lys-C digest conditions. 1% FDR threshold at peptide level 
was applied. 
3.3.9 Final comparison of in-gel trypsin digest and in-solution trypsin digest 
Following optimisation of buffer and digest conditions for in-gel trypsin digest and FASP 
method, it was important to verify the number of validated protein identifications using more 
sensitive MS instruments: MaXis 4G UHR-TOF and Q-Exactive HF (for instrument 
specifications, please refer to Appendix A). For each sample, 2 replicates were prepared using 
optimised sample preparation method and approximately similar amount of peptides 
analysed using MaXis 4G or Q-Exactive HF (Figure 3.43). The only difference was the number 
of loaded fractions (20 for MaXis, 10-18 for Amazon ETD and 6-8 for Q-Exactive HF) due to the 
difference in the speed of spectra acquisition.  
As expected, the number of unique protein identifications increased accordingly to the 
instrument sensitivity, starting from ion trap (Amazon ETD) to higher sensitivity Orbitrap (Q-
Exactive HF). In addition to increased number of protein identifications, the MS data 
acquisition is shorter when using Q-Exactive HF as the number of fractions can be reduced to 





Figure 3.43 Comparison of the number of unique protein identifications after optimised in-gel trypsin digest and 
FASP protocols. Data were obtained on three different mass spectrometers: ion trap (Amazon ETD), Q-TOF 
(MaXis 4G UHR-TOF) and Orbitrap (Q-Exactive HF). The protein identifications were validated based on 1% FDR 
at peptide level and ≥2 unique peptides. Each set of data was based on 2 technical replicates of the sample 
preparation method. 
3.4 Conclusions 
A qualitative proteomic workflow was developed for robust intracellular and extracellular 
protein extraction from Chinese Hamster ovary (CHO) cells. Three different methods were 
selected for the extraction of intracellular proteins from CHO cells: in-gel trypsin digest 
(Shevchenko et al., 2007), in-solution trypsin digest and its derivative, FASP method ( 
Wiśniewski et al. 2009).  
The first step of optimisation was finding the most optimal and robust cell lysis buffer to be 
compatible with sample preparation method for mass spectrometry. 
Radioimmunoprecipitation (RIPA) buffer was a starting point as it was routinely used in our 
lab (O’Callaghan et al. 2010; Davies et al. 2013) for protein extraction from both prokaryotic 
and eukaryotic cells. It was found that RIPA buffer, since it has very mild denaturing 
conditions, was not as efficient at protein solubilisation as expected. This was confirmed by 
treating the insoluble fraction with SDS-based 4xLB buffer (Karlsson et al., 1994) to reveal that 
even histone proteins, one of the most abundant proteins in the cell, were underrepresented 
in RIPA lysate (see section 3.3.6 and Appendix F). 
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Based on the literature, several buffers were selected for further testing, including general 
lysis buffer (GLB), PTY buffer (Chen, et al. 2010) and DIGE buffer (Magdeldin et al. 2014). The 
latter was found to be the most efficient, most likely due to optimal concentration of urea 
and thiourea. Finally, 4xLB buffer, commonly used for Laemmli buffer sample preparation was 
also tested as a sole lysing buffer and it was found to be even more robust and time-efficient.   
In parallel to lysis buffer optimisation, digest condition using trypsin or combined Lys-C and 
trypsin were also tested. There was not enough evidence that using Lys-C has any positive 
effect on the number of protein identifications. This was probably due to insufficient number 
of replicates or suboptimal digest conditions (Hustoft et al. 2010). In conclusion, 4xlb buffer 
and trypsin only digest conditions were selected for further MS data acquisition. 
In addition to in-gel trypsin digest, we have also tested commonly used in-solution trypsin 
digest and its derivative, filter-aided sample preparation (FASP) protocols. For traditional in-
solution trypsin digest, TEAB buffer, having mild denaturing conditions, was found to be 
relatively efficient at protein solubilisation and compatible with trypsin digestion, as 
confirmed by SDS-PAGE gel. For FASP method, three of the tested lysis buffers (SDS-based, 
SDC-based and urea-based) showed no significant difference in their extraction efficiency. 
The results did not agree with León et al. 2013, where SDC-assisted in-solution digestion and 
FASP generated better peptide recovery.  
Following Mascot Daemon (http://www.matrixscience.com/daemon.html) database search, we 
have found that FASP method was superior to in-solution digest in terms of validated protein 
identifications. One of the reasons why in-solution trypsin digest method has failed because 
it was difficult to control protein solubilisation. During the procedure, it is important to dilute 
the urea concentration in the sample to below ~1M for trypsin to work. On the other hand, 
insufficient protein solubilisation may cause proteins to re-fold in solution, making the target 
amino acid residues (K and R) inaccessible to trypsin. While using the FASP method, this 
problem was solved by full protein extraction with strongly denaturing SDS-based buffer, 
followed by capturing the proteins on the nitrocellulose filter (Wiśniewski et al. 2009). After 
digestion with trypsin, the extracted peptides were eluted from the filter while any 
undigested proteins remain inside the filter. SDS-based buffer was selected for FASP method 
as SDS has been long recognised for its benefits for protein solubilisation in many sample 
preparation workflows (Botelho et al. 2010) 
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In-gel trypsin digest and FASP method are very similar in terms of using high concentration of 
denaturing agent (SDS; 2% and 4%), temperature (both 95ᵒC) and trapping proteins into a gel 
matrix or nitrocellulose filter. It was expected that FASP performance might be better due to 
addition of second dimension of peptide separation with Hypercarb columns. On the other 
hand, trapping proteins into SDS-PAGE gel is beneficial for protein linearization, but leads to 
lower performance of trypsin due to presence of SDS. If the FASP method is perfomed 
correctly, residual SDS concentration is too low to cause any interference with trypsin. Finally, 
it was confirmed that Hypercarb was suitable for fractionation of tryptic peptides in 
agreement with (Griffiths et al. 2012) and can be also used for separation of glycoproteins 
(Zhao et al. 2014a).  
For comparison purposes, mascot generic files (.mgf) were derived from Q-Exactive HF 
spectra acquisition using freely available MsConvert program (freely available with other 
ProteoWizard tools: http://proteowizard.sourceforge.net/tools.shtml).  Unfortunately, search of 
spectra using Mascot Daemon provides very limited quantitative information and it does not 
support large-scale isotopic labelling experiments such as SILAC or pulse SILAC. Generated 
.raw files could also be analysed by MaxQuant (Cox and Mann 2008), which is not only open 
source software, but also performs complete analysis from protein identification to 
quantitation. Each software release brings the improvements in terms of peptide 
identifications that is closely linked with the development of new Orbitrap-based mass 
spectrometers (Scheltema et al. 2014), including peak picking, automatic 1% FDR threshold 
and data normalisation (Tyanova  et al., 2016). 
In conclusion, the most popular sample preparation methods for mass spectrometry analysis 
were tested and optimised. It was found that both in-gel trypsin digest and FASP method 
perform equally well for protein extraction from CHO cells and lead to similar number of 
unique protein identifications. It can be argued that in-gel trypsin digest method has the 
advantage over FASP in terms of simplicity and time as it does not require lengthy 
centrifugation steps and additional offline HPLC-based peptide separation (Hypercarb). It is 
also possible to combine FASP and in-gel trypsin digest method to gel-aided sample 
preparation (GASP) method, which is not only faster but easier to use and more sensitive 




Chapter 4: Relative quantitation of proteome changes 
between exponential and stationary phase in CHO cells 
using SILAC 
4.1 Abstract  
Quantitative proteomics is an increasingly powerful tool in molecular biology to study and 
compare relative changes in global protein abundance between different growth conditions. 
SILAC (stable isotope labelling of amino acids in the cell culture) is one of the most popular 
metabolic labelling methods to quantify protein expression in mammalian cells. Standard 
SILAC has been applied to study fundamental changes in protein expression between 
exponential and stationary phases of CHO cells grown in the chemically-defined medium. It 
was found that CHO cells have incorporated labelled lysine and arginine within two cell 
culture passages to >97%. What is more, arginine-to-proline conversion was minimal, most 
likely due to presence of excess free (>200 mg/ml) proline in the medium.  
Standard SILAC experiment was setup with reverse conditions, which provided an excellent 
biological replicate and confirmed no negative effect of labelled amino acids on cell growth. 
Using previously developed protocol for GeLC-MS/MS, >3000 proteins have been identified 
in both GS-KO parental and its derivative E22 producing cell line. They were 63 differentially 
expressed proteins found for E22 producing cell line and GS-KO were 109 proteins, from 
which 32 proteins were common between the two cell lines. Data strongly suggest that 
changes driving progression from exponential to stationary phase are highly conversed. Based 
on KEGG and GO annotation, these proteins are involved in processes such as protein 







4.2 Introduction  
Chinese hamster ovary (CHO) cells are the most popular mammalian host for producing 
recombinant proteins, especially monoclonal antibodies used to treat various medical 
conditions, including cancer and autoimmune diseases. Since the approval of tissue 
plasminogen (tPa) factor in 1986, 96 recombinant protein therapeutics have been produced 
using mammalian cells, bringing to US markets over 110-billion-dollar annual revenue (Lai, 
2013).  
There are several reasons why CHO cells are preferred in industrial biomanufacturing. The 
ability of CHO cells to produce proteins with the same glycosylation profile as human does 
not increase the quality of biotherapeutics, but also their bioavailability in the circulatory 
system. CHO cells can also be easily adapted to grow in suspension cultures using serum-free 
media, which significantly reduces the cost and increases the reproducibility (Kim et al., 2012). 
In addition, cloning techniques, expression vector design and clonal selection methods have 
been greatly improved, which has led to an increase in specific productivity from 0.05g/L to 
even 10g/L of a recombinant product (Huang et al, 2010; Wurm et al., 2004, Datta et al., 
2013). 
Despite enormous progress in research on CHO cells in the last decade, intracellular 
metabolism in cell culture is still not fully understood. Such limited knowledge about in vivo 
metabolism in industrially relevant culture conditions limits the potential of applying modern 
engineering techniques to further improve product yield and quality (Ahn and Antoniewicz, 
2012). The ability to characterize the cellular machinery of CHO cells and its changes in the 
cell culture is important for improving both growth and productivity (Dinnis and James, 2005).  
Cell growth is directly related to biomass increase due to substrate uptake from the 
environment. During exponential phase, cells direct energy to the proliferation and 
accumulation of biomass, the main components of which are proteins (Sinha and Kumar, 
2008).  In contrast, the stationary phase is characterized by a rate of growth equal to 
mortality. The cells are still metabolically active and produce secondary metabolites (non-
growth-related products).  Due to such a deregulation in metabolite production, the highest 
increase in the production of recombinant protein in mammalian cell factories occurs in the 
stationary phase (Shuler and Kargi, 1992). 
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A number of “omics”-profiling techniques, including proteomics, have been used to gain a  
better insight into the complex mechanisms of major cellular processes. The publication of 
the genome sequence of the ancestral CHO-K1 cell line (Xu et al., 2011) was a major milestone 
in better understanding of cell physiology. Further studies on global gene expression 
(transcriptomics) revealed that there over 29,000 genes are expressed by CHO cells under 
different growth conditions (Becker et al, 2011). 
For many prokaryotic and eukaryotic organisms, only 50% of the protein abundance can be 
explained by variations in mRNA concentration (de Sousa Abreu et al, 2009). That is why direct 
measurements of the global protein abundances inside the cell (proteomics) are much more 
informative. Changes in protein expression in response to changing environmental conditions 
directly determine physiological state of the cell. By comparing proteomic data (based on MS 
spectra) to genomic and transcriptomic information, it was found that there is generally good 
correlation between transcript levels and protein expression (Baycin-Hizal et al, 2012). By 
analysing such multidimensional data, it is possible to gain a deeper understanding of the 
basic mechanistic changes taking place inside the cell that can help in optimization of 
industrial bioprocesses (Chen et al, 2015). 
Proteomic analysis can be further extended by quantifying the amount of protein present in 
the sample (protein abundance) and comparing the relative changes in protein expression 
under different conditions. Quantitative proteomics can be achieved using two major 
approaches: label-free techniques and use of stable isotope labelling (reviewed in sections 
1.5.2-1.5.7). Label–free quantification is based on measurement of signal intensity of 
precursor ion spectra or spectral counting based on counting the number of peptides 
corresponding to a given protein in tandem MS experiment (Neilson et al, 2011).  
Labelling techniques can be divided into two groups: chemical labelling such as iTRAQ or ICAT 
(Ross, 2004; Gygi, 1999) or in vivo metabolic labelling (SILAC). In SILAC (stable isotope labelling 
of amino acids in the cell culture), proteins can be labelled in cell culture with heavy isotopes 
of essential amino acids. The auxotrophic cells are grown in media lacking an amino acid and 
are instead supplemented with its stable isotope form (Ong et al, ). Typically, cells are 
labelled with lysine and arginine because trypsin, a commonly used protease, cleaves at C-
termini of these amino acids, to form a complex peptide mixture in which all peptides are 
labelled and can be used for quantitation (Ong and Mann, ). Each peptide will be in a 
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“heavy” or “light” form that can be resolved in a mass spectrometer due to the mass 
difference and provides quantitative information on their relative abundances (Steen and 
Mann, 2004). 
We hope to unravel at least some of the complexity of the “CHO cell factories” to optimize 
cell culture process engineering. The aim of this chapter was to assess the basic changes in 
cellular machinery during the growth of CHO cells. To our knowledge, this was the first time 
SILAC has been utilised in conjunction with quantitative proteomic analyses in CHO cells. 
Analysis of differential protein expression was performed between exponential and 
stationary phases in both parental and stably producing CHO cells. 
4.2 Aims and objectives 
The aim of this chapter is to develop an accurate quantitative proteomic method using SILAC, 
which can be used to study changes in protein expression between the exponential and 
stationary phases of CHO cell growth. First, the necessary quality controls will be examined, 
including % incorporation of isotopes of amino acids and the degree of arginine-to-proline 
conversion. This will be followed by in-depth examination of SILAC data sets and methods for 
determining differential protein expression. The workflow for combining forward and reverse 
SILAC data sets will be evaluated for both parental and stably producing cell lines. Side-by-
side comparison of these data sets will also be presented using functional annotation and 
pathway analysis using publicly available databases. 
4.3 Results and discussion 
The following sections describe the results from forward and reverse SILAC experiments 
performed in parental and stably producing CHO cell lines. The quality of the data, 
reproducibility of label swap experiments, data quality controls check including % isotope 
incorporation and degree of arginine-to-proline conversion will be examined in detail. This 
will be followed by checking the correlation between biological and technical replicates , 1:1 
ratio mixing and data distribution. Quantitative data will be first presented separately for 
producing and parental cell line. This will be followed by combination of these data sets based 




Figure 4.44 The workflow of forward SILAC experiment. The cells are revived in custom SILAC medium containing 
light isotopes and are subcultured in either light or heavy labelled SILAC for three passages. Cells grown in 
commercial CD-CHO medium provide growth control to check if supplementation with lysine and arginine has 
any negative effect on growth or viability. The cells are grown under appropriate medium conditions until >97% 
incorporation. At passage 5 (p5), cells are harvested in exponential phase (light) and stationary phase (heavy), 
lysed separately and mixed in 1:1 ratio according to the protein concentration. Tryptic peptides are generated 
and analysed by LC-MS/MS. Raw data is processed by MaxQuant and further analysed by Perseus. 
4.3.1 Forward and reverse SILAC experiment in GS-KO cell lines 
4.3.1.1 Growth profile of GS-KO and E22 producing cell lines in custom SILAC medium 
The E22 producing and GS parental cells were revived and placed into a light SILAC medium 
(p1) before being split into 3 different flasks containing different media: light SILAC medium, 
heavy SILAC medium and CD-CHO (for cell growth control). The cells were passaged 3 times 
to ensure full (>97%) isotope incorporation (adaptation phase). At passage 5, the cells were 
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split into 3 flasks under each medium condition (technical replicates) and continued to grow 
in batch culture. Growth was measured daily with Vi-Cell (Fig. 4.45). 
 
Figure 4.45 Growth profile of cells cultured in light SILAC medium, heavy SILAC medium and CD-CHO (control). 
Cell growth and % viability was measured every 24h with Vi-CellTM Beckman Coulter. Top left graph (A) displays 
the results from forward SILAC (FS) labelling experiment in E22 producing cell line, while top right graph (B) come 
from reverse SILAC experiment. Corresponding data for GS parental cell line is presented below (C & D). The 
arrows (yellow - light isotope; red – heavy isotope) indicate the days of cell sampling for quantitative proteomics 
analysis. The values are displayed as mean ± SEM values; n=3. 
 
By analysing viable cell concentration (VCC) curves for forward SILAC (Fig 4.45 A), it can be 
assumed that cells growing in light SILAC medium had a faster growth profile than in heavy 
SILAC and CD-CHO medium. The cells grown in heavy SILAC and CD-CHO medium have very 
similar growth profile. In contrast, (Fig 4.5 B), VCC curves for reverse SILAC experiment were 
almost identical for light SILAC and heavy SILAC, but slightly different from CD-CHO (control). 
The difference might be due to two different batches of CD-CHO used for label-swap 
experiments despite identical batch and supplementation used for light SILAC and heavy 
SILAC culture. The differences between VCC curves might also result from the inherent 
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instability of this cell line rather than media. On the other hand, the % viability was high (98% 
on average) throughout exponential and stationary phase for both labelling experiments.  
4.3.1.2 % incorporation of arginine and lysine into proteins 
It is estimated that 5-10 cell doublings are needed for mammalian cells to fully incorporate 
the amino acids (Ong 2002). The doubling time in mammalian cells, including CHO cells, can 
range from 12 h to 36 h. Based on above data, the doubling time was estimated to be 27-28h, 
so full incorporation should be reached within 3 passages. To establish % of incorporation of 
labelled lysine and arginine, the cell pellet sample was taken at passage 1 (before labelling; 
negative control) and passages 2, 3 and 4 at 72 h (day 3; mid-exponential phase). The cell 
pellets were processed using in-gel digest protocol and data acquired using Q-Exactive HF, 
followed by analysis in MaxQuant, (see section 2.3.4, 2.4.8 & 2.4.9, respectively). 
% incorporation rate was found to be 97.82 % for GS-KO parental cell line and 97.93 % for E22 
producing cell line at p4. CHO cells can incorporate the label very quickly – only within 3 days 
of culture with heavy isotopes, the degree of incorporation rate was already >85% (Fig 4.46). 
One of the reasons is that amino acids from degraded proteins can be recycled and used for 
synthesis of new proteins, resulting in a faster incorporation rate than anticipated.  As 
mentioned before, the % incorporation efficiency is limited by the purity of the isotopes used 
(≥98% purity of each label), which is why the efficiency of incorporation is close to the 
maximum possible.  
 
Figure 4.46 Graph showing the % incorporation rate of heavy isotopes of lysine (Lys8) and arginine (Arg10) 




As an example of the progress of the incorporation of heavy isotopes, survey spectra of the 
heavy labelled peptides were examined (Fig 4.47 & 4.48). 
The first survey spectra are derived from heavy lysine labelled peptide, AAAEVNQDYGLDPK, 
doubly charged (z=2), assigned to Fumarate hydratase (G3H6M5) leading razor protein (as 
reported in evidence.txt result file). The spectra from passage 2, 3 and 4 were aligned to 
demonstrate the rate at which heavy isotopes were incorporated in proteins. After only 3 
days of cell culture, the light-labelled peptide is still present, but at relatively low abundance 
and it is hardly visible following passage 3 and 4, confirming the full incorporation. Similarly, 
the spectra for heavy arginine labelled peptide, AAVPSGASTGIYEALELR (from Alpha-enolase 
leading razor protein) have been aligned together and show the same trend. The spectra for 
passage 2 look much noisier than for passage 3 and 4 (B and C, respectively) since our peak 
of interest is not the base peak and has a lower intensity than for other presented spectra. 
4.3.1.3 Arginine to proline conversion  
Several studies have reported a problem when using arginine to label proteins in SILAC (see 
section 1.6.2). There is a metabolic pathway that can convert arginine to proline when excess 
arginine is used for the labelling. To assess whether the conversion occurred in CHOK1SV GS-
KO cell lines, the search was performed in MaxQuant using default parameters (see section 
2.4.9) with Pro6 as a variable modification. In addition, “Re-quantify” option has been 
disables.  
Of the 17587 peptide-to-spectrum matches (from the evidence.txt result file) only 6 
contained at least 1 heavy proline (Pro6). The degree of arginine to proline conversion was 
found to be <0.03%. It can be therefore assumed that the arginine to proline conversion is 
negligible. This additionally confirms % incorporation that was calculated earlier. 
Further studies have shown that if there is enough free proline (>200 mg/l) in the media to 
maintain cellular homeostasis, endogenous production of proline will not be favoured. It is 
also worth mentioning that CHO cells are auxotrophic for 15 different amino acids, including 
proline (see section 1.2.7). Another reason for negligible conversion to proline is the lack or 
low expression of the enzymes present in the pathway in CHO cells (Hefzi et al. 2016). This 
effect might be cell line specific, therefore it is important to individually test each auxotrophic 
cell line prior to SILAC experiment.  
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Figure 4.47 The survey spectra of a representative heavy lysine labelled peptide, AAAEVNQDYGLDPK; m/z= 
749.8, which is doubly-charged and has a retention time of 41-42 minutes. This peptide is assigned to G3H6M5 
(Fumarate hydratase) leading razor protein and it contains a single heavy lysine (expected mass shift of 4Da). 
The corresponding light-labelled peptide is present at m/z 745.86. The % incorporation has been tracked from 




Figure 4.48 The survey spectra of a representative heavy arginine labelled peptide, AAVPSGASTGIYEALELR; 
m/z=907.97, which is doubly-charged and has a retention time of 64-66 minutes. This peptide is assigned  to 
G3IAQ0 (Alpha-enolase) leading razor protein and it contains a single heavy arginine (mass shift of 5Da). The 
corresponding light-labelled peptide is present at m/z=902.98. The % incorporation has been tracked from 




4.3.1.4 SILAC experiment phase and sample preparation for mass spectrometry 
After confirming the full incorporation of heavy isotopes and the very low conversion of 
arginine to proline, the experiment phase begun. The cells were grown in parallel in batch 
culture in chemically-defined media with supplemented lysine and arginine in their light or 
heavy isotopic form. In forward SILAC labelling experiment, the exponential phase was 
marked by light (L) labelled sample and the stationary phase by heavy (H) labelled sample. In 
reverse SILAC experiment, the labels were swapped, providing both additional quantitation 
information and excellent biological replication (Fig 4.49 B). The cell pellet was washed twice 
with PBS and lysed in strong denaturing buffer, followed by SDS-PAGE separation and in-gel 
tryptic digestion (Figure 4.49A).  
 
Figure 4.49 (A) Representative SDS-PAGE gel from SILAC experiment in E22 producing cell line. M, protein ladder; 
L1H1 (mix of light labelled sample 1: heavy labelled sample 1); L2H2 (mix of light labelled sample 2: heavy labelled 
sample 2); L3H3 (mix of light labelled sample 3: heavy labelled sample 3). (B) The schematic explaining design of 
label-swap SILAC experiment to investigate changes in protein expression between exponential and stationary 
phase of batch culture of CHO cells growing in chemically-defined medium. 
4.3.1.5 Data distribution and quality between replicates 
SILAC experimental setup explained above, technical replicates are the replicates coming 
from the same labelling experiment, named here as forward SILAC (FS) and reverse SILAC (RS). 
On the other hand, biological replicates come from a separate labelling experiment (one from 
forward SILAC and another one from reverse SILAC).  
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Before determining the differential protein expression, it is important to check the quality of 
the data. Histograms are a good way of examining the distribution of the data. First, the 
histograms of H/L ratio are plotted to see if the data is centred around 1. It is expected that 
in a typical duplex or triplex SILAC experiment, about 90% of the proteins will remain 
(statistically speaking) “unchanged” between experimental conditions, and thus the overall 
median of the data will be very close to 1. In practice, it is difficult to achieve an ideal 1:1 ratio 
due to technical artefacts (e.g. pipetting small volumes of lysate or errors during cell counting) 
or unreliable results from protein concentration assays.  
MaxQuant performs automatic median normalisation to account for protein loading errors 
assuming that majority of proteins show no differential regulation (Cox and Mann 2008). 
When testing H/L ratios from forward SILAC experiment, there was an issue with the sample 
mixing (Fig 4.50 A), with median of this sample being closer to 2, meaning that there were 
more heavy labelled peptides than light labelled peptides in this sample. The median 
normalisation shifted the data toward 1 accordingly (Fig 4.50. B). In contrast, reverse SILAC 
H/L ratios are much closer to the ideal 1 (Fig 4.50.C) but median normalisation was still 
required (Fig 4.50.D). Side effect of median normalisation is condensation of the dynamic 
range (in this context, it is the ratio of the largest to smallest change that can be quantified).  
 
Figure 4.50 Representative histograms of H/L ratios before and after median normalisation. Forward SILAC H/L 
ratios (A) and H/L ratios normalised (B) and reverse SILAC H/L ratios (C) and H/L ratios normalised (D) for E22 
producing cell line. 
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When analysing SILAC datasets, it is useful to perform logarithmic transform of the ratios 
because it helps to linearize the data and make them normally distributed (Figure 4.51). The 
median of log2 H/L ratio will be equal to 0 (since log2 of 1 is equal to 0). Log2 transformed 
H/L ratio normalised shows the median centred on 0 and the data follows near normal 
distribution. Such transformed data can be readily analysed by statistical tests to find 
significantly differentially expressed proteins. 
 
Figure 4.51 Histograms of log2 transformed H/L (A) and L/H (B) median normalized ratios coming from forward 
SILAC experiment in E22 producing cell line. Histograms of log2 transformed H/L (C) and L/H (D) median 
normalised ratios derived from forward SILAC experiment in E22 stably producing cell line.  
Another way to visualise the data distribution is to plot log2 ratios against log2 intensities (Fig 
4.52), where we could examine the position of individual proteins in the whole data set. In 
addition to the examining the data distribution, it is also important to assess the dynamic 
range. The higher the dynamic range, the better chance for finding proteins with significantly 
different expression, regardless of what statistical test is used (Ong et al. 2003). There is no 
difference between the ranges of summed peptide intensities between forward and reverse 
SILAC experiments (Table 4.11 & 4.12) and the correlation is also high (R=0.873, Fig 4.53A).  
The correlation between summed heavy-labelled peptide intensities (R=0.867) and light-
labelled peptide intensities (R=0.856) is close to the average summed peptide intensities 







Figure 4.52 Representative scatterplots of log2 H/L (A) and log2 L/H (B) ratios against log2 intensities in forward 
and reverse SILAC experiments, respectively. In both data sets, most of the proteins have a ratio centred around 
0 (red solid line), meaning that globally there is no change in the protein expression between exponential and 
the stationary phase. Number of proteins with ≥2 razor + unique peptides and at least 1 valid ratio value was 
>3000 for both forward SILAC (n=3486) and reverse SILAC (n=3171) experiments prior to merging data for E22 
producing cell line.  
 
The dynamic range was found to be wider for reverse SILAC experiment than forward SILAC 
experiment in E22 producing cell line (Table 4.11).  
Table 4.11 The comparison of dynamic ranges between forward and reverse SILAC experiments in E22 
producing cell line. 
Dynamic range Forward SILAC Reverse SILAC 
Log2 H/L ratio   6.78 11.83 
Log2 H/L ratio normalised  6.67 8.36 
Log2 Summed peptide intensities 16.29 16.68 
 
Similarly, we have estimated dynamic range for GS parental cell line dataset (Table 4.12) and 
found some minor differences in dynamic range. 
Table 4.12 The comparison of dynamic ranges between forward and reverse SILAC experiments in GS K-O 
parental cell line. 
Dynamic range Forward SILAC Reverse SILAC 
Log2 H/L ratio   8.08 7.03 
Log2 H/L ratio normalised  8.14 6.82 




The wider dynamic range is directly correlated with the higher number of differentially 
expressed proteins between the experimental conditions. Proteins that are close to the 
vertical 0 line are not differentially expressed (H/L ratio being close to 1). To determine 
significantly expressed proteins, appropriate statistical test or fold-change cut-off must be 
applied. 
4.3.1.6 Reproducibility of forward and reverse SILAC experiments 
The main motivation for label exchange in the metabolic labelling approaches, such as SILAC, 
is to explain any variation that may be caused by the use of heavy isotopes of amino acids 
rather than because of the actual biological difference. There was a high reproducibility 
between forward and reverse SILAC experiments in terms of quantitative results (Fig 4.53).  
 
Figure 4.53 The scatterplots of log2 intensities and log2 ratios show high Pearson correlation (R) between 
forward and reverse SILAC labelling experiments in E22 producing cell line. The correlation of log2 H/L ratio 
normalised in FS experiment vs log2 L/H ratio normalised after merging the datasets together; n=2829 (number 
of proteins present in both experiments with ≥2 razor + unique peptides with 2 valid values). 
First, summed peptide intensities from forward and reverse SILAC (Fig 4.53 A) experiment 
were plotted against each other and showed a high linear correlation (R=0.873). Likewise, the 
correlation between log2 H/L ratio normalised (forward SILAC) and log2 L/H ratio normalised 
(reverse SILAC) was also positively correlated (Fig 4.53 B).  
Overall, 3486 proteins were identified in forward SILAC experiment and 3171 in reverse SILAC 
experiment (validated using 2 razor + unique peptides criteria) for E22 producing cell line 
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(Table 4.13). These two data sets were combined to include unique protein identifications 
and removal of duplicates. As a result, 4049 unique proteins were identified for E22 producing 
cell line. 
Table 4.13 Statistics for forward and reverse SILAC experiments in E22 producing cell line.  
State of data analysis Forward SILAC Reverse SILAC 
Proteins >1% FDR 4096 3813 
Proteins <1% FDR 4079 3784 
Min 2 peptides 3486 3171 
Common proteins 2829 
Min 1 valid value 2829 
2 valid values 2793 
 
The results for the parental GS cell line are also similar: 3463 proteins were identified in 
forward SILAC experiment and 3369 proteins identified in reverse SILAC experiment (Table 
4.14), giving total of 4075 unique proteins. 
Table 4.14 Statistics of forward and reverse SILAC experiments for GS parental cell line 
State of data analysis Forward SILAC Reverse SILAC 
Proteins >1% FDR 3931 4036 
Proteins <1% FDR 3924 4027 
Min 2 peptides 3463 3369 
Common proteins 2986 
Min 1 valid value 2986 
2 valid values 2967 
 
It might seem counter-intuitive to see why there is a difference between correlation of 
summed peptide intensities and H/L ratios. The H/L ratios are directly related to the 
intensities of labelled peptides. MaxQuant calculates H/L ratio as the median of all the 
individual peptide ratios, not the product of dividing the sum of the intensity of the heavy 
labelled peptides by the sum of the intensity of the light labelled peptides (Cox and Mann 
2008). Therefore, it is likely that some proteins will have both heavy and light intensities 
reported but no H/L ratio is calculated due to insufficient number of ratio counts or singlet 
peaks during MS data acquisition (Tyanova et al., 2016).  
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4.3.1.7 Determination of differential protein expression  
Several methods for the differential determination of protein expression are available. Fold-
change cut-off is the most common method and simply relies on finding proteins that have 
H/L ratio increased by least 1.5 or 2 (Figure 4.54). Using the cut-off criteria is one of the most 
widely used method for SILAC data analysis since it is the easiest to implement. 
 
Figure 4.54 Scatterplots of log2 H/L ratios normalised and log2 L/H ratios normalised from forward SILAC (FS) 
and reverse SILAC (RS) experiments, respectively. The proteins highlighted in red were found to be significantly 
differentially expressed using log2 fold-change of 1.5 (equal to 0.585; n=162) cut-off (A) or fold-change of 2 
(equal to 1; n=43) cut-off (B).  
Since SILAC ratios follow near normal distribution, Student’s t-test can be also used to 
determine differentially expressed proteins. One-sample both-sided t-test with Benjamin-
Hochberg FDR 5% correction did not find any significant proteins. It is possible that the spread 
of the data was not enough to find any proteins satisfying the FDR correction. However, 
performing t-test at p-values 0.05, 0.01 and 0.0001 allowed the determination of differentially 
expressed proteins (Fig 4.55).  
It is worth noting that regardless of the level of significance, one sample t-test found proteins 
that are statistically significant from 0, but by examining the graphs, some of the hits were 
actually very close to 0. By examining the ratios for significant proteins at p-value of 0.05, 
there was an excellent linear relationship (R=0.997) between the two experiments (Fig 4.56 
A), much stronger than on the global scale (R=0.619, compare with figure 4.53 B). It can be 
concluded that one sample t-test found statistically significant proteins with the most 
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reproducible SILAC ratios but not necessarily significantly different from the mean of 0 (which 
is the null hypothesis).  
 
Figure 4.55 Volcano plots are a function of t-test difference (equivalent to SILAC ratios) plotted against –log 
(negative log) t-test p-value, show differentially expressed proteins as being significant according to one sample 
both-sided t-test (mean different from 0; marked as solid black line). The proteins highlighted in red were found 
to be significant according to following p-values: 0.05(A; n=204), 0.01 (B; n=37) and 0.001 (C; n=6).   
 
The best way to determine which proteins are both statistically significant and biologically 
meaningful is to combine the t-test results with fold-change cut-off. In this way, the 
quantitative results are validated using two orthogonal methods, which leads to higher 
certainty of finding true biological difference.  
Since the results of the Student's t test were not satisfactory, another statistical test was used. 
This test is called significance A (and B, its more refined version), which is based on finding 
outliers in a given data set (Cox and Mann 2008). After applying Benjamin-Hochberg FDR 5% 
correction, similar number of significantly differentially expressed proteins were found using 
significance A (82 proteins) or significance B (83 proteins) outlier testing (Fig 4.57 A & B, 
respectively).  
Furthermore, significant proteins were positioned far from median 0 line as opposed to 
significant proteins found using t-test. It is worth noting that there were no significant 
proteins found using t-test at the same FDR truncation level. What is more, taking the 
negative logarithms of corrected p-values against log2 H/L ratio normalised (or L/H ratio 





Figure 4.56 (A)The scatterplot of t-test significant proteins at p-value of 0.05 shows perfect linear relationship 
as determined by Pearson correlation (R=0.997). Volcano plots display t-test difference (equivalent to SILAC 
ratios) against –log10 (negative logs) p-values obtained from one-sample both sided t-test. The proteins 
highlighted in red are both t-test significant and have log2 fold-change of at least 1.5 (B; n=45) or 2 (C;n=8).  
 
Figure 4.57 The scatterplots of log2 H/L ratios normalised (forward SILAC) and log2 L/H ratios normalised (reverse 
SILAC). The proteins highlighted in red were found to be differentially expressed using significance A (A; n= 82) 
and significance B (B; n=83) at Benjamini-Hochberg FDR 5% value.    
Since few methods were used to determine differentially expressed proteins, it was 
interesting to see how the results of each of the test correlate with each other. Venn diagrams 
were used to show the number of differentially expressed proteins found using tested 
methods (Fig 4.59). There was a very poor overlap between t-test significant proteins and fold 
change (FC) as well as significance A and B. They were only 7 proteins found to be differentially 
expressed using all methods. What is more, there was very poor agreement between t-test 





Figure 4.58 Volcano plots describe the function of fold-change (FC) cut-off plotted against –log 10 (negative log) 
significance B for forward SILAC (FS) and for reverse SILAC (RS; B). Benjamini-Hochberg FDR adjusted –log 10 p-
values, showing differentially expressed proteins as being significant (mean different from 0; marked as solid 
black line). 
Overall, Student’s t-test did not seem to find many proteins of biological significance (based 
on fold change value), although most of the test requirements were met in the acquired data 
set. One sample t-test did not work as expected, although it is extensively used to analyse 
proteomic data sets.  
 
Figure 4.59 The Venn diagram depicting the overlap between differentially expressed proteins found using fold 
change (FC) cut-off of 2; significance A and B at the Benjamini-Hochberg FDR 5% truncation level and one sample 
both-sided t-test at p-value of 0.05.  The data presented here was derived from E22 producing cell line. The Venn 
diagrams were prepared using Venny 2.1 online tool (Oliveros 2007).  
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In contrast, there is a relatively good overlap of proteins that were found significant by both 
fold-change cut-off method and significance A and B.  
4.3.1.8 Significance B and fold-change methods of choice for SILAC data analysis 
Significance A and B was found to work best for determination of statistically significant 
proteins for analysing label swap SILAC experiments. FC cut-off method can be used to find 
biological differences between the samples for label swap experiments. Two methods can be 
combined to find proteins that are both biologically (experimentally) and statistically 
significant. After selecting the proteins that were considered statistically significant using 
significance A and FC of 1.5, 63 differentially expressed proteins were found, the same 
number as using significance B and FC of 1.5 (Fig 4.60).  
 
Figure 4.60 The scatterplots of log2 H/L ratios normalised (forward SILAC) and log2 L/H ratios normalised (reverse 
SILAC for E22 cell line. The proteins highlighted in red were found to be both significantly differentially expressed 
using significance A (A; n= 63) and significance B (B; n=63) with Benjamini-Hochberg FDR 5% correction and fold-
change of ≥1.5. 
For GS K-O parental cell lines, 133 differentially expressed proteins were found using significance A 





Figure 4.61 The scatterplots of log2 H/L ratios normalised (forward SILAC) and log2 L/H ratios normalised (reverse 
SILAC) for GS K-O cell line. The proteins highlighted in red were found to be both significantly differentially 
expressed using significance A (A; n=133) and significance B (B; n=109) at Benjamini-Hochberg FDR 5% value and 
have fold-change of at least 1.5. 
In conclusion, both significance A and B combined with FC cut-off was found to be equally 
suitable for analysing SILAC data sets. Since significance B takes into the account both ratio 
and intensity, it was became a method of choice for determining proteins that have 
significantly different expression.   
4.3.2 Comparison of SILAC experiments in GS-KO parental and E22 producing cell lines 
4.3.2.1 Overlap between the two separate SILAC labelling experiments 
After analysing two separate SILAC experiments for GS-KO parental and E22 producing cell 
lines, it was interesting to investigate if there are any common trends in protein expression. 
Firstly, it was important to examine the overlap between significantly expressed proteins for 
E22 producing and GS parental cell lines (Figure 4.62).  
They were 63 differentially expressed proteins for E22 cell line and 109 for GS-KO cell line, 32 
of which were common between two data sets. This corresponded to more than 50% of the 
differentially expressed proteins found in E22 cell line (Table 4.15). All common proteins 
displayed the same level of regulation, suggesting consistent changes in protein expression 
between exponential and stationary phases, regardless of cell line used. GS-KO parental cell 
line was found to have additional 77 differentially expressed proteins. Most likely the data 
144 
 
quality of forward and reverse SILAC experiments was higher in terms of dynamic range, 
which led to higher number of differentially expressed proteins.  
 
Figure 4.62 Venn diagram of the overlap of differentially expressed proteins for E22 producing and GS K-O 
parental cell line. The differentially expressed proteins have been found using significance B at Benjamini–
Hochberg 5% FDR level and FC cut-off of 1.5.  
To examine correlation of data quality for SILAC experiments performed for GS-KO parental 
and E22 producing cell lines, each individual ratio H/L (or ratio L/H) normalised was plotted 
for against each other and presented as multi-scatter plots (Figures 4.63). It was found that 
there is medium correlation between the different cell lines and labelling experiments (values 
of R between 0.545-0.644) and slightly higher for the same cell line and between labelling 
experiments. The correlation for E22 producing cell line was 0.621 and for GS-KO parental cell 
line was 0.833.  
Such differences may have resulted from difference in the instrument performance during 
MS data acquisition. On the other hand, the correlation of log2 intensities between the cell 
lines and labelling experiments is much higher (ranging from 0.847-0.88) and for GS parental 
cell lines was 0.907, pointing out to strongly positive correlation between the two labelling 








Table 4.15 The list of differentially expressed proteins that were common between E22 producing and GS K-O 
parental datasets (see Appendix C & D for details). 
Uniprot ID Gene Symbol(s) Description 
G3HCT1 Kpna2, Rch1 Importin subunit alpha 
G3GUB4 Hat1 Histone acetyltransferase type B catalytic subunit 
G3H6D9 Dnmt1, Dnmt DNA (cytosine-5)-methyltransferase  
G3H9F5 Ikbkap, Elp1 Elongator complex protein 1 
G3HDZ2 Ifrd1, Tis7 Interferon-related developmental regulator 1 
G3I5N5 Top2a, Top- DNA topoisomerase 2  
G3H8G0 Gpx1 Glutathione peroxidase 
G3I2P6 Dnajc9 DnaJ-like subfamily C member 9 
G3HG79 Iqgap3 Ras GTPase-activating-like protein IQGAP3 
G3HP44 Kif15, Klp2 Kinesin-like protein KIF15  
G3I1F9 Kif4, Kif4a Chromosome-associated kinesin KIF4 
G3HWI7 Oplah 5-oxoprolinase 
G3H412 Pcna Proliferating cell nuclear antigen 
G3I1H0 Mcm3, Mcmd DNA helicase  
G3I2K8 Rrm1 Ribonucleoside-diphosphate reductase subunit M2 
G3I3B7 Rrm2 Ribonucleoside-diphosphate reductase  
G3I732 Pold1 DNA polymerase  
G3IFY1 Tyms Thymidylate synthase (Thymidylate synthase-like) 
G3IAI6 Hmox1 Heme oxygenase 1 
G3HLU1 Ube2c, Ubch10 Ubiquitin-conjugating enzyme E2 C 
G3HRN7 Timeless Protein timeless-like 
G3HVL1 Cdk1, Cdc2 Cyclin-dependent kinase 1 (CDK1)  
 G3I0R8 Anln Actin-binding protein anillin 
G3IAY2 Mcmbp Mini-chromosome maintenance complex-binding 
G3IFZ0 Mki67 Proliferation marker protein Ki-67 (Antigen KI-67) 
 G3GXG4 Cyp51a1, Cyp51 Lanosterol 14-alpha demethylase (LDM)  
 G3H0L7 Fdft1, Erg9 Squalene synthetase (SQS)  
 G3H6P9 Sc4mol Methylsterol monooxygenase 1 (C-4 methylsterol) 
G3HMY0 Hmgcs1, Hmgcs Hydroxymethylglutaryl-CoA synthase (HMG-CoA) 
G3HXP6 Hmgcr 3-hydroxy-3-methylglutaryl-coenzyme A reductase 
G3IFL1 Ppat, Gpat Amidophosphoribosyltransferase 





Figure 4.63 The scatterplots of log2 ratio H/L (FS) and log2 L/H ratio (RS) for E22 and GS cell line plotted against 
each other. The Pearson correlation value (R) is also displayed in for each combination.  
 
Figure 4.64 The scatterplots of log2 intensities (summed peptide intensities) obtained in label-swap SILAC 
experiments for E22 and GS cell line plotted against each other. The Pearson correlation value (R) is also displayed 
in for each combination.  
147 
 
4.3.3 Bioinformatic analysis of differentially expressed proteins  
4.3.3.1 Gene Ontology functional classification  
After differential protein expression analysis, 63 proteins were differentially expressed 
between exponential and stationary phase for stably producing E22 cell line. In the case of 
the parent cell line of GS ko cells, 109 proteins were found to be expressed in a variety of 
ways.  To investigate whether there are any specific trends related to the upregulation of 
proteins after transition from the exponential phase to the stationary phase, proteins have 
been functionally annotated using Gene Ontology (GO) Biological Process (GOBP) and Cellular 
Compartment (GOCC) definitions. The GO annotation turned out to be relatively poor for 
Chinese hamster, with many annotations missing and incomplete. Instead, Uniprot IDs were 
mapped to the appropriate gene names since they can be used for cross-comparison between 
species. Corresponding GO terms for mouse (Mus musculus) were used, as about 50% of 
genes are very close homologues and are often used instead (Baycin-Hizal et al. 2012). In the 
absence of mouse annotation, corresponding human (Homo sapiens) or rat (Rattus 
norvegicus) genes were examined instead.    
GO functional annotations are presented side by side for GS parental and E22 producing cell 
line to highlight the similarities between the two data sets (Figure 4.65). However, it is 
important to note that there was a higher number of differentially expressed proteins for GS 
parental cell line than for E22 producing cell line, so it is important to take this factor into 
account when comparing the data sets.  
In general, the largest number of proteins was involved in crucial cellular processes of cell 
division, important for CHO cells that are actively growing and dividing in the exponential 
phase. What is more, they numerous proteins important in regulating cellular transcription 
that had either positive or negative effect. Another major protein group was crucial for 
biosynthesis, control of DNA replication and cell cycle regulation.  
Interestingly, they were 4 differentially expressed proteins involved in tRNA aminoacylation 
which were exclusive for to the GS parental cell line. These were further examined using 
pathway analysis tools (see below). In addition, they were more differentially expressed 
proteins involved in the cell adhesion for GS parental cell line.  On the other hand, there were 





Figure 4.65 The combined bar chart shows differentially expressed proteins for E22 producing (green) and GS K-
O parental (red) cell lines that have been functionally annotated using Gene Ontology Biological Process (GOBP; 
A) and Cellular Compartment (GOCC) terms. 
While analysing GOCC annotation, it is worth seeing that the greatest number of differentially 
expressed proteins are located in the nucleus than in the cytoplasm. They were also several 
proteins present in the extracellular space and exosome. Perhaps these proteins are still 
present in CHO cells since they are derived from cells that were part of the tissue and required 
many proteins responsible for cell adhesion and short distance signal transduction.   
Complete list of significantly differentially expressed proteins together with functional Gene 
Ontology annotations can be found in Appendices.  
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A full list of proteins undergoing significant differential expression along with GO annotations 
can be found in the Appendices B & C. 
4.3.3.2 Pathway analysis of differentially expressed proteins using KEGG  
KEGG Mapper tool for pathway analysis was used to visualize up-regulated proteins in the 
exponential phase (blue) and up-regulated proteins in the stationary phase (red). This section 
presents only selected reference pathway maps for mouse (Mus musculus) of the greatest 
interest. Overall, there were similar trends in the protein expression between the two cell 
lines (Table 4.16). The highest number of proteins (18 and 25 respectively for E22 producing 
and GS parental cell line) was matched to metabolic pathways, followed by proteins involved 
in purine and pyrimidine metabolism, along with proteins involved in DNA replication. Data is 
consistent with the results obtained from GO annotations. It is suggested that overall 
differences in protein expression between exponential and stationary phases are similar for 
GS parental cell line and its E22 derivative. 
However, they were several differences between the two cell lines. Slightly higher number of 
proteins up-regulated in lysosome pathway was found for GS parental cell line in the 
stationary phase (Fig 4.66). There was similar trend observed for up-regulated proteins in 
exponential phase involved in cell cycle regulation (Fig 4.68).  
Table 4.16 The top 10 enriched  KEGG pathways for differentially expressed proteins for E22 producing and GS 
K-O parental cell lines. 
Pathway number Pathway name E22 GS 
Mmu01100 Metabolic pathways 18 25 
Mmu03030 DNA replication 7 5 
Mmu00480 Glutathione metabolism 7 4 
Mmu00240 Pyrimidine metabolism 7 6 
Mmu00230 Purine metabolism 7 4 
Mmu04110 Cell cycle 4 7 
Mmu04142 Lysosome 3 7 
Mmu03410 Base excision repair 5 2 
Mmu04066 HIF-1 signalling pathway 4 2 




As discussed before, four different amino-acyl tRNAs specific to GS K-O parental cell lines were 
found (Figure 4.67). What is more, additional 3 proteins were found solely in GS K-O cell line 
data set that were involved in HIF-1 signalling pathway, responsible for maintaining oxygen 
homeostasis (Fig 4.69). In contrast, they were more protein identified for E22 cell line that 
were involved in DNA repair. Again, this trend is consistent with GO annotations. 
 
Figure 4.66 Enlarged fragments of the KEGG pathway map of the lysosome pathway (Mouse Reference number 
mmu04142) highlighting the proteins that were up-regulated in the stationary phase (marked as red) in E22 
producing cell line (A) or GS  cell line (B).  
 
In conclusion, the use of KEGG Mapper tool with Colour & Search pathway option allowed to 
confirm most of the findings of the functional GO annotation. Up-regulation of 4 distinct 
aminoacyl-tRNA in stationary phase is probably a result of changes in protein translation. In 
addition, several interesting proteins were up-regulated in exponential phase that are 
involved in cell cycle regulation (4.69) This includes PCNA (proliferating cell nuclear antigen) 
and MCM (minichromosome maintenance proteins complex), both required for DNA 
replication, and CDK1 (cyclin-dependent kinase 1), which is a highly conserved protein 
regulating cell cycle.  On the other hand, up-regulation of lysosomal proteins in stationary 
phase can be a response to the depletion of nutrients in the cell culture. Similarly, up-
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regulation of proteins in HIF-1 signalling pathway during stationary phase may be a result of 





Figure 4.67 Enlarged fragments of KEGG pathway map of Aminoacyl-tRNA biosynthesis pathway (Mouse 
reference number mmu00970) highlighting the proteins up-regulated in the stationary phase (marked in red) 
found exclusively for GS ko parental cell line: Alanine--tRNA ligase (A), Tyrosine--tRNA ligase (B), Cysteine--tRNA 
ligase (C) and Cysteine--tRNA ligase (D).  
 
 
Figure 4.68 Enlarged fragments of KEGG pathway map of cell cycle (Mouse reference number mmu04110) 
highlighting the proteins up-regulated in the exponential phase (marked in blue) for E22 producing cell line (A) 




Figure 4.69 Enlarged fragments of KEGG pathway map of HIF-1 signalling pathway (Mouse reference number 
mmu 04066) highlighting protein up-regulated in stationary phase (marked as blue) found exclusively in GS K-O 
parental cell line (A). Proteins up-regulated in exponential phase (marked as red) found in GS K-O parental cell 
line (B) and E22 producing cell line (C).  
4.3.3.4 Analysis of differentially expressed enzymes using ExplorEnz database 
Since numerous proteins with enzymatic functions were discovered in the data set, these 
proteins were also annotated with their enzyme class using publicly available The Enzyme 
Database, ExplorEnz,  (McDonald et al., 2009). In the SILAC data set for GS ko parental cell 
line, approximately 50% (50 out of 109) differentially expressed proteins were found to be 
enzymes. In E22 data set, the number of differentially expressed enzyme was slightly over 
50% (36 out of 63).  All identified enzymes were assigned to their appropriate classes: 
hydrolase, transferase, oxidoreductase, ligase and isomerases (Figure 4.70). No enzymes 




Figure 4.70 Comparison of the number of enzyme classes identified in E22 producing (n=36) and GS K-O (n=50) 
cell lines using The Enzyme Database, ExplorEnz.  
In E22 producing cell line, the greatest number of differentially expressed transferases was 
found. On the other hand, there was much more hydrolases identified in GS ko parental cell 
line. There was a relatively similar number of oxidoreductases, ligases and isomerases 
differentially expressed for both cell lines. This suggests that these enzymes are essential for 
CHO cells to control in response to changing cell culture conditions.  
4.4 Conclusions  
Using SILAC labelling to study dynamic changes in the biomass accumulation in stably 
producing and parental CHOK1SV cells, over 4000 unique proteins were identified, from 
which about 3000 were successfully quantified in both label swap experiments. To our 
knowledge, this is the first time SILAC was utilised in conjunction with global quantitative 
proteomic analysis for CHO cells. In addition, SILAC experiment was applied for the first time 
in mammalian cell line grown in chemically-defined medium without the addition of foetal 
bovine serum (Ong 2002; Graumann et al. 2008).  
SILAC has worked as expected for CHO cells since they are auxotrophic for both arginine and 
lysine. The doubling time was calculated to be just over 24h for both parental and stably 
producing cell line (see Section 3.3.1.1)  Since full incorporation of amino acids takes around 
5-10 cell doubling, in practical terms full incorporation (>97%) is achieved for CHO cells within 
2-3 passages (6-9 days). In addition, there is a negligible amount of proline conversion from 
heavy arginine (Bendall et al. 2008), therefore the decrease in signal does not affect heavy 
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arginine labelled peptides and the accuracy of the quantitation is high. Most likely explanation 
for lack of proline conversion is high amount of free proline (>200 mg/ml) in CD-CHO  (see 
Appendix G), which does not favour the chemical reaction. Recent study also suggests that 
CHO cells are not able to synthesize proline from arginine or glutamate because of no 
expression of necessary enzymes (Hefzi et al. 2016). Above reasons make SILAC particularly 
applicable to study proteomics in CHO cells. What is more, performing reverse labelling 
experiment provides perfect experimental and biological replicate, as well as eliminates 
experimental artefacts (Ong and Mann 2006). This means that number of replicates can be 
kept low, reducing the cost and length of the experiment and the instrumentation time.  
For differential expression protein determination, ‘double-filtering’ criterion, using 
significance B (Cox and Mann 2008) and fold-change (Ong 2002). The ‘’volcano plot’  was 
found to be the most useful tool to visualise differentially expressed proteins (Li 2011) as it 
displays both biological (fold-change) and statistical significance (FDR corrected p-values 
found using significance B).  
Following MS data acquisition, 4049 unique proteins were identified for E22 producing cell 
line, from which 2793 were quantitated in both forward and reverse SILAC experiments. 
Similarly, 4075 unique proteins were found for GS-KO parental cell line, from which 2967 
proteins were quantitated in both forward and reverse SILAC experiments. In both datasets, 
we have found that SILAC ratios have dynamic range to be of up to 8.5 orders of magnitude 
following median normalisation and log transformation. The numbers of identified proteins 
are very similar to the published datasets, such as iTRAQ-based study of responses to glucose 
starvation on growth and productivity of CHO cells identified slightly over 5000 proteins (Fan 
et al. 2015). Similar study using TMT for in vitro chemical labelling found <5000 proteins (Liu 
et al. 2015). 
63 differentially expressed proteins were identified for E22 producing cell line and 109 
differentially expressed proteins for GS-KO parental cell line. To examine any trends behind 
differential protein expression, proteins were functionally annotated using Gene Ontology 
(Berardini 2009). High number of proteins was involved in crucial cellular processes such as 
cell division, cell cycle control and transcription regulation. Using KEGG database, protein up-
regulated in exponential phase were mapped to cell cycle regulation, translation elongation 
and DNA replication, which is expected of healthy growing cells. The data agrees well with 
155 
 
similar study in antibody-expressing CHO-GS cell line grown in bioreactors (Dorai 2013). Both 
data sets confirmed that many differentially expressed proteins are involved in cellular 
metabolism. This was also highlighted in obtained SILAC data sets for both cell lines as they 
are almost 50% of differentially expressed proteins were enzymes, including hydrolases and 
transferases.  
It is important to use orthogonal methods to validate quantitative proteomics. There are 
several options possible, including selecting a candidate protein and use specific antibodies 
to confirm the results on Western blot. The pros of Western blots is easy to set up and the 
results can be semi-quantitative using densitometry (Gorr et al., 2015). In addition, recent 
study has suggested the use of another reference protein, PARK-7 to improve the protein 
normalization problem (Wisniewski & Mann 2016). In fact, this protein is present in our 
dataset under Uniprot identifier G3IEU2 (Gene symbol: PARK7) and its H/L ratio is ≈1 in all 
label-swap experiments performed. The cons of using Western blot is that the results do not 
translate very well between Western blot and MS proteomics data. It might also be difficult 
to find a specific antibody for proteins for interest which might give misleading results.   
The better option for validation of proteomic data is to use genomics or transcriptomics. 
However, it is known that the correlation between transcriptomic and proteomic results is 
only 2/3 at best (Vogel et al. 2010). Another approach would be to closely monitor levels of 
specific metabolites, since several differentially expressed proteins were involved in 
metabolic pathways. It has been suggested that metabolomics should be combined with 
proteomic studies to fully understand biological processes (Fischer et etl., 2013). Recent 
metabolic studies in CHO cells have identified apoptosis-inducing metabolites (Chong et al. 
2011) and even found correlation between oxidative phosphorylation and citric acid cycle and  
specific mAb productivity (Chong et al. 2012). 
It is believed that many of the identified differentially expressed proteins are strong 
candidates for future targeted engineering approaches. There are several options possible, 
namely knocking-out expression of genes to enhance growth and/or productivity or use a 
specific drug to target a protein of interest. It has been confirmed by several recent studies 
that targeted approaches are the future of CHO cell engineering (Richelle and Lewis 2017). 
Presented SILAC study provided additional information about dynamic proteome changes 
between phases of the cell culture of industrially relevant cell lines.  
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In conclusion, presented proteomic workflow using SILAC workflow can be easily adapted in 
many laboratories for proof-of-concept studies, including effect of drug treatment and 
targeted gene knock-downs on global changes in protein expression. However, the cost of 
buying stable isotopes of amino acids is still high, so repeating the experiment in industrial 
size bioreactors would be expensive. Alternative quantitative methods can be used, for 
example TMT labelling has been shown to be of the similar accuracy to SILAC (Altelaar et al. 
2013). Alternatively, there has been a great progress in label-free quantitative proteomics in 



















Chapter 5: Defining the protein biomass objective in CHO 
cells using enhanced pulse SILAC and total protein 
approach (TPA) 
5.1 Abstract  
Quantifying the cellular matter called biomass is important to describe the behaviour of the 
biological system. Since the protein constitutes up to half of the total biomass of a cell, the 
absolute quantification of the entire proteome can help to estimate it. To derive absolute 
protein abundance values, total protein amount (TPA) method was used to calculate protein 
copy number per cell.  More than 4000 protein copy numbers were estimated for GS-KO 
parental and its derivative E22 producing cell line and data compared relatively well to 
published values in mouse and human cell lines. Next, protein turnover, described as the 
balance between protein synthesis and degradation, was estimated based on enhanced pulse 
SILAC data that relies on monitoring of stable isotope incorporation of de novo synthesised 
proteins. Using the improved exponential decay model, considering degree of amino acid 
recycling, protein turnover was calculated for >3000 cellular proteins.  
By combining protein turnover with absolute protein copy number, rate of protein turnover 
was derived describing how CHO cells control their synthesis and degradation machinery to 
maintain steady state protein abundance. Based on rate of protein turnover, it was found that  
top 10 proteins correspond to 20% of global turnover rate, whereas top 100 already 
contribute to more than half of it. The data agrees with non-linearity of protein abundance 
within a cell, where certain structural and housekeeping protein species are significantly more 
prominent. In case of E22 producing cell line, the production of monoclonal antibody was top 
priority, causing metabolic burden on cells. KEGG and GO annotation suggests that 600 up-
regulated proteins in E22 producing cell line explained their clonal selection based on highest 
growth and productivity. Interestingly, there was no major differences found between 
dynamic codon bias between two studies cell lines, so it is unlikely that heterologous protein 
expression has any effect on codon preference. 
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5.2 Introduction  
To describe the behaviour of a biological system under study, it is important to have some 
ways of quantifying cellular matter called biomass. Several methods are available, including 
direct measurement of dry cell weight or cell volume. In case of mammalian cells, it is often 
presented as the number of viable cells per unit volume (viable cell concentration, VCC).  
Direct measurement of animal cell biomass is difficult because it is difficult to obtain enough 
cells to accurately measure dry mass. In addition, the size of mammalian cells varies greatly 
between different cell types and even between stages of cell growth. The cell volume is the 
highest during the exponential phase, while cells are actively growing and dividing (Frame and 
Hu 1990).  
Proteins are the dominant part of cellular biomass since they often account for up to half of 
the total biomass. With the progress of mass spectrometry, it is now possible to quantify 
thousands of proteins in one experiment. Although measurements of cell volume can be a 
good indicator of cell biomass, it is difficult to calculate absolute protein concentrations in a 
cell. Quantitative methods such as iBAQ or Top3 (see section 1.5.4) can show up to 10-fold 
errors when measuring protein abundance and it is now recognised that published values 
must be reconsidered. To address this issue, a database called BioNumbers 
(http://bionumbers.hms.harvard.edu/) was created for researchers to compare experimental 
results with the values already published (Milo et al. 2009; Milo 2013).  
It is possible to estimate the number or amount of protein per cell volume for any type of 






Where (N – number of proteins, V – cell volume, Cp – protein mass per volume, Laa – average 
number of amino acids per protein, ma – average mass of an amino acid).  
Assuming an average mass of amino acid of 110 Da and protein mass per volume of 0.2 g/ml 
(Milo 2013), it is possible to estimate both the number of proteins per cell volume and the 




Table 5.17 Typical quantitative values for E. coli, yeast and Hela cell lines. Reproduced from Milo 2013. 
Organism Number of amino 
acids per protein 
Typical volume Number of 
proteins per cell 
volume 
Absolute number of 
proteins 
E. coli 300 ≈1µm3 ≈4.4 x 106/ µm3 ≈3 x 106 
Yeast 400 ≈30µm3 ≈3.8 x 106/ µm3 ≈100 x 106 
Hela cell line 400 ≈3000µm3 ≈2.7 x 106/ µm3 ≈10 x 109 
 
The above values can be used as a standard for comparison. It is recommended that all mass 
spectrometry studies should specify the cell volume and the stage of cell growth when 
reporting their values. Such estimates of the total number of proteins per cell volume, 
considering both total cell density and mean protein length, represent overall average cellular 
protein biomass (Milo 2013; Phillips and Milo 2009). The estimation does not consider any 
secreted proteins, although these are small fractions of the total proteome in most cells.  
As mentioned earlier, only a fraction of cellular proteome is not reported due to limits in the 
available instrumentation (see section 1.4.2 & 1.5.8). However, it has been shown that the 
1000 most abundant proteins in a cell already account for over 80% of the proteome mass. 
What is more, these highest expressed proteins already constitute over 90% of the protein 
copies and the corresponding amino acids (Nagaraj et al. 2011). However, care must be taken 
during the sample preparation for mass spectrometry to ensure that there is no global loss of 
crucial protein groups, such as difficult to solubilise membrane proteins, as this may lead to 
an underestimation of protein biomass.   
There are several methods based on mass spectrometry that can be used to quantify absolute 
protein abundance as the number of protein copies per cell. Most of these methods are based 
on stable isotope labelled standards (such as discussed QconCAT).  that are added in known 
concentrations to the sample of interest. Peaks derived from the standard can be used to 
calculate the abundances of other proteins in the sample. Such methods are limited to only 
30 to 50 proteins at the time, which makes them unsuitable for global proteomic analysis 
(Simpson and Beynon 2012). 
One of the newer developed method is total protein approach (TPA). TPA method was shown 
to have very high accuracy for quantifying E.coli proteome (Wiśniewski and Rakus 2014). The 
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number of protein copies can be estimated using total protein concentration which needs to 
be determined separately. TPA approach has been further developed into ‘proteomic ruler’ 
approach that uses the intensity of histone proteins to calculate protein copy number 
(Wiśniewski et al. 2014).  By deriving the absolute number of protein copies for any cell line, 
it is possible to gain greater insight into both physiological and architectural changes within 
cells. Mammalian cells undergo changes in cell volume during cell culture or increase the size 
of individual organelles in response to stressful conditions. It is not possible to quantify those 
changes by simply using relative quantitative methods.  
Changes in absolute abundance of cellular proteins is direct effect of opposing processed of 
protein synthesis and protein degradation. The balance between those two processes is 
known as protein turnover (see section 1.7.1). The protein turnover is one of the most energy-
demanding processes in the cell and is also one of the causes for the low correlation between 
mRNA abundance and protein abundance (Pratt 2002). The balance between protein 
synthesis and degradation is a feature of healthy, growing cells and allows them to control 
their intracellular protein levels. For instance, proteins with faster turnover rates are likely to 
have faster dynamics or are simply more tightly regulated at transcriptional or translational 
level. In contrast, low-turnover proteins either do not possess regulatory functions or are 
regulated via post-translational modifications (Yee et al. 2010). 
When modelling the protein turnover, it is assumed that the rate of protein synthesis is a 
function of three different parameters: mRNA concentration, the rate of translation initiation 
and the rate of translation elongation. On the other hand, protein degradation is mainly 
controlled by activity of protein degradation pathways and status of protein pool that can 
change dynamically due to stress or environmental changes (Beynon 2005). Measurement of 
global protein turnover is a complex process and, for simplicity, steady-state system is 
assumed where abundance of individual proteins does not change generally due to balance 
between protein synthesis and degradation. That is why most research on protein turnover 
is focused on actively growing cells. In addition, the most well-known method for studying 
protein turnover, pulsed SILAC, requires cells to quickly incorporate stable isotope labels after 
switching the media. 
There are several experimental designs using pulse SILAC to study protein turnover. Pulse 
SILAC was applied to study protein turnover in non-synchronised mouse fibroblasts 
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(Schwanhäusser et al. 2011) or to examine protein turnover in myeloma producing cells (Yen 
et al. 2010). Data obtained after implementing any of pulse SILAC methods is comprised of 
degradation rates (or times) for proteins identified in the experiment.  Proteins can have 
short, intermediate and long degradation rates, but it is not possible to determine what part 
of biosynthetic and degradation machinery is used. Conversely, the calculation of protein 
abundance using TPA method can estimate the average number of copies for a given protein. 
By combining the protein copy number with separately determined protein turnover, it is 
possible to estimate the rate of accumulation of cellular proteins per unit time to assess 
protein biomass objective of CHO cells. 
5.2 Aims and objectives 
The aim of this chapter is to develop an accurate method for calculating the absolute protein copy 
numbers for individual proteins using mass spectrometry. Pulse SILAC, a common stable isotope-
based method, will be used to estimate discrete protein turnover. By combining the two 
parameters, it will be possible to calculate how many protein copies are turned over by unit 
time.  This value will be referred to as “rate of turnover”, i.e. the number of proteins turned 
over per unit of time. Estimated protein copy numbers will be also corrected for their 
associated molecular weights to derive ‘total protein mass’, reflecting the proportion of 
protein in the global protein mass. Finally, available bioinformatics tools will be used to 
investigate trends in protein expression for stably producing and parental CHO cell lines. 
5.3 Results and discussion 
The following sections describe the growth of parental GS K-O and stably producing E22 cell 
line in the custom (chemically-defined) SILAC medium containing either light, medium and 
heavy isotopes  of lysine and arginine. The details on the experimental design, sample 
preparation and mass spectrometry data acquisition will be presented, followed by raw data 
processing and analysis in MaxQuant and Perseus. The distribution of the data and the quality 
of the proteomic ruler estimation will be also examined. Calculation of protein turnover and 
half-lives will be demonstrated using  in-house developed script in Matlab. Finally, the results 
of the bioinformatics analysis, including GO annotation and KEGG pathway mapping, will be 
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described.  The method for calculating  dynamic amino acid and codon usage based on protein 
and mRNA sequence data, respectively, will be also presented. 
 
Figure 5.71 The workflow of enhanced pulse SILAC experiment to study protein turnover in CHO cells. The cells 
are grown until full incorporation of stable isotopes in custom (chemically-defined) SILAC media containing either 
light (L) or medium (M) isotopes (adaptation phase). The samples for calculation of % incorporation are taken 
from passage 2 to 4. At passage 5, the media is switched during mid-exponential phase to conditioned SILAC 
media containing heavy isotopes and samples are taken at 6 time points. Samples are prepares using FASP 
method, followed by fractionation of tryptic peptides using Hypercarb and data acquisition using MaxQuant. 
Corresponding protein turnovers and half-lives are calculated using in-house developed script.  
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5.3.1 Enhanced pulse SILAC and TPA method development 
5.3.1.1 Spent media experiment – pilot study 
A pilot study with media exchange was conducted to examine the effects of media exchange 
on VCC and % viability of CHO cells. Efficient media exchange with heavy isotopes of amino 
acids is an important part of every successful pulse SILAC. Usually, fresh media is used 
(Boisvert et al. 2012), but it is possible that the addition of unconditioned media can disrupt 
the natural course of cells to the stationary phase. It is believed that the addition of 
conditioned (spent) media containing heavy isotopes of amino acids facilitates undisturbed 
cell growth. 
The experiment was set up using 125 ml Erlenmeyer flasks in 30 ml working volume using 
chemically-defined CD-CHO medium supplemented with or without 6mM L-glutamine, 
respectively for GS-KO parental and E22 producing cell line (see section 2.5.1). The media 
switch was carried out during passage 5 in the mid-exponential phase (=120 h; Figure 5.72).  
 
Figure 5.72 Growth and % viability of stably producing E22 producing cell line growing in CD-CHO medium in 125 
ml working volume. In the mid-exponential phase, the medium was switched to fresh CD-CHO medium, as 
required or to conditioned medium. The experiment also included control of cell growing in CD-CHO medium 
without media switch. 
Performing media exchange with fresh CD-CHO media completely changed the growth profile 
of CHO cells, causing an unnatural extension of the exponential phase. The cells, 
supplemented with fresh nutrients, continued to divide exponentially by day 8, followed by a 
rapid death phase without entering the stationary phase. On the other hand, media exchange 
with conditioned media had the same effect on cell growth and % viability as growing cells 
without media exchange. It can be assumed that using conditioned media is crucial to 
replicate typical mammalian growth curve (see sections 1.2.1 & 1.2.2).   
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5.3.1.2 Growth of GS-KO parental and E22 producing cell line in SILAC medium supplemented 
with light, medium or heavy isotopes  
The enhanced pulse SILAC experiment was performed in both GS-KO parental and E22 
producing cell lines (Figure 5.71) according to original protocol (Boisvert et al., 2012) with 
slight modifications. Firstly, lysine and arginine were supplemented in their correct isotopic 
form according to the concentration normally present in CD-CHO. Secondly, spent 
(conditioned) media was used (instead of fresh media) during the media exchange step to 
cause the least disturbance in the culture of CHO cells.  
Cells were first revived into light SILAC medium (p1) before being divided into three different 
media conditions: light SILAC (internal control), medium SILAC and heavy SILAC and grown to 
full incorporation, similarly to the standard SILAC adaptation phase. In p5, day 4 (=96 h), cells 
grown in light SILAC medium continued to grow in the same conditions to provide internal 
control. Cells grown in medium SILAC and heavy SILAC were gently centrifuged, supernatant 
(“conditioned media”) removed and exchanged respectively: medium to heavy (MTOH) and 
heavy to medium (HTOM). HTOM culture provided growth control after media exchange.  
In line with the results of pilot study, there was no loss of viability after the exchange and the  
cells continued to grow normally. After replacing the medium, the samples were collected for 
analysis by mass spectrometry at 6 time points: 0.5h, 4h, 7h, 11h, 27h and 48h. The sampling 
window was in the exponential phase, while cells are actively growing and dividing, and 







Figure 5.73 Growth profile of E22 producing and GS K-O parental cell lines during enhanced pulse SILAC 
experiment. Viable cell number (A) and % viability (B) of GS parental cells  growing in light SILAC medium (internal 
control), MTOH SILAC or HTOM SILAC was collected at regular time intervals. Similarly,   viable cell number of (C) 
and % viability (D) of E22 producing cells is displayed. Cell growth and % viability was determined using Vi-CellTM 
Beckman Coulter, based on Trypan blue exclusion essay. The blue squares highlight the sampling window. Values 
are displayed as mean ± SEM values; n=6.MTOH; a medium isotope to heavy isotope media exchange; HTOM – 
heavy isotope to medium isotope media exchange (growth control).  
5.3.1.3 Data distribution after raw data analysis 
For each cell line, cell pellets were collected at 6 time points following media switch. Each cell 
pellet was extracted using SDS-based lysis buffer and tryptic peptides were obtained using 
FASP method. Following MS data acquisition on Q-Exactive HF, raw files were combined into 
single MaxQuant search against CHO database (see section 2.5.6).  
Over 150,000 peptide-to-spectrum matches (PSMs) were obtained for each technical 
replicate, allowing identification of more than 4,000 proteins for GS K-O parental cell line and 




Figure 5.74 Overview of data sets obtained for GS K-O and E22 cell lines, presented as the number of peptide-to-
spectrum matches (PSMs; A) and the corresponding number of identified CHO proteins (B).   
According to the experimental design, three separate ratios were obtained: H/M ratio, for 
determining protein turnover, H/L ratio, for determining protein synthesis and M/L ratio, for 
determining protein degradation. The ratios were calculated independently from raw MS data 
using MaxQuant, but there is a very strong correlation (R>0.99) between ratio H/M values 
and ratio H/L/ratio M/L values (Figure 5.75).  
 
Figure 5.75 Correlation between the ratio H/L / ratio M/L values and derived H/M ratios for all peptide-to-
spectrum matches (PSMs)  obtained for GS K-O parental cell line (n=154,806) and E22 producing cell line 
(n=154,743) based on Pearson correlation (R).  
5.3.1.4 Recycling of medium isotope of lysine and arginine  
One of the associated with pulse SILAC labelling is the recycling of amino acid isotopes during 
de novo protein synthesis that might interfere quality of data. To examine the degree of 
recycling, several missed cleaved peptides, containing either two lysines (2K) or two arginines 
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(2R), were selected. Data was examined at the latest time point (48h), as was the case with 
Boisvert et al., 2012, as this is where the maximum labelling was achieved. The following table 
shows how to calculate mass shifts for all possible isotope combinations (Table 5.18).  
Table 5.18 Table showing possible doubly charged peptides containing two stable isotope labels.  
 
For simplicity, only  doubly charged peptides with one missed cleavage were considered. 
There are also other possibilities, including peptides with both lysine and arginine or peptides 
with two missed cleavages (MaxQuant search settings allows up to three labels per peptide). 
Below, mass spectra are presented for several different peptides (and corresponding 
proteins) that contain a  variable degree of recycling of medium-labelled amino acids. 
A total of three different doubly charged peptides containing two lysines (Figure 5.76) were 
used to estimate recycling of medium-labelled lysine into proteins. Recycling of lysine was 
estimated to at 5-10% (8%, 6% and 4% for A, B & C, respectively). Next, mass spectra for  
doubly charged peptides containing two arginines were examined (Figure 5.77). A slightly 
higher degree of recycling found, up to 15% for the examples presented. Data suggest that 
the global degree of amino acid recycling for both isotopes is around 10%, which is lower than 
15-20% reported by Boisvert et al., 2012. The difference between the values may be specific 
to a cell line.  
 
2K containing peptide 
z=2+ 
Mass shift (m/z value) 2R containing peptide 
z=2+ 
Mass shift (m/z value) 
L 0  L 0  
M 4  M 6  
M+H 6 M+H 8  




Figure 5.76 Representative mass spectra of three doubly charged (z=2+) lysine labelled peptides at 48 h time 
point from the following proteins: Galectin (G3I4Z7, A),  Heavy chain Mab fragment (PRY54HC, B) and Heat shock 
cognate 71 kDa protein (G3IDL8, C), each containing two lysines (2K). Spectra from light (L), medium (M), 




Figure 5.77 Representative mass spectra of three doubly charged (z=2+) arginine labelled peptides at 48 h time 
point from the following proteins: Histone H3 (G3H2T7, A),  Nucleoside diphosphate kinase (G3HBS8, B) and 
Vimentin (G3HHR3, C), each containing two arginines (2K). Spectra from light (L), medium (M), medium& heavy 
(M+H) and heavy (H) peptide species are labelled accordingly.  
170 
 
5.3.1.5 Estimation of total cellular protein concertation 
Since it is believed that protein abundance does not change, the protein copy number will be 
calculated as the average over the 48h of pulse SILAC labelling. According to the “proteomic 
ruler”, the MS signal for individual proteins is summed up together after the peptide assembly 
into leading razor protein.  Since Chinese hamster is not a model organism, Perseus is unable 
to adjust protein copy numbers according to histone intensities. In addition, due to clonal 
heterogeneity and instability of CHO cells, there is no guarantee that the cells are still diploid. 
Therefore, total protein approach (TPA) will be used to estimate protein copy number. Two 
input parameters are required: total cellular protein concentration (g/l) and protein content 
per cell (pg).  
Although Wisniewski et al., 2012 states that the mean total cellular protein concentration 
should be in the range of 200-300 g/l, it is more accurate to estimate the values on the basis 
of experimental data. Protein content per cell can be obtained by calculating protein 
concentration (mg/ml), as estimated in the protein assay after extraction using SDS-based 
FASP buffer (proven to be efficient in fully solubilising proteome) and the number of cells used 
for extraction. To illustrate that the protein content is specific feature of a given cell line, data 
for five different cell lines used in The University of Sheffield laboratories are presented. The 
data comes from cells harvested during exponential phase of cell growth (Table 5.19).  
Table 5.19 Estimated protein content per cell (pg) for several CHO cell lines. 
Cell line Protein content per cell (pg) 
CHOK1SV GS knock-out stably producing (E22) 200-220 
CHOK1SV GS knock-out parental  170-190 
CHOK1SV parental 150-200 
CHOK1SV cold-adapted  300-350 
CHO-S parental 80-140 
 
It is noticeable that there are large differences between the protein content per cell between 
the cell lines. In addition, E22 producing cell line has a generally higher protein content (up to 
220 pg), most likely due to production of monoclonal antibody, than parental GS K-O cell line 
(up to 190). What is more, cold-adapted CHOK1SV parental cell line has about twice as much 
protein content as the parental CHOK1SV cell line (unpublished values). All the measurements 
of the protein content per cell were made during the exponential phase, where the cells are 
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the largest. It is likely that the protein content can be reduced as cells enter the stationary 
phase.  
To calculate total cellular protein concentration, cell size is used, as estimated by trypan blue 
exclusion assay (using Vi-CellTM). If the cell shape is spherical, cell volume can be calculated 
from cell diameter using mathematical equation (equation 12). Estimated values of protein 
content per cell, total cellular concentration and cell volume for both cell lines are presented 
in Table 5.20. The values of protein concentration and average cell diameter has been 
calculated based on data from 6 replicate cultures at passage 5 of mid-exponential phase. 
Estimated values compare relatively well with predicted values of total number of protein 
copies estimated for Hela cell line (≈10 x 109; see Table 5.17). Slightly lower values may arise 
from inadequate representation of certain groups of proteins, e.g. membrane proteins, or 
unavoidable sample losses during sample preparation. In general, it TPA method for absolute 
protein quantitation correctly estimated the number of protein copies in both cell lines.  
Table 5.20 Relationship between protein content per cell, total cellular concentration and cell volume. 
Estimated cell parameter E22 producing cell line GS parental cell line 
Number of cells used  107 107 
Protein concentration (mg/ml)a 2.20±0.2 1.90±0.2 
Protein content (pg) per cellb 220 190 
Average cell diameter (µm)c 15.1±0.3 16.2±0.2 
Average cell volume (µm3)d 1802±80 2226±50 
Total cellular concentration (g/l)e 122 85 
Total number of protein copies in celle 3.8x109 3.6x109 
Number of proteins per µm3 2.1x106 1.62x106 
a – as estimated by RC DC protein assay; b – calculated from equation 11; c – based on ViCellTM readings; d – calculated from equation 12; e 
– results from TPA method. Values derived as the average of two technical replicates for each cell line. 
In addition, TPA method has also estimated cell volume: 2235 µm3 for parental cell line and 
1803 µm3 for producing cell line, which is very close to independently calculated values 
(assuming spherical cell shape). Using default values of total cellular concentration of 200 g/l 
and protein content per cell of 200 pg, TPA method predicts the cell volume to be about 1000 
µm3, corresponding to cell diameter of 12 µm which is lower than both experimental and 
published values (14-17 µm; according to BioNumbers database).  
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5.3.1.6 Estimation of global protein abundance by TPA method 
As shown in the previous section, TPA approach estimated both the total number of protein 
copies per cell and the cell volume close to expected values for Hela cells. It should be 
remembered that the estimates provided are theoretical and come from human derived cell 
line with overall higher cell volume (see Table 5.17). Using the values calculated above, 
protein copy number was estimated for over 4000 different proteins for both producing and 
parental cell lines. For each of the cell line, two replicate values were obtained 
 
Figure 5.78 Correlation of the estimated protein copy number per cell between two replicates for GS K-O parental 
cell line (A) and E22 producing cell line (B) using Person correlation (R).  
Pearson correlation value (R>0.98) suggests strong correlation between two replicates (Figure 
5.78) for each of the cell lines. It can be assumed that the TPA method works extremely well 
and in a predictable manner. In addition, the ranges of protein abundance are very similar, 
only slightly wider for E22 producing cell line. The final calculation of the protein copy number 
for each individual protein is expressed as the average of 2 replicates (Figure 5.79). 
Since the protein abundance is non-linear (Nagaraj et al. 2011), there several protein species 
with very high protein copy number per cell. Data for both the producing and the parental 
cell line displays also shows that trend, with the average protein copy number per cell that is 




Figure 5.79 Global assessment of the number of protein copies per cell for GS K-O parental cell line in ranking 
order (A); magnified to top 1000 proteins in terms of protein abundance (B). Global assessment of the number of 
protein copies per cell for E22 producing cell line (C) with highlighted top 1000 proteins. The red dotted line 
indicates the average protein copy number per cell. 
The table below presents the top 10 most abundant proteins in terms of the protein copy 
number for both cell lines (Table 5.21). 
Table 5.21 Top 10 most abundant (in protein copy numbers) proteins for GS-KO and E22 cell lines. 
Rank GS K-O parental cell line E22 producing cell line 
1 Histone H4 (2.05e8) Light chain (LC) Mab fragment (1.1e8) 
2 Actin, cytoplasmic 1 (1.51e8) Histone H4 (9.93e7) 
3 Glyceraldehyde-3-phosphate dehydrogenase (5.62e7) Actin, cytoplasmic 1 (9.90e7) 
4 Peroxiredoxin-1 (5.49e7) Glyceraldehyde-3-phosphate dehydrogenase (7.45e7) 
5 Cofilin-1 (5.16e7) Peroxiredoxin-1 (7.14e7) 
6 Galectin (4.28e7) 78 kDa glucose-regulated protein (6.45e7) 
7 14-3-3 protein epsilon (3.95e7) Heavy chain (HC) Mab fragment (5.61e7) 
8 Fatty acid-binding protein (3.13e7) Cofilin-1 (4.01e7) 
9 Histone H2A type 1 (3.05e7) Elongation factor 1-alpha 1 (3.98e7) 




Comparing the data for GS K-O parental and E22 producing cell line, it is noticeable that trends 
are very similar. At the top of the list there are structural proteins: chromatin-regulating 
histones, cytoskeleton-building actin and galectin, important for cytoskeleton remodelling. In 
addition, a glycolytic enzyme, glyceraldehyde 3-phosphate dehydrogenase and a protein with 
antioxidant function (periodoxin-1) have been identified. Data agrees well with that for Hela 
cells, where these proteins are reported to be among top 1 % of the dataset (Boisvert et al. 
2012). Regarding the differences between the two cell lines, the most abundant species is the 
light chain (LC) of monoclonal antibody while its heavy chain (HC) occupies 8th position from 
the top. What is more, chaperone protein, 78 kDa glucose regulating protein (also known as 
Binding immunoglobulin protein, BiP) ranked high for E22 producing cell line as it is associated 
with higher monoclonal antibody expression. The full list of quantified proteins can be found 
in Appendix F.  
5.3.1.7 Calculation of protein turnover using flexible model coefficients 
Protein turnover was calculated as cross between fitted curves for degradation (M/L) and 
synthesis (H/L). For each cell line, two replicates were obtained by separately fitting obtained 
MS data to the exponential decay model facilitated by the Levenberg-Marquardt algorithm. 
An example of a protein fit is shown in Figure 5.80.  
For the details on data normalisation, fitting to the line and calculation of protein turnover 
(see section 2.5.7). If the raw H/L and M/L ratios were plotted on a single graph, it would be 
impossible to fit a curve (Figure 5.80 A). Since the protein turnover describes the balance 
between protein synthesis and protein degradation, M/L and H/L ratios were normalised to 
1 (Figure 5.80 C). Normalised M/L ratios collected over time were fitted using the exponential 
decay model, f(t), facilitated by the Levenberg-Marquardt algorithm (Figure 5.80 C). A 
corresponding synthesis curve, based on normalised H/L ratios, was calculated as 1- f(t). The 





Figure 5.80 The overview of non-linear square fitting. Plotted M/L (degradation) and H/L (synthesis) ratio before 
normalisation A) and C) after H/L + M/L = 1 normalization, D) The exponential decay curve f(t) is fitted to 
degradation M/L ratios B). The corresponding curve is fitted as 1-f(t) to calculate the corresponding synthesis 
profiles D).  
By using methodology described by Boisvert et al., 2012, many proteins did not fit into 
exponential model with positive (acceptable) values. They were > 3,500 proteins suitable for 
GS K-O data set and >4000 proteins for E22 data set meeting the minimum 3 time points 
criteria. However, many proteins did not fit the experimental boundaries (0<A<2; 0<B<1; 
0<τ’70). Rejected protein were defined as having at least one of the coefficients was outside 







Table 5.22 Overview of the number of identified and fitted proteins using Boisvert et al., 2012 methodology for 
all analysed replicates. 
Replicate Protein identified Fitted (min 3 time 
points) 
Proteins accepted Proteins rejected 
GS rep 1 4441 3943 2520 1420 
GS rep 2 4200 3654 2561 1091 
E22 rep 1 5002 4050 2077 1973 
E22 rep 2 5281 4365 2344 2020 
 
After excluding the proteins fitted to unsuitable coefficients, approximately 2500 protein 
turnover values for GS parental cell line and 2000 protein turnover values for E22 producing 
cell lines have been calculated. The mean of the two replicates was used for each cell line and 
the resulting data ranked in descending order (Fig 5.81).  
 
Figure 5.81 Ranked protein turnover (h) for GS K-O parental cell line (A) and E22 producing cell line (B). Red 
dotted line indicates the mean value of protein turnover (h).  
5.3.1.8 Estimation of protein turnover using fixed model coefficients 
By careful inspection of the rejected proteins, it was found that in most cases the B coefficient 
(described as “offset” by Boisvert et al., 2012 or “plateau” of exponential decay model) had a 
negative value. As a result, two most abundant proteins, actin and peroxiredoxin-1, were 
rejected in data set for E22 producing cell line, which was unacceptable for the accurate 
determination of the protein biomass (Fig 5.82). 
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In the visual examination, the original model did not correctly fit the data despite multiple 
time points available. In addition, the B coefficient is only slightly negative for both proteins, 
but they had to be rejected from further analysis using the original criteria. The B coefficient 
value indicates offset when the curve begins to plateau. Looking at the fitted curves, the value 
of plateau should be positive and possibly between 0.2-0.3 for these proteins.  
 
Figure 5.82 The normalised M/L ratios fitted to the exponential decay model according to the original method by 
Boisvert et al., 2012. Actin cytoplasmic 1 (G3GVD0, A) had the following fitted coefficient: A=0.99; B= -0.08; τ’= 
46.17; whereas peroxiredoxin-1 (G3GYP9, B) had: A=1.00; B= -0.07; τ’= 50.22.  
The value of A in this model indicates the span of the curve and can be calculated by 
subtracting the value of offset B from beginning of the fitted curve (“A0”) at time 0. Both 
values must be positive since value of A should be as close to 1 as possible (time 0 of pulse 
SILAC corresponds to the value of M/L = 1), whereas offset B is related to the degree of amino 
acid recycling in our system. After examining several miscleaved peptides, containing both 
medium and heavy isotopes of amino acids at time 48h (because this is the latest sampling 
point), the degree of recycling  was estimated to about 5-10%. It was decided to fix parameter 
A and B in three different ways and compare it with the original method (Figure 5.83).  
Fixing the parameters A and B in the exponential model would cause the value of τ’ (time 
coefficient) to be always calculated as a positive value, but it can still be above the upper limit 
(>70). By visual checking of data fitted to the exponential model with fixed parameters, they 
were a few cases of incorrect data fitting to the model (data not shown). 
Next, it was decided to check whether fixing the parameter B would lead to better fit of the 
data. Value of B (offset) in pulse SILAC experiment is assumed to be an internal noise and is 
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directly related to the degree of amino acid recycling. Boisvert et al., 2012 proved that by 
continuously adding heavy isotopes, the value of B is reduced to 0. Based on manual 
examination of spectra, amino acid recycling occurred at relatively low level (5-10%). These 
values have been used to fix B coefficient in the exponential model (Figure 5.84). 
Both the 5% and 10% values for the B coefficient performed well, but 5% has led to a slightly 
higher number of fitted proteins. In addition, for all analysed replicates >90% of the fitted 
proteins were within desired boundaries and can be used for further analysis as opposed to 
the original method.  
 
Figure 5.83 Examples of 4 different proteins proteins (shown as Uniprot ID)  fitted with the original method 
(control, marked as blue) and three fixed parameter conditions: fixed A=1 & B=0 (marked as pink); fixed A=0.9 & 




Figure 5.84 Examples of 4 different protein fitted with the original method (control, marked as blue) and two 
fixed B parameter conditions: B=0.1(marked as red) and B=0.05 (marked as pink).   
Table 5.23 The overview of the number of proteins fitted and rejected using fixed B coefficient exponential 
model. 
Replicate Proteins identified Fitted (min 3 time 
points) 
Proteins accepted Proteins rejected 
B=0.01 
GS rep 1 4441 3943 3607 336 
GS rep 2 4200 3654 3402 252 
E22 rep 1 5002 4050 3793 257 
E22 rep 2 5281 4365 4118 247 
B=0.05 
GS rep 1 4441 3943 3623 320 
GS rep 2 4200 3654 3388 266 
E22 rep 1 5002 4050 3805 245 
E22 rep 2 5281 4365 4147 218 
 
Using the fixed B exponential model, proteins were rejected only based on coefficient A and 
τ’ outside the established limits. Proteins with very large values of τ’ indicate very slow protein 
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degradation and turnover cannot be estimated during the experiment. These proteins can be 
regarded as having an infinite half-time. To sum up, by adjusting the B coefficient of the 
exponential model to a fixed value, protein turnover was calculated for more than 3500 
proteins (Fig 5.85). 
 
Figure 5.85 Ranked protein turnover (h) for GS parental cell line (n=3637; A) and E22 producing cell line (n=4001; 
B). Red dotted line marks the mean value for protein turnover (h).  
5.3.1.9 Estimation of rate of protein turnover  
Protein turnover rate (protein copies/h) is derived from dividing the protein copy number by 
the protein turnover (h) and is an estimate of the number of protein copies made per unit of 
time. The 10 most turned over proteins were examined in detail for both E22 producing and 
GS K-O parental cell lines (Table 5.24).  
Table 5.24 Top 10 proteins in terms of turnover rate (h-1) for GS K-O and E22 cell lines. 
Rank GS K-O cells (turnover rate h-1)  E22 producing cell line (turnover rate h-1) 
1 Actin, cytoplasmic 1 (5.36e6) Light chain (LC) Mab fragment (2.31e7) 
2 Histone H4 (4.79e6) Heavy chain (HC) Mab fragment (6.97e6) 
3 Ubiquitin (2.20e6) Actin, cytoplasmic 1 (4.04e6) 
4 Peroxiredoxin-1 (2.19e6) Histone H4 (3.60e6) 
5 Cofilin-1 (1.55e6) Glyceraldehyde-3-phosphate dehydrogenase (2.72e6) 
6 Glyceraldehyde-3-phosphate dehydrogenase (1.46e6) Ubiquitin (2.65e6) 
7 14-3-3 protein epsilon (1.35e6) Peroxiredoxin-1 (2.50e6) 
8 Peptidyl-prolyl cis-trans isomerase (1.36e6) 78 kDa glucose-regulated protein (1.94e6) 
9 Fatty acid binding protein (FABP) (1.23e6) 14-3-3 protein epsilon (1.53e6) 
10 Galectin (1.22e6) Cofilin-1 (1.50e6) 
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Interestingly, LC and HC of mAb are expressed at the highest rate for E22 producing cell line, 
even higher that the most important structural protein, actin. The results for GS K-O parental 
cell line suggest that actin is the most turned over protein, followed closely by histone H4. For 
both cell lines, ubiquitin, a protein involved in marking proteins for degradation, is also rapidly 
turned over, which is consistent with their function. Fatty acid binding protein (FABP) is also 
important for parental cell line and plays a role in both transport and metabolism of fatty 
acids.  14-3-3 protein epsilon is also important for both cell lines, exerting regulatory functions 
in many pathways, including cell cycle, MAPK cascade and signal transduction. 
5.3.1.10 Calculation of total protein mass 
In addition to calculating protein turnover rate, the total cellular mass for individual proteins 
was also estimated. By combining the values of protein copy number values, derived from 
TPA data, and molecular weight (mW) for each protein, ‘’total protein mass” was derived. The 
top 10 proteins in terms of total protein mass are shown in Table 5.25. 
Table 5.25 Top 10 protein with highest total cellular mass (kDa) for GS-KO and E22 cell lines. 
Rank GS K-O cells (total cellular mass, kDa) E22 cells (total cellular mass, kDa) 
1 Actin, cytoplasmic 1 (5.21e9) 78 kDa glucose-regulated protein (4.67e9) 
2 Histone H4 (2.33e9) Actin, cytoplasmic 1 (3.41e9) 
3 Glyceraldehyde-3-phosphate dehydrogenase (1.75e9) HC Mab fragment (2.72e9) 
4 Elongation factor 1-alpha 1 (1.71e9) LC Mab fragment (2.58e9) 
5 Pyruvate kinase (1.52e9) Endoplasmin (2.34e9) 
6 78 kDa glucose-regulated protein (1.34e9) Glyceraldehyde-3-phosphate dehydrogenase (2.33e9) 
7 Heat shock protein HSP 90-beta (1.30e9) Elongation factor 1-alpha 1 (2.19e9) 
8 Peroxiredoxin-1 (1.22e9) Vimentin (1.65e9) 
9 Elongation factor 2 (1.19e6) Peroxiredoxin-1 (1.59e9) 
10 Alpha-enolase (1.16e6) Alpha-enolase (1.49e9) 
 
Interestingly, the top protein for E22 producing cell line is 78 kDA glucose-regulated proteins 
(BiP), a molecular chaperone that is important for correct protein folding. In contrast, the top 
protein for GS K-O parental cell line is actin, whereas BiP protein is ranked 6th from the top. 
The results suggest that E22 producing cell line has up-regulated BiP protein due to 
production of recombinant antibody. 
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5.3.1.11 Protein turnover and abundance of recombinant antibody  
In the case of  E22 producing cell line, it was also possible to obtain accurate information on 
the dynamics of mAb production. According to the protein abundance data, the expression 
of LC (1.1e8) and HC (5.6e7) is in almost perfect 2:1 ratio (precisely, 1.96:1), which is a 
desirable standard for recombinant protein expression (Schlatter et al. 2005). Excess LC is 
apparently required to make mAb folding and assembly more efficient. 
The results of pulse SILAC experiment suggest that turnover of LC takes shorter than HC and 
is equal to 4.77 h and 8.05 h, respectively (Figure 5.86). Similarly, protein degradation was 
estimated to be shorter for light chain (5.86 h) than for heavy chain (12.02 h). Protein turnover 
rate data predicts that there are more than three times more LC fragments (23,128,589 
molecules/cell/h) turned over than HC fragments (6,971,762 molecules/cell/h) for each E22 
producing cell.  
It is important to mention the limitation of both protein copy number and protein turnover 
estimation for the recombinant protein. Firstly, the analysis was exclusively focused on 
intracellular proteins without analysing spent media containing the secreted protein. 
Secondly,  values of LC and HC production were obtained separately, so it is not possible to 
calculate how many complete mAb molecules (which are dimers of LC and HC) are actually 
produced per unit time. Based on the qMab calculations (see section 3.3.2), approximately 
3.2e6 molecules of the complete Mab were produced by the E22 producing cell per hour. This 
translated to only about half of HC molecules and only 14% of LC molecules. There might be 
several reasons for the discrepancy between these numbers. Studies have shown that LC can 
be secreted from the cell on its own as opposed to HC molecules. What is more, none of the 
estimates takes into account the passage of translated molecules through endoplasmic 
reticulum (60 min) and Golgi (30 min), which have been proved experimentally using heavy 
labelled leucine (Choi et al., 1971). Finally, bottom-up proteomic data cannot distinguish 
between complete Mab molecules and free chains, since  proteins are identified on the basis 




Figure 5.86 Calculation of recombinant protein turnover. Degradation profiles for light chain (LC) were calculated 
based on normalised M/L ratios (A) and corresponding synthesis profiles using normalised H/L ratios (B); the 
intercept point was used to calculate protein turnover. Same process has been repeated for heavy chain (C & D).  
5.3.2 Bioinformatic analysis of protein turnover and abundance data 
5.3.2.1 Visual representation of abundance of CHO cell proteins with Proteomaps 
Proteomap is an online tool (https://www.proteomaps.net/) that can visually show the 
quantitative composition of proteomes for a given organism. Each protein is represented by 
a polygon that reflect protein abundance, as estimated by TPA method, weighted by protein 
size. Functionally related proteins are grouped together hierarchically based on the KEGG 
pathways classification into coloured regions (Liebermeister et al. 2014). Currently, Chinese 
hamster is not a supported organism, so identified proteins were mapped to its mouse (Mus 
musculus) homologs using the information available on CHOGenome database 
(http://www.chogenome.org/). More than 3000 proteins were mapped for each cell line (3266 
proteins for GS parental and 3587 proteins for E22 producing cell line).  
In general, the proteome composition between the two cell lines was very similar (Figure 
5.87). Most proteins were involved in genetic information processing (marked as blue), which 
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includes not only transcription and translation, but also protein folding, modification and 
degradation in proteasomes. In agreement with KEGG and GO annotation (described below), 
there were relatively more proteins involved in the latter processes in E22 producing cell line. 
The second largest group of proteins were involved in cellular processes (marked as red), 
including regulation of cell cycle and cytoskeletal proteins.  
 
 
Figure 5.87 Quantitative representation of the global proteome composition between GS K-O parental (A) and 
E22 producing (B) cell lines based on their protein copy number. More detailed look is available below (C&D) to 
highlight the most important groups of cellular proteins. Figures were produced using Proteomap tool 
(https://www.proteomaps.net/).  
The third largest groups of proteins were responsible for metabolism, mainly glycolysis and purine and 
amino acid metabolism. The proteins involved in TCA cycle and oxidative phosphorylation were less 
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abundant, probably because CHO cells rely mainly on glycolysis as a source of energy (“Warburg 
metabolism”), as discussed in detail (see section 1.2.5). 
5.3.2.2 Defining protein biomass objective  
Previous studies have shown that the 1000 most abundant proteins reflect over 90% of 
proteome coverage (Nagaraj et al. 2011). To estimate the protein biomass objective, only 
identified and quantitated proteins were used, and those below the limit of detection were 
not taken into account.  
Firstly, quantitated proteins were ranked in descending order in terms of their “total protein 
mass”. It was found that top 10 ‘heaviest’ proteins constitute almost 20% of the total cellular 
protein mass. Similarly, top 100 proteins correspond to more than 50% and top 1000 
correspond to more than 90% of the total cellular protein mass (Figure 5.88 A). 
Likewise, rate of protein turnover data shows similar trends: top 10 proteins with the highest 
turnover rates correspond to quarter of the total, whereas top 100 constitute almost 60% of 
the total and top 1000 proteins  - 90% of the whole data set (Figure 5.88 B). These results 
agree confirm that most of the cellular degradation and synthesis machinery (as well as total 
cellular protein mass) is occupied only by several protein species with the most important 
functions. In the case of E22 producing cell line, the synthesis of LC and HC of mAb was also 
present in the top 10 proteins. It can be assumed that the production of heterologous protein  
exerts a significant burden on cellular metabolism. The trend is likely to also exist in other 





Figure 5.88 Pie charts highlighting the proportion of the total protein mass (A) and the rate of protein turnover 
(B) encompassed by the top 10, top 100 and top 1000 proteins in E22 producing cell line data set (n=4001).  
5.3.2.3 Combining data sets of GS-KO parental and E22 producing cell lines  
Since two separate data sets were obtained using pulse SILAC and TPA approach, it was 
interesting to investigate their overlap and correlation (Fig 5.89). They were 3261 common 
proteins between the data sets of E22 producing and GS K-O parental cell lines with complete 
values of protein turnover, copy number per cell and the corresponding protein turnover 
rates and total protein masses.  
In general,  strong correlation was found between protein turnover values (R=0.7747) and the 
number of copies per cell (R=0.7469). There may be several reasons why the correlation is not 
higher, even though the cell lines are so closely related. Regarding the estimation of protein 
turnover, lack of several data points (less peptides identified or not at many time points) can 
lead to poor model fit. Discrepancies in the copy number estimation were most likely due to 
differences in cell volume. According to the protein copy numbers, E22 producing cells are 
smaller but have a higher protein content. Interestingly, the correlation between the rate of 
protein turnover, which is obtained by combining the two values together, had higher 




Figure 5.89 Venn diagram of common proteins between two data sets for E22 producing and GS K-O parental 
cell lines (A); Scatterplot showing the correlation (Pearson correlation value, R)  between protein turnover (h) 
values obtained for E22 producing and GS K-O parental cell lines (B), protein copy number per cell (C) and 
obtained protein turnover rate (h-1; D).   
5.3.2.4 Functional analysis of up-regulated proteins using Gene Ontology classification 
Since they were some differences in the protein abundance between the two cell lines, it was 
important to examine if there are any groups of proteins that have been significantly up- or 
down-regulated.  The reliability of the protein abundance values was confirmed by DJ-1 
protein, which is known to have “the lowest variability in abundance among different cell 
types in human, mouse, and amphibian cells” (Wisniewski & Mann 2016). The abundance of 
DJ-1 protein was almost identical for E22 producing cell line (6.39e6) and GS K-O parental cell 
line (6.42e6), which resulted in almost 1:1 expression. 
After final verification of the estimated protein abundance, 679 out of 3261 proteins common 
between two data sets had at least 2-fold higher expression in E22 producing than in GS K-O 
parental cell line. On the other hand, 196 protein were up-regulated in GS K-O parental cell 
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line. PANTHER database (http://www.pantherdb.org/ ) was used to classify proteins according to 
their functions (Fig 5.90).  
 
 
Figure 5.90 A) Pie chart shows 2-fold up-regulated PANTHER protein classes. B) Pie charts shows associated Gene 
Ontology (GO) terms for biological process (BP) for 2-fold up-regulated proteins, C) Molecular function (MF) and 
D) Cellular Compartment (CC). The functional annotation was performed using PANTHER database (Mi et al. 
2013).  
Regarding the PANTHER protein classes, the most significant groups of proteins were involved 
in the binding of nucleic acids. These proteins play an important role in genetic information 
processing, including transcription and translation. Proteins up-regulated for E22 producing 
cell line included enzymes (hydrolases and transferases) and proteins modulating enzyme 
functions. Similarly, the GO annotation of BP shows that about 1/3 (~200) up-regulated 
proteins was involved in variety of metabolic processes and another 1/3 in cellular processes, 
followed by cellular organisation and biogenesis. This is also confirmed by the analysis of 
GOMF annotation, in which more than 50% of up-regulated proteins have catalytic activity 
and about 1/3 binding activity. These findings may suggest that E22 producing cell line is 
metabolically more active than GS K-O parental cell line. The level of GOCC annotation is 




5.3.2.5 Pathway analysis of up-regulated proteins using KEGG database 
Following the analysis of PANTHER classification,  the patterns of up-regulated proteins were 
further examined using KEGG Mapper tool.  Up-regulated proteins were matched to 715 
different KEGG identifiers and down-regulated proteins to 205 KEGG identifiers. 
Unsurprisingly, the largest number of proteins was linked to metabolic pathways (102), which 
agrees with GOBP annotation presented above (Table 5.26). 
Table 5.26 Top 15 KEGG pathways matched to up-regulated proteins. 
Pathway 
number 
Pathway name Number of matches 
Mmu01100 Metabolic pathways 102 
Mmu05200 Pathways in cancer 25 
Mmu04144 Endocytosis 23 
Mmu03013 RNA transport 21 
Mmu04141 Protein processing in endoplasmic reticulum 20 
Mmu03008 Ribosome biogenesis in eukaryotes 20 
Mmu03040 Spliceosome 20 
Mmu05165 Human papillomavirus infection 19 
Mmu00230 Purine metabolism 18 
Mmu04151 PI3K-Akt signalling pathway 18 
Mmu00240 Pyrimidine metabolism 17 
Mmu04142 Lysosome 16 
Mmu05169 Epstein-Barr virus infection 16 
Mmu05203 Viral carcinogenesis 15 
Mmu04217 Necroptosis 15 
 
Other highly matched KEGG pathways include Pathways in Cancer (25) and Endocytosis (23), 
RNA transport (21) and Protein Processing in Endoplasmic Reticulum (20). Several of matched 
pathways are of particular importance from the perspective of cellular engineering. For 
example, several translation initiation factors were found to be up-regulated in E22 producing 
cell line (e.g., eIF5, eIF1 or eIF4G), while CYFIP was down-regulated for E22 producing cell line 
(Figure 5.91 A). CYFIP is a protein with dual functionality: it inhibits local protein synthesis but 
can also favour actin remodelling (DeRubeis et al. 2013). Such specific up-regulation of 
translation factors may be a direct effect of producing the recombinant protein production 
and a feature of E22 producing cell line.  
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What is more, several proteins were found to be involved in exon-junction complex (MLN51 
and Tap) that are important during splicing. Another interesting group of up-regulated 
proteins forms a nuclear pore complex (Tpr, Nup50, Sec13), which is important for 
transferring molecules from and to nucleus (figure 5.91B). 
 
Figure 5.91 Fragment of KEGG map of RNA transport (mmu03013) showing translation initiation factors (eIFs) 
and exon-junction complex (EJC) (A), Nuclear pore complex (NPC) (B) and surviva motor neuron (SMN) complex. 
Proteins up-regulated are marked as red; proteins down-regulated are marked as blue.  
In addition, multiple proteins involved in ribosome biogenesis pathway were found to be up-
regulated (marked as red; Figure 5.92). Up-regulation of these proteins could have led to 
more efficient translation, resulting in overall higher number of protein copies per cell in E22 





Figure 5.92 KEGG map of ribosome biogenesis in eukaryotes (mmu03008), highlighting multiple proteins up-
regulated (marked as red) in E22 producing cell line.   
In addition, several proteins involved in protein processing in endoplasmic reticulum (Figure 
5.93) were up-regulated. It was confirmed that BiP protein was up-regulated in E22 producing 
cell line along with HSP40 and GRP94 proteins, all of which play a role in the recognition of 
proteins by luminal chaperones. Two proteins that form in coat protein complex II (COPII) 
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were also up-regulated. Their function is facilitating export from endoplasmic reticulum. 
There are also several up-regulated proteins involved in degradation that is ER-associated or 
directly form ubiquitin ligase complex. These findings were consistent with PANTHER 
database analysis.  
 
Figure 5.93 Fragment of KEGG map showing protein processing in endoplasmic reticulum (A). Enlarged fragment 
of ER-associated degradation (ERAD; B) and ubiquitin ligase complex. Proteins up-regulated are marked as red; 
proteins down-regulated are marked as blue. 
In summary, E22 producing cell line, although smaller in volume, can be considered an 
efficient “cell factory”. Key proteins involved in ribosome biogenesis and translation initiation 
were up-regulated, both promoting higher yield of mAb. In addition, there was up-regulation 
of proteins involved in protein folding in ER, possibly due to heterologous protein expression. 
Studies have shown that up-regulation of chaperone proteins such as BiP has been associated 
with better productivity of CHO cells (Smales et al. 2004; Alete et al. 2005; Pybus et al. 2014). 
The data suggest that clonal selection of E22 producing  cell line might have been a direct 
cause of proteins up-regulated in translation and protein folding, ultimately leading to better 
growth and productivity profile. 
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5.3.2.6 Dynamic usage of amino acids  
By combining protein turnover and protein copy number data, rate of protein turnover was 
obtained, which calculates the number of protein copies made per hour. These values should 
also correspond to the number of amino acids used to support the protein turnover in CHO 
cells. For each value of the protein turnover rate, corresponding amino acid sequence 
(available in FASTA file format) was matched (see section 2.5.12) and amino acid rates for 
individual proteins were calculated and summed together (Figure 5.94). Data for both E22 
producing and GS K-O parental cell line suggest that the most frequently used amino acid was 
leucine (L), followed by lysine (K) and alanine (A). The least used amino acids are histidine (H), 
cysteine (C) and tryptophan (W). The use of serine (S) has been greater for E22 producing cell 
line than for GS parental cell line due to recombinant protein production, as mAbs are rich in 
this amino acid (based on amino acid sequence analyses).  
 
Figure 5.94 Combined bar charts showing rates of usage of individual amino acids in descending order for E22 
producing and GS K-O parental cell lines.  
The dynamic usage data agrees relatively well with predicted amino acid frequencies for 
vertebrates. Since there are 61 codons coding for 20 naturally occurring amino acids, there is 
a strong correlation between genetic code and amino acid composition of proteins. Except 
for arginine, the most important factor determining amino acid frequency is the number of 
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possible codons (Dyer 1971). Serine (S), leucine (L) and alanine (A) are the most frequent 
amino acids whereas histidine (H), methionine (M) and tryptophan (W) are the least frequent 
amino acids. When comparing obtained data to amino acid content of CD-CHO media (see 
Appendix G), this medium is not tailored to the needs of any of the two cell lines. Arginine is 
the most abundant amino acid in CD-CHO, yet it is not as much used by CHO cells. On the 
other hand, the alanine content of CD-CHO is very low. The amount of lysine and serine is 
high and fits well with the requirements of both cell lines. 
5.3.2.7 Dynamic usage of codons and estimation of codon usage bias 
In addition to calculating the rates of amino acid usage, protein sequence data was linked to 
coding sequence data using EMBL database information (see section 2.5.13). The number of 
individual codon usage was calculated for each identified protein and the values were 
adjusted using protein turnover data (Figure 5.96). Both sense codons (coding for amino 
acids) and nonsense codons (TAA, TAG and TGA) were included in the calculations. 
The most frequently used codons were TCT (Serine), ACG (Threonine) and TCC (Serine). On 
the other hand, the least frequent codons were TTA (Leucine), TCA (Serine) and CTA (Leucine). 
The data somehow agrees with amino acids usage, but to get true view on codon usage, it 
was decided to determine dynamic codon usage bias as opposed one established solely based 
on the CHO-K1 reference genome (Table 5.27). Control codon bias from reference CHO-K1 
genome since Uniprot protein database was based directly on it. A recently published study 
compared codon biases for CHO cells based solely on 10% most expressed and 10% lowest 
expressed proteins (Ang et al. 2016). In contrast, presented calculations consider individual 
codon usage per unit time for all proteins quantified in the proteomic data set.  
There are many similarities between the genomic codon bias and codon usage corrected by 
rate of protein turnover. For instance, the most frequently used stop codon is TGA, which 
occurs around 50% of the time. There was not much difference in codon use bias for several 
amino acids, including cysteine (C), aspartic acid (D), glutamic acid (E), phenylalanine (F), 
histidine (H), asparagine (N) and tyrosine (Y). Minor differences were observed lysine (K) and 
glutamine (Q). On the other hand, codon usage was significantly altered for GCG (alanine), 
CCG (proline), TCG (serine) and ACG (threonine) codons, as they were used at a much higher 




Figure 5.95 Combined bar chart of rates of codon usage in descending order for E22 producing and GS K-O 
parental cell lines.  
This finding suggests that there is a specific dynamic codon usage bias during exponential 
phase of growth for both cell lines.  Based on this data, it would be possible to optimise codon 
sequence for heterologous recombinant proteins to facilitate the process of translation to 




Table 5.27 Comparison of the genomic codon bias (control) and the corrected dynamic codon use bias for E22 
producing and GS K-O parental cell lines.  
Amino 
acid Codon Control E22 GS 
 
Amino 
acid Codon Control E22 GS 
* 
 TAG  0.23 0.20 0.24 
 
M  ATG  1.00 1.00 1.00 
 TGA  0.49 0.52 0.44 
 
N 
 AAT  0.48 0.61 0.62 
 TAA  0.28 0.28 0.32 
 
 AAC  0.52 0.39 0.38 
A 
 GCT  0.31 0.26 0.26 
 
P 
 CCT  0.33 0.21 0.23 
 GCG  0.06 0.21 0.20 
 
 CCG  0.07 0.25 0.22 
 GCC  0.36 0.36 0.37 
 
 CCC  0.28 0.29 0.34 
 GCA  0.26 0.17 0.18 
 
 CCA  0.31 0.25 0.22 
C 
 TGT  0.52 0.45 0.43 
 
Q 
 CAG  0.72 0.47 0.50 
 TGC  0.48 0.55 0.57 
 
 CAA  0.28 0.53 0.50 
D 
 GAT  0.48 0.35 0.35 
 
R 
 CGT  0.09 0.17 0.14 
 GAC  0.52 0.65 0.65 
 
 CGG  0.17 0.10 0.13 
E 
 GAG  0.55 0.54 0.52 
 
 AGG  0.23 0.13 0.16 
 GAA  0.45 0.46 0.48 
 
 CGC  0.14 0.30 0.28 
F 
 TTT  0.48 0.46 0.47 
 
 CGA  0.13 0.09 0.09 
 TTC  0.52 0.54 0.53 
 
 AGA  0.24 0.20 0.21 
G 
 GGT  0.19 0.29 0.27 
 
S 
 TCT  0.21 0.30 0.29 
 GGG  0.23 0.16 0.18 
 
 AGT  0.17 0.16 0.16 
 GGC  0.3 0.32 0.36 
 
 TCG  0.04 0.20 0.18 
 GGA  0.28 0.23 0.19 
 
 TCC  0.2 0.25 0.26 
H 
 CAT  0.46 0.36 0.36 
 
 AGC  0.22 0.08 0.09 
 CAC  0.54 0.64 0.64 
 
 TCA  0.16 0.01 0.01 
I 
 ATT  0.37 0.30 0.30 
 
T 
 ACT  0.27 0.20 0.24 
 ATC  0.46 0.43 0.43 
 
 ACG  0.08 0.39 0.36 
 ATA  0.18 0.27 0.27 
 
 ACC  0.32 0.33 0.30 
K 
 AAG  0.57 0.40 0.41 
 
 ACA  0.32 0.08 0.10 
 AAA  0.43 0.60 0.59 
 
V 
 GTT  0.19 0.28 0.27 
L 
 CTT  0.15 0.22 0.21 
 
 GTG  0.44 0.26 0.25 
 TTG  0.14 0.19 0.20 
 
 GTC  0.23 0.30 0.32 
 CTG  0.37 0.15 0.15 
 
 GTA  0.13 0.15 0.16 
 CTC  0.18 0.38 0.38 
 
W  TGG  1.00 1.00 1.00 
 TTA  0.08 0.03 0.03 
 
Y 
 TAT  0.47 0.37 0.37 
 CTA  0.09 0.04 0.03 
 




5.4 Conclusions  
Using total protein approach (TPA) method to quantify the number of protein copies, it was 
calculated that a single CHO cell contains 3-4 billion protein molecules, over 90% of which are 
covers the top 1000 proteins in terms of protein abundance. The data agrees relatively well 
with the values reported in the literature (Nagaraj et al. 2011). The advantage of TPA method 
over other MS-based approaches for absolute protein quantification is that there are no 
requirements of any stable isotope labels or significant biochemical input (Wiśniewski 2017). 
The method is based solely on the information that could be routinely obtained in any 
molecular biology lab, namely cell diameter and estimation of cellular protein concentration. 
In addition, TPA method requires the depth of coverage of at least 12,000 peptide-to-
spectrum matches (PSMs) (Wiśniewski et al. 2012) and this can be easily acquired even during 
single run of in-solution trypsin peptide digest. Such data can be produced by using even older 
version of Orbitrap instruments, such as LTQ Orbitrap (Scigelova and Makarov 2006) or Q-
Exactive (Michalski et al. 2011). After MS data acquisition of suitable proteomic coverage, raw 
data can be easily processed using freely available MaxQuant (Cox & Mann 2008) and Perseus 
(Tyanova et al. 2016) using well-established protocols. In addition, it was found that the 
estimated protein copy numbers match well those reported for mouse fibroblasts, as 
estimated using alternative quantification method (Zeiler et al. 2014; Schwanhäusser et al. 
2011). The quality of TPA method was also confirmed on the basis of PARK7 protein 
expression (Wisniewski and Mann 2016).  
In addition to calculating protein copy number, protein turnover was estimated using 
enhanced pulse SILAC method (Boisvert et al. 2012), which was slightly changed to match the 
requirements of CHO cells. Using spent media for media exchange, there was no change in 
the growth profile of CHO cells as compared to the control conditions. The depth of the 
proteome coverage for both datasets was at least 150,000 PSMs, corresponding to >5000 
unique proteins. Despite great progress in mass spectrometry research using stable isotopes 
(Chahrour et al. 2015; Altelaar et al. 2013), there was no available software for analysing 
protein turnover data. In-house program was developed using Matlab computing 
environment (Matlab 2016b) to fit data into simple exponential decay model and Levenberg-
Marquardt algorithm was used to enhance nonlinear square fitting (Appendix D). According 
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to the original methodology (Boisvert et al. 2012), only 50-70% of the proteins fitted into the 
model, while fixed B coefficient model, taking into account degree of amino acid recycling,  
fitted >90% of identified proteins. In conclusion, protein turnover was calculated for more 
than >3000 proteins in both GS-KO parental and E22 producing cell lines. The data is of similar 
scope to that previously published for NIH3T3 mouse fibroblasts (Schwanhäusser et al. 2011), 
where >5000 were identified and quantified. Regarding human-derived Hela cell line, >8000 
proteins were identified and quantified (Boisvert et al. 2012). Considering the differences in 
the size of the databases used (Chinese hamster Uniprot database contains >23,000 
sequences, while Mus Musculus Uniprot database contains >54,000 sequences and Homo 
sapiens: >73,000 sequences), the presented enhanced pulse SILAC data is of similar quality. 
By combining protein abundance with protein turnover data, protein turnover rate was 
derived, based on which it is possible to identify proteins recruiting majority of synthesis and 
degradation machinery for cellular homeostasis. Derived protein turnover rate was strongly 
influenced by the value of protein abundance. Unsurprisingly, the highest expressed proteins 
for E22 producing cell line were LC and HC of mAb, followed by structural proteins: actin, 
histone and glycolytic enzyme, glyceraldehyde-3-phosphate dehydrogenase. Top 10 proteins 
in terms of protein turnover rate corresponded to 20% of total dataset, while top 100 – 
already accounted for 50% of the data set. 
Protein copy number and protein turnover was also calculated for LC and HC of mAb for E22 
producing cell line. It was found that LC and HC were expressed in almost perfect 2:1 ratio, 
which has been shown before to be optimal (Schlatter et al. 2005).  According to the protein 
turnover data, it takes less than 5h to turn over LC and 8h to turn over HC of mAb. The 
observed difference might be due to several reasons, the most obvious of which is the 
sequence length. On the other hand, it is impossible to quantify how many complete 
monoclonal antibodies have been assembled within a cell so alternative method is required 
(O’Callaghan et al. 2010). BiP chaperone protein was also prominent in E22 producing cell line 
for its important role in protein folding (Pybus et al. 2014). In fact, this protein was found to 
be the heaviest following correction of protein abundance data with molecular weight (in 
kDa). Based on those findings, production and folding of mAb seems to have a priority even 
over housekeeping proteins for E22 producing cell line. 
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The calculated proteome composition was visualised using Proteomap (Liebermeister et al. 
2014). It was found that CHO cells focus mainly on the processing of genetic information, 
followed by cellular processes and metabolism. Interestingly, some differences have been 
found between the two cell lines: more than 600 proteins were up-regulated in E22 producing 
cell line, having the most crucial functions within a cell, including metabolic process and 
ribosome biogenesis. These findings agreed well with KEGG pathway and PANTHER analysis. 
Several possible engineering targets were identified, including translation initiation factors 
and proteins that are part of nuclear pore complex (NPC). Higher productivity of E22 
producing cell line was associated with proteins involved in protein processing in endoplasmic 
reticulum, as confirmed by successful targeted engineering approaches (Pybus et al. 2014). 
Finally, the concept of dynamic usage of amino acids and codons by CHO cells was explored. 
Based on protein sequence data, the number of amino acids used by both cell lines during 
exponential phase was estimated. Both GS-KO parental and E22 producing cell lines require 
several billions of individual amino acid molecules to support protein production, with the 
highest use of leucine, lysine and alanine. Further integration of dynamic usage data with 
amino acid flux analysis (Ahn and Antoniewicz 2011) might lead to the development of novel 
chemically defined media tailored to individual cell lines. There are already several examples 
of successful media engineering in the literature (Xing et al. 2011; Torkashvand et al. 2015). 
It has been already recognized that heterologous protein expression can be increased by 
codon optimisation. The first proteomic paper for CHO cells showed differences between 
human and CHO codon biases (Baycin-Hizal et al. 2012). The proof-of-principle paper was 
published the following year, showing increased expression of codon optimized interferon 
gamma in CHO cells based on reference CHO-K1 genome sequence (Chung et al. 2013).  
Codon usage bias calculated for both E22 and GS K-O cell lines agrees relatively well with 
published values (Baycin-Hizal et al. 2012), based purely on proteomic data. There was no 
difference in codon usage for Phenylalanine (Phe) and Cysteine (Cys), whereas TCA and ACA 
were the least used codons for Serine (Ser) and Threonine (Thr), respectively. The codon bias 
data was also directly compared to the integrated ‘omic’ dataset (Ang et al. 2016). Overall, 
there were many similarities between static and dynamic codon use bias except for four 
codons (GCG, CCG, TCG and ACG). This bias was true for both GS-KO parental and E22 
producing cell line, so it was unlikely to be driven by heterologous protein expression. It is 
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suggested that codon pair bias has a great influence on translational efficiency and might be 
more important in synthetic gene design (Papamichail et al. 2018; Kunec and Osterrieder 
2016). In fact, recently published studies have shown that “synonymous codons provide a 
secondary code for protein folding in the cell” (Buhr et al. 2016), which means that 
synonymous codon changes can significantly affect the folding of a protein. This can lead to 
increased number of misfolded proteins, leading to loss of protein, which is not desirable for 
production of mAbs. 
In conclusion, high-coverage proteomic data set was produced for industrially relevant CHO 
cell lines using modern mass spectrometry-based techniques: TPA and enhanced pulse SILAC. 
Protein abundance and discrete protein turnover rates have been calculated for >3000 
proteins. It is believed that the novelty of combining these two techniques will be explored 


















Chapter 6: Conclusions and future work 
6.1 Conclusions 
The overall aim of this thesis was to increase the understanding about mechanisms underlying 
CHO cells physiology. Global protein expression was being chosen to study as a reflection of 
biological state of CHO cells growing in cell culture.  
In chapter 3, different protein extraction protocols and sample preparation protocols were 
developed for use in quantitative proteomics methods presented in chapter 4 and 5. Firstly, 
protein extraction protocols were optimised using different combinations of salts, detergent 
and chaotropes to achieve the most robust protein solubilisation. It was found that 4xLaemli 
based (4xLB) buffer and SDS-based buffer were the most robust and efficient due to their high 
content of SDS. In addition, three different protocols for extraction of proteins from spent 
media were teste, which can be used for analysis of host cell proteins (HCPs) during industrial 
bioprocesses.   
As for sample preparation methods for bottom-up proteomics, in-gel trypsin digest and filter 
aided sample preparation (FASP) methods have been used and compared against each other. 
At first, optimised FASP protocol seemed to offer an improvement in number of protein 
identifications over optimised in-gel trypsin digest protocol when analysing data on lower 
sensitivity mass spectrometer. However, by using higher resolution Orbitrap mass 
spectrometer (Q-Exactive HF), there was no significant difference found between number of 
validated protein identifications. It was concluded that both in-gel trypsin digest and FASP 
method were equally efficient to produce tryptic peptides and could be used for quantitative 
proteomics approaches.   
In chapter 4, the feasibility of using standard SILAC for global quantitation of dynamic changes 
in protein expression between exponential and stationary phases of CHO cells was 
demonstrated. The adaptation phase has confirmed that full incorporation efficiency (>97%) 
was achieved within 2 passages for both GS-Ko parental and E22 producing cell lines. In 
addition, there was no arginine to proline conversion. More than 4000 unique proteins were 
identified and quantitated, which agreed with published values. Data analysis protocol for 
forward and reverse SILAC experiments was demonstrated using MacQuant and Perseus, 
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including removal of reverse and contaminant sequences, validated protein identifications (at 
1% FDR), log transformation of data and, finally, merging forward and reverse SILAC 
experiments together. The protocol is robust enough to be easily adapted to study other 
experimental condition, including effects of temperature shift or culture media additives on 
growth and productivity of CHO cells.  
Finally, fold-change cut off and significance B was demonstrated to be the best method for 
determination of differential expression, as both biological and statistical significance were 
considered. Interestingly, one-sample t test was not suitable for analysis of standard SILAC 
data, as it selected proteins with the least variable ratios between forward and reverse 
experiments. 63 differentially expressed proteins were identified between exponential and 
stationary phases for E22 producing cell line and 109 for GS parental cell lines. Functional 
annotation based on GO and KEGG pathway analysis suggested that many of these proteins 
are involved in the most crucial biological processes within a cell, including cell cycle, 
metabolism and transcription regulation or even translation elongation (tRNA 
aminoacylation). It Is believed that some of these proteins are interesting targets for cellular 
and metabolic engineering. 
In chapter 5, dynamic and absolute changes in protein expression of CHO cells were studied 
using enhanced pulse SILAC and TPA method. Firstly, the relationship between the cell volume 
and total cellular protein concertation for mammalian cells was demonstrated. Based on 
these parameters, protein copy numbers of CHO cells were estimated using TPA method. It 
was found that CHO cell lines vary in terms of protein content per cell and change during 
phases of cell growth, so it is important to determine it prior to any proteomic experiment. 
TPA method was found to be reliable at determining protein copy number in CHO cells, based 
on both PARK7 protein abundance and values published for closely related mouse fibroblasts 
using an alternative quantitation method. >5000 unique proteins have been identified and 
quantified. 
Protein turnover, described as a balance between protein degradation and synthesis, can be 
used to investigate steady-state system of mechanisms controlling protein abundance in CHO 
cells during exponential phase of batch culture. Based on enhanced pulse SILAC data, protein 
turnover was determined for >3000 proteins for both GS-KO parental and E22 producing cell 
lines. Thanks to correction of B coefficient based on degree of amino acid recycling, more 
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than 90% of identified proteins were fitted. These numbers are comparable to those 
published for mouse (Schwanhäusser et al. 2011) and human (Boisvert et al. 2012).. 
In addition to host cell proteins, protein turnover and copy number was also determined for 
LC and HC of model mAb. LC and HS were expressed in 2:1 ratio in terms of protein copy 
number, with their protein turnover being equal to 5h and 8h, respectively. However, bottom-
up proteomics approach used here does not indicate on how many complete molecules of 
mAb were assembled and secreted outside the cell. Alternative methods were needed to 
study kinetics of antibody production and secretion, such as by calculating specific 
productivity (qMab): more than 3 million complete monoclonal antibodies were released per 
hour.  
Protein turnover rate, a combination of protein abundance and turnover data, is believed to 
be more accurate way of representation how much degradation and synthetic machinery is 
recruited for a given protein per unit time. Another parameter, total protein mass, was also 
calculated by correcting protein copy number by molecular weight (in Da). Interestingly, “the 
heaviest” protein for E22 producing cell line was chaperone BiP, important for protein folding 
and associated with higher productivity. What is more, there were 600 proteins up-regulated 
in E22 producing cell lines, with the functions in metabolism, cellular processes and ribosome 
biogenesis, as confirmed by KEGG pathway and GO annotation. Some of those up-regulated 
proteins have the potential to be novel engineering targets for CHO cell engineering. 
Based on dynamic use of amino acids, both cell lines were found to require billions of 
individual amino acids molecules per hour, with the highest requirement for leucine, lysine 
and alanine. This data can be used in the development of novel metabolic feeds for CHO cells. 
This can be achieved by performing amino acid flux analysis to evaluate how amino acids are 
transported from chemically-defined medium into CHO cells to support dynamically changing 
protein synthesis. It can be hypothesised that supplementing high demand amino acids can 
increase protein synthesis rate and promote both cell growth and recombinant protein 
expression.  
In addition, codon usage bias can be used to develop novel in silico gene design tools. We 
have estimated our dynamic codon usage bias to be relatively similar to static determined 
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from genomic sequences except for few codons. This bias was true for both GS K-O parental 
and E22 producing cell line, so it was unlikely to be driven by heterologous protein expression. 
In summary, we have generated a large-scale proteomic dataset containing qualitative, 
quantitative and dynamic information about protein expression at molecular level in 
industrially relevant GS-KO cell lines. 
6.2 Future work 
Although data presented in this work proved to be reproducible, the findings could be further 
improved and validated. One possibility is to include secreted host cell proteins into SILAC-
based quantitative studies. Host cell proteins (HCPs) are one of bioprocess impurities that 
must be separated from the product. Their identification can lead to more efficient 
development and improved recombinant product yield (Valente et al. 2014). The integration 
of intracellular and extracellular proteomic data might be challenging to due significant 
overlap of the protein species. Obtained protein turnover values might be also more difficult 
to interpret. What is more, some proteins identified in the spent media might be products of 
degradation rather than fully functional proteins.   
The obvious next step is to map proteomic data to transcriptomic data to estimate mRNA 
stability as well as translational efficiency for individual proteins as demonstrated by 
(Schwanhäusser et al. 2011). By simultaneous measurement of mRNA abundance, gene 
expression and protein synthesis rates can be quantified simultaneously. 
It is also important to validate quantitative proteomic data using alternative methods. Results 
show that measured protein expression can vary 4-10 fold between the replicates even for 
the same tissue (Higdon and Kolker 2015). For example, metabolic flux analysis could be used 
to study changes in certain metabolites level in the culture, for example lactate accumulation 
or glucose consumption (Ahn & Antoniewicz 2012). Global study of metabolites using 
metabolomic approaches is challenging but might be vital for a better understanding of global 
metabolism of CHO cells. 
Another choice for validating the protein expression data is to use transcriptomic methods, 
such as RNA-seq. Recent study has shown the unique fingerprint of genes contributing to 
recombinant antibody glycosylation that is cell-type specific (Könitzer et al. 2015). Although 
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it is known that correlation between protein expression and transcript expression levels is 
about 60% at best (Vogel et al. 2010), it will undoubtedly provide another layer of 
information. In addition, combining proteomic and transcriptomic data will allow the 
estimation of translational efficiency for a given gene or even mRNA stability. This can in turn 
lead to establishment of better in silico gene design and identification of possible bottlenecks 
in heterologous protein production.  
At the interface between proteomics and genomics lies proteogenomics. In proteogenomics, 
peptide search is performed using six-frame translation of genome sequence to identify 
proteins missing from protein databases or with incorrect amino acid sequence. As a result, 
so-called “proteogenomic maps” are generated that can provide new evidence for protein 
translation, validate existing gene annotations and even identify novel genes (Nagaraj et al. 
2015). Since there are still many issued with missing or incomplete annotation of protein 
sequences for CHO cells, this might improve the number of proteins identifications. However, 
the danger of using six-frame translation is the possibility of significantly increasing false 
discovery rate, leading to higher number of false positive identifications. On the other hand, 
the intersection of genomic and proteomic data sets can improve gene annotation, which is 
still a significant problem for CHO cell research. 
Downstream bioinformatics analysis is especially affected by lack of functional and pathway 
annotation. Currently, we must rely on mouse (Mus musculus) annotations to derive any 
meaningful conclusions of ‘omic’ studies. Future developments in bioinformatics resources 
and annotation will undoubtedly facilitate the integration of ‘omic’ data sets to improve 
industrial bioprocesses. In addition, it might be desirable to create custom databases for 
various CHO cell lines to reflect both their mutation patterns, genetic instabilities and 
auxotrophies.  Further bioinformatics analysis might also provide us with information about 
protein redundancies. In this way, biosynthetic resources might be re-directed towards the 
expression of monoclonal antibody, leading to better yields. If better mapping of 
chromosomal locations is to become available, it would be possible to delete whole 
chromosome to reduce genome size.  
In addition to targeted cellular and metabolic engineering, genetic engineering still plays an 
important role. Derived estimations of dynamic codon usage bias for both parental and 
producing cell lines can be used to optimize coding sequences. Commercial tools are already 
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available, such as GenScript (https://www.genscript.com/tools/rare-codon-analysis), which are 
used routinely in many laboratories. Other directions of research might be signal peptide 
examination of the most and least abundant proteins. It is known that signal peptides are 
responsible for targeting proteins for their functions, for example into nucleus, endoplasmic 
reticulum or destined for secretion. By analysing the latter, we could find the correlation 
between the signal peptide sequence and higher protein copy numbers. The correlation 
between using optimized signal peptides and the secretion efficiency has been already 
demonstrated (Kober et al. 2013). 
Presented SILAC-based data highlighted the differences between two closely related cell lines. 
Recent study has also confirmed that diversity between host cell performance is also directly 
affected by the type of recombinant protein expressed, model IgG4 or FC-fusion protein 
(O’Callaghan et al. 2015). This again demonstrates that large diversity exists for CHO cells and 
the need for integration of “omic” data sets of multiple CHO cell lines is crucial. Such 
integrated data sets will help to develop host cell lines with different performance 
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Appendix A: Suppliers of reagents and equipment  
Table A1. The complete list of used chemicals, enzymes and analytical solutions  
Reagent  Supplier/Manufacturer 
2-Mercaptoethanol 
40% Acrylamide/Bis-acrylamide 
Acetone, LC-MS grade 






Bovine serum albumin 
Bradford protein concentration assay 
CD-CHO media 
Coomassie Brilliant Blue G-250 
Dimethyl sulphoxide (DMSO) 
Dithiotreitol 
EDTA 
Ethanol, LC-MS grade  
Formic acid, LC-MS grade 
Glycerol 
Glycine 
Halt Protease Inhibitor Cocktail, EDTA-free, 100x 
HEPES 






Phosphate buffered saline tablet 
Prestained Protein Ladder Broad Range (10-230 kDa) 














































Trypsin porcine proteomics grade 
Urea 















Table A2. The key features of mass spectrometers available for presented research project. 
Feature Amazon ETD MaXis 4G UHR-TOF Q-Exactive HF 
Manufacturer Bruker Daltonics Bruker Daltonics Thermo Scientific 
Mass analyser Linear Ion trap Quadrupole TOF Hybrid Quadrupole- 
Orbitrap High Field  
Resolution 20,000 60,000 240,000 
Accuracy (p.p.m) <50 <2 <1 
Ionisation Method(s) ESI ESI, ESI-nano, APCI, 
APPI 
API 
Fragmentation CID, ETD/PTR CID CID, HCD 
Mass Range (m/z) 50 to 3000 50 to 20,000  50-6000  
MS Acquisition Rate 20Hz 30Hz up to 18Hz 
*ESI; Electrospray ionisation; APCI; atmospheric pressure chemical ionisation, APPI, 
atmospheric pressure photoionisation;  API; atmospheric pressure ionisation; p.p.m; parts 





Table A3. The list of analytical equipment and consumables  
Equipment/consumable Supplier/Manufacturer 
Amazon ETD 
Costar® Spin-X® centrifuge tube filters 
Erlenmeyer 125ml flask, sterile, disposable  
Hypercarb™ HPLC Column 
Hypersep TM  extraction tip 
LoBind 1.5 ml tubes 
MaXis 4G UHR-TOF  
Microcentrifuge 
Mini-Protean PAGE apparatus 
Microcon®-10 centrifugal filters 
Orbital shaker 
PepMap C18 AcclaimTM trap column (0.3 mm I.D. x 5 mm) 




Sonication water bath 
SpeedVac 
Syringe-filter membrane 0.2µm 
Ultimate 3000 (U3000) nano liquid chromatography system 
Ultracentrifuge 
UV Spectrophotometer 






























Appendix B: Differentially expressed proteins for E22 producing cell line classified in the 
main GO classes.  









G3GSZ6 Slc9a9, Nhe9 Sodium/hydrogen exchanger 9  0.8734195 0.038475375 1.612638 0.000237065 
G3HCT1 Kpna2, Rch1 Importin subunit alpha (Importin alpha P1) (Karyopherin subunit 
alpha-2)  
-1.88534 1.05E-08 -2.032876 2.63E-10 
G3HRT6 Slc12a1, Nkcc2 Solute carrier family 12 member 1 -3.11591 3.99E-14 -2.532192 2.95E-10 
G3IKA3 Plin2, Adfp Perilipin-2 (Adipophilin) (Adipose differentiation-related protein) 
(ADRP) 
1.086444 0.004934098 2.183769 2.32E-10 
Transcription regulation 
G3GUB4 Hat1 Histone acetyltransferase type B catalytic subunit (EC 2.3.1.48) -0.9484469 0.002760414 -1.338339 0.000467625 
G3H6D9 Dnmt1, Dnmt, Met1 DNA (cytosine-5)-methyltransferase (EC 2.1.1.37) (Dnmt1) (Met-1) -1.076919 0.000393862 -1.921436 4.54E-07 
G3H9F5 Ikbkap, Elp1, Ikap Elongator complex protein 1 (ELP1) (IkappaB kinase complex-
associated protein) (IKK complex-associated protein) 
-0.687149 0.008522372 -1.057624 0.001056715 
G3H9N7 Elp2, Statip1 Elongator complex protein 2 (ELP2) (STAT3-interacting protein 1) 
(StIP1) 
-3.405558 4.55E-12 -3.103028 2.42E-09 
G3HE67 Creg1, Creg, Unq727 Protein CREG1 1.408766 0.000738941 0.9997404 0.017406274 
G3HRN7 Timeless Protein timeless-like -0.8676996 0.024503874 -1.564037 0.000616579 
G3I5N5 Top2a, Top-2, Top2 DNA topoisomerase 2 (EC 5.99.1.3) -1.332607 4.54E-07 -2.201163 7.67E-12 
G3I6L2 Elp3 
 




G3H8G0 Gpx1 Glutathione peroxidase (GPx-1) (GSHPx-1) (EC 1.11.1.9) -1.345381 1.23E-05 -1.79693 2.37E-08 
G3HF60 Gpx4 Phospholipid hydroperoxide glutathione peroxidase, mitochondrial 
(PHGPx) (EC 1.11.1.12) (Glutathione peroxidase 4) (GPx-4) (GSHPx-4) 
-1.326986 0.000644894 -2.092005 2.05E-07 
G3I2P6 Dnajc9 DnaJ-like subfamily C member 9 -0.9721949 0.014293315 -1.352984 2.71E-05 
Signal transduction 
G3HG79 Iqgap3 Ras GTPase-activating-like protein IQGAP3 (IQ motif-containing 
GTPase-activating protein 3) 
-1.30397 0.007373836 -2.565451 1.01E-06 
Post-translational modifications 
G3HSJ6 Dohh Deoxyhypusine hydroxylase (DOHH) (EC 1.14.99.29)  -1.537089 0.001634231 -1.570074 0.00010295 
Microtubule-based movement 
G3HP44 Kif15, Klp2, Knsl7 Kinesin-like protein KIF15 (Kinesin-like protein 2) (Kinesin-like protein 
7) 
-0.781504 0.012175409 -1.360083 0.000376114 
Metabolic process 
G3H6H1 Nceh1, Aadacl1, Kiaa1363 Neutral cholesterol ester hydrolase 1 (NCEH) (EC 3.1.1.-) 
(Arylacetamide deacetylase-like 1) 
1.049143 0.000587278 0.880604 0.006378838 
G3HWI7 Oplah 5-oxoprolinase (EC 3.5.2.9) (5-oxo-L-prolinase) (5-OPase) 
(Pyroglutamase) 
1.510658 0.000421508 0.9771849 0.019792959 
G3HXN7 Hexb Beta-hexosaminidase (EC 3.2.1.52) 1.313304 0.000101762 0.7778137 0.047132633 
G3ILF1 Gstm5, Fsc2, Gstm3 Glutathione S-transferase (EC 2.5.1.18) -0.7120786 0.00645197 -1.827372 4.99E-11 
G3IMZ0 Vldlr Very low-density lipoprotein receptor (VLDL receptor) 1.092952 0.009190575 1.417309 0.001105401 
DNA replication 
G3H412 Pcna Proliferating cell nuclear antigen (PCNA) (Cyclin) -0.6367952 0.01459347 -0.9895023 0.000315931 
G3I1H0 Mcm3, Mcmd, Mcmd3 DNA helicase (EC 3.6.4.12) -0.7124568 0.015552952 -0.9024209 0.000990307 
G3I2K8 Rrm2 Ribonucleoside-diphosphate reductase subunit M2 (EC 1.17.4.1)  -2.247491 9.32E-09 -3.636335 1.12E-19 
G3I3B7 Rrm1 Ribonucleoside-diphosphate reductase (EC 1.17.4.1) -2.184884 4.27E-11 -3.41657 2.08E-19 
G3I732 Pold1 DNA polymerase delta catalytic subunit (EC 2.7.7.7) (EC 3.1.11.-) -1.264582 9.08E-05 -2.149487 9.31E-08 
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G3I9M7 Pold3 DNA polymerase delta subunit 3 (Polymerase (DNA-directed), delta 3, 
accessory subunit) 
-1.907522 9.74E-05 -2.163466 4.40E-05 
DNA repair 
G3H7M2 Lig1 DNA ligase 1 (EC 6.5.1.1) (DNA ligase I)  -1.36736 0.000441056 -2.689948 2.75E-07 
G3HMA2 Pold2 DNA polymerase delta subunit 2 (DNA polymerase delta subunit p50) -1.089482 0.004943961 -1.806901 6.63E-05 
Development 
G3HDZ2 Ifrd1, Tis7 Interferon-related developmental regulator 1 (TPA-induced sequence 
7) (TIS7 protein) 
2.24732 1.37E-07 2.789462 3.38E-12 
G3IFY1 Tyms Thymidylate synthase (TS) (TSase) (EC 2.1.1.45) -1.247388 0.001325216 -1.910272 5.30E-07 
G3IIK9 Sprr1a Cornifin-A (Small proline-rich protein 1A) (SPR1 A) 1.033793 0.007635611 1.832694 1.02E-07 
Cellular homeostasis 
G3HUI4 Prcp Lysosomal Pro-X carboxypeptidase (EC 3.4.16.2) (Proline 
carboxypeptidase) (Prolylcarboxypeptidase) (PRCP) 
2.415596 5.58E-09 1.202306 0.005001264 
G3IAI6 Hmox1 Heme oxygenase 1 (HO-1) (EC 1.14.14.18) (P32 protein) 1.231187 0.000120339 1.210763 8.16E-05 
G3IEF1 Fth1, Fth Ferritin (EC 1.16.3.1) -4.250577 9.92E-25 -2.440049 1.28E-09 
Cell division 
G3HLU1 Ube2c, Ubch10 Ubiquitin-conjugating enzyme E2 C (EC 2.3.2.23) (E3-independent) E2 
ubiquitin-conjugating enzyme C) (EC 2.3.2.24)  
-3.716585 4.48E-14 -3.609519 2.81E-16 
G3HVL1 Cdk1, Cdc2, Cdc2a Cyclin-dependent kinase 1 (CDK1) (EC 2.7.11.22) (Cell division control 
protein 2) 
-1.078899 0.000384833 -2.098588 6.83E-11 
G3HXF9 Ndc80, Hec1, Kntc2 Kinetochore protein NDC80 (Kinetochore protein Hec1) (Kinetochore-
associated protein 2) 
-1.451346 0.002913086 -2.18954 3.51E-05 
G3I0R8 Anln Actin-binding protein anillin -1.399502 0.00407649 -2.564085 8.93E-09 
G3I1F9 Kif4, Kif4a, Kns4 Chromosome-associated kinesin KIF4 (Chromokinesin) -0.7020222 0.070983788 -1.460847 0.000307336 
G3IAY2 Mcmbp Mini-chromosome maintenance complex-binding protein (MCM-BP) 
(MCM-binding protein) 




G3H8N5 Zwilch Protein zwilch-like (kinetochore-associated) -0.7337951 0.126191375 -1.641315 0.000313434 
G3IFZ0 Mki67 Proliferation marker protein Ki-67 (Antigen KI-67) -1.834082 0.000177661 -2.801366 3.00E-12 
G3H056 Mak16 Protein MAK16 homolog -2.520521 2.84E-07 -2.626976 3.72E-09 
G3HCF9 Chaf1a, Caip150 Chromatin assembly factor 1 subunit A (CAF-I 150 kDa subunit) (CAF-I 
p150) 
-1.2768 0.008673496 -2.505103 1.99E-08 
G3HZP7 Prim2 DNA primase large subunit (EC 2.7.7.-) -0.9516242 0.013831009 -1.420833 0.00045068 
G3IN30 Plk1, Plk Serine/threonine-protein kinase PLK (EC 2.7.11.21) (Polo-like kinase) -1.918279 8.90E-05 -2.799564 8.36E-08 
Cell adhesion 
G3H2I6 Ncam1, Ncam Neural cell adhesion molecule 1 (N-CAM-1) (NCAM-1) (CD antigen 
CD56) 
1.094439 0.001388337 2.130808 7.07E-11 
Catabolic process 
G3I1H5 Lgmn, Prsc1 Legumain (EC 3.4.22.34) (Asparaginyl endopeptidase) (Protease, 
cysteine 1) 
0.5981746 0.064019096 1.578715 1.27E-06 
G3IDE4 Tpp1, Cln2 Tripeptidyl-peptidase 1 (TPP-1) (EC 3.4.14.9) (Lysosomal pepstatin-
insensitive protease) (LPIC) 
0.7446778 0.017929148 1.161556 0.000343966 
Biosynthetic process 
G3GXD7 Fasn Fatty acid synthase (EC 2.3.1.85) -0.9291435 0.000406654 -0.9593992 0.000473721 
G3GXG4 Cyp51a1, Cyp51 Lanosterol 14-alpha demethylase (LDM) (EC 1.14.13.70) (CYPLI) 
(Cytochrome P450 51A1) 
-3.41818 3.13E-18 -2.918176 3.56E-13 
G3H0L7 Fdft1, Erg9 Squalene synthetase (SQS) (EC 2.5.1.21) -1.715486 0.00044879 -2.125684 6.08E-05 
G3H6P9 Sc4mol Methylsterol monooxygenase 1 (EC 1.14.13.72) (C-4 methylsterol 
oxidase) 
-0.9683789 0.012278293 -1.398296 0.000556779 
G3HG36 Glul Glutamine synthetase (GS) (EC 6.3.1.2) -0.9245633 0.000433835 -1.961364 1.09E-09 
G3HLB3 Glul Glutamine synthetase (EC 6.3.1.2) -0.9822491 0.013369191 -1.810443 1.86E-08 
G3HMY0 Hmgcs1, Hmgcs Hydroxymethylglutaryl-CoA synthase (EC 2.3.3.10)  -2.816749 3.12E-26 -3.659468 5.29E-39 
G3HXP6 Hmgcr 3-hydroxy-3-methylglutaryl-coenzyme A reductase (HMG-CoA 
reductase) (EC 1.1.1.34) 
-3.466688 1.89E-12 -2.00389 0.000165944 
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G3IFL1 Ppat,Gpat Amidophosphoribosyltransferase (ATase) (EC 2.4.2.14)  -1.426044 0.00041242 -1.974125 9.64E-07 
Apoptosis 
G3GXZ0 Tgm2 Protein-glutamine gamma-glutamyltransferase 2 (EC 2.3.2.13) 
(Transglutaminase-2) (TGase-2) 
1.213129 0.000151692 0.6957693 0.04172682 
Unknown 





Appendix C: Differentially expressed proteins for GS parental cell line classified in the 
main GO classes.  









G3H935 Yars Tyrosine--tRNA ligase, cytoplasmic (EC 6.1.1.1) (Tyrosyl-tRNA 
synthetase) (TyrRS) [Cleaved into: Tyrosine--tRNA ligase, 
cytoplasmic, N-terminally processed] 
1.457121 0.000180792 1.873397 1.41E-07 
G3HJM2 Gars Glycine--tRNA ligase (EC 3.6.1.17) (EC 6.1.1.14) (Diadenosine 
tetraphosphate synthetase) (AP-4-A synthetase) (Glycyl-tRNA 
synthetase) (GlyRS) 
1.020627 0.016214941 0.9194515 0.001732351 
G3IG23 Aars Alanine--tRNA ligase, cytoplasmic (EC 6.1.1.7) (Alanyl-tRNA 
synthetase) 
1.229957 0.00152039 1.230431 2.90E-05 
G3IIT6 Cars Cysteine--tRNA ligase, cytoplasmic (EC 6.1.1.16) (Cysteinyl-
tRNA synthetase) (CysRS) 
1.454808 0.000643041 1.305895 0.000235314 
Transport 
G3H241 P2rx7, P2x7 P2X purinoceptor 7 (P2X7) (ATP receptor) (P2Z receptor) 
(Purinergic receptor) 
1.688315 0.000546088 2.128535 2.82E-06 
G3HBE1 Abcc3, Cmoat2, Mrp3 Canalicular multispecific organic anion transporter 2 1.817664 0.000219751 1.810663 5.59E-05 
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G3HCT1 Kpna2, Rch1 Importin subunit alpha-1 (Importin alpha P1) (Karyopherin 
subunit alpha-2) (Pendulin) (Pore targeting complex 58 kDa 
subunit) (PTAC58) (RAG cohort protein 1) (SRP1-alpha) 
-2.474813 3.45E-10 -2.823872 1.44E-09 
G3HEY8 Sil1 Nucleotide exchange factor SIL1 1.121877 0.002605244 1.372692 0.000440531 
Transcription regulation 
G3GUB4 Hat1 Histone acetyltransferase type B catalytic subunit (EC 
2.3.1.48) (Histone acetyltransferase 1) 
-1.740529 3.25E-05 -1.763369 0.000177141 
G3H6D9 Dnmt1, Dnmt, Met1 DNA (cytosine-5)-methyltransferase (EC 2.1.1.37) -1.765965 2.46E-05 -1.820363 1.52E-06 
G3H9F5 Ikbkap, Elp1, Ikap Elongator complex protein 1 (ELP1) (IkappaB kinase complex-




G3H9S4 Ivns1abp, Kiaa0850, 
Nd1, Nd1l 
 
Influenza virus NS1A-binding protein homolog (NS1-BP) (NS1-
binding protein homolog) (Kelch family protein Nd1-L) (ND1-
L2) (Nd1-S) 
-1.904656 0.033722845 -1.852598 0.000967954 
G3HCI2 Uhrf1, Np95 E3 ubiquitin-protein ligase UHRF1 (EC 2.3.2.27) (Nuclear 
protein 95) (Nuclear zinc finger protein Np95) (RING-type E3 
ubiquitin transferase UHRF1) (Ubiquitin-like PHD and RING 
finger domain-containing protein 1) (mUhrf1) (Ubiquitin-like-
containing PHD and RING finger domains protein 1) 
-2.25484 0.010558327 -2.416624 0.000859059 
G3HD13 Asf1b Histone chaperone ASF1B (Anti-silencing function protein 1 
homolog B) (mCIA-II) 
-2.592049 0.002934313 -3.192573 7.73E-06 
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G3HDZ2 Ifrd1, Tis7 Interferon-related developmental regulator 1 (Nerve growth 
factor-inducible protein PC4) (TPA-induced sequence 7)  
ntal regulator 1 
2.574949 3.60E-07 2.638007 6.10E-10 
G3HG87 Glmp Glycosylated lysosomal membrane protein (Lysosomal 
protein NCU-G1) 
1.597078 2.35E-05 1.814514 4.32E-06 
G3HID6 Cnbp, Znf9 Cellular nucleic acid-binding protein (CNBP) (Zinc finger 
protein 9) 
-2.067818 1.61E-07 -1.490108 8.47E-05 
G3I1Z7 Drg1, Drg, Nedd-3, 
Nedd3 
Developmentally-regulated GTP-binding protein 1 -0.857312 0.031476203 -1.476071 0.001485548 
G3I2L7 Chchd2 Coiled-coil-helix-coiled-coil-helix domain-containing protein 
2, mitochondrial 
-1.671899 0.000687188 -2.34639 2.80E-07 
G3I5N5 Top2a, Top-2, Top2 DNA topoisomerase 2-alpha (EC 5.99.1.3) (DNA 
topoisomerase II, alpha isozyme) 
-2.166568 3.21E-12 -2.437387 2.52E-16 
G3IJF2 Nufip2, Kiaa1321 Nuclear fragile X mental retardation-interacting protein 2 (82 





Q6E6J6 Cbx5, Hp1a Chromobox protein-like 5 (Heterochromatin protein 1 alpha) -1.4478 0.000605467 -1.164336 0.002174122 
Stress response 
G3H8G0 Gpx1 Glutathione peroxidase 1 (GPx-1) (GSHPx-1) (EC 1.11.1.9) 
(Cellular glutathione peroxidase) (Selenium-dependent 
glutathione peroxidase 1) 
-1.181051 0.00291211 -1.750864 3.78E-06 
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G3HCJ1 Lonp1, Lon, Prss15 Lon protease homolog, mitochondrial (EC 3.4.21.-) (Lon 
protease-like protein) (LONP) (Mitochondrial ATP-dependent 
protease Lon) (Serine protease 15) 
1.002378 0.009430654 1.157367 8.33E-05 
G3HDJ3 Sdc1 Syndecan-1 (SYND1) (CD antigen CD138) -1.399121 0.134291734 -2.499425 0.000551051 
G3HVP7 Nhlrc3 NHL repeat-containing protein 3 1.410287 0.00044257 0.9983851 0.018397299 
G3I2P6 Dnajc9 DnaJ-like subfamily C member 9 -1.412769 0.000830958 -1.506754 0.001410137 
Splicing 
G3H5P9 Aqr, Kiaa0560 Intron-binding protein aquarius -1.158526 0.006693848 -1.681089 0.000355658 
Signal transduction 
G3GX55 Baiap2 Brain-specific angiogenesis inhibitor 1-associated protein 2 -1.363271 0.000578044 -
0.9167059 
0.055897785 
G3HA54 Serpine1, Pai1, Planh1 Plasminogen activator inhibitor 1 (Serine (Or cysteine) 
peptidase inhibitor, clade E, member 1, isoform CRA_b) 
2.24735 7.26E-06 3.566203 2.13E-14 
G3HD57 Sdcbp Syntenin-1 (Scaffold protein Pbp1) (Syndecan-binding protein 
1) 
0.8162311 0.039077121 1.227557 0.000659972 
G3HG79 Iqgap3 Ras GTPase-activating-like protein IQGAP3(IQ motif-
containing GTPase-activating protein 3) 
-2.174426 0.013994142 -3.099396 1.45E-05 
G3HJS0 Sptbn1, Elf, Spnb-2, 
Spnb2, Sptb2 
Spectrin beta chain, non-erythrocytic 1 (Beta-II spectrin) 
(Embryonic liver fodrin) (Fodrin beta chain) 
-
0.8238559 
0.009375249 -1.680954 1.69E-08 
G3HJS1 Sptbn1, Elf, Spnb-2, 
Spnb2, Sptb2 
Spectrin beta chain, non-erythrocytic 1 (Beta-II spectrin) 
(Embryonic liver fodrin) (Fodrin beta chain) 
-
0.8570508 
0.006807948 -1.735176 4.61E-06 
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G3HLW9 Stat3, Aprf Signal transducer and activator of transcription 3 (Acute-
phase response factor) 
-1.716623 4.21E-05 -2.041698 1.34E-05 
G3I9X6 Sptan1, Spna2, 
Spta2 
Spectrin alpha chain, non-erythrocytic 1 -0.780785 0.075924328 -1.634872 0.00051919 
G3I9X8 Sptan1, Spna2, 
Spta2 
Spectrin alpha chain, non-erythrocytic 1 (Alpha-II spectrin) 
(Fodrin alpha chain) 
-
0.7790757 
0.014193992 -1.630965 4.44E-08 
Microtubule-based movement 
G3HP44 Kif15, Klp2, Knsl7 Kinesin-like protein KIF15 (Kinesin-like protein 2) (Kinesin-like 
protein 7) 
-1.47317 0.000479283 -1.424653 0.002575196 
G3I1F9 Kif4, Kif4a, Kns4 Chromosome-associated kinesin KIF4 (Chromokinesin) -1.476619 0.019767303 -1.457016 0.001720829 
Metabolic 
process 
      
G3H3P8 Hexa Beta-hexosaminidase (EC 3.2.1.52) 1.653381 1.22E-05 1.449769 0.000421797 
G3HNG2 Acot2, Mte1 Acyl-coenzyme A thioesterase 2, mitochondrial 1.056722 0.012849899 1.19856 0.000730608 
G3HWI7 Oplah 5-oxoprolinase 1.095182 0.018015126 1.581001 0.000375599 
G3I8P7 Gns N-acetylglucosamine-6-sulfatase (EC 3.1.6.14) (Glucosamine-
6-sulfatase) 
1.423094 0.000154966 0.9308203 0.026523368 
DNA replication 
G3GZQ9 Lct,Lph DNA helicase (EC 3.6.4.12) -1.285354 0.001183008 -1.264717 2.27E-05 
G3H412 Pcna Proliferating cell nuclear antigen (PCNA) (Cyclin) -
0.8539183 
0.007019869 -1.051024 0.000440189 






Rbbp7 Rbap46 Histone-binding protein RBBP7 -
0.8571553 
0.00680098 -1.008057 0.000752499 
G3I1H0 Mcm3, Mcmd, 
Mcmd3 
DNA helicase (EC 3.6.4.12) -1.211765 0.002248967 -1.281787 1.76E-05 
G3I2K8 Rrm2 Ribonucleoside-diphosphate reductase subunit M2 (EC 
1.17.4.1) (Ribonucleotide reductase small chain) 
(Ribonucleotide reductase small subunit) 
-3.628305 2.97E-20 -4.33928 9.57E-21 
G3I3B7 Rrm1 Ribonucleoside-diphosphate reductase large subunit (EC 
1.17.4.1) (Ribonucleoside-diphosphate reductase subunit M1) 
(Ribonucleotide reductase large subunit) 
-4.434964 4.03E-20 -3.948975 2.00E-17 
G3I732 Pold1 DNA polymerase delta catalytic subunit (EC 2.7.7.7) (EC 
3.1.11.-) 
-1.424959 0.000744882 -1.260869 0.007840598 
DNA repair 
G3H3B1 Mta1 Metastasis-associated protein MTA1 (Metastasis-associated 





G3H4J1 Hectd1, Kiaa1131 E3 ubiquitin-protein ligase HECTD1 (EC 2.3.2.26) (HECT 
domain-containing protein 1) (HECT-type E3 ubiquitin 
transferase HECTD1) (Protein open mind) 
-1.150049 0.007130692 -1.61122 0.000627787 
G3IDN7 Fam3c, 
D6wsu176e, Ilei 
Protein FAM3C (Interleukin-like EMT inducer) -
0.8016567 
0.448703735 -3.080914 1.64E-05 
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G3IFY1 Tyms Thymidylate synthase (TS) (TSase) (EC 2.1.1.45) -2.378344 1.63E-09 -2.585203 3.14E-08 
Cellular homeostasis 
G3GSM5 Tfrc Transferrin receptor protein 1 (TR) (TfR) (TfR1) (Trfr) (CD 
antigen CD71) 
1.461633 0.000606619 0.8440177 0.016977339 
G3IAI6 Hmox1 Heme oxygenase 1 (HO-1) (EC 1.14.14.18) (P32 protein) 2.379205 1.25E-09 0.7869202 0.007234406 
Cell proliferation 
G3H7C7 Kiaa1524, Cip2a Protein CIP2A (Cancerous inhibitor of PP2A) (p90 autoantigen 
homolog) 
-1.774725 0.004598699 -1.535506 0.000928791 
G3HF56 Cnn2 Calponin -1.557327 8.26E-05 -0.79452 0.099636287 
Cell division 
G3GU82 Spc25, Spbc25 Kinetochore protein Spc25 -2.496794 5.07E-05 -2.420429 1.14E-07 
G3GUM5 Ncapd2, Capd2, 
Cnap1, Kiaa0159 
Condensin complex subunit 1 (Chromosome condensation-
related SMC-associated protein 1) (Chromosome-associated 
protein D2) (mCAP-D2) (Non-SMC condensin I complex 
subunit D2) (XCAP-D2 homolog) 
-
0.9030906 
0.004290998 -1.118094 0.000183193 
G3GYS0 Kif2c, Knsl6 Kinesin-like protein KIF2C (Mitotic centromere-associated 
kinesin) (MCAK) 
-3.009611 5.68E-10 -2.384962 1.59E-05 
G3H2N7 Clasp2, Kiaa0627 CLIP-associating protein 2 -1.72738 0.000446501 -
0.9149471 
0.05553598 
G3HE13 Cdca8 Borealin -2.588834 0.002972616 -2.361852 0.001143567 
G3HEA6 Tpx2, C20orf1, C20orf2, 
Dil2, Hca519 
Targeting protein for Xklp2 -2.372655 0.00012151 -3.186707 8.05E-06 
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G3HLU1 Ube2c, Ubch10 Ubiquitin-conjugating enzyme E2 C (EC 2.3.2.23) ((E3-
independent) E2 ubiquitin-conjugating enzyme C) (EC 
2.3.2.24) (E2 ubiquitin-conjugating enzyme C) (UbcH10) 
(Ubiquitin carrier protein C) (Ubiquitin-protein ligase C) 
-4.260166 4.65E-07 -5.1587 1.97E-30 
G3HR76 Cul7, Kiaa0076 Cullin-7 -1.089759 0.265141533 -2.27852 3.91E-05 
G3HRN7 Timeless Protein timeless homolog (mTim) -2.558686 3.22E-05 -2.417839 1.19E-05 
G3HVL1 Cdk1, Cdc2, Cdc2a Cyclin-dependent kinase 1 (CDK1) (EC 2.7.11.22) (EC 
2.7.11.23) (Cell division control protein 2 homolog) (Cell 
division protein kinase 1) (p34 protein kinase) 
-1.312402 2.81E-05 -1.567059 1.47E-07 
G3I0R8 Anln Actin-binding protein anillin -4.109869 1.11E-23 -3.332708 1.90E-13 
G3I2J5 Sun2, Unc84b Protein unc-84-like B -
0.8726045 
0.028523413 -1.577731 3.13E-05 
G3IAY2 Mcmbp Mini-chromosome maintenance complex-binding protein 
(MCM-BP) (MCM-binding protein) 
-2.049845 0.000972988 -2.652509 0.000233743 
G3IEL3 Mad2l1, Mad2a Mitotic spindle assembly checkpoint protein MAD2A (Mitotic 
spindle assembly checkpoint protein MAD2A-like protein) 
-1.493662 0.002519652 -1.731574 0.000232728 
Cell cycle 
G3IFZ0 Mki67 Proliferation marker protein Ki-67 (Antigen identified by 
monoclonal antibody Ki-67 homolog) (Antigen KI-67 
homolog) (Antigen Ki67 homolog) 
-2.647739 1.84E-11 -2.657366 1.27E-08 
G3H7B2 Dlgap5, Dlg7, Kiaa0008 Disks large-associated protein 5 -2.254083 0.000269548 -3.401767 5.85E-14 
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G3H9C5 Hells,Lsh,Pasg Lymphocyte-specific helicase (EC 3.6.4.-) (Proliferation-
associated SNF2-like protein) 
-3.370176 8.21E-05 -2.459143 0.000685104 
G3HNI7 Pbk,Topk Lymphokine-activated killer T-cell-originated protein kinase 
(EC 2.7.12.2) (PDZ-binding kinase) (T-LAK cell-originated 
protein kinase) 
-1.835214 1.13E-05 -2.000072 1.32E-05 
G3HV51 Espl1, Esp1, Kiaa0165 Separin (EC 3.4.22.49) (Caspase-like protein ESPL1) (Extra 
spindle poles-like 1 protein) (Separase) 
-1.852719 0.039488552 -2.496156 0.000560945 
G3I0H1 Ercc6l DNA excision repair protein ERCC-6-like -1.611711 0.001081351 -1.014427 0.089241905 
G3I2I1 Mcm4, Cdc21, 
Mcmd4 
DNA replication licensing factor MCM4 (EC 3.6.4.12) (CDC21 
homolog) (P1-CDC21) DNA helicase (EC 3.6.4.12) 
-1.215345 0.000107854 -1.2027 0.001538818 
G3IDR5 Rif1 Telomere-associated protein RIF1 (Rap1-interacting factor 1 
homolog) (mRif1) 
-1.962295 6.24E-05 -1.483364 0.001403613 
Cell adhesion 
G3H8Y5 Col6a1 Collagen alpha-1(VI) chain -1.241884 0.053045188 -1.857702 0.000934881 
G3HLY4 Cntnap1, Caspr, 
Nrxn4 
Contactin-associated protein 1 (Caspr) (Caspr1) (MHDNIV) 
(NCP1) (Neurexin IV) (Neurexin-4) (Paranodin) 
1.678658 9.08E-06 1.289686 0.001537755 
G3HRL6 Cd63 Tetraspanin CD63 antigen (CD antigen CD63) 1.177599 0.005627405 1.452333 4.37E-05 
G3IA26 Hpse,Hpa Heparanase (EC 3.2.1.166) (Endo-glucoronidase) [Cleaved 
into: Heparanase 8 kDa subunit; Heparanase 50 kDa subunit] 
1.59684 2.35E-05 1.283106 0.000982787 
G3ICD3 Mfge8 Lactadherin (MFGM) (Milk fat globule-EGF factor 8) (MFG-E8) 
(SED1) (Sperm surface protein SP47) (MP47) 
2.111632 6.76E-08 3.039903 8.57E-25 
G3IK05 Mfge8, Ags 
 




G3H604 Gla,Ags Alpha-galactosidase A (EC 3.2.1.22) (Alpha-D-galactosidase A) 
(Alpha-D-galactoside galactohydrolase) (Melibiase) 
1.357045 0.0003019 0.6070452 0.083080178 
G3HC47 Gba Glucosylceramidase (EC 3.2.1.45) 1.753262 2.07E-05 1.531573 2.39E-05 
G3HFM0 Abhd6 Monoacylglycerol lipase ABHD6 (EC 3.1.1.23) (2-
arachidonoylglycerol hydrolase) (Abhydrolase domain-
containing protein 6) 
1.196985 0.003129531 1.733843 1.09E-05 
G3HNQ5 Pld3 Phospholipase D3 (PLD 3) (EC 3.1.4.4) (Choline phosphatase 
3) (Phosphatidylcholine-hydrolyzing phospholipase D3) 
(Schwannoma-associated protein 9) (SAM-9) 
1.354509 0.001474005 1.367955 0.000117571 
G3HRK9 Mmp19, Rasi Matrix metalloproteinase-19 (MMP-19) (EC 3.4.24.-) (Matrix 
metalloproteinase RASI) 
1.163112 0.012761942 2.678257 6.06E-09 
G3HX53 Scarb1 Scavenger receptor class B member 1 (SRB1) (SR-BI) 1.411589 0.000925096 1.687939 2.08E-06 
G3I0X5 Ephx1 Epoxide hydrolase 1 (EC 3.3.2.9) (Epoxide hydratase) 
(Microsomal epoxide hydrolase) 
1.059701 0.006129007 0.9211443 0.001698971 
G3I4W7 Ctsd Cathepsin D (EC 3.4.23.5) 1.117097 0.003904889 1.083416 0.000228329 
Biosynthetic process 
G3GR90 Idi1 Isopentenyl-diphosphate Delta-isomerase 1 (EC 5.3.3.2) 
(Isopentenyl pyrophosphate isomerase 1) (IPP isomerase 1) 
(IPPI1) 
-1.090526 0.006033875 -1.682079 1.65E-08 
G3GVU5 Acadm Medium-chain specific acyl-CoA dehydrogenase, 
mitochondrial (MCAD) (EC 1.3.8.7) 
1.231862 0.00099204 0.7898107 0.036722121 
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G3GXG4 Cyp51a1, Cyp51 Lanosterol 14-alpha demethylase (LDM) (EC 1.14.13.70) 
(CYPLI) (Cytochrome P450 51A1) (Cytochrome P450-14DM) 
(Cytochrome P45014DM) (Cytochrome P450LI) (Sterol 14-
alpha demethylase) 
-1.919479 0.00208261 -2.568956 0.000375485 
G3H0L7 Fdft1, Erg9 Squalene synthase (SQS) (SS) (EC 2.5.1.21) (FPP: FPP 
farnesyltransferase) (Farnesyl-diphosphate 
farnesyltransferase) 
-1.206662 0.015551168 -1.847315 6.00E-05 
G3H3F8 Tk1 Thymidine kinase, cytosolic (EC 2.7.1.21) -3.279144 7.74E-08 -3.189698 2.01E-12 
G3H4W0 Dtymk,Tmk Thymidylate kinase (EC 2.7.4.9) (dTMP kinase) -1.512267 0.000331896 -1.650719 0.000456519 




0.317310509 -1.4829 0.001408704 
G3HMY0 Hmgcs1, Hmgcs Hydroxymethylglutaryl-CoA synthase, cytoplasmic (HMG-CoA 
synthase) (EC 2.3.3.10) (3-hydroxy-3-methylglutaryl 
coenzyme A synthase) 
-2.170069 2.96E-12 -2.808612 3.47E-21 
G3HXP6 Hmgcr 3-hydroxy-3-methylglutaryl-coenzyme A reductase -
0.7314937 
0.502412739 -2.613154 0.000292732 
G3I0U4 Gyg1, Gyg Glycogenin-1 (GN-1) (GN1) (EC 2.4.1.186) 1.608667 2.06E-05 1.507255 0.000257355 
G3I3J1 Asns,As Asparagine synthetase [glutamine-hydrolyzing] (Asparagine 
synthetase [glutamine-hydrolyzing]-like isoform 2) (EC 
6.3.5.4) 
2.204391 1.79E-08 2.045431 9.24E-09 








Lamp1 Lysosome-associated membrane glycoprotein 1 (LAMP-1) 
(Lysosome-associated membrane protein 1) (120 kDa 
lysosomal membrane glycoprotein) (CD107 antigen-like 
family member A) (LGP-120) (Lysosomal membrane 
glycoprotein A) (LGP-A) (P2B) (CD antigen CD107a) 
1.784001 4.88E-06 1.383417 2.64E-06 
Unknown 






Appendix D: Matlab scripts for analysis of enhanced 
pulse SILAC data 
__________________________________________________________________________________ 
%%This is the master script controlling the flow of the scripts used for the 
%%data analysis of enhanced pulse SILAC data using LM algorithm fitting 
%%according to the Boisvert et al. 2012 methodology but with slight 
%%modifications 
%% The raw data is first imported here. There are three inputs: 
%PSM - containing protein names and ratios information 
%timepoints - provides matching protein names and timepoints information 
%tcc - the values of the cell cycle 
 
%%Following data import, there are 5 scripts altogether that need to  
%%be executed consecutively 
%1. Data exploration and normalisation 
%2a. Data curation based on the number of peptides 
%2b. Data curation based on the number of timepoints  
%3. Levenberg-Marquardt algorithm fitting 
%3a. post fitting QC 
%4. Calculation of half-lives and turnover 
%5. Drawing the graphs for the fitted proteins 
 
%% Data import   
%Three inputs needed: PSM, timepoints and tcc 
% read PSM data from Excel file (.xlsx) file 
[data,txt,raw] = xlsread('PSM.xlsx') ; 
%extract all ratios - [H/L], [M/L] and [H/M] 
ratiosHML = data(:,[4:6]); 
%extract protein names and raw file names 
raw(1,:) = []; %remove the first row - header 
proteins = raw(:,[2,3]);  
clear data txt raw 
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% read timepoints Excel file 
[data,txt,raw] = xlsread('timepoints_GS.xlsx'); 
% save timepoints as a variable 
times = data(:,3); 
% save the timepoints named 
nameT = raw([2:end],2); 
% tcc, the experimental time of cell cycle, determined from viable cell count 
tcc=35.4400751159673; 
clear data txt raw 
__________________________________________________________________________________ 
%1. Data exploration and normalisation 
%%This script will be used for data clean-up and preparation 
%1. Data exploration - correspondence of H/L, M/L and H/M ratios 
%2. Mapping of each SILAC record (PSM) with time point 
%3. Ratio normalisation of H/L and M/L ratios 
 
%do a check correlation of [H/L]/[M/L] and [H/M] 
%H/L ratios are in the first column; M/L ratios are in the second column 
%H/M ratios are in the third column 
 
%create a variable v which is a ratio of [H/L]/[M/L]  
v = ratiosHML(:,1)./ratiosHML(:,2); 
 
%% plot it as individual points - blue circles (bo) 
plot(v,ratiosHML(:,3), 'ro'); 
xlabel('Ratio [H/L]/Ratio [M/L] '); 
ylabel('Ratio [H/M]'); 
title('Ratio correlation'); 
%use different (smaller) axis to see better 
axis([ 0 100 0 100]) % vector of 4 values to define x and y axis 
 
%% remove the NA values from the dataset - to calculate correlation 
% find the positions of NA values first 
%position of NA values in v 
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pos = find(isnan(v)==1); 
%position of NA values in H/M 
pos1 = find(isnan(ratiosHML(:,3))==1); 
%find positions of NA values in both H/M and v 
posF = unique([pos;pos1]);  
%find the number of elements of v, then transpose 
nn = (1:1:numel(v))'; 
%find the positions that have values for both v and H/M 
posOK = setdiff(nn,posF); 
%calculate Pearson correlation now 
rho = corr(v(posOK), ratiosHML(posOK,3)); 
 
%% find correspondence for each SILAC record with time point 
%first create a matrix of the size of ratioHML with  
%one column filled with zeros 
timeArr = zeros(size(ratiosHML,1),1); 
 
%create a loop that will translate nameT into times(0.5h, 4h, etc.) 
for i = 1:numel(nameT) %from 1 to 30 
    pos=find(strcmp(proteins(:,2),nameT{i})==1); 
    timeArr(pos)=repmat(times(i), numel(pos),1); 
end  
 
%% make normalisation of ratios 
%normalized M/L ratios 
normML = ratiosHML(:,2)./(ratiosHML(:,1) + ratiosHML(:,2)); 
%normalized H/L ratios 
normHL = ratiosHML(:,1)./(ratiosHML(:,1) + ratiosHML(:,2)); 
__________________________________________________________________________________ 
%2a. Data curation based on the number of peptides 
%% This script will be used for the data curation before the fits  
%1. Make a unique list of proteins 
%2. Calculate how many datapoints for each protein 
%3. Optional: Check if things have worked correctly for an example protein 
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%4. Merge uniqueProtein list with the number of datapoints 
%5. Optional: Produce histogram to visualise number of datapoints per 
%protein 
%6. Data curation - set the threshold (n=?)to the number of datapoints per 
%protein - save it 
  
%% make a unique list of proteins and look at numbers of datapoints 
%for each protein 
 
%make a list of unique proteins 
uniqProteins = unique(proteins(:,1)); 
%calculate how many unique proteins 
numel(uniqProteins);  
 
%% calculate how many datapoints for each protein  
%this will calculate how many peptides were overall associated with a given 
%protein at all 6 timepoints 
peptideNum=zeros(size(uniqProteins,1),1); %empty vector to store values 
%now for the looping 
for i=1:numel(uniqProteins); %has 3815 elements - for the loop 
    %calculate the number of data points for each unique Proteins, ndata 
 ndata=numel(find(strcmp(proteins(:,1),uniqProteins{i})==1)); 
    %export the values into the uniqProtArr vector 
 peptideNum(i)=ndata; 
end 
%takes about 120 s 
 
%% OPTIONAL: visualize on histogram how many peptides per protein 
h.BinEdges = [0:100]; %sets the number of bins 
histogram(peptideNum, h.BinEdges); 







%% create uniqProteinsn, protein list with minimum 3 peptides 
%set up our threshold of datapoints as n - adjust as needed 
n=3; 
%then find the indices of entries when values are above n 
fn=find(peptideNum >= n); 
 
%% now find the proteins with minimum 3 peptides 
uniqProteinsn=uniqProteins(fn); 
%extract peptide Num for those proteins 
peptideNumn=peptideNum(fn); 
 
%% remove contaminants and reverse sequences from uniqProteinsn 
posCon=[]; 
for i=1:numel(uniqProteinsn) 
    excluCon=regexp(uniqProteinsn{i},'CON_'); 
    if ~isempty(excluCon) 
      posCon=[posCon,i]; 
    end 
    excluCon=regexp(uniqProteinsn{i},'REV_'); 
    if ~isempty(excluCon) 
      posCon=[posCon,i]; 
    end 




%% This script will be used for the data curation before the fits  
%1. Data curation - keep the proteins that have at least 3 timepoints  
            %(0.5h, 4h, 7h, 11h, 27h and 48h) 
            % 0.5 or 4 timepoint needed for correct amplitude, A 
            % 27 and 48 timepoint needed for correct coefficient, tau_dash 
%2a. Create a quality matrix for the unique proteins which will 
%give us a score of 1 if data present at the timeoint or score 0 if data is 
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%missing at this timepoint 
%2b. Based on the quality matrix, we can sum up the scores to give us the 
%number of timepoints with data present (sumQualityMat) and apply the 
%threshold here 
%3. Use the sumQualityMat to find the position of the proteins with the minimum  
%three timepoints 
%4. Find the position of score=1 to figure out if the data is 
%present for the given timepoint 
 
%% 1. Data curation - keep the proteins that have at least 3 timepoints  
%(0.5h, 4h, 7h, 11h, 27h and 48h) 
%we need to have either 0.5 or 4 
%we need to have both of 27 and 48 
%optional: 7 and 11 
 
%% 2a. Create a quality matrix for the unique proteins which will 
%give us a score of 1 if data present at the timeoint or score 0 if data is 
%missing at this timepoint 
 
qualityMat=zeros(size(uniqProteins,1),6);     %create empty quality matrix 
sumqualityMat=zeros(size(uniqProteins,1),1);  %calculate how many timepoints have data 
for j=1:numel(uniqProteins);                  %for all 3815 records 
    nameP=uniqProteins{j};                    %extract the protein name 
    pos=find(strcmp(proteins(:,1),nameP)==1); %find the indices to extract timepoints and ratios 
    t=timeArr(pos);                           %find the position of timepoints 
     
    if ~isempty(find(t==0.5)')                %this will give 1 if empty or 0 if not empty 
     a=1; %it has data at timepoint 0.5 
 else 
     a=0; %it does not have any data 
    end  
  
 if ~isempty(find(t==4)')                     %this will give 1 if empty or 0 if not empty 




     b=0; %it does not have any data 
 end 
  
 if ~isempty(find(t==7)')                     %this will give 1 if empty or 0 if not empty 
    c=1;  %it has data at timepoint 7 
 else 
     c=0; %it does not have any data 
 end  
  
 if ~isempty(find(t==11)')                    %this will give 1 if empty or 0 if not empty 
    d=1;  %it has data at timepoint 11 
 else 
     d=0; %it does not have any data 
 end 
  
 if ~isempty(find(t==27)')                    %this will give 1 if empty or 0 if not empty      
    e=1;  %it has data at timepoint 27 
 else 
     e=0; %it does not have any data 
 end  
  
  if ~isempty(find(t==48)')                   %this will give 1 if empty or 0 if not empty  
    f=1; %it has data at timepoint 48 
 else 
    f=0; %it does not have any data 
  end  
  
%save the scores into the output   
output=[a,b,c,d,e,f]; 
 










%concatenate the results into quality check, qcheck 
qcheck=[qualityMat,sumqualityMat]; 
%export as the Excel spreadsheet 
xlswrite('qcheck.xlsx',qcheck); 
 
%% 3. Use the sumQualityMat to find the position of the proteins with at least 3 timepoints 
%three timepoints (threshold >=3) 
 
%find the indices of the proteins with at least 3 timepoints 
pos3=find(sumqualityMat>=3); 
%use pos3 to filter the proteins with the minimum of the 3 timepoints 
uniqProteins3=uniqProteins(pos3);  
 
%% 6. Find the position of score=1 to figure out if the data is 
%present for the given timepoint 
 
%from the qualityMat, we can find the position of the data present at given 
%timepoint  
%qualityMat has 6 columns corresponding to the timepoint (0.5,4,7,11,27,48) 
 
 
pos05h=find(qualityMat(:,1));           %find indices of data present at timepoint 0.5 
pos4h=find(qualityMat(:,2));            %find indices of data present at timepoint 4 
 
pos05or4=union(pos4h,pos05h);           %find the indices of data present at either 0.5 or 4 timepoint 
 
pos27h=find(qualityMat(:,5));           %find indices of data present at timepoint 27 




pos27and48=intersect(pos27h,pos48h);    %find the indices of data present at both 27 and 48 
timepoint 
%pos27or48=union(pos27h,pos48h);      %v2: find the indices of data present at either 27 or 48 
timepoint  
 
posCor=intersect(pos05or4,pos27and48);%find the indices of data present at either 0.5 or 4 & 27 
and 48 timepoint 
 
%now use poCor to filter out the proteins having the correct combination of 
%datapoints and save to uniqProteinsCor 
 
%uniqProteinsCor has the best 3 combinations of timepoints 
uniqProteinsCor=uniqProteins(posCor); 
 
%these are the corresponding peptide numbers 
peptideNum3=peptideNum(posCor); 
 
%here are peptide numbers for best 3 timepoints data 
peptideNumCor=peptideNum(posCor); 




%% remove contaminants and reverse sequences from uniqProteinsCor 
posCon=[]; 
for i=1:numel(uniqProteinsCor) 
    excluCon=regexp(uniqProteinsCor{i},'CON_'); 
    if ~isempty(excluCon) 
      posCon=[posCon,i]; 
    end 
    excluCon=regexp(uniqProteinsCor{i},'REV_'); 
    if ~isempty(excluCon) 
      posCon=[posCon,i]; 
    end 
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end 
uniqProteinsCor(posCon)=[];    
 
%% remove contaminants and reverse sequences from uniqProteins3 
posCon=[]; 
for i=1:numel(uniqProteins3) 
    excluCon=regexp(uniqProteins3{i},'CON_'); 
    if ~isempty(excluCon) 
      posCon=[posCon,i]; 
    end 
    excluCon=regexp(uniqProteins3{i},'REV_'); 
    if ~isempty(excluCon) 
      posCon=[posCon,i]; 
    end 
     
end 
uniqProteins3(posCon)=[];    
__________________________________________________________________________________ 
%% This script will be used for fitting the proteins to LM algorithm 
%1. First define the matrices for storing the parameters of LM algorithm 
%2. Choose the curProteinLists, the proteins with defined thresholds  
%in script 2 
%3. Loop over the list of curated datapoints, remove Nan values 
%4. Call the curve-fitting function from fitCurve.m script (has to be in 
%the same folder!) 
%5. Store the parameters found from the LM algorithm in the arrays 
%separately, then concatenate everything together 
%6. Concatenate the fits together wtih curProteinList names 
%7. Export the dataset as table (then open as xlsx file)? 
 
%% loop over all proteins to find exponential fit and extract values 
tic 





%choose which proteins used for fitting: curProteinListCor(3 specific 









for j=1:numel(curProteinList); %for all records 
    nameP=curProteinList{j};   %extract the protein name 
    pos=find(strcmp(proteins(:,1),nameP)==1); %find the indices to extract timepoints and ratios 
    t=timeArr(pos); %find the position of timepoints 
    y=normML(pos);  %find the position of ratios 
    posNan=find(isnan(y)==1); %find indices of NaN values 
    if ~isempty(posNan) %if posNan is not empty 
        %exclude nan values 
        t(posNan)=[]; %remove any Nan from timepoints 
        y(posNan)=[]; %remove any Nan from ratios 
    end 
    %now call curve-fitting function (from function fitCurve) 
    %choose a version here: v0, v1, v3 and v3 - use replace function 
    %or chose fixedAB function  - v1, v2, v3 
   [alpha,resNorm,diagn,success, iternum] = fitCurvefixedAB(t,y); 
    %[alphav1,resNormv1,diagv1,successv1, iternumv1] = fitCurvefixedABnew(t,y); 
    %[alphav3,resNormv3,diagv3,successv3, iternumv3] = fitCurvefixedABv3(t,y); 
    %store the diagonal (5 columns) and success (1 column) for each fitted 
    %protein 
    %diagArr(j,:)=diag(1,:); %store resNorm, A,B,tau_dash and exitflag 
    %choose a version here: v0, v1, v2 and v3 
    successArr(j)=success;  %store success rate 
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    resArr(j)=resNorm;      %store residual Norm 
    %flagArr(j)=diag(1,5);   %store exitflag 
    flagArr(j)=diagn(1,3);      
    %alphArr(j,:)=alpha;     %store alpha (A,B and tau_dash) 
    alphArr(j,3)=alpha;     %store alpha (A,B and tau_dash) 
    iternumArr(j)=iternum; 
        
end 
toc 
%% concatenate all together 
 




















%% This script will be used for the quality check of the LM fitted proteins 
%all proteins have converged to the minimum, however we are looking at the 







%1. Import the LM fitted parameters  
%2. Using the following criteria, exclude the rows with unsuitable values 
 
%% use parameterArr data to filter out suitable parameters 
% let's extract the positions of all entries (posAll here) 
posAll=find(parameterArr(:,1) > 0); %resNorm always positive! 
 
%% set the criteria here for extracting only suitable set of values 
%for the fixed AB, we only need to filter tau_dash 
 
%find all tau_dash 
tau_dash=alphArr(:,3);            % extract tau_dash values    
postau_dash=find(tau_dash < 70);  % find the position of tau_dash below 70 
postau_dash0=find( tau_dash > 0); % find the position of tau_dash above 0 
postau_dashGood = intersect(postau_dash,postau_dash0); % find the position of 0 < tau_dash < 70 
 
%% to test: can I just use posGoodABtau_dash on parameterArr?  
parameterArrGood=parameterArr(postau_dashGood,:); 
 




%% now filter out the corresponding protein names  
uniqProteinsCorGood=uniqProteinsCor(postau_dashGood); 
uniqProteinsCorBad=uniqProteinsCor(posBad); 






%% write curDataGood and curDataBad to a separate excel file for futher analysis 
 
%set up your header 
header={'UniprotID','resNorm','A','B','tau_dash',... 
    'exitflag', 'success','iternum'}; 
 
%set up filename 
filename='curDataGoodbest3timepointsABopt3.xlsx'; 





%write to Excel spreadsheet 
xlswrite(filename,[header;curDataBad]); 
__________________________________________________________________________________ 
%% This script will be used for the calculation of half-lives and turnovers 
%1. Import the dataset with coefficients - from script 3 
%2. Extract alphaGood containing A, B and tau_dash 
%3. Enter tcc, the experimental time of the cell cycle 
%4. Define empty matrices for storing thalf and turnovers 
%5. Calculate tau and store it in the array  
%6. Concatenate the values of tau, thalf and turnover  
%7. Write the data to the table, export 
%8. Concatenate with the fulldata to get a complete dataset for all 
%downstream analysis 
 
%% calculate half-life and turnover the coefficients A, B, tau_dash  
%LM algorithm fitting script 
 
%alpha has 3 columns: 
%we will need the value of tau_dash (3rd value), 






%assign zero matrices to store the values  
thalfArr=zeros(size(alphaGood(:,1)));    %calculate half-lives from tau_dash 




    tau_dash=alphaGood(k,3); %extract tau_dash first 
     
    %check if tau_dash is not larger than tcc/log2 - refer to the paper 
    if tau_dash<tcc/log(2) 
        tau=1/(1/tau_dash-log(2)/tcc); 
    else 
        tau=Inf;           % tau is intrinsic e-folding (decay) factor 
    end 
    % (A - B)/2*A > 0 
    if (alphaGood(k,1)-alphaGood(k,2))/(2*alphaGood(k,1)) > 0 
        % 
         
         thalf=-tau_dash*log((alphaGood(k,1) - alphaGood(k,2))/(2*alphaGood(k,1))); 
      thalfTau=-tau     *log((alphaGood(k,1) - alphaGood(k,2))/(2*alphaGood(k,1))); 
    else 
         thalf=NaN; 
         thalfTau=NaN; 
    end 
     
    if (0.5-alphaGood(k,2))/alphaGood(k,1) > 0  
        turnover=-tau_dash*log((0.5-alphaGood(k,2))/alphaGood(k,1)); 
        turnover=turnover; 
    else 
        turnover=NaN; 
    end 
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    % store estimated values in array 
     %thalfArr(k)=real(thalf); %extract real part of the complex number  
     thalfArr(k)=thalf; 
     thalfTauArr(k)=thalfTau; 
     turnoverArr(k)=turnover; 
     tauArr(k)=tau; 
      
end 
  








%% export the data for further analysis 
%set up your header 
header={'UniprotID','resNorm','A','B','tau_dash',... 
    'exitflag', 'success','iternum', 'tau','thalfTau','thalf','turnover'}; 
 
%set up the filename 
filename='thlaf and turnover Good v1 rep1.xlsx';  
%write to Excel spreadsheet 
xlswrite(filename,[header;completeDataGood]); 
function [alpha,resNorm,diag,success, iternum] = fitCurvefixedBonly(t,y) 
%fitCurve will fit curve f(t)=A exp(-t/tau_dash)+B to M/L ratio versus time data 
%    
%  parameters which we are seaching for is defined as alpha=[A, B, tau_dash] 
 
% INPUT: t - experimental timepoints (vector) 
%        y  - expermental values of normalised M/L ratios (vector) 
% OUTPUT: alpha - fitted parameters (row-vector), alpha=[A, B, tau_dash] 
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%         resNorm - resulting residual norm 
%         diag - array containing residual norms, parameters found and exitflags 
%                (5 columns) for all good outcomes (converged) or for all if convergence 
%                did not happen. 
%         success - = 2 if converged, =1 if found something but did not 
%                   converge well, 0 - no minimum was found, not 
%                   convergence at all 
 
%% define function for curve, which we are trying to fit 
%funH=@(alpha,t) alpha(1)*exp(-t/alpha(3))+alpha(2);    
B=0; 
funH=@(alpha,t) alpha(1)*exp(-t/alpha(3))+B;  
 
%% set up intial conditions 
%test conditions (after Boisvert et al. 2012) v0 - blue 
%fixed B here to 0.2 
lb=[0.05,B,0.05];    % lower bound 
ub=[20,B,50];        % upper bound 
 
%% generate random initial conditions  
 
rng(1,'twister');% fix the seed to get repeatability if required 
%rng('shuffle','twister'); %do not fix the seed 
Nsamp=100;           % number of initial conditions 
parRand=zeros(Nsamp,3); 





%% set parameters for curve fitting algorithms 
% NOTE: levenberg-marquardt method does not allow boundary conditions 
%       trust-region-reflective method is OK for boundary conditions, but 
%       does not work with underdetermined problems, that is fewer 
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%       equations than parameters we are trying to determine (the case 
%       here) 
 
options = optimoptions('lsqcurvefit','Display','off','Algorithm','levenberg-marquardt'); 
          %  this is for levenberg-marquardt method 
options1 = optimoptions('lsqcurvefit','Display','off',... 
    'Algorithm','trust-region-reflective'); 
          %  this is for trust-region-reflective method 
 
%% call the curve fitting algorithm many times with different starting points 
% algorithm is called Nsamp times 






    alpha0 = parRand(j,:);   % initial value to start optimisation 
  
 % select below which method to use and perform curve fit  
 %   [alpha,resnorm,~,exitflag,output]= lsqcurvefit(funH,alpha0,t,y,lb,ub,options1); 
                    % this is trust-region-reflective 
   [alpha,resnorm,residual,exitflag,output]= lsqcurvefit(funH,alpha0,t,y,[],[],options);  
                    % this is levenberg-marquardt                     
                  
     
    %store found parameters 
    alphaArray(j,:)=alpha;    % record found parameters  
    resnormArr(j)=resnorm;    % record residual norm - shows how good is the fit  
    flagArr(j)=exitflag;      % exit flag, the best is 1; 2,3,4 are acceptable; <=0 not good 
     
end 
 




posGood=find(flagArr==1);    % this is the best result, when the congergence to minimum was 
achieved 
success=2; 
if isempty(posGood)          % if there is not good result, take second best, exitflag>0 
   posGood=find(flagArr>0); 
   success=1; 
end 
 
if isempty(posGood)          % if there is no good results at all 
   alpha=alphaArray(1,:);    % take the first found parameter values 
   resNorm=resnormArr(1);    % and corresponding norm 
   diag=[resnormArr,alphaArray,flagArr];  % store all values of norm and parameters and flag 
   %calculate the iteration number 
   iter=numel(diag(:,1)); 
   iternum=iter; 
   success=0; 
else 
   [resNorm,nn]=min(resnormArr(posGood));   % find there the minimum of residual norm is 
   alpha=alphaArray(posGood(nn),:);    % take corresponding parameter to that minimum value 
   diag=[resnormArr(posGood),alphaArray(posGood,:),flagArr(posGood)];   
                    % store values of norm and parameters and flag for good outcomes 
   %calculate the iteration number 
   iter=numel(diag(:,1)); 




%% this script will be used to plot the data  
%1. Read data from csv or Excel file 
%2. Read timepoints from timepoints file 
%3. Find the corresponding times, t and ratios, y 
%4. Call the funH function (which is a part of fitCurve.m function) 
%5. Draw figure(1) M/L ratios over time before normalization 
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%6. Draw figure(2) M/L ratios normalised 
%6. Draw figure(3) with normalized M/L ratios and fitted curve 
%7. Draw figure(4) with both M/L and H/L fitted curves 
 
%% now write a loop that will produce several consecutive figures... 
 
for n=1 
    nameP=uniqProteinsGood(n); 
    pos=find(strcmp(proteins(:,1),nameP)==1); 
    t=timeArr(pos); 
    y=normML(pos); 
    posNan=find(isnan(y)==1); 
    if ~isempty(posNan) 
     % exclude nan values 
      t(posNan)=[]; 
      y(posNan)=[]; 
    end 
     
    % now find corresponsing alpha values from alphArr 
    alpha1=alphaGood (n,:);  %control 
    
      % now name the funH function 
       funH=@(alpha,t) alpha(1)*exp(-t/alpha(3))+alpha(2); 
     % draw the values and the fit 
     figure(n) 
     times = linspace(0,50); 
     plot(t,y,'go',times,funH(alpha1,times),'b') % blue line 
     legend('Data','Fitted exponential') 
     title(nameP) 
     xlabel('Time (h)'); 
     ylabel('Ratio'); 
     axis([0 50 0 1]); 
     legend('Data','Fitted line') 





%%  write the loop to draw fitted M/L and H/L ratios 
 
%plot the fitted and H/L, get turnover 
for n=1:10 
    nameP=uniqProteins3(n); 
    pos=find(strcmp(proteins(:,1),nameP)==1); 
    t=timeArr(pos); 
    y=normML(pos); 
    alphav1=alphArrv1(n,:); 
    alphav2=alphArrv2(n,:); 
    % now name the funH function 
       funH=@(alpha,t) alpha(1)*exp(-t/alpha(3))+alpha(2); 
    % draw the values and the fit 
     figure(n) 
     times = linspace(0,50); 
     plot(times,funH(alphav1,times),'b', times,1-funH(alphav1,times),'r') 
     legend('M/L ratio', 'H/L ratio') 
     title(nameP) 
     xlabel('Time (h)'); 
     ylabel('M/L and H/L ratios normalised'); 
     axis([ 0 50 0 1]) 












Appendix E: Matlab scripts for calculating amino acid and 
codon usage 
__________________________________________________________________________________ 
%% This script will be used to calculate amino acid frequency for a given set of  
%proteins 
 
%The inputs here will be:  
%fasta file containing the sequences of proteins 
%protein list to scan which protein sequences to extract 
%header containing amino acid list 
 
%the output will be a list of proteins with amino acid frequencies 
 
%% import the fasta file here: 
% this is simplified fasta (header = Uniprot ID); regex 
[UniprotID, ProtSequence] = fastaread('CHOuniprot10029_pRY54 processed.fasta'); 
S=fastaread('CHOuniprot10029_pRY54 processed.fasta'); 




















clear data raw 
 
% import the header with amino acids 
[data,~,raw]=xlsread('aminoacids.xlsx'); 
aminoacids=raw(1,:); %extract amino acids - these will be used as a header 
clear data raw 
 
%% now call AminoAcidCount function 
%[proteinlistFasta,AminoAcidArr,AminoAcidSum,AminoAcidTotal, TotalNumberAA] = 
AminoAcidCount(aminoacids, proteinlist,ProtSequence,UniprotID); 
[AminoAcidArr,AminoAcidSum,AminoAcidTotal, TotalNumberAA] = AminoAcidCount(aminoacids, 
proteinlist,ProtSequence,UniprotID); 
%% calculate the rate of amino acid usage 







%% calculate the sum of each column 
aaRateTotal=zeros(size(aminoacids,2),1); 
%from aminoacidArr, now we need to get the sum for each column 




for i=1:20 %because it is 20 aminoacids..... 
    aaRateSum=sum(RateaaArr(:,i)); 





%let's just sum up the whole thing now... 
TotalRateaa=sum(aaRateTotal); %  3.1010e+10 close to the expected 
__________________________________________________________________________________ 
function [AminoAcidArr,AminoAcidSum,AminoAcidTotal, TotalNumberAA] = 
AminoAcidCount(aminoacids, proteinlist,ProtSequence,UniprotID); 
%% amimoAcidCount will count the number of individual amino acids for a given list 
% and derives the ProtSequence from the fasta file 
 
%INPUT:  
%aminoacids - the list of 20 amino acids in this order 
%A,    R,    N,    D,    C,    Q,    E,    G,    H,    I,    L,    K,    M,    F,    P,    S,    T,    W,    Y,    V} 
 
%proteinlist - the list of proteins we want to get the ProtSequence for 
 




%AminoAcidArr - this array contains the number of individual amino acids 
%calculated for the proteinlist 
 
%AminoAcidSum - contains the sum of amino acids for this ProtSequence = 
%ProtSequence length(quality control) 
 




%% first calculate the number of individual amino acids for given ProtSequences 
%% let's find now the way to match the proteinlist with UniprotID; 
%  we need to find the indices in the UniprotID so we can extract the ProtSequences 




% let's set up an empty array for collecting the indices 
posProt=zeros(size(proteinlist,1),1); 
 
for i = 1:numel(proteinlist) 
    pos=find(strcmp(UniprotID,proteinlist(i))==1); 
    posProt(i)=pos; 
end 
     
% now use posProt to extract the ProtSequences for our list of proteins: 
seqArr=ProtSequence(posProt); 
 
%write to the fasta file for downstream processing with Blast2GO 
%proteinlistFasta=fastawrite('proteinlistGSko.fasta', proteinlist,seqArr); 
 
%% first set up an empty array to collect the values 




    seq=seqArr{j}; 
    AA=aacount(seq); 
    testAA=struct2cell(AA);        % turn into the cell 
    transposeAA=transpose(testAA); % transpose data from column formato into rows 
    matAA=cell2mat(transposeAA);   % data is now in numeric format 
    AminoAcidArr(j,:)=matAA; 
      
end 
%it's working!!!!!!!!! 
%% let's calulate how many amino acids in a protein = ProtSequence length!!! 
AminoAcidSum=zeros(size(AminoAcidArr,1),1); 
for i=1:size(AminoAcidArr,1); 
    aasum=sum(AminoAcidArr(i,:)); 





%% calculate the total number of individual amino acids for a proteinlist 
AminoAcidTotal=zeros(size(aminoacids,2),1); 
for i=1:20 %because it is 20 aminoacids..... 
    aasum=sum(AminoAcidArr(:,i)); 
    AminoAcidTotal(i)=aasum; 
    %AminoAcidTotal=AminoAcidTotal'; 
end  
 





%% This script will be used to calculate codon bias from a given protein/transcript list 
 
%The inputs here will be:  
%fasta file containing the nucleotide sequence from RNA seq data 
%protein list to scan which mRNA sequences to extract 
%header containing codon list 
 
%the output will be a list of proteins with codon frequencies  
%% import the fasta file here: 
% this is simplified fasta (header = Uniprot ID); regex 
[emblID, CodonSequence] = fastaread('CHO_EMBL_custom + Mab.fasta'); 
%transpose the sequences so they are in row format 





%%  import the protein list 





















clear data raw 
%%  
% import the header with codons 
[data,~,raw]=xlsread('codonlist.xlsx'); 
codons=raw(1,:)'; %extract codons - these will be used as a header 
clear data raw 
 
% import the header with anticodons 
[data,~,raw]=xlsread('anticodonlist.xlsx'); 
anticodons=raw(1,:)'; %extract anticodons - these will be used as a header 
clear data raw 
 
%% %% now call CodonCount function 
[CodonArr,CodonSum,CodonTotal, TotalCodonSum, TotalSenseCodon] = CodonCount(codons, 
accessionlist,proteinlist,CodonSequence,emblID); 
%% quality check: is the number of sense codons matching to the number of amino acids? 
275 
 




    isq=isequal(AminoAcidSum(i), CodonSum1(i)); 
    mismatchArr(i)=isq; 
    end 
 






%% calculate the rate of codon usage usage 







%% calculate the sum of each column 
CodonRateTotal=zeros(size(codons,1),1); 
%from aminoacidArr, now we need to get the sum for each column 




for i=1:64 %because it is 64 codons..... 
    CodonRateSum=sum(RateCodonArr(:,i)); 





%let's just sum up the whole thing now... 
TotalRateCodon=sum(CodonRateTotal);  
__________________________________________________________________________________ 
function [CodonArr,CodonSum,CodonTotal, TotalCodonSum, TotalSenseCodon] = 
CodonCount(codons, accessionlist,proteinlist,CodonSequence,emblID); 
%% CodonCount will count the number of individual codons for a given list 
% and derives the CodonSequence from the fasta file 
 
%INPUT:  






%codonlist - the list of proteins/mRNA we want to get the CodonSequence for 
 
%CodonSequence - the protein CodonSequence as loaded from fasta file using fastaread 
%function 
%emblID - the accession name from fasta 
 
%OUTPUT:  
%CodonArr - this array contains the number of individual codons 
%calculated for the accessionlist 
 
%CodonSum - contains the sum of amino acids for this CodonSequence = 
%CodonSequence length(quality control) 
 
%AminoAcidTotal - total sum of the amino acids for this proteinlist 
 
%TotalCodon - total sum of all codons for all CodonSequences 
 
%disclaimer: the script does not count properly the cases when the exact 
%nucleotide is unknown (just states 'n') - the number is 1 off for those 
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%cases (below 1% anyway)- for the last codon before the series of 'n's 
%there are only two nucleotides - due to wobbling, you can still tell what 
%it is 
 
%% find indices of the accessionlist to CodonSequence 
posAcc=zeros(size(accessionlist,1),1); %length of the accession list 
 
for i = 1:numel(accessionlist) 
    pos=find(strcmp(emblID,accessionlist(i))==1); 
    if isempty(pos) ==1 %if missing in fasta file, then index is 0 
     pos=0; 
    end 
   if numel(pos) >= 2 % is more than 2 records, take the first value 
        posAcc(i)=pos(1); 
   else 
       posAcc(i)=pos; 
   end 
     
end 
 












    seq=accesslist{j}; 
    cds=codoncount(seq); 
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    testcds=struct2cell(cds);        % turn into the cell 
    transcds=transpose(testcds); % transpose data from column formato into rows 
    matcds=cell2mat(transcds);   % data is now in numeric format 
    CodonArr(j,:)=matcds; 
      
end 
 
%% let's calulate how many codons in a protein = CodonSequence length!!! 
CodonSum=zeros(size(CodonArr,1),1); 
for i=1:size(CodonArr,1); 
    cdsum=sum(CodonArr(i,:)); 
    CodonSum(i)=cdsum;     
end 
 
%% total number of individual codons for a given list 
CodonTotal=zeros(size(codons,2),1); 
for i=1:64 %because it is 64 aminoacids..... 
    codonsum=sum(CodonArr(:,i)); 
    CodonTotal(i)=codonsum; 
end  
 
%let's just sum up the whole thing now... 
TotalCodonSum=sum(CodonTotal); 
 
%% exclude stop codons 
%assumption: each sequence has 1 stop codon 
% so we can just deduct the number of proteins from the total codon sum 
TotalSenseCodon = TotalCodonSum - size(proteinlist,1); 
%TGA = CodonTotal(50); 
%TAA = CodonTotal(52); 
%TAG = CodonTotal(20); 
 
%TotalStopCodon = TGA + TAA + TAG; % high number - suggests a high number 
%of stop codons within sequences 
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%possible explanation: TGA (stop codon) codes for tryptophan in the 
%mitochondria 
 


























Appendix F: attached CD with presented proteomic data 
Appendix G: Amino acid analysis of CD-CHO media  









































*The analysis of CD-CHO media (Life Technologies, Paisley, UK) was performed by Abingdon Health 
(https://www.abingdonhealth.com/). The data was done in triplicates and presented as mean±SEM. 
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